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Abstract 
The aim of this thesis was to develop and evaluate an internet-based cognitive 
behavioural therapy (CBT) program for men treated for localised prostate cancer. 
The internet-based program, My Road Ahead, was developed to address the unmet 
psychosocial needs of men treated for prostate cancer. These needs include enhanced 
support to manage psychological distress, sexual difficulties, and relationship 
difficulties. In addition the program addressed urinary dysfunction, uncertainty about 
the future and communication with friends and health professionals. Partner 
involvement was also an important aspect of this program. My Road Ahead consisted 
of six modules covering the above areas and an asynchronous forum which was 
moderated with weekly topics posted to promote discussion. My Road Ahead was a 
self-directed intervention and several functions were used to enhance engagement, 
including a highly interactive interface (e.g., videos and online exercises), weekly 
email reminders and encouragement to continue moving through the program, offline 
exercises, a mood monitor, and open access to modules. Fifty-seven men who had 
been treated for prostate cancer were randomised into one of three treatment groups: 
Modules only, Modules-plus-Forum, and Forum-only. It was predicted that that those 
in the Modules-plus-Forum group (and to a lesser extent those in the Modules only 
group) of My Road Ahead would demonstrate greater improvement across sexual, 
psychological, and relationship functioning measures from pre-test to post-test than 
those only accessing the forum. After attrition, a total of 41 men participated in the 
evaluation of the efficacy of My Road Ahead. Findings failed to reveal any 
significant effects for the different groups across sexual, psychological and 
relationship functioning measures. There were trends towards significance in some of 
the sexual and relationship variables. The small sample size may have led to a lack of 
significant findings. Participants also provided feedback on the usability and 
xvi 
 
feasibility of My Road Ahead.  Limitations of this research are discussed both in 
terms of the content of the internet-based program and the research methodology. 
Strategies to improve My Road Ahead and the direction for general internet-based 
interventions for men with prostate cancer in the future are discussed. 
 
1 
 
Chapter 1: Introduction and Overview of Thesis 
This chapter provides an overview of prostate cancer, including 
epidemiological data with regards to prevalence and survival, information on the 
most common treatment options and an overview of the psychosocial impact of 
prostate cancer and its treatment. It concludes with a summary of the aims and 
outline of this thesis. 
Prostate Cancer and Epidemiology 
Prostate cancer is a form of cancer located in the prostate. Cancer results when 
a lump of cells form to make a tumour as a result of abnormal and uncontrolled cell 
division (Robbins, 2010). The prostate gland is located below the bladder and 
surrounding the urethra and is responsible for producing part of the fluid that makes 
semen (Cousins, 2010a). The malignant growth or tumour may be confined to the 
prostate (localised prostate cancer) or the cancer may metastasise beyond the prostate 
becoming more serious as it enters the lymph nodes or the blood stream (Robbins, 
2010). 
 Cancer of the prostate is the second most common serious cancer diagnosed 
(after breast cancer), with 889,102 cases diagnosed worldwide in 2008 (Ferlay et al., 
2010). It is the second most common cancer in Australia, after non-melanoma skin 
cancer, and the most common form of cancer in Australian males, making up 32% of 
all male cancer diagnoses in 2007 (Australian Institute of Health and Welfare & 
Australasian Association of Cancer Registries, 2010). In Australia, 19,403 new cases 
were reported in 2007 (AIHW & AACR, 2010). Prostate cancer was expected to 
continue to be the most common cancer diagnosed in men in Australia in 2012 
(AIHW & AACR, 2012). Prostate cancer is largely diagnosed in older men, where 
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AIHW 2007 statistics found that the risk of a prostate cancer diagnosis increased 
from one in seven before 75 years of age to one in four before the age of 85 (AIHW 
& AACR, 2010).  
 Survival rates for prostate cancer are generally high. Worldwide survival 
rates are around 71% (Ferlay et al., 2010). In Australia, the five year survival rate for 
those diagnosed between 1998 and 2004 was 85% (AIHW & AACR, 2010). Early 
detection and treatment methods are likely to contribute to high survival rates (Ferlay 
et al., 2010; National Health and Medical Research Council and Australian Cancer 
Network, 2002). Prostate-specific antigen (PSA) levels are considered the most 
sensitive marker for prostate cancer, and PSA levels are frequently used to aid 
diagnosis, contributing to treatment choice and providing prognosis information 
(Kunkel, Bakker, Myers, Oyesanmi, & Gomella, 2000). Screening techniques using 
PSA levels have allowed detection of the disease at an earlier and less aggressive 
stage (NHMRC & ACN, 2002). Consequently, in around 91% of men diagnosed 
with prostate cancer, the cancer is localised in the prostate (Yan, Carvalhal, Catalona, 
& Young, 2000).   
Treatment for Prostate Cancer 
Improved detection methods and subsequent increases in the number of 
patients diagnosed with localised prostate cancer, has led to an examination of the 
various treatment methods available (Yan et al., 2000). As such, there are many 
guidelines written across the world regarding the optimal treatment options for 
prostate cancer, both for consumers and urologists, for example, from the European 
Association of Urology (Heidenreich et al., 2012) and the American Urological 
Association (2008). Once a diagnosis is confirmed, treatment decisions can be 
difficult, largely due to the controversy and unclear consensus of the optimal 
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treatment and management of prostate cancer. Cooperberg, Broering and Carroll 
(2010) suggested that this is partly a result of the lack of clinical trials evaluating the 
efficacy of the main treatment options. 
Treatment decisions are dependent on several variables including age, general 
health, tumour stage, PSA levels, outcome of prior prostate cancer treatment, and 
physicians’ and patients’ preferences (Incrocci, 2006a; Incrocci et al., 2001; Smith et 
al., 2009; Yan et al., 2000). The goal of treatment for prostate cancer is often a 
balance between risk, cure, and aiming to minimise the impact of several areas of 
quality of life (QoL) (Anandadas, Davidson et al., 2011; Eller et al., 2006). 
Localised prostate cancer is generally treated by active surveillance, surgery 
(radical prostatectomy), external beam radiotherapy, or brachytherapy (implantation 
of radioactive seeds in the prostate) (Baade et al, 2012; Yan et al., 2000). Active 
surveillance has been introduced as a treatment option for localised prostate cancer in 
recent years, moving away from the term watchful waiting. Watchful waiting is now 
used for older men or men with a shorter life expectancy where a more regimented 
surveillance protocol as used in active surveillance, is not deemed to be appropriate. 
It is often used as a method for older patients who have other serious medical 
comorbidities, making them poor surgical candidates, and in patients who are less 
likely to die from prostate cancer than other medical illnesses (Duchesne, 2011; 
Kunkel et al., 2000). In fact, an asymptomatic patient is unlikely to die from prostate 
cancer if their life expectancy is under 10 years, making watchful waiting a good 
option (Eylert, 2012; Kunkel et al., 2000). 
Radical prostatectomy and radiation therapy are the two most commonly used 
treatments across the various stages of disease and are also used with curative intent 
(Baade et al., 2012; Lu-Yao & Yao, 1997; Penedo et al., 2006). Radical 
prostatectomy involves surgical removal of the prostate, seminal vesicles, the vas 
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deferens, and the bladder cuff (Kunkel et al., 2000). NHMRC and ACN (2002) 
suggested that radical prostatectomy has the best prognosis for localised prostate 
cancer. In comparison to open surgical techniques, laparoscopic and robotic surgery 
are thought to reduce the rate and impact of side effects (Menon, Shrivastava, and 
Tewari, 2005). Patients opting for surgery tend to be younger than those undergoing 
radiation therapies (Lu-Yao & Yao, 1997; Duchesne, 2011), have a long life 
expectancy (> 10 years), low volume PSA,  and display no surgical risk factors 
(NHMRC & ACN, 2002). The major advantage for a patient undergoing surgery is 
that, if successful, it can provide a definitive cure, as well as more detailed 
information regarding the nature and severity of the cancer (Walsh, 2010).  
Radiotherapy also plays a significant role in the management of prostate 
cancer. External-beam radiotherapy offers an attractive alternative to surgery, most 
often involving a 7-9 week course consisting of 35-41 treatments (Castles, 2010). It 
is usually considered suitable for those with no risk factors for radiation toxicity, 
those with low PSA volume, or those who simply have a preference for radiotherapy, 
(NHMRC & ACN, 2002). Brachytherapy is a form of internal radiotherapy where 
the radiation is placed in the area affected, allowing high doses of radiation to be 
given to the prostate whilst protecting surrounding tissue (Duchesne, 2011). 
Although not heavily used in Australia, brachytherapy is growing in popularity 
(NHMRC & ACN, 2002).  
Active surveillance is offered to men with low and intermediate risk prostate 
cancer, taking into account the man’s age, comorbidities and life expectancy (Eylert, 
2012). There are various active surveillance protocols used by different treatment 
centres across the world and often clinicians tailor their approach to the patient or 
clinical setting. Active surveillance typically involves PSA testing every 3-12 months 
and regular biopsies to monitor cancer status or growth (Eylert, 2012). More invasive 
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treatment is undertaken if there is any sign of PSA rise or cancer growth (Duchesne, 
2011; Eylert, 2012). 
 Androgen Deprivation Therapy (ADT) deprives prostate cancer with the 
hormonal fuel it requires to grow; by reducing the available androgens in the system. 
ADT is used to treat locally advanced or advanced prostate cancer as well as 
metastatic prostate cancer (Maugham, 2010). ADT may also, but very rarely, be used 
to reduce the size of a tumour prior to surgery (Fergus, Gray, & Fitch, 2002).  ADT 
may also be used in combination with radiotherapy to treat advanced prostate cancer 
(Cousins, 2010b). While ADT is effective in slowing down the growth of cancer 
cells, it is not a curative treatment option (Maugham, 2010).  Prostate cancer will 
become castrate resistant after a period of time, which is variable for each individual, 
and PSA will start to rise again indicating prostate cancer cell growth (Maugham, 
2010). When this occurs ADT has failed and other drug therapies including 
chemotherapy are used (Cousins, 2010b). 
Overview of the Impact of Prostate Cancer and Prostate Cancer Treatment 
While the incidence of prostate cancer is growing, treatment of localised 
disease has become very effective and many patients are reportedly living longer 
(AIHW & AACR, 2010). Over the last few decades PSA testing has changed the 
profile of men with prostate cancer, with the majority now diagnosed with low risk 
early stage localised disease (Anandadas, Davidson et al., 2011). Considering 
survival rates of prostate cancer are high, issues surrounding QoL become 
significant, as many men live with both the impact that cancer and treatment has on 
their lives. Prostate cancer and its treatment are widely accepted to have an impact on 
both a patient’s physical and emotional QoL (Manne, Badr, Zaider, Nelson, & 
Kissane, 2010). Similar to most cancers, men with prostate cancer need to adjust to 
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the shock of diagnosis and the confrontation of facing the possibility of death and 
cancer recurrence. There may also be physiological symptoms including insomnia, 
fatigue, and pain (Hervouet et al., 2005; Lintz et al., 2003). As with other cancers, 
prostate cancer can negatively impact on many areas of a patient and their family’s 
life, including work and social functioning, financial strain as a result of treatment 
costs or decreased employment, emotional health, and general QoL (Albaugh & 
Hacker, 2008; Holland, Watson, & Dunn, 2011; Jayadevappa, Bloom, Fomberstein, 
Wein, & Malkowicz, 2005).  
In addition to these factors, men who undergo treatment for prostate cancer are 
faced with major morbidities including urinary incontinence, bowel dysfunction, and 
erectile dysfunction (ED). These side effects are thought to pose particular 
challenges to a man’s social, mental, emotional and physical well-being (Albaugh & 
Hacker, 2008; Stanford et al., 2000; Weber & Sherwill-Navarro, 2005). In particular, 
ED is highly prevalent in men treated for prostate cancer and is thought to pose 
particular challenges to a man’s wellbeing and can be difficult to adjust to (Manne et 
al., 2010; Weber & Sherwill-Navarro, 2005).  
A man’s intimate partner relationship is also likely to be impacted by prostate 
cancer directly and as a consequence of the impact of side effects from treatment, 
particularly sexual changes (Banthia et al., 2003; Beck, Robinson, & Carlson, 2009; 
Boehmer & Babayan, 2004; Bokhour, Clark, Inui, Silliman, & Talcott, 2001; 
Galbraith & Crighton, 2008). In fact prostate cancer is often referred to as the 
“relationship disease” (Gray, Fitch, Phillips, Larecque, & Klotz, 1999). 
Physical side effects such as erectile dysfunction (ED) as well as psychological 
outcomes have both been found to have lasting effects (Schover et al., 2002a; 
Wootten, Burney, Frydenberg et al., 2007). Considering these factors, survivorship 
issues in the prostate cancer population therefore pose unique challenges in terms of 
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QoL over the long term. In order to provide support for this population, research 
needs to focus on ways to support these men and their partners in order to minimise 
the impact of cancer on their psychological health, relationships and overall well-
being (Newton, Burney, Frydenberg, Millar, & Ng, 2007). 
Overview of this Thesis  
This thesis was conducted to address limitations associated with the current 
literature regarding the effectiveness of psychosocial treatments with men treated for 
localised prostate cancer, and to examine the suitability of the internet as a medium 
to provide psychological treatment to men who have been treated for prostate cancer. 
It involved the development and evaluation of an internet-based cognitive 
behavioural therapy (CBT) program for men treated for localised prostate cancer. 
The program also encouraged the participation of partners. This thesis forms part of a 
larger study which plans to evaluate the efficacy of the program with a larger sample 
over extended time points. This thesis focuses on the development, useability and 
feasibility of the internet-based program and provides preliminary efficacy findings. 
In order to explore psychosocial treatment for men treated for prostate cancer, 
it is important to understand the areas of a man’s life that are likely to be impacted by 
prostate cancer and its treatment in more detail. Therefore, the next three chapters 
explore the current literature related to sexual functioning, psychological functioning, 
and relationship functioning in men treated for prostate cancer. Chapter 5 discusses 
medical treatments that have been used to treat ED, followed by an evaluation of 
psychosocial interventions that have been used to target sexual, psychological and 
relationship functioning in men treated for prostate cancer. This chapter concludes 
with a discussion of the current limitations associated with psychosocial approaches. 
Chapter 6 explores the growing literature regarding online psychological treatment in 
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different areas including cancer. Chapter 7 provides a rationale for our research and 
outlines the development of a psychosocial internet-based program for men with 
prostate cancer (My Road Ahead). 
The empirical component of this thesis evaluates the efficacy of this program 
specifically related to sexual, psychological and relationship functioning. The 
hypotheses and method are outlined in Chapter 8, and the results of this study are in 
Chapters 9 and 10. Chapter 11 provides an overall discussion of the development and 
evaluation of My Road Ahead. Implications of the findings from this thesis for the 
treatment of psychosocial issues in men treated for prostate cancer, limitations of the 
research, and recommendations for future research are also explored. 
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Chapter 2: Sexual Functioning and Prostate Cancer Survivors 
Erectile dysfunction (ED) is considered to have a significant impact on a 
prostate cancer survivor’s life. This chapter presents a general overview of ED in 
men treated for prostate cancer. The incidence of ED in this population is 
summarised, followed by how prostate cancer treatment may impact on multiple 
areas of sexuality. Masculinity theory as a way of conceptualising how ED may 
impact on sexual functioning and intimacy is also explored. This chapter concludes 
with consideration of the implications for treatment of ED in prostate cancer 
survivors. 
ED and Prostate Cancer Treatment 
During a normal erectile response, both vascular and neurological mechanisms 
are activated by either psychological or physical stimulation (Darst, 2007). Such 
stimulation leads to relaxation of the smooth muscle in the penis, allowing blood to 
flow into spongy tissue of the penis, thus creating an erection (Darst, 2007). ED has 
been described as “the incapacity to achieve and maintain a penile erection enough to 
attain satisfactory sexual relations” (Castelo-Branco, Huezo, & Lagarda, 2008, p. 
55).  
ED is highly prevalent in men treated for prostate cancer because many nerve 
fibres involved in normal erectile functioning surround the prostate and these nerves 
are damaged during treatment for prostate cancer (Schover et al., 2002a). For 
example, during a prostatectomy, even when utilising nerve sparing techniques, 
damage occurs in the neurovascular bundle, interfering with the mechanisms 
necessary for erectile functioning (Darst, 2007). Some research has reported greater 
sexual recovery for nerve-sparing radical prostatectomy than non-nerve-sparing 
radical prostatectomy (Pardo et al., 2010). However, even with surgical technology 
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advancements using nerve-sparing techniques, incidence and severity of ED remains 
high (Briganti & Montorsi, 2006). 
The onset and course of ED differs across both individuals and type of 
treatment undertaken. After surgery, ED occurs immediately and return of erections 
may take up to two years, if at all. In contrast, ED following radiation therapy is 
gradual, with symptoms peaking at approximately two years post-treatment 
(Anandadas, Davidson et al., 2011; Incrocci, 2005; Wittmann, Northouse et al., 
2009).  
Rates of ED have been evaluated by several researchers, either focusing on one 
treatment type for prostate cancer or across treatments. Penson et al. (2005) reported 
sexual outcomes for 1,288 men at baseline, and at follow up 6 months, 12 months, 24 
months, and 60 months post-surgery. Baseline data were recalled retrospectively no 
more than 6 months after diagnosis. In terms of erectile function, the percentage of 
men reporting erections not firm enough for intercourse were 17% at baseline, 89% 
(6 months), 81% (12 months), 75% (24 months), and 71% (60 months).  
A postal survey with 1,236 men treated for localised prostate cancer by either 
radical prostatectomy or radiotherapy, found that 79% reported ED within the past 6 
months at a mean of 4.3 years post-treatment at the time of survey, with no 
significant differences between the two types of treatment (Schover et al., 2002a). Of 
the 21% who had functional erections, 38% were using an ED medical aid. Clinician 
reports of baseline ED prior to treatment were 36%, which was similar to patient 
retrospective reporting. Having good erections pre-treatment was predictive of 
functional erections post-treatment.  In this study, although nerve sparing techniques 
showed a significant advantage, rates were still above normal rates of ED in the 
general population.  
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Other studies have found a difference across treatment types. For example, 
using a sample of 1,187 men, Potosky et al. (2004) found that 79% had ED after 
prostatectomy compared to a lower rate of 64% after radiation therapy at five years 
after diagnosis. At two years after diagnosis the difference was greater, with 82% 
reporting ED for the radical prostatectomy group and 50% for the radiation therapy 
group. The use of concurrent ADT with each of the treatments was associated with 
greater levels of ED at the five year time point. 
One population-based prevalence study from the Netherlands compared 
erectile functioning of men (5-10 years post diagnosis) who underwent a range of 
treatments for prostate cancer, as well as a proportion who opted for watchful 
waiting, and compared this to the outcome data of a large sample of age-matched 
men without prostate cancer (Mols et al., 2009). Erectile difficulties were found in 
74% (prostatectomy), 67% (radiotherapy or hormonal therapy), 40% (watchful 
waiting), and 18% (normative population sample).  
While these studies demonstrate high rates of ED, they frequently employ 
comparisons between post-treatment functioning and retrospective reporting of pre-
treatment functioning. As a result, there is some suggestion that the rates of ED 
reported in outcome studies mentioned previously are overstated, since pre-treatment 
erectile functioning is often not taken into account and is frequently low when 
considering the average age of patients (Monga, Kerrigan, Garber, & Monga, 2001). 
It is well known that erectile function declines with age and many men admit to 
problems with potency before prostate cancer (Boehmer & Clark, 2001).  
In one prospective study by Jayadevappa et al. (2005), 40 men diagnosed with 
prostate cancer and treated by surgery were matched to 40 cancer free men. Health 
related QoL data, including sexual function, were taken prior to treatment, and at 3 
months, 6 months, 12 months, and 24 months follow up. At baseline, prior to 
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treatment, 74% reported a good or very good ability to function sexually and at 24 
months post-treatment only 28% reported this. Although a small sample size, this 
study was unique in that it provides evidence of declines in erectile functioning 
without retrospective reporting.  
Other prospective studies have explored the recovery of potency from pre-
operative erectile function, rather than reporting rates of ED specifically. An earlier 
study by Litwin, Melmed, and Nakazon (2001) used a prospective longitudinal 
design to assess sexual function outcomes for 247 men who underwent a radical 
prostatectomy taking baseline scores (before surgery) and every 3 months to a year 
post-surgery. About a third of the sample returned to baseline sexual function at one 
year, with the mean recovery time at 11 months. Tseng et al. (2006) measured sexual 
function at baseline (before surgery), and at six time points leading up to 18 months 
post-surgery with 90 men who underwent robotic radical prostatectomy (both nerve 
sparing and non-nerve sparing). Only 11.9% reported returning to baseline scores of 
sexual function at 12 and 18 months post-surgery. An analysis of 42 men who had 
erections firm enough for intercourse at baseline were found to return to pre-
operative erections at a mean time of 13.5 months post-surgery. 
Some more recent research has explored erectile function recovery also by 
assessing potency at baseline (pre-operatively) and at several time points up to one to 
two years post-surgery (Murphy, Kerger, Crowe, Peters, & Costello, 2009; Patel et 
al., 2011). Potency was measured on the Sexual Health Inventory for Men (SHIM) 
which focuses on the number and quality of erections. The percentage of men who 
returned to previous potency was found to be 62% (Murphy et al., 2009) and 89.8% 
(Patel et al., 2011) at 12 months follow-up post-surgery. The reason for these higher 
rates is likely to be a result of the inclusion criteria in these studies, which was men 
who had a certain level of potency prior to surgery and who underwent nerve sparing 
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surgery. The use of PDE5 (phosphodiesterase type 5) inhibitor was also likely to play 
a major role in recovery with the majority of Murphy et al.’s (2009) sample using 
this aid.  
The studies highlighted in this section reported rates of ED in these populations 
based on a definition of ED as the degree of ability to have an erection firm enough 
for intercourse (Penson et al., 2005; Potosky et al., 2004), or by using the erectile 
function specific scales (Murphy et al., 2009; Patel et al., 2011; Schover et al., 
2002a), and the use of specific questions about the degree of erection problems 
(Moles et al., 2009). Other researchers have used scales including items focusing on 
erectile function in addition to desire and orgasm function (e.g., Litwin et al., 2001; 
Tseng et al., 2006) or a scale including questions about function and degree of bother 
by symptoms (e.g., Pardo et al., 2010). In these studies, without separation of 
subscales or items in analyses, reports of erectile function and more broadly sexual 
function were merged. Although measuring rates of actual erectile function are 
important, most researchers acknowledge that sexual function goes beyond the 
ability to be able to achieve an erection and emphasise the multidimensional nature 
of sexual function. Before covering this in more detail, the next section explores the 
role of urinary incontinence in prostate cancer treatment and its impact on sexual 
function and sexuality.  
Urinary Incontinence 
Urinary dysfunction refers to one’s “ability to maintain urinary control” 
(Litwin et al., 2000). Urinary dysfunction is also considered a difficult side effect of 
prostate cancer treatment to adjust to (Stanford et al., 2000).  Surgery for prostate 
cancer is more likely to cause urinary dysfunction than radiation treatment (Litwin et 
al., 2000, p. 1973). Rates of urinary dysfunction vary in the literature and range from 
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5.8%-48% in samples of men with prostate cancer treated by surgery (Augustin et 
al., 2002; Burkhard et al., 2006; Mols et al., 2009; Penson et al., 2005). Such 
variations in rates of urinary dysfunction may be due at least in part to no clear 
consensus of the definition of urinary continence or incontinence (Bauer, Bastian, 
Gozzi, & Stief, 2009; Litwin et al., 2000). For example, definitions include “needing 
to wear pads” (Augustin et al., 2002) versus the level of reported control of leakage 
(Penson et al., 2005), both these factors together (Burkhard et al., 2006), or a 
measure of QoL in the urinary domain incorporating these factors (Mols et al., 2002). 
Assessment time points varied in the above studies in terms of the time at 
which measurements were taken post-treatment. For example, Burkhard et al. (2006) 
measured function at one year post-surgery and Augustin et al.’s (2002) timeframe 
ranged from 12-78 months. Penson et al.’s (2005) study highlighted earlier measured 
urinary control for men treated for prostate cancer by surgery prior to diagnosis and 
at 6 months, 12 months, 24 months and 60 months post-surgery. While 87% of men 
reported “total control” of urinary function at baseline, rates were 23%, 35%, 39% 
and 35% at each of the post-surgery follow-up time points. This study demonstrated 
that urinary dysfunction remains for a long time post-surgery for many men. Gacci et 
al. (2009) explored factors contributing to urinary dysfunction and found a trend 
towards better urinary function after nerve sparing surgery; however, this was non-
significant, highlighting that even with improved technology many men are still 
impacted by incontinence.  
Although there has been a greater research focus on surgery outcomes, Litwin 
et al. (2000) compared urinary dysfunction in a cohort of 564 men who underwent 
surgery or radiation therapy within 6 months of diagnosis of localised prostate 
cancer. Surgery was found to have significantly worse urinary outcomes immediately 
following treatment compared to radiation therapy; however, urinary function 
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improved steadily during the first year post-treatment and rates of urinary function 
remained stable and comparable to radiation at one and two years post-treatment. 
Similarly, Anandadas, Davidson et al. (2011) found that men who had surgery for 
prostate cancer reported significant declines in urinary function compared to those 
who had radiation or brachytherapy, which improved over time but did not return to 
baseline levels. A prevalence study mentioned previously of longer term prostate 
cancer survivors after a range of treatments also found surgery to have significantly 
and clinically worse urinary function outcomes than other treatment, and all 
treatments were found to be worse than a normative control group (Mols et al., 
2009). Urinary incontinence was found to be 48% (radical prostatectomy), 23-24% 
(other treatments), and 4% (age-matched normative population sample). 
Even with inconsistent rates of urinary difficulties and incontinence, it appears 
that prostate cancer treatment impacts negatively on urinary functioning and that this 
is distressing for many men. Focus group research of men treated for prostate cancer 
has found that urinary dysfunction can cause both physical and emotional distress 
resulting in behavioural changes and difficulties (Clark, Bokhour, Thomas, Silliman 
& Talcott, 2003). Levels of urinary bother (impact and annoyance associated with 
urinary dysfunction) have been reported by Penson et al. (2005) to be highest at 6 
months post-surgery (29% stated it was a moderate or big problem) compared to 3% 
at baseline. These rates improved over time but still remained elevated at 13% at 60 
months post treatment. Litwin et al. (2000) also explored level of urinary bother and 
surprisingly found that at all time points urinary bother was higher for those who 
underwent radiation compared to surgery, even though surgery had higher post-
operative urinary dysfunction rates. However, Mols et al.’s (2009) found no 
difference in levels of urinary bother across the different treatments for prostate 
cancer and in comparison to an age matched normative sample. 
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Urinary incontinence and sexuality. Urinary continence difficulties can 
negatively impact on sexual function and relationships. Pad use is frequently 
associated with urinary dysfunction and often makes a man feel embarrassed by 
wetness or unpleasant odours and this is thought to impact on a man’s sex life (Clark 
et al., 2003; Litwin et al., 2000; Penson et al., 2005). Incontinence can also directly 
impact sexual activity by occurring during arousal or orgasm (Mitchel, Jain, Laze, & 
Lepor, 2011).  A recent study by Mitchell et al. (2011) found that 44% of men that 
had undergone a prostatectomy reported bother from incontinence specifically during 
sexual activity at 3 months post-surgery. Nilsson et al. (2011) explored orgasm-
associated urinary incontinence in a large sample of men treated for prostate cancer 
by surgery and found 21% of men had experienced this type of incontinence in the 
past 6 months. Further, out of those men who were sexually active, those 
experiencing orgasm-associated incontinence were more likely to experience 
depressive and anxious symptoms and lowered sexual esteem.  
Treatment of incontinence after surgery includes making lifestyle changes, use 
of physiotherapy including pelvic floor exercises and biofeedback, medication, and 
sometimes operative procedures (Bauer et al., 2009). Psycho-education and CBT 
based strategies are likely to assist men with anxiety associated with urinary 
dysfunction, especially around hypervigilance to bodily signals and social 
interactions, which is likely to also influence sexual function, and to assist with 
coping with uncertainty about the future. 
Sexuality, Prostate Cancer and its Treatment 
The physiology of erectile function plays an integral role in sexual behaviour 
(Beck et al., 2009). The alteration in sexual response for men after prostate cancer 
treatment means that the movement from desire to arousal within the excitement 
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phase is impacted as a result of physiological changes preventing erections 
(Wittmann, Northouse et al., 2009b). There may also be further physiological 
changes related to ejaculation and penile length. A recent study by Parekh et al. 
(2013) that a small percentage of men reported a reduction in penis size following 
prostate cancer treatment. Importantly these changes were found to be related to 
difficulties with close relationships and regretting cancer treatment type (Parekh et 
al., 2013). Radiation therapy can result in a reduction of ejaculation fluid which may 
even result in dry orgasms (King, 2010).  
Just because a man’s ability to have an erection has diminished, it does not 
necessarily mean that other aspects of sexuality need to be impacted. For example, a 
man can still have an orgasm (dry orgasm) without an erection, and sexual desire and 
skin sensitivity remains (Schover, 1994). This is because the nerves are spared that 
provide transmission of sensations related to pleasure or orgasm (Schover et al., 
1994).  
Changes in sexual function after treatment for prostate cancer are considered to 
be multifactorial, including vascular, neurogenic and psychological factors 
(Dubbelman, Wildhagen, & Dohle, 2006). The changes in sexual desire, for example, 
evident in men treated for prostate cancer are complex and likely to be 
psychologically based, excluding the loss of desire associated with androgen 
deprivation therapy, which is related to hormone ablation (Wittman, Foley, & Balon 
2011). Impact on other aspects of sexuality is likely to still occur for men treated for 
prostate cancer, either directly (through the impact on actual erectile function) or 
indirectly (e.g., from having cancer itself or relationship difficulties). Jakobsson, 
Lovén, and Hallberg (2001) suggested that psychological and somatic stress from 
surgery and other prostate cancer treatments could lead to a reduction in sexual 
desire and ability to perform. 
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Beyond erectile function, sexuality encompasses gender identity, sexual 
orientation, desire, intimacy, and reproductive processes, and expression of sexuality 
may occur through thoughts, attitudes, activities, roles and relationships (Knight & 
Latini, 2009; Wilmoth, 2006). More specifically, sexual functioning involves not 
only erectile function (quality and quantity), but sexual satisfaction, and interest or 
desire for sex (Boehmer & Clark, 2001; Schover, 1993). The impact of prostate 
cancer and its treatment on broader aspects of sexuality is considered below. 
 Sexual satisfaction, desire and orgasm function.   Sexual satisfaction and 
erectile function are thought to be highly correlated (Nelson, Choi, Mulhall, & Roth, 
2007). Nelson et al. (2007) conducted a cross-sectional study with 352 prostate 
cancer survivors and found that men reported low sexual satisfaction. The sample 
consisted of men treated for prostate cancer by a range of treatments. Although 
sexual satisfaction was reported to be lowered, no control group was used in this 
study. Nelson et al. also found erectile functioning, relationship closeness, and 
psychological distress (anxiety and depression) predicted sexual satisfaction in their 
sample of men with prostate cancer, the majority of whom had received a range of 
treatments. Therefore, it appears that treatment type, erectile functioning and 
psychological distress may contribute to a man’s sexual satisfaction in a complex 
interrelated process. Targeting all these areas may increase a man’s level of sexual 
satisfaction, whether or not he can have an erection. 
In Schover et al.’s (2002a) outcome study, sexual satisfaction as measured on 
the International Index of Erectile Function (IIEF), was found to be significantly 
lower among men with prostate cancer, treated by radiotherapy or prostatectomy, 
compared to men from a normative sample with mixed types of ED.  Jakobsson et al. 
(2001) used a cross-sectional design and compared pre-treatment and post-treatment 
satisfaction with sex life in 155 men treated for prostate cancer to 129 men from the 
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general population. While 12.4% of the general population reported they were “not at 
all” satisfied with their sex life in the general population, the response of men with 
prostate cancer to this question increased from 5.2% pre-treatment to 56.1% post-
treatment. 
Dahn et al. (2004) explored the relationships between sexual functioning, 
sexual desire and general QoL in a sample of men treated for prostate cancer, and 
found that both sexual function and sexual desire were necessary for optimal QoL. In 
Schover et al.’s (2002a) study, 45% of men treated for prostate cancer reported low 
sexual desire in the last 6 months, and 65% reported problems with achieving 
orgasm. Jakobsson et al. (2001) also found lower rates of sexual desire and pleasure 
among men treated for prostate cancer compared to the general population. While 
only 2.3% of the general population cohort reported never experiencing desire or 
pleasure, 43.2% of men post-treatment for prostate cancer reported never 
experiencing desire, and 29.7% never experiencing pleasure. Le et al. (2010) found 
that sexual desire out of several domains of sexual function declined by the least 
amount over time, suggesting that some level of desire remains intact compared to 
other sexual changes. 
Changes in desire and orgasm have also been reported prospectively. In 
Jayadevappa et al.’s (2005) prospective study covered earlier, men treated for 
prostate cancer also reported poor sexual desire, and only 53% reported an ability to 
achieve orgasm compared to 79% prior to treatment.   
These findings highlight that although ED is the most prevalent form of sexual 
dysfunction in men treated for prostate cancer, there are other areas of sexual 
functioning within the normal sexual response cycle that may be impacted.  
Sexual bother and distress. The severity of reported symptoms of ED is not 
the same as the degree of symptom related bother (Gacci et al., 2009). Sexual bother 
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therefore refers to the degree of interference and impact of changes in sexual 
function. Gore et al. (2010) found that the relationship between sexual function and 
bother was weak in a sample of men treated for prostate cancer, highlighting the 
importance of separating these variables. Sexual bother is thought to encompass 
feelings of shame, embarrassment and may negatively impact general QoL (Nelson, 
Deveci, Stasi, Scardino, & Mulhall, 2010).  
Research also suggests that ED causes more bother and distress than other side 
effects from treatment. For example, in a sample of 1,291 men who underwent 
surgery, only 8.7% were bothered by a lack of urinary control compared to 41.9% 
bothered by changes to sexual function (Stanford et al., 2000). Other research has 
found high rates of sexual bother. Litwin et al. (1995) found that 78% of men treated 
for prostate cancer, who had poor or very poor sexual function, viewed it as a “big 
problem”. Similarly, from a large sample of men who underwent surgery or radiation 
therapy, 61% reporting having been distressed by their ED (Schover et al., 2002a). In 
this study, 60% reporting distress related to desire issues and 64% distress in relation 
to orgasm difficulties (Schover et al., 2002a). Potosky et al.’s (2004) outcome study 
of men treated for prostate cancer, also broke sexual bother down into bother about 
several areas including lack of sexual interest, lack of sexual enjoyment, orgasm 
difficulty, and erectile difficulties. There was no significant difference between those 
who underwent surgery and radiation for sexual bother scores, and around 41%-63% 
of men were bothered by each of these domains. Steinsvik et al. (2012) found that 
one year post-prostatectomy 66% of men reported high sexual bother and that being 
sexually active pre-operatively was associated with greater bother. 
Variability in levels of sexual bother has also been investigated across time. In 
Penson et al.’s (2005) five year outcomes study for men who underwent radical 
prostatectomy the level of perceived bother of sexual function declined over time, 
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however, 46% were still bothered by changes in sexual function at 60 months post-
diagnosis. In Jayadevappa et al.’s (2005) prospective study, sexual bother peaked at 3 
months, and began to improve at 24 months. However, the men remained statistically 
more bothered at 24 months compared to prior to treatment. Interestingly, in a recent 
study using a sample of men surgically treated for prostate cancer, even men with 
good erections post-operatively were found to have high sexual bother scores which 
remained stable from 12 to 24 months post-surgery (Nelson et al., 2010). This 
finding is important as it suggests that men may not adjust to changes in sexual 
function, even when erections improve. Similarly, Parker, Wang, He, and Wood 
(2011) found that sexual bother persisted across several time points (up to 60 
months) post-surgery for localised prostate cancer. In this sample sexual function 
scores returned towards baseline in less time than sexual bother, providing further 
evidence that men struggle to adjust to the loss, even when some function returns. 
Sexual quality of life.  This chapter has covered changes as a result of prostate 
cancer and its treatment to erectile function, more broadly sexual function, and the 
degree of bother or distress associated with symptoms. Clark et al. (2003) suggested 
that the degree of symptom severity and associated bother does not encompass 
aspects such as sexual intimacy, sexual confidence, affection and masculinity. These 
are considered important facets of sexuality impacting a man, his partner and the 
relationship.  
Bokhour et al., (2001) conducted a series of focus groups with prostate cancer 
survivors investigating the psychosocial issues surrounding sexual dysfunction. 
Results found that men spoke little of the mechanics of ED and focused instead on 
the wide reaching psychosocial impact on areas such as social relationships, 
including sexual intimacy in romantic relationships, sexual self-concept, difficulty 
engaging with a partner sexually, and ways in which they saw themselves as men.  
22 
 
One way to conceptualise the impact ED, as a result of prostate cancer and its 
treatment, has on men’s sexuality and sexual intimacy, is to acknowledge the 
potential threat ED has on a man’s sense of masculinity (Gray, Fitch, Fergus, 
Mykhalovskiy, & Church, 2002; Wootten, 2010). Hegemonic masculinity is used to 
describe the idealised form of masculinity within a given culture and time, 
encompassing characteristics such as independence, competence and virility (Gray et 
al., 2002). In a western culture, hegemonic masculinity is focused on the penis, 
specifically the size and associated performance, and this is considered an important 
factor determining one’s level of masculinity (Beck et al., 2009; Gray et al., 2002). 
Performance is favoured over emotional connections, which may limit the ways in 
which a man can express his sexuality (Brubaker & Johnson, 2008).  
Both a prostate cancer diagnosis and its treatment can influence a man’s sense 
of identity and masculinity. Firstly, cancer itself can lead a man to be less 
independent in caring for himself, and secondly ED can directly impact on a man’s 
sense of masculinity (Beck et al., 2009; Conwell, Caine, & Olsen, 1990). An 
Australian qualitative study found that some men reported that changes to their 
bodies from surgery, weight gain, and genital appearance were difficult to adjust to 
and could impact a man’s sense of masculinity (O’Shaughnessy & Laws, 2009). In 
the face of prostate cancer, Helgeson and Lepore (2004) described how a man must 
adjust from the “healthy self” to the “chronically ill self” and that identification with 
male gender roles of control, independence and emotional inhibition may influence 
how one adjusts.  
In terms of ED specifically, being able to have penetrative sex may be viewed 
as an essential part of sex and sexuality (Arrington, 2008) and of being a man 
(Fergus et al., 2002). If sexual performance and masculinity are greatly entwined, ED 
may serve as a major disruption to a man’s masculinity (Fergus et al., 2002).  
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Research has found that masculinity concerns are important factors at both pre-
treatment and post-treatment time points for prostate cancer. Using semi-structured 
interviews with men prior to treatment for prostate cancer, men saw erectile function 
as an important dimension of their masculine identity (Boehmer & Babayan, 2004). 
Similarly, when using focus groups consisting of men who had undergone treatment 
for prostate cancer, Boehmer and Clark (2001) found that lack of sexual functioning 
threatened their masculinity, which impacted on a man’s relationships, his fantasy 
life, and their view of themselves as men, impacting both general and sexual 
confidence. 
Consistent with the changes seen in men treated for prostate cancer across 
several domains of sexual function, Wittman et al. (2011) suggested that the loss men 
experienced may be related to desire, arousal or orgasm and that the consequence of 
such loss and changes to masculinity can be huge for some men. Motivation to 
engage in sexual activity may be impacted and avoidance behaviours related to 
anxiety can become prevalent, further complicating sexual function (Messaoudi, 
Menard, Ripert, Parquet, & Staeman, 2011; Wittman et al., 2011). In fact, when a 
man’s sexual capacity is no longer in line with his gender identity he may completely 
avoid any sexual activity (Fergus et al., 2002). 
A man’s degree of conformity to masculine norms or scripts may determine 
how well he adjusts to ED. Successful adaption to erectile changes and associated 
sexual relationship changes may require a man to restructure his current definition of 
masculinity and broaden his understanding of sexuality to a much larger concept than 
erectile functioning (Fergus et al., 2002; Gray et al., 2002; Wittmann, Northouse et 
al., 2009). In achieving this restructuring, men may need to be reminded that sexual 
feelings, penile sensitivity, orgasm function and intimacy are still available 
(Wittmann, Northouse et al., 2009), and a loss of erectile functioning does not 
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necessarily need to result in a complete loss of enjoyment of sex and sexual intimacy 
(Schover, 1994).  
Apart from qualitative research, research evaluating changes to masculinity 
related factors in the context of prostate cancer has only begun to be explored in 
recent years. Messaoudi et al. (2011) found that 61.9% of men reported loss of 
masculine identity in sample of men who had predominately undergone surgery for 
prostate cancer. The impact on masculine identity was rated as overwhelming by 
25.6% of men and partially overwhelming by 74.4%. Messaoudi et al. (2011) also 
found that 38.1% reported a loss of self-esteem. The measure used to assess 
masculine identify was one item from a questionnaire designed by the researchers, 
“Do you feel a loss of masculine identity since your operation?” 
Clark et al. (2003) developed a QoL scale (Prostate Cancer-Related Quality 
of Life Scale) to address the gaps in the literature which fail to acknowledge and 
assess the emotional, behavioural and interpersonal dimensions of men’s experiences 
to prostate cancer and its treatment, including sexual intimacy, sexual confidence, 
and masculine self-esteem subscale. Clark et al. evaluated the scale on a sample of 
men predominately treated for prostate cancer with comparison group and found 
significantly poorer QoL across these sexuality variables. 
Thornton, Perez, Oh, and Crocitto (2011) explored several dimensions of 
sexuality in a cohort of men treated for localised prostate cancer by prostatectomy, 
using Clark et al’s (2003) QoL subscales of sexual intimacy, sexual confidence and  
masculine self-esteem. Thornton et al. (2011) found that sexual intimacy, sexual 
confidence and masculine self-esteem all decreased from pre-surgery to post-surgery 
time points. Using the same masculinity scale and a sample of men treated for 
prostate cancer on average 8.1 months prior, Zaider, Manne, Nelson, Mulhall and 
Kissane (2012) found that 30%-37% of men reported a loss of masculinity. Zaider et 
25 
 
al. found that the measure of masculinity was the strongest predictor of sexual bother 
out of other measures of sexual functioning including ED, desire and intercourse 
satisfaction. Importantly, the authors highlight the potential bi-directional 
relationship between masculinity and sexual bother.  
While these studies demonstrate the importance of measuring masculinity and 
self-esteem changes in the context of prostate cancer, further research is needed 
using controls groups and follow-up time points. 
Summary and Treatment Implications 
ED is highly prevalent in men treated for prostate cancer, with rates ranging 
across studies, which is likely to be due to inclusion and exclusion criteria of men. 
Even though erections may return, many men experience ongoing erectile difficulties 
up to 4 to 5 years post-treatment (Penson et al., 2005; Schover et al., 2002a).  
Although documenting the prevalence of the actual ability to have an erection 
is important, research suggests other aspects of sexual functioning may be affected 
by prostate cancer and its treatment, including sexual interest, sexual satisfaction, 
sexual desire, orgasm function, and sexual intimacy. Recognition of the importance 
of measuring and exploring these areas of sexuality is a result of an increasing 
awareness of the multi-dimensional nature of sexuality. Even more recent research 
has begun to acknowledge the psychosocial impact of changes to sexual function by 
exploring the role of factors such as sexual intimacy, masculinity, sexual confidence 
and motivation. 
In terms of treatment it is clear that a holistic approach to sexuality is more 
appropriate and beneficial for sexual rehabilitation and assisting with the bother and 
distress associated with changes to sexual function. Implications for treatment also 
come from research which considers masculinity issues. Men may benefit from 
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assistance with grieving the loss of erectile functioning and spontaneity (Wittmann, 
Northouse et al., 2009), followed by psycho-education and open discussions about 
ways to express and fulfil sexual needs beyond intercourse (Oliffe, 2005).  
Addressing urinary dysfunction may also assist men’s sexual functioning.  
This chapter has explored how prostate cancer impacts on a man’s erectile 
function, his broader sexual function, and how this may impact on a man’s sense of 
self and his confidence. Both prostate cancer itself and the impact of treatment 
(sexual and otherwise) may have an influence on relationships and general 
psychological health. Focus group research suggests that in re-evaluating their sexual 
functioning, men need to explore how this relates to intimacy and their relationship 
(Bokhour et al., 2001). This suggests that a man’s partner and the dyadic relationship 
play a significant role in successful adaption to ED. This will be addressed in 
Chapter 4. The use of medical aids for ED will be covered in Chapter 6. 
Psychological functioning and prostate cancer will be covered in the next chapter. 
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Chapter 3: Psychological Functioning and Prostate Cancer 
Psychological implications of cancer have been well documented.  A cancer 
diagnosis requires a patient, their partner and family to adjust to everything that a 
cancer diagnosis brings, including uncertainty about the future (Edwards & Clarke, 
2004). Depression and anxiety have been previously viewed to be the most 
significant psychological comorbidity for cancer patients (Frick, Tyroller, & Panzer, 
2007). This chapter discusses the rates of psychological distress in samples of men 
with prostate cancer, considers aetiological factors, explores the impact of 
psychological distress, and the implications for psychosocial treatment. 
Psychological Distress and Prostate Cancer and its Treatment 
Research exploring QoL of men with prostate cancer has been criticised for 
frequently focusing on the physical impact of prostate cancer and its treatment (e.g., 
sexual, urinary and other physical symptoms), while often ignoring psychological 
symptoms (Eller et al., 2006; Monahan et al., 2007). However, research investigating 
the impact of prostate cancer and its treatment on psychological well-being has 
increased over the last decade.  
Several studies report levels of psychological distress, anxiety and depression, 
in a variety of prostate cancer samples using a range of scales evaluating levels of 
depressive and anxiety symptoms (e.g., Hospital Anxiety and Depression Scale- 
HADS; Brief Symptom Inventory – BSI).  These studies have found rates of 
psychological distress in men with prostate cancer ranging from 17% - 38% 
(Balderson & Towell, 2003; Cliff & MacDonagh., 2000; Couper et al., 2006; 
Hervouet et al., 2005; Roth et al., 1998; Sharpley, Bitsika, & Cristie, 2009). Within 
the same studies, sample rates of anxiety tend to be higher than depressive symptoms 
(Bisson et al., 2002; Cliff & MacDonagh, 2000; Hervouet et al.; 2005; Roth et al., 
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1998) and one study using a large sample found depression and anxiety comorbidity 
to be 16% (Sharpley, Bitsika & Christie, 2010). Research has found traumatic stress 
symptoms to be elevated in a sample of newly diagnosed men with prostate cancer 
(Bisson et al., 2002). 
Elevated rates of psychological disorders according to the DSM-IV (Diagnostic 
and Statistical Manual of Mental Disorders, American Psychiatric Association, 2002) 
criteria or by clinical interview have also been found in men with prostate cancer. 
Couper et al. (2006) found rates of major depression to be almost twice that of 
previously reported general population rates (5.6% versus 3.0%). Pirl, Greer, Goode, 
and Smith (2002) found high rates of major depressive disorder for men receiving 
ADT for prostate cancer (12.8%). Roth et al. (1998) found that 47.1% of men who 
were above a specified cut-off point of distress on the HADS were consequently 
diagnosed by a psychiatrist with a psychological disorder based on the DSM-IV 
criteria. However, a significant proportion of Roth et al.’s sample had sub-clinical 
levels of depression, highlighting the importance of using different screening 
methods to identify psychological distress. Love et al. (2008) compared rates of 
psychiatric disorders across men recently diagnosed with early prostate cancer, 
advanced prostate cancer and a comparison group within the same study. Love et al. 
found little difference between the three groups; however, anxiety disorders were 
slightly higher in the prostate cancer groups. 
Elevated levels of distress may have important implications. Suicide rates have 
been found to be elevated in older men with prostate cancer in population based 
samples (Bill-Axelson et al., 2010; Fang et al., 2010; Llorente et al., 2005). Llorente 
et al. (2005) reported that men with prostate cancer were over four times more likely 
to commit suicide than an age and gender matched cohort. A diagnosis of depression 
during the treatment phase for prostate cancer was found to be correlated with an 
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increased risk of death during later follow-up periods for men over 65 years 
(Jayadevappa, Malkowicz, Chhatre, Johnson, & Gallo, 2011). 
Many studies reporting rates of psychological distress and psychological 
disorders frequently include samples of men with a variety of stages of disease, 
receiving different treatments for prostate cancer, and collecting data collected at 
different time points from diagnosis and treatment. Some researchers explored these 
factors in their analyses. 
In relation to disease stage, Couper et al.’s (2006) sample consisted of men 
with both localised and metastatic disease, and contrary to expectations found no 
significant difference in levels of psychological distress associated with the level of 
disease. Similarly, Pirl et al. (2002) found no difference in levels of depression when 
comparing “stable” versus “progressive” disease stage.  
In terms of treatment type, Hervouet et al. (2005) explored the rates of 
psychological difficulties in men treated for prostate cancer by radiotherapy, 
brachytherapy, and radical prostatectomy in 861 men who had been diagnosed within 
the past seven years. Rates of anxiety and depression were higher for men who 
underwent radiotherapy; however, the authors suggested that although statistically 
significant, the effect size was small. In a prospective study of men with prostate 
cancer, final treatment choice was found to be unrelated to psychological distress 
(Steginga, Occhipinti, Gardiner, Yaxley, & Heathcote, 2004). Couper et al. (2009) 
compared men who had radical prostatectomy, hormone therapy, other treatment 
(including radiation) or watchful waiting and found that those who underwent 
treatment for prostate cancer were more likely to experience symptoms of anxiety 
and depression at the time of diagnosis and treatment and 12 months later compared 
to those who opted for watchful waiting. However, only the hormone therapy group 
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had significantly greater levels of psychological distress than the watchful waiting 
group. 
The samples in these studies varied greatly in terms of the time since diagnosis 
and/or treatment, both between studies and within studies. Bission et al. (2002) found 
that a sample of newly diagnosed men with localised prostate cancer, prior to 
treatment, only experienced mildly evaluated levels of psychological distress, 
suggesting that treatment for prostate cancer may be associated with increased 
psychological distress levels. Couper et al. (2006) found that psychological distress 
increased from the diagnosis point to 6 months post-diagnosis using a sample of men 
at different stages of disease and who had different treatments. Couper et al. (2006) 
found rates of psychiatric caseness (meeting criteria for a diagnosable psychiatric 
disorder) were 10% at the time of diagnosis and 15% at 6 months post-diagnosis.  
Others have found that time since diagnosis was not related to anxiety and 
depression (Heurovet et al., 2005), however average time since diagnosis and 
treatment was quite long (30 months) and in a large sample of men diagnosed and 
treated for prostate cancer in the last one to eight years, depressive symptoms were 
not found to have lasting impacts on these men (Blank & Bellizzi, 2006). Similarly, 
Steginga et al. (2004) found that levels of psychological distress decreased from the 
time around diagnosis of localised prostate cancer to when men were surveyed again 
between 2 and 12 months post-treatment. These studies suggest that time from 
treatment for prostate cancer either has no impact or results in a decrease in 
symptoms.  
Korfage, Essink-Bot, Janssens, Schroder and de Koning (2006) conducted a 
prospective, longitudinal study with 299 men treated for localised prostate cancer by 
surgery or radiation, measuring anxiety and depression at pretreatment 
(approximately 1 month), and 6 months, 12 months and 5 years follow up. At 6 
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months after treatment, levels of anxiety and depressive symptoms significantly 
improved and remained at longer term follow-ups. The authors in these studies 
suggest that most men show resilience to psychological distress in the face of 
prostate cancer and its treatment. However Korfage et al. (2006) did find that levels 
of anxiety and depression were elevated in comparison to the general population at 
baseline and emphasised that it was important for clinicians to identify a sub-group 
of men likely to continue to experience clinical levels of anxiety and depression. 
Factors that Influence Psychological Functioning in Men with Prostate Cancer 
There are many emotional and practical challenges associated with a diagnosis 
of cancer, including coping with the life threatening nature of the illness (Darst, 
2007; Manne et al., 2010), which may impact on a man’s mental health. For prostate 
cancer there are specific challenges that explain the higher rates of psychological 
distress, and these can occur at different stages of the cancer journey. Men with 
prostate cancer often have the added distress of making difficult treatment choices 
when considering the potential impact of side effects, effectively being forced to 
make trade-offs between various levels of side effects and benefits from different 
treatments (Anandadas, Clarke et al., 2011).  
Sharpley et al. (2009) highlighted that the withdrawal from unpleasant 
experiences related to diagnosis and treatment for prostate cancer, and losses related 
to changes in sexual function, fits a framework for psychological distress, 
particularly depression. Using an Australian sample, Sharpley et al. surveyed 150 
men treated for localised prostate cancer and found significant links between 
depressive symptoms and the losses inherent in side effects of prostate cancer 
treatment. Some of the most common losses experienced by men in this survey were 
related to sexual function (ability and desire), disappointment, fatigue, memory 
32 
 
difficulties, sleeping problems, bowel changes, and inability to exercise as 
previously. Greater number of lifestyle changes and losses experienced were 
associated with greater levels of clinical anxiety and depression.  
 The side effects of prostate cancer treatment resulting in a functional loss 
(especially ED and urinary dysfunction) may be particularly challenging and pose a 
threat to a man’s psychological well-being and be associated with anxiety and 
depression (Manne et al., 2010; Sharpley et al., 2009). Research has investigated the 
relationship between psychological distress and erectile functioning, as well as 
sexual bother and sexual satisfaction. Using a sample of 70 men treated for prostate 
cancer by radiation therapy, Howlett et al. (2010) found that men without sexual 
problems before and after radiation therapy reported lower levels of anxiety and 
depression compared to men with sexual problems. Wootten, Burney, Foroudi et al. 
(2007) found that for those men treated for prostate cancer who demonstrated 
ongoing psychological difficulties, sexual bother was found to be a main variable 
associated with mood disturbance. Similarly, Nelson et al. (2010) found that poorer 
erectile function was associated with higher rates and severity of depressive 
symptoms in sample of men treated for prostate cancer. Finally, anxiety and 
depression rates have been found to be correlated with sexual satisfaction in a sample 
of men predominately treated for prostate cancer (Nelson et al., 2007). 
The relationship between depression and anxiety, and sexual functioning is 
considered bi-directional, where psychological distress has also been implicated in 
the aetiology and maintenance of sexual difficulties (Althof et al., 2005). Sexual 
functioning may be impacted even before treatment of prostate cancer, as the fears, 
worries and stress associated with both the diagnosis and decision making may 
increase levels of psychological distress (Darst, 2007; Galbraith & Crighton, 2008; 
Schover, 1993). Post-treatment, the psychological and somatic stress as a result of 
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treatment may contribute to a reduction of sexual functioning, including sexual 
desire and potency (Jakobsson et al., 2001). Further, the process of dealing with the 
possibility of death and cancer recurrence and the psychological impact of the cancer 
itself are also likely to impact on a patient’s sexual functioning (Weber & Shervill-
Navarro, 2005). Nelson et al. (2007) have commented that addressing psychological 
distress may be important when providing therapeutic assistance to men and couples 
to improve sexual functioning. 
 Other individual factors have been implicated in psychological distress and 
prostate cancer. Higher levels of psychological distress have been related to younger 
age (Bisson et al., 2002), pre-existing psychological symptoms (Pirl et al., 2002; 
Nordin et al., 2001), living in a rural location (Corboy, McLaren, & McDonald, 
2011), lower levels of social support (Nelson, Mulhall, & Roth, 2009) and use of 
maladaptive coping styles (Blank & Bellizzi, 2006). In terms of factors buffering 
against depression, Sharpley, Wootten, Bitsika, and Christie (2013) found that 
psychological resilience, especially “confidence to cope with change”, was 
associated with lower levels of depression over time.  
Research suggests that fear of cancer recurrence may also have an impact on 
psychological functioning. Fear of recurrence has been related to mental health 
related QoL in a mixed cancer sample (Crist & Grunfeld., 2012). The perceived lack 
of control and uncertainty related to a cancer diagnosis may also contribute to 
psychological distress (Cunningham, Lockwood, Cunningham, 1991). Even when in 
remission, men often undergo frequent PSA testing which is likely to provoke fear 
and anxiety especially when PSA levels are unstable (Chism & Kunkel, 2009; Roth 
et al., 2006). Changing PSA levels may lead to the need for further treatment which 
may increase psychological distress.  
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Treatment Implications 
Depression and level of perceived stress contribute to the QoL of men with 
prostate cancer. Depressive symptoms have been found to be the strongest predictor 
of physical, emotional and functional well-being in a sample of men treated for 
prostate cancer (Eller et al., 2006). Depressive symptoms measured at 4 weeks post 
localised prostate cancer treatment have been found to predict a large number of 
disease specific and general QoL outcomes 4 months, 7 months, and 12 months post-
treatment (Monahan et al., 2007).  Not surprisingly, depression in men with prostate 
cancer has also been found to increase health resource utilisation (Jayadevappa et al., 
2011). 
 Evaluation of psychological distress, and the use of strategies to treat 
depression and anxiety, may be of use if incorporated into a comprehensive 
psychological treatment program for prostate cancer survivors. Changes in 
psychological function as a result of the losses and changes in function and lifestyle 
inherent in prostate cancer and its treatment may be in part a normal and adaptive 
response rather being pathological (Sharpley et al. 2009). Men may benefit from 
assistance in managing their loss of function (e.g., sexual function) in reducing 
psychological distress (Sharpley et al., 2009). In addition, addressing the uncertainty 
associated with the future of having prostate cancer should also be targeted when 
aiming to prevent and decrease rates of psychological distress. 
Kiss & Meryn (2001) suggested that psychological distress is too frequently 
ignored due to a belief that it is a normal response to having cancer. For some men, 
directly targeting psychological functioning may be of benefit, since for some men, 
distress, depression, and anxiety may be transient and decrease over time, while for 
others they may be sustained (Blank & Bellizzi, 2006). In addition, Roth et al. (1998) 
suggested that the use of educational and supportive type interventions as a 
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preventative measure to reduce distress and prevent development of psychological 
disorders. 
Summary 
Psychological implications of prostate cancer and its treatment are well 
documented. Some research has found that high rates of depression and anxiety have 
been found in samples of prostate cancer survivors, and there is some evidence that 
this has lasting effects. Mixed findings regarding the longer term psychological 
adjustment for men with prostate cancer highlight that potentially for some men 
distress improves over time, whereas for others it remains stable or increases. 
Adjusting to and managing some of the side effects of prostate cancer treatment, 
especially ED, is likely to influence a man’s psychological health. Several factors 
have been found and hypothesised to be implicated in the higher rates of 
psychological distress in men with prostate cancer and these factors should be 
integrated into psychosocial interventions. Such interventions should target both 
symptom management (e.g., sexual dysfunction) and psychological distress directly. 
Although rates of clinical depression are elevated in this population, lower sub-
threshold levels of psychological distress in men are still likely to require 
psychological support and assistance, particularly as a preventative measure in 
protecting against the development of significant psychological distress including 
anxiety and depression.   
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Chapter 4: Relationship Functioning and the Role of the Partner 
The patient and his partner are generally affected by the challenges of a cancer 
diagnosis together (Banthia et al., 2003; Galbraith & Crighton, 2008). In fact, 
prostate cancer has been referred to as the “relationship disease”, and the dyadic 
relationship is frequently framed as the “couple has cancer” (Badr & Taylor, 2009; 
Gray et al., 1999). This chapter outlines the theory and research relevant to 
relationship functioning, and the role of a partner with men who have prostate 
cancer. This section predominately focuses on men having a female partner. In this 
chapter, implications for psychosocial treatment for men with prostate cancer will 
also be evaluated. A core component of relationship functioning relates to intimacy. 
While sexual intimacy is covered in this section, the focus is on general intimacy 
which refers to the interpersonal process of expressing and responding to each 
other’s emotions within a relationship (Manne & Badr, 2008). 
Relationship Functioning and Prostate Cancer  
A cancer diagnosis can place significant strain on a relationship (Banthia et al., 
2003; Galbraith & Crighton, 2008). A couple’s relationship may be impacted at 
various stages of the cancer journey, including at cancer diagnosis, when discussing 
and deciding on treatment options, when going through treatment, and when dealing 
with post-treatment side effects (Beck et al., 2009; Manne et al., 2010). Manne et al. 
(2010) found that how a couple manages the concerns regarding cancer recurrence 
and progression, as well as personal and relationship needs, can impact on 
relationship functioning, in particular, relationship intimacy. 
 At the same time, the nature of relationship functioning prior to diagnosis can 
impact on how the disease and side effects are managed and coped with. One of the 
most important influences the spousal relationship has on the reaction to the 
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introduction of cancer is social support (Banthia et al., 2003). A strong and 
supportive relationship dyad can act as a buffer against distress (Banthia et al., 2003; 
Maliski, Heilemann, & McCorkle, 2001) and the negative effects of sexual 
dysfunction (Badr & Taylor, 2009) for both members of a couple.  
On the other hand, the degree of social support given to a patient from his 
spouse can be greatly reduced in a relationship which is under conflict and strain 
(Banthia et al., 2003). A recent study by Zaider et al. (2012) actually found that the 
diminishing relationship between sexual bother and masculinity was stronger for 
those reporting lower marital affection. In terms of relationship satisfaction, Couper 
et al. (2006) found that level of relationship satisfaction was different between 
patients treated for prostate cancer and partners at 6 months post-diagnosis, with 
partners displaying lower relationship satisfaction, while there was not difference at 
time of diagnosis. This suggests that a couple’s relationship is negatively impacted 
by prostate cancer and its treatment, and this may be experienced differently by each 
member of the couple. 
In addition, the level of support offered by a partner may be influenced by the 
negative impact prostate cancer can have on the partner. For example, higher rates of 
psychological distress have been found in partners of men diagnosed with prostate 
cancer, with one study reporting partners’ levels of major depression as twice that of 
a community sample (Couper et al., 2006). Levels of psychological distress have also 
been reported to be higher in partners than men (Cliff & MacDonagh, 2000; Couper 
et al., 2006). However, Ezer, Chachamovick, and Chachamovich (2011) found that 
men were more emotionally distressed than spouses at pre- and post-prostate cancer 
treatment and Eton, Lepore, and Helgeson (2005) found that there was no difference 
between men and partners on a measure of depression. Eton et al. (2005) found that 
while partners reported more distress than patients, this only applied to cancer-
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specific distress and there was no difference between men and partners on depressive 
symptoms. These differences could be in part because the samples used in these 
studies varied greatly in terms of time since diagnosis and treatment and the type of 
prostate cancer.  
The Partner, the Relationship, and Sexual Functioning 
While a cancer diagnosis alone is stressful and may impact on relationship 
functioning, the side effects of prostate cancer treatment, such as incontinence and 
ED, may also have a direct impact on a couple’s relationship (Gray et al., 1999). ED, 
and its potential impact on sexual functioning and sexual intimacy, may in turn lead 
to severe disruption of the couple’s relationship in other areas (Beck et al., 2009; 
Giesler et al., 2005). This is why ED is often referred to as a shared problem for 
couples, as the side effects impact on the man, his partner, and the dyadic 
relationship. Not surprisingly, clinical research has found that sexual dysfunctions in 
either sex can be both a cause and a result of relationship problems (Althof et al., 
2005). This may be particularly the case when many men react to ED by retreating 
from all physical contact or sexual intimacy, including touching, hugging and 
kissing, if intercourse is not possible (Boehmer & Clark, 2001; Galbraith & 
Crighton, 2008). 
Research using interviews and focus groups has found that both members of a 
couple are concerned about how the loss of erectile function, and how the man’s 
ability to cope with this will influence the relationship (Boehmer & Babayan, 2004). 
Indeed relationship quality has been found to be correlated with sexual satisfaction in 
a sample of men predominately treated for prostate cancer (Nelson et al., 2007). 
However, research has found differences in the emphasis men and women in a 
relationship place on the importance of the loss of erectile functioning. Men have 
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been found to be more distressed than their partners across sexual relationship and 
sexual adjustment domains of functioning, which may threaten their identity (Ezer et 
al., 2011). 
On the other hand, women have been found to place more importance on 
prolonging their partner’s life over maintaining sexual function (Boehmer & Clark, 
2001; Petry et al., 2004), and to be less concerned with their partner’s actual sexual 
function compared to how their partner would cope with these changes and how 
these problems would impact on intimacy and relationship quality (Boehmer & 
Babayan, 2004; Petry et al., 2004). Women do not appear to be as focused on the 
necessity of an erection for sexual pleasure and satisfaction (Neese, Schover, Klein, 
Zippe & Kupelian, 2003; Wittmann, Northouse et al., 2009) and to be more focused 
on other dimensions of a relationship, such as companionship (Boehmer and 
Babayan’s, 2004).  
Other research has found that female partners are concerned about the direct 
impact ED may have on their sexual relationship (Neese et al., 2003; Sanders, Pedro, 
Bantum, & Galbraith, 2006). Neese et al.’s (2003) focus group study with 164 female 
partners of prostate cancer survivors found that 38% were dissatisfied with their sex 
life and many were found to believe that seeking help for a sexual problem would be 
beneficial and should be a mutual decision (Neese et al., 2003). This suggests that 
while many women are supportive of their partners during cancer and its treatment, 
women are significantly impacted by the changes in their partner’s sexuality.  
However, Neese et al. (2003) found that many female partners admitted to 
having no interest in getting help for sexual problems, and suggested that both the 
stress of the prostate cancer and the negative impact a man’s ED has had on the 
couple’s sexual relationship, may contribute to a partner’s loss in sexual desire and 
interest. Not surprisingly, female sexual dysfunction can be a further complicating 
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factor in sexual rehabilitation for men (Badr & Taylor, 2009; Schover et al., 2002a; 
Wittman, Montie, Hamstra, Sandler, & Wood Jr, 2009; Wittmann, Northouse et al., 
2009). Partners’ sexual problems, often related to postmenopausal difficulties, can 
further contribute to a difficult time in adjusting to the changes of male sexual 
functioning, often provoking joint anxiety surrounding sexually pleasuring each 
other (Wittmann, Northouse et al., 2009). Hence, incorporating sexual therapy that 
aims to improve female sexual function may impact on sexual functioning for the 
male and the overall relationship. Research has also found that having a partner who 
still enjoyed and wanted sex was as an important factor in improving sexual 
rehabilitation outcomes (Schover et al., 2002b). 
Communication and Relationship Functioning  
 A couple’s communication is thought to be especially affected by prostate 
cancer and its treatment, and poor communication by either partner can lead to 
misunderstandings (Galbraith & Crighton, 2008). Specifically, couples may not 
openly discuss their concerns regarding sexual dysfunction (Galbraith & Crighton, 
2008), or the possibility of the man’s life being under threat (Manne et al., 2010). 
The Relationship Intimacy Model of Cancer (Manne & Badr, 2008) suggests 
communication can either be defined as relationship enhancing or relationship 
compromising. Relationship enhancing communication has a positive effect on the 
relationship functioning by improving aspects such as closeness, self-disclosure of 
cancer-related concerns and associated emotions. This model suggests that 
improving relationship communication may influence a couple’s psychological 
distress and adaption by its impact on relationship intimacy. On the other hand, 
relationship compromising communication and behaviour, for example, withholding 
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concerns and avoiding discussions, can reduce the level of relationship intimacy 
(Manne & Badr, 2008). 
 Research on men with prostate cancer and their partners has found couples 
struggle to disclose some information to each other and may use avoidant coping 
styles in discussing cancer related concerns and worries (Lavery & Clarke, 1999). 
Specifically, men have been found to have difficulty discussing physical changes, 
including erectile functioning, while women showed hesitation in sharing their 
emotional reactions to cancer and discussing their concerns (Boehmer & Clark, 
2001). Research with couples has also found mutual avoidance communication style 
was associated with higher marital distress (Badr & Taylor, 2009). 
  In relation to ED, open sexual communication is considered imperative to the 
adjustment to sexual functioning changes after prostate cancer treatment (Incrocci, 
2006b). Garos, Kluck, and Aronoff (2007) found that men with prostate cancer 
reported less frequent communication around sexual difficulties in comparison to a 
sample without sexual problems. Mutually avoidant communication has been 
associated with poorer erectile function (Badr & Taylor, 2009) and to inhibit sexual 
pleasure and emotional intimacy (Darst, 2007). Such a lack of communication may 
mean that men simply assume women are unaffected by changes in erectile 
functioning and associated intimacy, and coping mechanisms of avoidance and 
resignation are employed rather than actually having conversations with their 
partners (Boehmer & Clark, 2001).    
Treatment Implications 
Given the importance partners have in providing support for a man surviving 
prostate cancer, as well as the role that effective communication plays in relationship 
functioning, researchers have highlighted the importance of including the patient’s 
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partner in psycho-educational and counselling sessions regarding ED (Berterö, 2001; 
Neese, et al., 2003; Schover et al., 2002b; Wittmann, Northouse et al., 2009). 
However, in Australia, Chambers et al. (2008) suggested that current medical and 
support services are largely focused on patient outcomes and do not take into account 
a couple’s relationship, as well as overlooking the female partners’ needs.  
Research from focus groups mentioned previously would suggest it is 
particularly important to include partners when differing needs and levels of distress 
are apparent and at different times across the cancer journey. Different reactions and 
experiences to prostate cancer and its treatment, including sexuality and 
psychological functioning, suggest that interventions need to be sensitive to this 
information. For example, in regards to sexual functioning, Ezer et al. (2011) 
suggested that interventions should allow men to adapt to the loss of sexual function 
while encouraging women to support their men by providing reassurance about their 
masculinity. In addition, information provision to the couple about how their sex 
lives can be improved is also important (Ezer et al., 2011). 
Targeting communication style could be one means to help address these 
differences. The impact of communication style on relationship functioning and 
sexual functioning, suggests that therapy should aim to address both general and 
sexual communication skills. Improved communication, both general and sexual, 
may play a role in allowing different ways of expressing intimacy (both sexual and 
non-sexual), and as a result may assist to maintain a couple’s relationship and 
facilitate both partners’ adaptation in the face of sexual dysfunction (Badr & Taylor, 
2008). Specifically, improving knowledge of sexuality and developing sexual 
communication skills may result in improved communication, sexual relations, and 
intimacy potentially beyond pre-cancer levels (Darst, 2007; Wittmann, Northouse et 
al., 2009). Alternatively, avoidance will inhibit any potential sexual pleasure and 
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emotional intimacy and couples may withdraw from each other (Darst, 2007; 
Incrocci, 2006b). 
One way to improve couples’ communication is to develop skills using role 
plays, followed by discussion in a counselling session (Galbraith & Crighton, 2008). 
Homework assignments and spending time identifying problematic sexual and 
intimacy areas may facilitate improvements in dyadic communication (Galbraith & 
Crighton, 2008). Researchers have also cited the importance for psychosexual 
counselling to encourage and expand physical sexual contact to other forms of 
pleasure, since sexual desire and skin sensitivity remain unchanged post-treatment 
(Berterö, 2001; Schover, 1994). 
To date there has been limited literature focusing on the outcomes and 
relationship functioning for homosexual and bisexual men. It has been emphasised 
that homosexual men may have differing needs in the face of ED and relationship 
disruption, and that consideration of sexual preferences may be necessary when 
considering psychological treatment for this cohort of men (Latini, Hart, Coon, 
Knight, 2009; Kleinmann et al., 2012). The program developed in this thesis was 
open to men of any sexual orientation, however given the past research focus on 
heterosexual relationships the content was more appropriate for heterosexual men.  
Summary 
The impact that prostate cancer and its treatment can have on relationship 
functioning, as well as the impact of prior relationship functioning on management of 
symptoms is complicated. However, it is apparent that prostate cancer and the 
impacts of treatment, especially on ED, can have a significant effect on relationship 
functioning. There is also evidence for conflicting needs and opinions between men 
and women in dealing with erectile and sexual problems within a relationship, and 
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couples may often avoid discussing the impact of prostate cancer on their emotions 
and relationship. For some couples, communication needs to be addressed before 
sexual dysfunction improves, and general communication may need to be targeted 
prior to sexual communication specifically (Wincaze & Carey, 2001). Even if 
erectile function returns, men may be left with psychological and relationship 
distress and disruption, as a result of the loss of sexual function not being adequately 
addressed. As such, the importance of including the partner, and addressing general 
and sexual communication skills in treatment and intervention programs has been 
highlighted by several authors (Berterö, 2001; Darst, 2007; Incrocci, 2006b; Neese et 
al., 2003; Schover et al., 2002b; Wittmann, Northouse et al., 2009). 
This chapter provided an overview of the research on the impact prostate 
cancer and its treatment has on a man, his partner, and their relationship. In order to 
establish a psychosocial treatment program for men with prostate cancer, research 
suggests that inclusion of the partner may be beneficial.  The previous three chapters 
looked at sexual, psychological, and relationship functioning in men with prostate 
cancer. The next chapter will explore and evaluate treatment programs that have 
addressed these areas.  
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Chapter 5: Treatments for Sexual Functioning, Relationship Functioning, 
and Psychological Functioning in Prostate Cancer Survivors 
This chapter examines and evaluates past research targeting sexual, 
psychological, and relationship functioning in men who have been treated for 
prostate cancer. Initially, the chapter considers medical treatments for ED in men 
treated for prostate cancer. This is followed by an evaluation of psychosocial based 
interventions that have been developed and evaluated, focusing on sexual, 
psychological, and relationship functioning. T5he findings of these studies are 
summarised and limitations of the intervention programs are provided. 
Medical Treatments for ED 
Medical treatments for ED vary in their level of invasiveness and efficacy. The 
most common medical options include oral medications, vacuum constriction 
devices, intracavernosal injection therapy, and penile implant surgery. These aids are 
commonly used in men treated for prostate cancer. For example, Bergman, Gore, 
Penson, Kwan, and Litwin (2009) reported that from a sample of 425 men treated for 
localised prostate cancer, 56% of participants used some form of erectile aid within 
the 4 years post-treatment, even though none of the men in this selected sample used 
these aids prior to treatment for prostate cancer. Not surprisingly, those who were 
significantly bothered by their ED were more likely to use an aid. A much lower rate 
of 15% was found by Mols et al. (2009) in a sample of men 5-10 years post diagnosis 
who underwent a range of prostate cancer treatments. Schover et al. (2002b) found 
that 30% of their sample was currently using and 59% had tried at least one medical 
treatment for ED previously. 
Oral medications provide phosphodiesterase type 5 (PDE5) inhibitors in an 
easily utilised tablet form and are one of the most common forms of drugs used to 
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treat ED generally, as well as in men suffering ED as a result of prostate cancer 
treatment. PDE5-inhibitors, such as sildenafil, more commonly known as Viagra, 
produce their effects by relaxing the smooth muscles of the penis and increasing 
blood flow to the penis (Darst, 2007). Although oral medications are often a 
preferred treatment choice as they are not as invasive as other treatments, they 
generally have limited success in treating men with prostate cancer (Schover et al., 
2002b). Perhaps partly as a result of PDE5-inhibitors’ reduced effectiveness in ED 
caused by prostate cancer treatment, men may be less likely to continue using these 
drugs compared to men with ED from other causes (Schover et al., 2002b). 
Rates of success for erectile aids tend to vary. After undergoing surgery, 
researchers have found positive responses to sildenafil in their samples to be 29% 
(Zagaja, Mhoon, Aikens, & Brendler, 2000) and 31% (Blander, Sanchez-Oritz, 
Wein, & Broderick, 2000). In a review of studies, Montorsi and McCullough (2005) 
also found a greater response rate for successful use of sildenafil for nerve-sparing 
surgery (35%-75%) versus non-nerve-sparing surgery (0%-15%). After radiation 
therapy, positive erection response rates have been found to be between 71% (Kedia, 
Zippe, Agarwal, Nelson, & Lakin, 1999) and 91% (Valicenti et al., 2001). However, 
post-radiation (and pre-sildenafil), potency was comparably higher in Valicenti et 
al.’s (2001) study compared to Kedia et al.’s (2001). 
There are some proponents for the use of intracavernosal injections at regular 
time points aimed at preventing tissue damage and increase recover of spontaneous 
erections (Mulhall & Morgentaler, 2007). While there are some promising results for 
this method there have been calls for further research supporting its efficacy (Mulhall 
& Morgentaler, 2007). 
More invasive treatments for ED include penile injection therapy and vacuum 
constriction devices. Penile injection therapy is often used when drug therapy is 
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unsuccessful (King, 2010). CaverjectTM or other pharmacy mixed injection 
medications, drugs containing prostaglandins, are injected directly into the penis to 
create erections (King, 2010). Injection therapy has more positive results within the 
initial months after surgery compared to other treatments, as intact penile nerves are 
not essential (King, 2010). Vacuum devices consist of a cylinder which is placed 
over the penis, creating a vacuum which increases blood flow to the penis, allowing 
an erection to be maintained for up to 30 minutes (King, 2010). Vacuum devices 
have been suggested to be gaining in popularity recently as an attractive alternative 
to PDE-5 inhibitors which may be ineffective or produce unwanted side effects 
(Pahlajani, Raina, Jones, Ali, & Zippe, 2012). These devices may also be used in 
combination with PDE-5 inhibitors (Pahlajani et al., 2012). Pahlajani et al. (2012) 
state that although there may be high initial dropout rates for vacuum devices’ use, 
the proportion of men who are satisfied typically continue with this option for the 
long-term. Earlier research found that men displayed preferences for injections over 
vacuum devices (Soderdahl, Thrasher, & Hansberry, 1997). Fifty men were 
randomised to use penile injections or vacuum constriction devices, and 57% of men 
preferred penile injections compared to 27% preferring vacuum devices (Soderdahl 
et al., 1997). 
 Penile prosthesis (implants) are frequently used when a positive result from 
other ED treatments cannot be achieved (King, 2010; Wittmann, Montie et al., 2009). 
While the implant is highly likely to provide a firm erection, the surgery is invasive 
and not usually performed until 2 years post-radical prostatectomy (King, 2010; 
Wittmann, Montie et al., 2009). Penile prosthesis have been found to have a more 
positive impact on sexual functioning than drug therapy such as sildenafil and to also 
have the highest rates of satisfaction (Schover et al., 2002b). Schover et al. (2002b) 
found that only 16% of men reported that sildenafil greatly improved their sexual 
48 
 
functioning, whereas 44% reported that the penile prosthesis greatly improved their 
sexual functioning. Penile prosthesis may be particularly beneficial for those men for 
whom spontaneity of erections remains an important factor (Wittmann, Montie et al., 
2009). 
Limitations of medical treatments.  Although there are several medical 
treatments available to treat ED, there are large variations in reported efficacy rates. 
In addition, some men display a reluctance to use these treatments and men may also 
have unrealistic expectations of the efficacy of medical aids (Neese et al., 2003; 
Schover et al., 2002b). Research suggests that men want firm erections by non-
invasive means (Neese et al., 2003). Even though invasive treatments for ED have 
demonstrated greater efficacy, men appear more reluctant to utilise these treatments 
(Schover et al., 2002b), and find them difficult and not worthwhile (Neese et al., 
2003). Common complaints from men who use medical aids and reasons for 
reluctance to use these treatments include disruption in the spontaneity of sex 
(Mishel et al., 2002; Wittmann, Northouse et al., 2009) and fear of needles (Titta, 
Tavolini, Dal Moro, Cisternino, & Bassi, 2005). In Schover et al.’s (2002b) study, 
while 59% of men had tried one or more medical treatments for their ED, only 38% 
of these men actually found it helpful in improving their sex lives. In Potosky et al.’s 
(2004) large outcome study of men treated for prostate cancer by surgery or radiation 
therapy, the use of medical interventions for ED were not significantly correlated 
with ED at five years after diagnosis. 
Bergman et al. (2009) stated that given the generally higher rates of ED 
reported within prostate cancer samples compared to the rates of erectile aid use, this 
would suggests that there are a proportion of men who do not use erectile aids in the 
face of sexual changes after prostate cancer treatment. There may be some men who 
would prefer to improve their sexual function and sex lives by other means, either 
49 
 
exclusively or in conjunction with medical aids. Even if erectile function returns, 
with or without the assistance of medical aids, many men experience sexual and 
relationship distress and disruption, and changes in self-confidence (Beck et al., 
2009; Boehmer & Babyan, 2004; Bokhour et al., 2001; Schover et al., 2002a). These 
factors suggest that targeting sexuality, relationship functioning and psychological 
functioning through psychosocial interventions may be of benefit in conjunction to 
medically based interventions. In addition, such interventions may have a direct 
positive impact on erectile function, sexual function and sexuality more broadly, 
relationship function and psychological function.  
Psychosocial Interventions Targeting Sexual, Psychological, and Relationship 
Functioning  
There are a growing number of intervention studies in the literature targeting 
sexual, psychological and/or relationship functioning in men treated for prostate 
cancer. Identification of relevant studies was through a literature search using 
electronic databases: Medline, PsychINFO, PsycARTICLES and Cinahl. A variety of 
keywords were used to access psychosocial interventions and patient outcome 
variables and these were used separately and in combination. Keywords used to 
search title and abstract included prostate*, AND random*, AND psychosocial 
intervention OR psychological intervention OR psychosocial support OR 
psychological support OR psychotherapy OR *education OR *education OR 
counseling OR counseling OR rehabilitation OR social support OR behaviour*. 
Abstracts of identified records were screened for relevance according to the inclusion 
criteria (see below). Considering that not all abstracts highlighted the use of sexual, 
psychological and relationship functioning strategies, short-listed papers were 
retrieved in full and method sections were examined against these criteria. The 
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reference lists of relevant papers were screened for identification of additional 
relevant studies that may have been missed using the search strategy listed above. 
Retrieved studies were included if they were randomised controlled trials using 
samples of men diagnosed for prostate cancer of any stage, making up at least 80% 
of the sample (multi-tumour site interventions were included). Studies were required 
to have a psychosocial intervention in at least one arm of the study design, which had 
at least one strategy explicitly designed to address sexual, psychological and/or 
intimate relationship functioning difficulties. Interventions focusing exclusively on 
men with advanced prostate cancer or men who had not been treated for prostate 
cancer (e.g., decision making interventions) were also excluded. Studies were not 
retained if they included partners but did not also target sexual, psychological or 
relationship functioning. Finally, studies were not retained if they targeted partners 
only. 
Types of measures used by the interventions covered in this section vary, 
however the majority used some form of quality of life (QoL) measure which 
frequently addressed disease symptoms, psychological distress, self-concept, coping, 
social functioning, and overall adjustment to cancer. Outcomes for partners are 
specifically excluded as this is not a focus in this thesis. Table 1 summarises each of 
the interventions covered in this section, and only lists those measures that are 
relevant to sexual, psychological, and relationship functioning, which will be the 
focus of this thesis. In particular sexual functioning in terms of erectile function, 
sexual function, and other variables related to sexuality or masculinity; psychological 
functioning in terms of measures of psychological distress; and relationship 
functioning in terms of communication, support and relationship satisfaction with an 
intimate partner. Table 1 can be found at the end of this chapter. This section 
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categorises studies based on intervention type: peer support based, 
supportive/educative, and counselling/skills based interventions. 
 Peer support interventions.  Peer support is one means by which 
psychosocial issues in men surviving prostate cancer can be targeted. Support groups 
are thought to provide an opportunity to educate, explore and confirm specific 
opinions and issues that men find important or of concern (Weber et al., 2007). Two 
studies (Weber et al., 2004; Weber et al., 2007) implemented a dyadic peer support 
program where men recently treated for prostate cancer with surgery were paired 
with longer term survivors (3 or more years). Men were required to have sexual and 
urinary dysfunction in the anticipation that they would discuss these sensitive topics. 
Each dyad was required to meet eight times over eight weeks and were encouraged 
to discuss physical and emotional aspects of prostate cancer and treatment.  
In Weber et al.’s (2004) study, 30 men were allocated to the one-on-one peer 
support program or a control group.  A measure of depression, sexual function 
(erectile ability, sexual desire and orgasm function), and sexual bother was taken. 
The intervention significantly lowered depression scores at 4-weeks compared to 
controls; however these benefits were not maintained at 8-weeks. While the peer 
support program was not associated with any benefits in sexual function, sexual 
bother was significantly reduced for those who underwent the support program 
compared to controls at 8 weeks. Meetings typically went for around 60 minutes with 
the most popular topics discussed being incontinence, ED, and prostate specific 
antigen testing. While this study highlights the immediate change support can have, 
the sample size was very small. 
Weber et al. (2007) extended upon this peer support program by training peer 
support partners to recognise signs and symptoms of clinical depression. Seventy-
two men were randomly assigned to a control group or treatment group. Again, men 
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were encouraged to discuss thoughts and feelings associated with prostate cancer and 
the sexual and urinary side effects of treatment. It was found that the peer support 
group demonstrated significantly improved depressive scores from baseline and 
immediately following intervention (8-weeks), compared to controls. This study did 
not directly compare efficacy of intervention on sexual function.  
Supportive/educative interventions.  Several studies have used supportive 
and/or educative strategies to address sexual, psychological, and relationship 
functioning. Lepore, Helgeson, Eton, and Schulz (2003) randomly assigned 279 men 
treated for localised prostate cancer to a control, education or education-plus-
discussion intervention group. Interventions consisted of six weekly 1-hour face-to-
face lectures on a variety of topics including control of physical side effects, stress 
and coping, relationships and sexuality. These were run by experts in the area. The 
discussion group included an additional 45 minute weekly discussion on topics 
relevant to group members and female family members who attended separate group 
discussions. No treatment effects were found for sexual function or depressive 
symptoms. Lepore et al. (2003) found the education-plus-peer facilitated discussion 
arm of their intervention had a positive impact on sexual bother compared to 
controls, whereas education alone did not. Further analysis on the data from this 
study revealed significant moderator effects (Helgeson, Lepore, & Eton, 2006). 
Specifically, men with lower general self-esteem at baseline demonstrated greater 
improvement on psychological variables as a result of both of the interventions.  
Berglund et al. (2007) compared the efficacy of education sessions in a group 
format compared to a control group. Berglund et al.’s sample consisted of 158 men 
who had been diagnosed with prostate cancer in the last 6 months, were at different 
stages of disease progression and had used a variety of cancer treatments. Men were 
randomised into seven weekly sessions of face-to-face group therapy in three 
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formats: physical training only, information only, physical training and information 
combined, or usual care. Physical training consisted of general fitness training and 
relaxation training. Information sessions included information about prostate cancer, 
associated treatment, and the common side effects (including incontinence and 
sexual function). Group participants were given the opportunity to discuss 
experiences with each other and group leaders. Outcome measures included variables 
for depression and anxiety. The authors anticipated that physical activity would be 
associated with improvements in depressive symptoms, and information giving 
would be associated with reductions in anxiety. However, the interventions were not 
found to have any effect on the outcomes measures of anxiety and depression. 
Although nurse-led education targeted several topics that are likely to be distressing 
for men, education around anxiety and depression was not provided directly which 
may not have provided men with the knowledge to implement strategies to deal with 
psychological distress. 
Three other nurse run supportive/educative studies were conducted over the 
telephone. Firstly, Mishel et al. (2002) randomly assigned 239 men treated for 
localised prostate cancer into a control group or to an 8-week psycho-educational and 
support program delivered by trained nurses over the telephone. The intervention 
was given in one of two formats, with or without a significant other. The program 
targeted the specific needs of patients in relation to difficulties they experienced 
managing and coping with the impact of prostate cancer treatment. Although nurses 
were given a list of standardised topics to cover, semistructured interviews were 
conducted to assess areas of uncertainty and concern and men were encouraged to 
focus on topics important to them. Nurses assisted with providing information, 
problem solving, and communication, all relevant to specific problem areas. 
Strategies for ED included potency enhancement methods and information on 
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intimacy expression beyond penetrative sex. The most common problem areas 
identified were urine function, ED, communication with health professionals and 
general treatment side effects. This study found no effect of the interventions on 
erectile function or sexual satisfaction. Mishel et al. (2002) did find a moderator 
effect, where African American men displayed improved sexual satisfaction in the 
support group when a close family member was included compared to the control 
group.  
Northouse et al. (2007) conducted a supportive/educative intervention 
comprising of a 10-week couple program incorporating three home visits and two 
telephone calls from nurses. The final sample consisted of 218 men newly diagnosed 
and treated for prostate cancer at various stages of disease. The intervention focused 
on communication about prostate cancer and providing support and symptom 
management. The study demonstrated no effect of the intervention compared to the 
control group for general symptom distress, or prostate cancer specific symptoms 
including sexual function. Communication about the illness was improved at a 4 
month follow-up time point for patients; however, partner outcomes demonstrated 
improved communication at all three follow-up time points. Limited impact of this 
intervention on sexual function may be because, although symptom management was 
targeted, the program had limited material specific to sexual functioning.  
McCorkle, Siefert, Dowd, Robinson and Pickett (2007) also investigated a 
supportive/educative program for couples, by evaluating the efficacy of an 8 week 
post-hospital standardised nursing intervention with men with a variety of stages of 
prostate cancer. Contact was equally divided by the nurses between telephone 
sessions and home visits. The program targeted sexual, relationship and 
psychological functioning in both men and their partners. This program provided 
information and medical symptom management during the initial recovery after 
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surgery. The intervention also focused on restoration of sexual function and 
increasing intimacy between partners. Both patients and partners completed 
measures of sexual function, martial interaction, and depressive symptoms at 
baseline and 1, 3, and 6 months post-surgery. For patients, the intervention did not 
impact on sexual, relationship, or psychological functioning measures. Although 
emotional distress was listed as a major aim on their intervention, specific education 
and strategies targeting psychological functioning were not covered in any detail. 
In a comprehensive study of a supportive/educative intervention, Giesler et al. 
(2005) also addressed and measured aspects related to sexual, relationship and 
psychological functioning.  Giesler et al. (2005) examined the efficacy of a 6-session 
computer-assisted-nurse-driven intervention with 99 localised prostate cancer 
survivors and their partners, where participants were randomised to the intervention 
or standard care group. Sessions were over over 6 months, twice in person and four 
times by telephone. Giesler et al.’s intervention was highly tailored to the needs of 
participants. The program was aimed at targeting symptom management and 
providing psycho-educational strategies for dealing with a variety of problems 
according to patients’ individual needs. While all participants were provided with 
information on bowel and urinary function problems and given a video with 
sexuality and relationship content, a computer-assisted program was used to identify 
problem areas for further exploration. Strategies for further assistance with ED and 
dyadic adjustment difficulties were provided, including information on ED medical 
intervention methods, as well as communication skills development, such as active 
listening and expression of feelings. Depression associated with the side effects of 
prostate cancer treatment was targeted by addressing cancer worry (anxiety over 
cancer reccurrence). 
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At 4 months post-treatment, those who were in the intervention group reported 
significant improvements in sexual functioning. Although sexual bother was not 
reduced by their intervention, the degree to which activities were limited by sexual 
dysfunction improved in the intervention group at 7 and 12 month follow-ups (but 
not initial 4 month follow-up). The program did not impact on depression levels or 
dyadic adjustment scores. This study was particularly innovative in that computer 
assisted technology was utilised to provide the intervention information, and the 
study was also highly tailored to the needs of participants, including sexual needs. 
Lack of a treatment effect on relationship functioning measures may be because this 
was considered a more distal consequence of prostate cancer side effects, and not a 
major focus of the program. Further, the program was largely educational and no 
homework was given to consolidate new skills learnt. 
Skills based/Counselling interventions.  There have been a growing number 
of studies that have attempted to use skills based strategies in addition to psycho-
education in addressing psychosocial issues in prostate cancer survivors. Campbell et 
al. (2006) compared the efficacy of a 6-weekly couple telephone based CBT Coping 
Skills Training intervention to a control group using a sample of African American 
men with localised prostate cancer. Sessions were run by psychologists for men and 
their partners. The sessions included education around involving partners; 
developing skills for managing cancer symptoms and emotional distress; developing 
problem solving skills; relaxation training; communication skills; cognitive 
restructuring; and coping maintenance planning. A variety of measures were taken 
including the EPIC (Expanded Prostate Cancer Index) – see Table 1 for details. 
There was an effect size of .45 for sexual bother but this was non-significant, and 
there was no treatment effect for sexual functioning. A measure of mood state or 
relationship functioning was not taken for the men. Although Campbell et al. 
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emphasised the importance of the partner and the relationship in the context of 
prostate cancer, there were limited specific strategies targeting sexual functioning for 
the man and the couple. Additionally, there was a small final sample size of 30 
accounting for the non-significant moderate effect size found for sexual bother. 
Stress management has been viewed as an appropriate intervention for 
improving psychological distress and other QoL domains in cancer survivors (Chism 
& Kunkel, 2009). A research group led by Penedo (Penedo et al., 2004; Penedo et al. 
2006; & Penedo et al., 2007) conducted a series of RCTs (Randomised Controlled 
Trials) investigating the efficacy of a group-based Cognitive Behavioural Stress 
Management (CBSM) program using various populations of men with prostate 
cancer. The CBSM program was run over 10 weeks, led by a psychologist or 
graduate level psychologist, and focused on developing relaxation and cognitive 
behavioural approaches to stress management aimed at improving QoL in men with 
prostate cancer. The intervention included targeting distorted cognitions and 
communication skills training, in addition, some of the skills were designed to assist 
with the management of ED and spousal relations. Information was provided on ED 
and it was emphasised that prostate cancer is a couple’s disease. All three studies 
used the Function Assessment of Cancer-Therapy General Module (FACT-G) to 
measure QoL across four domains (physical, social and family, emotional, and 
functional). 
Firstly, Penedo et al. (2004) investigated the efficacy of this program using an 
ethnically diverse sample of 91 men treated for localised prostate cancer and 
secondly Penedo et al. (2006) used a larger sample of 191 men treated for localised 
prostate. Both these studies did not take specific measures of sexual, psychological, 
or relationship functioning, and instead focused on general QoL as this was the focus 
of their intervention. Both studies found treatment effects for QoL.  
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Penedo et al. (2007) investigated the efficacy of the CBSM group intervention 
using a sample of Spanish Monolingual Hispanic men treated for localised prostate 
cancer. Penedo et al. (2007) analysed the emotional well-being subscale of the 
FACT-G separately and found that this improved for the intervention group relative 
to control group. Penedo et al. (2007) also obtained a measure of sexual functioning 
using the EPIC and found that overall sexual function improved for those in the 
intervention group compared to controls. 
Molton et al. (2008) utilised a similar 10-session group-based CBSM program 
specifically aimed to improve sexual functioning as well as general psychosocial 
outcomes, using a sample of 101 men treated for localised prostate cancer. The 
comprehensive intervention program included psycho-education about sexual 
function restoration, relaxation exercises, challenging distorted cognitions 
surrounding sexual performance, redefining sexuality beyond intercourse, and 
developing sexual communications to use with partners. Participants who received 
the intervention demonstrated significantly better sexual functioning (quality and 
frequency of erections as well as desire) in comparison to participants who 
completed the control condition of a 4-hour workshop on stress management skills. 
Although a measure of sexual bother was taken, this was not detailed in the results. 
Men with higher interpersonal sensitivity (reflecting a tendency to be overly sensitive 
and more likely to see ED as a threat to their masculinity) demonstrated a 
significantly greater improvement in sexual functioning as a result of taking part in 
the CBSM intervention. This suggests that targeting masculinity as a part of psycho-
education may be beneficial for improving sexual functioning. However, while 
Molton et al.’s program attempted to broaden men’s definitions of sexuality, psycho-
education on masculinity was limited.  
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Three skill based studies used couple or individual therapy to assist with sexual 
and relationship difficulties as a major focus. Canada, Neese, Sui, and Schover 
(2005) and Titta et al. (2006) developed two couple focused face-to-face manalised 
interventions using strategies from CBT and sex therapy to address the complex 
relationship between sexual problems and relationship variables. Firstly, Canada et 
al. (2005) developed a manualised face-to-face sexual rehabilitation program for 
localised prostate cancer survivors that also targeted sexual and relationship 
functioning. Fifty-one men who had undergone surgery or radiation therapy were 
randomised to one of two intervention formats. This study also incorporated aspects 
of sex therapy, including sensate focus exercises, which aimed to expand physical 
and sexual contact.  The program incorporated CBT techniques focused on negative 
beliefs surrounding cancer and sexuality; psycho-education on the impact of 
treatment on sexual function; assistance with medical treatments for ED; and skills 
training to improve general and sexual communication. Participants were required to 
complete behavioural exercises by themselves and with their partners. Measures of 
sexual, relationship, and psychological functioning were taken at baseline, post-
treatment, and at three and 6 month follow-ups. 
Canada et al. (2005) also aimed to directly assess the influence of including the 
partner in a treatment program by comparing the 4-session program in a couple 
versus individual format.  Since no difference was found between the two 
interventions, the groups were merged for further analyses. Psychological distress 
improved across all time points relative to baseline, but was only significantly 
different at 3-month follow up. Both intervention groups demonstrated positive 
effects for erectile and orgasmic function, intercourse satisfaction, overall sexual 
satisfaction, and partners’ sexual function at 3 months; however, these gains 
regressed to baseline at 6 month follow up. The programs found reductions in 
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emotional distress at 3-month and 6-month follow ups. Positive effects were also 
found for use of medical treatments for ED, where the use increased from 31% at 
baseline to 49% at 6-months follow up. Those who completed their homework 
exercises were more likely to use ED treatments successfully, suggesting use of 
homework exercises can make an intervention more efficacious. The presence of a 
partner did not appear to influence outcomes and the intervention did not impact on 
dyadic adjustment scores. While this study uniquely compared the potential benefits 
of a partner, no control group was used. A further limitation of this study was the 
high level of non-compliance and a drop-out rate of 39%. Reason for dropping out 
included high marital distress and discomfort with explicit sexual topics.  
Titta et al. (2006) investigated the effects of a couples’ sexual counselling 
intervention. While some studies have incorporated education about the use of ED 
medical treatments, Titta et al. directly compared a medical intervention for ED with 
and without counselling. Fifty-seven men who had been treated for localised prostate 
cancer by surgery or muscle-invasive bladder cancer by cystectomy, were 
randomised to receive intercavernosal injection therapy (ICI) or sexual counselling-
plus-ICI. The sample was predominately prostate cancer survivors. Female partners 
were encouraged to attend therapy sessions. Although both intervention groups 
experienced improvements in erectile function over an 18 month period, the 
counselling-plus-ICI group reported comparatively higher erection function, sexual 
desire and satisfaction, and higher compliance with medical treatments. While this 
study did not use a control group, it highlights the potential positive influence 
counselling can have on medical treatment compliance. The counselling group 
demonstrated greater response to Sildenafil and greater satisfaction with injection 
therapy in an ICT-plus-counseling group as opposed to an ICT-only group. Also, 
participants who received the ICT-plus-counselling intervention demonstrated much 
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higher partner participation in the medical intervention than participants who 
received ICT-alone (89.6% versus 28.5%). 
Both the Canada et al. (2005) and Titta et al. (2006) studies demonstrated 
improvements in several aspects of men’s sexual functioning, including erectile 
function. Importantly, these studies also provided support for the utility of sexual 
intimacy programs that assist with compliance of medical treatments for ED. It is 
important to note, however, that these findings were observed in studies with a small 
sample size (Canada et al., 2005, Titta et al., 2006), a mixed cancer sample (Titta et 
al., 2006), or no control group (Canada et al., 2005).  
Finally, a recent study by Manne et al. (2011) investigated the impact of 5-
sessions of couple based Intimacy Enhancement Therapy (IET). Sessions were run 
by psychologists for men diagnosed and treated for localised prostate cancer in the 
last year. The IET program aimed to improve couple’s ability to share thoughts and 
feelings regarding cancer, facilitate discussion of concerns, and improve overall 
emotional intimacy. There was in-session practice of skills (e.g., communication) 
and joint homework. A final 54 couples who completed the IET or usual care were 
compared across a variety of relationship quality, communication and psychological 
distress measures. The authors did not find any treatment main effects for 
psychological distress, dyadic adjustment or a variety of relationship communication 
outcomes, including level of disclosure, responsiveness, and use of mutually 
constructive communication.  
However, Manne et al. (2011) found several moderator effects for patients. 
Those patients with lower levels of effective communication demonstrated 
significant improvements for each of those measures (including self-disclosure, 
perceived partner disclosure, and partner responsiveness) as a result of engaging in 
the intervention. While Manne et al. demonstrated that a couple focused intimacy 
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intervention can assist couples with more severe relationship difficulties, this 
intervention did not adequately address sexual function, which is known to influence 
relationship variables.  
Most recently Collins et al. (2013) developed and pilot tested a 4 week face-to-
face couple’s program for men recently diagnosed with localised prostate cancer 
called Cognitive Existential Couple Therapy. This intervention focused on the 
patient-partner relationship and aimed to reduce psychological distress, and enhance 
coping and relationship functioning. The program focused on several areas 
commonly viewed as a concern including dealing with uncertainty about the future, 
coping with diagnosis and treatment side effects while focusing on the impact on the 
couple’s relationship with an emphasis on sexual impact. Although the intervention 
was manualised, a questionnaire after the first session gave some direction on which 
concerns to address. The intervention was pilot tested on 12 men, with 10 men 
reporting outcome data. There was no significant effect on relationship function 
measures or depression and anxiety. There was significant improvements on a scale 
reporting psychological distress in relation to experience of traumatic events. 
Summary of psychosocial interventions.  Studies that have been evaluated in 
this section vary in terms of the use of platforms (telephone, face-to-face); strategy 
(group, supportive, educative, counselling); partner inclusion (no, requirement, or 
recommendation); the degree of assistance (self-management versus therapist 
assisted); and whether the intervention targeted a single problem or had a multi-
problem focus. Some studies focused on sexual, psychological or relationship 
functioning as a minor focus within the context of general symptom or stress 
management focus, whereas others made these factors a major focus of the 
intervention.  
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The majority of reviewed studies targeted sexual functioning to some degree, 
with approximately half of these finding significantly positive effects for at least one 
arm of their intervention (Canada et al, 2005; Giesler et al., 2005; Molton et al., 
2008; Penedo et al., 2007; Titta et al., 2006). There was a trend towards interventions 
that had sexual functioning as a major focus, and used more complex intervention 
strategies (psychological counselling or CBT), as opposed to supportive/educative 
strategies, being more effective in improving sexual functioning. Studies that used 
sex therapy techniques, aimed to broaden a man’s definition of sexuality and 
intimacy, engaged the partner in the intervention, and included information on ED 
medical aids appeared to be efficacious (Canada et al., 2005; Molton et al., 2008; 
Titta et al., 2006). One study using a supportive/educative strategies had a positive 
effect on overall sexual functioning (Giesler et al., 2005), and this study was also 
highly tailored to the needs of participants, including sexual needs, suggesting some 
level of choice may be important when engaging and addressing men’s difficulties. 
Several studies took a measure of sexual bother; only four studies analysed this 
in the results and only half found a positive effect. Some form of peer discussion was 
involved in those interventions that found a positive effect (Lepore et al., 2003 and 
Weber et al., 2004), suggesting that this may reduce a man’s feelings of bother 
around sexual problems. However, only four studies measured sexual bother, with 
half finding no effect of the intervention on sexual bother, making it difficult to draw 
any conclusions.   
Although several studies reported used a measure of psychological functioning, 
only three found a positive treatment effect in this area (Canada et al., 2005; Weber 
et al., 2004; Weber et al., 2007) and a further study found improvements for 
psychological distress related to traumatic events (Collins et al., 2013). Some studies 
reported that this may be because psychological functioning was low at baseline 
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(Canada et al., 2005; Lepore et al., 2003). Two of the studies that did find a positive 
influence on psychological functioning were peer support programs which found 
improved levels of depression (Weber et al., 2004; Weber et al., 2007). One study 
that had a positive influence on psychological distress largely focused on sexual and 
relationship functioning, suggesting that aiming to improve those areas can have an 
impact on psychological distress (Canada et al., 2005).  
For relationship functioning outcomes, the reviewed interventions provided 
limited evidence for the efficacy of interventions in improving relationship 
functioning for men, in terms of dyadic adjustment, marital distress, and 
communication. This was found across two supportive/ educative interventions 
(McCorkle et al., 2007; Gieser et al., 2005) and three counselling/psychological 
therapy interventions (Canada et al., 2005; Collins et al., 2013; Manne e al., 2011). 
The only positive effect found for relationship functioning was improvements in 
men’s communication with their spouse about their illness (Northouse et al., 2007). 
Even though a number of studies included a partner as an essential or 
recommended part of treatment (Campbell et al., 2007; Canada et al., 2005; Collins 
et al., 2013; Giesler et al., 2005; Lepore et al., 2003; Manne et al., 2011; McCorkle et 
al., 2007; Mishel et al., 2002; Northouse et al., 2007; Titta et al., 2006), only two 
studies directly compared the efficacy of an intervention with and without an 
intimate other (Canada et al., 2005; Mishel et al., 2002), with only one study having 
this person exclusively as a romantic partner (Canada et al., 2005). Both studies did 
not find a benefit from including a partner (Canada et al., 2005) or close family 
member (Mishel et al., 2002). However, Mishel et al. (2002) did find a moderator 
effect, where African American men displayed improved sexual satisfaction in the 
support group when a close family member was included. The lack of evidence for 
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the benefits of partner inclusion is consistent with a past review (Cockle-Hearne & 
Faithfull, 2010). 
Given the suggestion that both a patient and partner may benefit from an 
intervention with partner inclusion (Berterö, 2001; Darst, 2006; Neese et al., 2003; 
Schover et al., 2002b; Wittmann, Northouse et al., 2009), it is surprising that more 
studies have not investigated this variable. While no other study directly compared 
the efficacy of an intervention with and without a partner, Titta et al. (2006) found 
that participants who received the ICT-plus-counseling intervention demonstrated 
much higher partner participation in the medical intervention than participants who 
only received ICT-only. 
Limitations of psychosocial interventions.  Several limitations need to be 
taken into account when interpreting the findings from these studies. Firstly, the wide 
variety of approaches to address sexual, psychological, and relationship functioning 
made interpretations of the findings difficult. As well as differences in the 
overarching strategy and theory, intervention techniques differed in terms of format 
and delivery, the use of homework, discussions, and in-therapy practice. Given that 
many interventions covered a range of areas in their intervention protocol, details 
about the specific nature of strategies for sexual, psychological and relationship 
functioning were sometimes limited. 
In terms of the content of interventions, although several interventions stated 
that their specific aims were to address areas of sexual, psychological and 
relationship functioning, some studies did not adequately address these areas. For 
example, they provided information on ED side effects without further strategies and 
skill development in the broader area of sexual functioning. For psychological 
functioning, the programs frequently targeted psychological distress and included an 
outcome measure on this, but failed to specifically address anxiety and depression, 
66 
 
instead focusing only on other areas that may indirectly influence these outcomes. 
Given the complex relationship between psychological functioning and sexual 
function, including intimacy and a man’s sense of manhood, it may be beneficial to 
target both areas directly. 
There were also limitations related to overall study design and characteristics. 
The heterogeneity of study characteristics, represented by differences in the duration 
of intervention, timing of interventions, follow-up times, measures used and sample 
characteristics (e.g., stage of disease), made it difficult to draw many definitive 
conclusions as to whether particular study design features were associated with 
greater efficacy. Control groups varied from non-specific interventions to basic 
information only. A further limitation was the use of small sample sizes and high 
dropout rates in some studies, making generalisability of any significant findings 
difficult.  
Although there was some consistency in the type of sexual, psychological and 
relationship functioning measures employed in the studies, single item measures 
were frequently used and several studies did not separate subscales on sexual, 
relationship, and psychological functioning for analyses (often within QoL scales). 
Separation of subscales in analyses is beneficial when comparing actual erectile 
function changes against other sexual functioning measures, and between sexual 
functioning and bother associated with sexual problems. The importance of this is 
highlighted in the results of the studies that found a positive impact on sexual bother 
(Lepore et al., 2003; Weber et al., 2007) but did not have an impact on other sexual 
functioning measures.  
Further, typical prostate cancer QoL  measures have been criticised for failing 
to assess the complexity of sexual functioning and call for the inclusion of aspects 
such as sexual self-concept and masculine identity in addition to symptom severity 
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and bother (Clark et al., 2003). Only two studies explored broader sexual QoL 
measures including interpersonal sensitivity (linked to masculine identify) (Molton et 
al., 2008) and activity limitations brought on by sexual changes (Giesler et al., 2005). 
In order to expand our understanding of sexual functioning after prostate cancer, 
researchers need to utilise measures that assess all aspects of sexual functioning 
including intimate activities, sexual bother, the use of therapeutic aids, and 
psychosexual constructs such as masculine identity and self-esteem. Recent research 
has emphasised the important of masculinity in men treated for prostate cancer 
(Messaoudi et al., 2011, Thornton et al., 2011; Zaider et al., 2012).  
Finally, participants were frequently heterosexual, partnered, Caucasian men 
from Western countries. There was only one study that acknowledged homosexual 
men by asking about sexual orientation (Manne et al., 2011). Latini, Hart, Coon and 
Knight (2009) has previously emphasised that homosexual men may have differing 
needs in the face of ED and relationship disruption. Demographic information 
provided from several studies in this review, suggests that around 20% of samples 
consist of single men. However, no study addressed the particular needs a single man 
may have in relation to his sexuality and thoughts around future relationships.  
Summary and Conclusion 
This chapter focused on reviewing psychosocial interventions addressing 
sexual, psychological and relationship functioning for men treated for prostate 
cancer. It was found that there is considerable variability in the attention to these 
aspects and in the types of psychosocial interventions used. The chapter highlighted 
the range of strategies that can be used to assist men and their partners cope with 
sexual, psychological and relationship functioning difficulties in the context of 
prostate cancer and its treatment. In summary, interventions where sexual 
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functioning was a major focus and where more complex strategies were employed 
(e.g., CBT and sex therapy), demonstrated some benefits for improving sexual 
functioning for men treated for prostate cancer. There is not yet sufficient evidence 
to determine whether psychosocial interventions are efficacious in improving sexual 
bother, psychological functioning, patients’ relationship functioning, or whether 
inclusion of an intimate partner improves treatment outcome. Any significant effects 
found in these studies should be treated with caution in the light of the 
methodological issues highlighted previously.  
These limitations indicate the need for further research to clarify whether 
psychosocial interventions improve sexual, psychological, and relationship 
functioning for men treated for prostate cancer. Limitations included poor use of 
measures (including failure to explore sexual bother separately from sexual and 
erectile function), lack of control groups, and failure to adequately address sexual, 
psychological and relationship functioning in the intervention protocol of these 
studies. Only three studies have addressed and measured all three areas of 
functioning. 
Past treatment approaches outlined in this chapter have predominately focused 
on the use of face-to-face, telephone, or a combination of face-to-face and telephone 
modalities, either in individual, couple or group format, and each with a moderate to 
high level of assistance and direction. Less is known about the use of largely self-
directed psychosocial treatment programs for men with prostate cancer. The 
following chapter introduces the internet as a platform for delivery of psychosocial 
interventions and the potential for this to be used in a self-directed manner for men 
with prostate cancer. 
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Table 1    
Characteristics and Outcomes of Included Studies 
Study Intervention 
Treatment 
Groups 
Sample size and 
characteristics 
Aspects of 
intervention related to 
SF, PF, RF 
Partner 
inclusion 
Outcome 
measures related 
to SF, PF, RF 
Assessment 
times Findings 
Berglund 
et. al., 
2007 
(Sweden) 
7 weekly 
sessions of 
face-to-face 
group therapy. 
(1) Physical 
training 
(2) Information 
(3) Physical 
training and 
information 
(4) Usual care 
(printed leaflets 
and opportunity 
to call nurse) 
Patients within 6 
months of PCa 
diagnosis. Range 
of treatments and 
disease 
progression. 
Mage = 69 
N(rand): 211 
N(base): 194 
N(comp: 158 
Two sessions led by 
psychologist on side 
effects (including 
sexual dysfunction). 
Information on sexual 
aids, solving 
problems related to 
sexual related side 
effects, and 
opportunity to discuss 
experiences with 
participants and group 
leaders. 
No EORTC - 
several subscales 
related to 
functioning and 
symptoms, 
however no 
questions 
regarding sexual 
function 
directly. 
HADS – 
depression & 
anxiety subscale. 
Baseline, 6m 
and 12m post-
intervention 
No treatment effect on 
anxiety or depression. 
Campbell 
et. al., 
2006 
(USA) 
6 weekly 
sessions 
telephone 
based CBT 
sessions.  
(1) Coping 
Skills Training.  
(2) Usual care 
(routine care) 
African American 
men with 
localised PCa 
(beyond the acute 
phase and 
treatment). 
Session 1: 
Information on how 
PCa affects 
relationship and the 
need to include 
partner. Session 3: 
Partner 
encouraged to 
listen to phone 
conversations. 
 
M age = 58.7 
EPIC: sexual 
function (erectile 
function, sexual 
desire, orgasm 
function), sexual 
bother, & sexual 
Baseline and 
post-
intervention. 
No significant impact 
on sexual function or 
sexual bother. 
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Study Intervention 
Treatment 
Groups 
Sample size and 
characteristics 
Aspects of 
intervention related to 
SF, PF, RF 
Partner 
inclusion 
Outcome 
measures related 
to SF, PF, RF 
Assessment 
times Findings 
Mage = 62.1 
N(rand): 40 
N(comp): 30 
 
communication skills 
including effective 
listening and 
speaking. 
total. 
 
 
Canada et. 
al., 2005 
(USA) 
4 face-to-face 
sessions of sex 
therapy. 
(1) Counseling 
without partner. 
(2) Counseling 
with partner. 
Men with 
localised PCa 
treated with 
surgery or 
radiation therapy 
in the previous 3-
60 months. 
Sample 88% 
Caucasian; 4% 
African 
American; 8% 
Hispanic. 
Mage = 65.5 
 
N(rand) = 84 
N(comp) = 51 
                      
Major focus on both 
relationship and 
sexual function. 
Obtained a 
relationship and 
sexuality history and 
set goals. Provided 
education around PCa 
and sexual 
dysfunction, 
information on 
medical treatments 
and troubleshooting 
problems with these. 
Communication 
strategies to improve 
discussions about 
cancer related 
emotions and sexual 
problems. Provided 
ways to increase 
intimacy and enjoy 
Criteria were 
man to be 
married/ 
defacto and 
partner willing 
to participate. 
 
M age  = 61.8  
IIEF: subscales 
for erectile 
function, sexual 
desire, orgasm 
function, 
intercourse 
satisfaction, 
overall 
satisfaction, and 
overall function. 
Also measured 
ED medical 
treatment use. 
DAS: 
relationship 
quality and 
satisfaction. 
BSI: global 
distress score, 
and depression, 
anxiety 
subscales.   
Baseline, 
post-
treatment, and 
follow-ups at 
3 and 6 
months. 
Presence of female 
partner at counseling 
did not influence 
outcomes; therefore 
the data from 2 groups 
was combined. At 
post-treatment and 3 
months there was 
improved male overall 
sexual function, 
erectile function, 
orgasmic function, 
intercourse 
satisfaction, and 
overall satisfaction. At 
6 month follow-up 
only sexual 
satisfaction remained 
significant. Use of 
erectile medical aids 
increased post-
treatment, and 
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Study Intervention 
Treatment 
Groups 
Sample size and 
characteristics 
Aspects of 
intervention related to 
SF, PF, RF 
Partner 
inclusion 
Outcome 
measures related 
to SF, PF, RF 
Assessment 
times Findings 
sex without an 
erection (including 
sensate focus 
exercise). Also 
addressed partner’s 
sexual needs and had 
joint homework tasks. 
 
 
remained stable at 3 
and 6 months. 
Psychological distress 
improved at 3 months 
relative to baseline. 
No changes in 
relationship function. 
Collins et 
al., (2013) 
Cognitive 
Existential 
Couple 
Therapy (6 
weekly couple 
face-to-face 
sessions) 
Pilot study – 
intervention 
only. 
Men undergoing 
treatment for PCa. 
Final sample 
60% surgery,  
40% radiation, 
hormone, surgery 
combinations 
Medianage = 64 
N(enrolled) = 12 
N(comp) = 10 
 
 
Exploring 
psychological 
changes and impact 
on couple’s 
relationship including 
sexual; major focus 
on exploring and 
promoting open 
communication and 
mutual support, 
including partner’s 
perspective. 
Criteria to be 
married/ 
defacto for at 
least 1 year and 
partner 
included 
throughout. 
MHI: overall 
mental health 
and subscales 
for depression 
and anxiety. 
IES-R: 
psychological 
distress related 
to traumatic life 
events. 
FRI: relationship 
function, 
expressiveness 
and conflict 
resolution. 
CSI: perceived 
level of support 
regarding PCa. 
Baseline and 
immediately 
post-test 
No significant 
treatment effects for 
general psychological 
distress and 
relationship variables. 
Positive impact on 
distress related to 
traumatic events. 
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Study Intervention 
Treatment 
Groups 
Sample size and 
characteristics 
Aspects of 
intervention related to 
SF, PF, RF 
Partner 
inclusion 
Outcome 
measures related 
to SF, PF, RF 
Assessment 
times Findings 
Giesler et. 
al., 2005  
(USA) 
Computer 
assisted 
symptom 
management 
program, 6 
monthly 
sessions (2 
face-to-face, 4 
phone) 
(1) Intervention  
(2) Usual care 
(not specified) 
Diagnosed with 
localised PCa and 
scheduled to have 
or had surgery, 
radiation, 
brachytherapy. 
Sample 87% 
Caucasian; 8% 
African 
American; 2% 
other. 
Mage = 63.8. 
 
N(rand) = 99 
N(comp) = 85 
At 1st visit all patients 
were given a video on 
PCa, managing 
symptoms, and 
sexuality and 
relationships. 
Program was then 
tailored to individual 
needs and sexual and 
dyadic adjustment 
concerns were in top 
three areas covered 
for tailored 
interventions. 
Sexual function - 
teaching dyadic 
communication skills, 
providing information 
about medical ED 
interventions. 
Relationship function 
- teaching active 
listening and how to 
express feelings to 
partner. 
Depression – one of 
Criteria for man 
to have 
spouse/partner 
who was 
willing to 
participate. 
PCQoL: sexual 
function, sexual 
bother, activity 
limitation by 
sexual 
dysfunction. 
 
DAS (cohesion 
and satisfaction 
subscales only). 
 
CESDS – 
depression.  
 
Baseline, 
follow-ups at 
4, 7, and 12 
months post-
intervention. 
Intervention displayed 
improved sexual 
function at 4m and 
sexual limitation 
improved at 7m and 12 
m follow up. 
No treatment effect on 
sexual bother or on 
dyadic satisfaction or 
cohesion. 
No main treatment 
effect for depression. 
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Study Intervention 
Treatment 
Groups 
Sample size and 
characteristics 
Aspects of 
intervention related to 
SF, PF, RF 
Partner 
inclusion 
Outcome 
measures related 
to SF, PF, RF 
Assessment 
times Findings 
the major problem 
areas. 
Lepore, 
2003  
(USA) 
6 weekly group 
lectures. 
(1) Education 
(2) Education-
plus-discussion 
(3) Usual care 
(not specified) 
Men with 
localised PCa 
treated in last 
month (range of 
treatments). 
Sample: 90% 
Caucasian; 9% 
African 
American; <1% 
other. 
Mage = 65.07 
N(rand) = 279 
N(comp) = 250 
One education session 
on stress and coping 
and on relationships 
and sexuality taken by 
a psychologist. 
Education-plus-
discussion arm 
included an additional 
45 minutes of 
facilitated group 
discussion. Female 
partners who attended 
lectures had separate 
discussions. 
Patient was 
encouraged to 
attend lectures 
with a 
significant 
other. 
UCLA-PCI: 
Sexual function 
(erectile ability, 
sexual desire & 
orgasm function) 
and sexual 
bother. 
 
CESDS – 
depression. 
Baseline, 2 
weeks, 6m, 
12m post-
intervention 
Men in the education-
plus-discussion 
intervention were less 
bothered by sexual 
problems than 
controls.  
Did not report how 
significant changes 
occurred over time. 
No treatment effect on 
sexual function. 
No treatment effects 
for depression. 
Manne et 
al., 2011  
(USA) 
5 couple 
sessions of 
manualized 
therapist IET 
(Intimacy-
Enhancement 
Therapy) 
(1) IET 
(2) Usual care 
(potentially a 
social worker 
visit and 
referral to 
psychologist/ps
ychiatrist). 
Men diagnosed 
localised PCa in 
last year and 
treated by 
radiation therapy, 
surgery or 
hormone therapy.  
Sample 88.7% 
Caucasian and 
IET aimed to improve 
couples ability to 
share 
thoughts/feelings 
regarding cancer, 
facilitate discussion of 
concerns, and 
improve emotional 
intimacy. In-sessions 
Criteria for man 
to be married/ 
defacto and 
include partner. 
 
M age = 55.7 
DAS: marital 
quality and 
satisfaction. 
PAIR: 
relationship 
intimacy. 
Communication 
measures (self-
disclosure, 
Baseline and 
post-
intervention. 
No effect of 
intervention on 
relationship 
satisfaction, intimacy, 
communication, or 
psychological 
functioning.  
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Study Intervention 
Treatment 
Groups 
Sample size and 
characteristics 
Aspects of 
intervention related to 
SF, PF, RF 
Partner 
inclusion 
Outcome 
measures related 
to SF, PF, RF 
Assessment 
times Findings 
11.3% non-white. 
Mage = 60 
N(rand) = 71 
N(comp) = 54 
skill practice and 
homework. 
responsiveness) 
CPQ: Mutually 
constructive and 
demonad-
withdrawn 
communication. 
MHI: 
psychological 
distress and 
psychological 
well-being 
subscales. 
McCorkle 
et al., 2007 
(USA) 
8 weekly post-
hospital 
standardized 
nursing 
intervention 
(SNIP) with 16 
contacts (50% 
home and 50% 
telephone). 
(1) SNIP 
(2) Usual care 
(as specified by 
urology clinic). 
Men with variety 
of diagnoses 
(including 
metastatic PCa). 
Sample 86% 
Caucasion. 
Mage = 60 
N(rand) = 126 
N(comp) = 107 
Patient, spouse and 
couple content 
focusing on 
reinforcing open 
communication, ways 
to coney love and 
support, exploring 
areas of conflict, and 
sharing concerns 
about intimacy. 
Booklet provided 
containing 
information on 
common myths, 
Criteria for man 
to be married or 
in a committed 
relationship and 
to include 
partner.  
 
M age = 56 
CARES: Sexual 
function (sexual 
interest, sexual 
dysfunction) 
Marital 
interaction 
(affection, 
overprotection 
by partner, and 
neglect by 
partner). 
CESDS- 
depression. 
 
Baseline and 
1, 3, and 6m 
post-surgery. 
Intervention did not 
impact on sexual, 
psychological or 
relationship 
functioning. 
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Study Intervention 
Treatment 
Groups 
Sample size and 
characteristics 
Aspects of 
intervention related to 
SF, PF, RF 
Partner 
inclusion 
Outcome 
measures related 
to SF, PF, RF 
Assessment 
times Findings 
misconceptions and 
sexual concerns, 
communication, and 
intimacy. 
 
Mishel et 
al., 2002  
(USA) 
8 weekly 
telephone calls 
for uncertainty 
management. 
(1) Telephone 
support  
(2) Telephone 
support and 
family member 
support. 
(3) Control 
(usual care & 
printed health 
information 
materials 
unrelated to 
PCa). 
Men with 
localised PCa with 
2 weeks 
postcatheter 
removal after 
surgery and/or 3 
weeks into current 
radiation therapy. 
Sample 56% 
Caucasian and 
44% African 
American. 
Mage = 64 
N(rand) = 252 
N(comp) = 239 
Information on 
potency enhancement 
methods, ways of 
expressing intimacy 
in other ways than 
intercourse, and 
general problem 
solving.  
Criteria for man 
to include 
family member 
(most were 
partners.) 
SDS: erectile 
function and 
sexual 
satisfaction. 
Baseline, 2m 
and 5m post-
intervention. 
No effect of 
interventions on 
erectile function or 
sexual satisfaction. 
Significant moderator 
effect for African 
American men where 
sexual satisfaction 
improved at 2 month 
follow-up in the 
telephone support and 
family member 
support intervention 
group compared to 
control. 
Molton et 
al. 2008  
(USA) 
10 weekly 
group CBSM 
sessions 
focusing on 
promotion of 
sexual 
(1) Intervention  
(2) Control (4 
hour workshop 
on stress 
management 
skills). 
Men recovering 
from surgery for 
localised PCa 
within 18 months. 
Sample 43% non-
hispanic white; 
Promotion of sexual 
functioning by 
providing information 
on treatment options 
for ED, broadening 
definition of 
No UCLA-PCI: 
Sexual function 
(erectile ability, 
sexual desire, 
orgasm function) 
and sexual 
Baseline and 
post-
intervention 
Improved sexual 
function in 
intervention group. 
Did not report sexual 
bother scores. 
Moderator effect also 
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Study Intervention 
Treatment 
Groups 
Sample size and 
characteristics 
Aspects of 
intervention related to 
SF, PF, RF 
Partner 
inclusion 
Outcome 
measures related 
to SF, PF, RF 
Assessment 
times Findings 
functioning. 38% Hispanic; 
18% African 
American. 
Mage = 60. 
N(rand) = 121 
N(comp) = 101 
sexuality, developing 
skills to discuss ED 
with partners, and 
challenging distorted 
cognitions around 
performance. 
bother. 
CASF: sexual 
function and 
masculine 
identity. 
found where those 
with greater 
interpersonal 
sensitivity 
demonstrated a greater 
increase in sexual 
function. 
Northouse 
et al., 2007  
(USA) 
10 weekly 
couple FOCUS 
sessions (3 
home visits 
and 2 
telephone 
calls). 
(1) FOCUS  
(2) Usual care 
(standard clinic 
care and 
support). 
Men newly 
diagnosed with 
PCa (65% - 
surgery and 
radiation therapy), 
biochemical 
recurrence (14%), 
or advanced stage 
PCa (21%). 
Sample 84% 
Caucasian; 14% 
African 
American; 2% 
other. 
Mage = 63. 
N(rand) = 263 
N(comp) = 218 
Couple intervention 
focused on 
communication about 
illness and providing 
each other with 
support. Symptom 
management was part 
of intervention but 
authors did not 
specify targeting sex 
or ED. 
Criteria for man 
to have a 
spouse/partner 
willing to 
participate. 
M age = 59. 
EPIC: erectile 
function, desire, 
orgasm, and 
sexual bother. 
FACT-G: 1 item 
related to 
satisfaction with 
sex life and 1 
item related to 
closeness with 
partner. 
MISS: 
communication 
with partner 
around illness. 
Baseline, and 
4, 8, 12 
months post-
intervention. 
No intervention effects 
on sexual function. 
Did not report sexual 
bother scores. 
Communication with 
spouse about patient's 
illness improved in the 
intervention group at 4 
month follow-up. 
77 
 
Study Intervention 
Treatment 
Groups 
Sample size and 
characteristics 
Aspects of 
intervention related to 
SF, PF, RF 
Partner 
inclusion 
Outcome 
measures related 
to SF, PF, RF 
Assessment 
times Findings 
Penedo et 
al., 2004  
(USA) 
10 weekly 
group-based 
CBSM 
sessions. 
(1) CBSM 
(2) Control 
(half day 
education 
seminar on 
stress 
management 
skills).  
Men with 
localised PCa 
treated by surgery 
or radiation in 
past 18 months. 
Sample 35% non-
hispanic white; 
34% Hispanic; 
22% African 
American; 9% 
other. 
Mage = 63.1 
N(rand): 92 
N(comp): not 
specified 
Focus on relaxation 
skills with cognitive-
behavioural 
approaches to stress 
management, 
including 
communication 
training. Skills were 
partially designed to 
assist with 
management of ED 
and spousal relations. 
Also provided some 
information on the 
mechanics and 
treatment for sexual 
dysfunction. PCa as a 
couple’s disease was 
emphasised.  
No FACT-G: 1 item 
related to 
satisfaction with 
sex life and 1 
item related to 
closeness with 
partner. 
 
Baseline, 2 to 
3 weeks post-
intervention. 
While overall QoL 
improved for those in 
intervention group, no 
analysis for sexual 
function separately. 
Penedo et 
al., 2006  
(USA) 
10 weekly 
group-based 
CBSM 
sessions. 
(1) CBSM 
(2) Control 
(half day 
education 
seminar on 
stress 
Men with 
localised PCa 
treated by surgery 
or radiation 
therapy in past 18 
months, and 45+ 
Focus on relaxation 
skills with cognitive-
behavioural 
approaches to stress 
management, 
including 
No FACT-G: 1 item 
related to 
satisfaction with 
sex life and 1 
item related to 
closeness with 
Baseline, 2 to 
3 weeks post-
intervention. 
While overall QoL 
improved for those in 
intervention group, no 
analysis for sexual 
function separately. 
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Study Intervention 
Treatment 
Groups 
Sample size and 
characteristics 
Aspects of 
intervention related to 
SF, PF, RF 
Partner 
inclusion 
Outcome 
measures related 
to SF, PF, RF 
Assessment 
times Findings 
management 
skills).  
years old. 
Sample 40% Non-
hispanic white; 
41% Hispanic; 
18% African 
American; other 
1%. 
Mage = 65.1 
N(rand): 235 
N(comp):191    
communication 
training. Skills were 
partially designed to 
assist with 
management of ED 
and spousal relations. 
Also provided some 
information on the 
mechanics and 
treatment for sexual 
dysfunction. PCa as a 
couple’s disease was 
emphasised.  
partner. 
 
Penedo et 
al., 2007  
(USA) 
10 weekly 
group-based 
CBSM 
sessions. 
(1) CBSM 
(2) Control 
(half day 
education 
seminar on 
stress 
management 
skills).  
Men with 
localised PCa 
treated by surgery 
or radiation 
therapy in past 21 
months. 
Sample Hispanic 
monolingual men. 
Mage = 65.5 
N(rand) = 93 
N(comp) = 71 
Focus on relaxation 
skills with cognitive-
behavioural 
approaches to stress 
management, 
including 
communication 
training. Skills were 
partially designed to 
assist with 
management of ED 
and spousal relations. 
Also provided some 
No EPIC: sexual 
function (erectile 
function, sexual 
desire, orgasm 
function), sexual 
bother, and 
sexual total 
score. 
FACT-G: 1 item 
related to 
satisfaction with 
sex life and 1 
item related to 
Baseline, 2 to 
3 weeks post-
intervention. 
Improved sexual 
function for the 
intervention group 
compared to control 
group. 
Did not report sexual 
bother scores. 
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Study Intervention 
Treatment 
Groups 
Sample size and 
characteristics 
Aspects of 
intervention related to 
SF, PF, RF 
Partner 
inclusion 
Outcome 
measures related 
to SF, PF, RF 
Assessment 
times Findings 
information on the 
mechanics and 
treatment for sexual 
dysfunction. PCa as a 
couple’s disease was 
emphasised.  
closeness with 
partner. 
 
Titta et al., 
2006 
(Italy) 
Short-term 
psycho-
dynamic 
counseling 
aimed at 
increasing use 
of erectile 
medical aids. 
(1) Intercaver- 
nosal injection 
therapy (ICT)-
plus-
counseling. 
(2) ICT-only 
88% of sample 
consisted of men 
treated for PCa 
with surgery. 
Mage = 63.5 
N(rand) = 57 
N(comp) = 49  
Couple's sexual 
history taken and a 
therapeutic alliance 
was formed between 
partners during 
counseling. Used 
sexual therapy 
techniques to consider 
couples' sexual 
behaviour and 
relationship and 
facilitate couples' 
communication about 
sexual problems. 
Investigate and assist 
with any fears & 
difficulties with ICT.  
Female partners 
encouraged to 
attend 
counseling 
therapy 
sessions and 
assist with ICT. 
IIEF: erectile 
function desire, 
orgasm function, 
intercourse 
satisfaction, 
overall 
satisfaction. 
Measured level 
of 
responsiveness 
to Sildenafil. 
Prior to 
surgery, post-
surgery, and 
3, 6, 9, 12, 18 
follow-up 
post-
intervention. 
Sexual function 
improved in both 
groups. At 18 month 
follow-up 
(significance not 
reported at other 
months) ICT-plus-
counseling group 
demonstrated greater 
improvements in 
erectile function, 
intercourse 
satisfaction, and desire 
than ICT-only group.  
ICT-plus-counseling 
group were also better 
responders to 
sildenafil and 
demonstrated higher 
partner involvement 
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Study Intervention 
Treatment 
Groups 
Sample size and 
characteristics 
Aspects of 
intervention related to 
SF, PF, RF 
Partner 
inclusion 
Outcome 
measures related 
to SF, PF, RF 
Assessment 
times Findings 
(89.6% versus 28.5%) 
and more partners 
performed ICT (37,5% 
versus 14.2%). 
Weber et 
al., 2004  
(USA) 
Dyadic peer 
support 
program. Met 
8 times in 8 
weeks. 
(1) Peer 
support  
(2) Control 
(usual care - 
not specified 
what this 
involved). 
Men with 
localised PCa 
recruited 6 weeks 
after surgery 
which resulted in 
urinary and sexual 
dysfunction. 
Sample 83% 
Caucasian; 13% 
African 
American; 2% 
Hispanic. 
Mage = 58 
N(rand) = 32 
N(comp) = 30 
Recent patients were 
paired with long term 
survivors (3+ years) 
who had surgery that 
resulted in urinary 
and sexual 
dysfunction. 
Encouraged to talk 
about sensitive topics 
including sexual 
dysfunction. 
No UCLA-PCI: 
sexual function 
(erectile ability, 
sexual desire, 
orgasm function) 
and sexual 
bother. 
GDS: 
depression. 
Baseline, 4 
weeks (middle 
of 
intervention) 
and 8 weeks 
(end of 
intervention). 
Peer support group 
was not associated 
with any benefits in 
sexual function, 
however less sexual 
bother was found for 
the peer support group. 
Lowered depression at 
4 weeks for 
intervention group, but 
not maintained at 8 
weeks. 
Weber et 
al., 2007  
(USA) 
Dyadic peer 
support 
program. Met 
8 times in 8 
weeks. 
(1) Peer 
support 
(2) Control 
(usual care - 
provided by 
their urologists) 
Men with 
localised PCa 
recruited 6 weeks 
after surgery 
which resulted in 
urinary and sexual 
Recent patients were 
paired with long term 
survivors (3+ years) 
who had surgery that 
resulted in urinary 
and sexual 
No UCLA-PCI: 
Sexual function 
(erectile ability, 
sexual desire, 
orgasm function) 
and sexual 
Baseline, 8 
weeks (end of 
intervention). 
Improved depressive 
symptoms in 
intervention group. 
Did not directly 
compare efficacy of 
intervention on sexual 
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Study Intervention 
Treatment 
Groups 
Sample size and 
characteristics 
Aspects of 
intervention related to 
SF, PF, RF 
Partner 
inclusion 
Outcome 
measures related 
to SF, PF, RF 
Assessment 
times Findings 
dysfunction. 
Sample 83% 
Caucasian; 11% 
African 
American; 2% 
Hispanic; 1% 
Asian. 
Mage = 60 
N(rand) = 81 
N(comp) = 72 
dysfunction. Support 
partners trained to 
recognise clinical 
depression. 
Encouraged to talk 
about sensitive topics 
including sexual 
dysfunction. 
bother. 
GDS: 
depression. 
function. 
SF= sexual functioning, PF = psychological functioning, RF = relationship functioning; PCa = Prostate Cancer; N(rand) = number participants randomized; N(comp) = number 
participants completed; EORTC = EORTC Quality of Life Questionnaire; HADS – Hospital Anxiety and Depression Scale; EPIC = Expanded Prostate Cancer Index; IIEF: 
International Index of ED; DAS = Dyadic Adjustment Scale; BSI = Brief Symptom Inventory; MHI = Mental Health Inventory; IES-R: The Impact of Events Scale-Revised; FRI = 
Family Function Index; CSI = Cancer Support Inventory; PCQoL = Prostate Cancer Quality of Life Scale; CESDS: Center of Epidemiologic studies- Depression Scale; UCLA-PCI: 
UCLA Prostate Cancer Index; PAIR = Personal Assessment of Intimacy in Relationships; CPQ = Communication Pattern Questionnaire; MHI = Mental Health Inventory; CARES = 
Cancer Rehabilitation Evaluation System; SDS = Symptom Distress Scale ; CASF = Concern about sexual functioning; FACT-G = Functional Assessment of Cancer Therapy; MISS 
= Lewis Mutuality and Interpersonal Sensitivity Scale; GDS = Geriatric Depression Scale. 
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Chapter 6: Internet-Based Treatment 
This chapter introduces the internet as a platform for providing psychological 
treatment for men with prostate cancer and their partners. In general, internet-based 
treatment for psychological difficulties and health problems are thought to have 
many advantages. These include the ability to provide psychological services to 
those who are geographically isolated with limited options for face-to-face treatment, 
to those with time constraints, and to those who prefer to work at their own pace, to 
their own needs and be able to review material as desired (Chambers, Baade, & 
Pinnock, 2010; Cuijers, Van Straten, & Andersson, 2008; Spek et al., 2007). The 
internet may also overcome any stigma and uncertainty in accessing mental health 
support services (Gega, Marks, & Mataix-Cols, 2004; Klein et al., 2009). Although 
the internet may not be appealing or helpful to everyone, the internet may capture 
those people who previously would not have accessed treatment (Spek et al., 2007). 
Internet-based treatment has been growing in many areas in the past 15 years, 
and more rapidly in the past 10 years. The following sections will outline and review 
the types of internet-based treatment used for mental health, health behaviour, and 
chronic illness, followed by a focus on the use to date of internet-based interventions 
for cancer with a specific focus on any interventions specific to prostate cancer. 
Throughout this chapter, research which has identified which structural or content 
related components of an intervention are likely to be effective will be highlighted. 
Internet-Based Treatment for Mental Health  
Internet-based psychological treatment has been used for a range of 
psychological disorders including panic disorder (e.g., Klein, Richards, & Austin, 
2006), , post-traumatic stress disorder (e.g., Lange, van den Ven, Schrieken, & 
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Emmelkamp, 2001), and depression (e.g., Cristensen, Griffiths, & Jorm, 2004). More 
recently internet-based psychological treatment has been applied to maternal 
depression (e.g., Sheeber et al., 2012), bipolar disorder (e.g., Smith et al., 2011) and 
eating disorders (e.g., Pretorius et al., 2009). 
The most common strategies used in internet-based psychological treatment for 
mental health has been Cognitive Behavioural Therapy (CBT). CBT is thought to be 
particularly amenable to the internet due to its structured format and ability to be 
converted to text (Cuipers et al., 2008; Ritterband, Thorndike, Cox, Kovatchev, & 
Gonder-Frederick, 2009; Spek et al., 2007). The rapid increase in internet-based 
treatment has resulted in some recent comprehsive reviews and meta-analyses.   
Firstly, Spek et al. (2007) reviewed RCTs evaluating the efficacy of internet-
based CBT programs for mood and anxiety disorders. Spek et al. (2007) included 
studies with no therapist assistance or minimal assistance, while specifically 
excluding studies where there was high level of support and where a relationship 
between therapist and participant developed. Measures included self-rating and 
clinican rating of depression and anxiety symptoms. Overall meta-analytic results of 
the 11 treatment studies found a large mean effect size, with a small mean effect size 
for depression and a large mean effect size for anxiety. Drop out rates for reviewed 
studies were between 3% and 24%. Spek et al. (2007) conducted further analyses 
comparing the studies based on level of support or assistance, categorised as having 
minimal support  (e.g., feedback and monitoring emails or telephone calls) or no 
support. Those studies that incorporated minimal support found a large effect size 
compared to a small effect size when no support was given. 
A second recent review paper by Griffiths, Farrer, and Christensen (2010) 
investigated the efficacy of CBT internet-based intervention targeting depression and 
anxiety. Studies included were also self-help websites or websites that had a self-help 
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component. Studies were excluded that had an active treatment control goup (e.g., 
peer support, medication, or other form of therapy). The review included eight 
studies targeting depression, 16 targeting anxiety, and two targeting both.  
Recruitment of participants varied greatly from formal diagnosis of a mood or 
anxiety disorder, use of screening self-report clinical screening tools, or participants’ 
self-selection. Studies also varied in terms of level of therapist assistance/support, 
with two out of eight of the depression studies having therapist support, and the 
majority of the anxiety trials having support. Median therapist time for the 
interventions was 155 minutes.   
Overall, Griffiths et al. (2010) found that 23 of these trials reported some 
evidence of effectiveness. The effect sizes found for anxiety and depression were at 
least as large as the effect sizes of previously reported face-to-face treatment. Effect 
sizes for depression were also comparable to anti-depressant medication. Although 
not statistically evaluated, the authors reported that this review suggests that internet-
based treatment can be effective without therapist input. This review was also limited 
in that it excluded studies that had an active treatment control group and only made 
comparisons of effect sizes to face-to-face treatment of previously reported statistics 
within past research. 
The comparative efficacy of face-to-face treatment to internet-based treatment 
is an important research question. Although no review paper has directly made this 
comparison, Cuijpers et al. (2010) conducted a systematic review and meta-analysis 
of studies that directly compared the effectivenesss of face-to-face therapy to guided 
self-help therapy for depression and anxiety disorders. The review covered guided 
self-help interventions including the internet, and also the use of booklets, computer 
programs, and audio recordings. Cuijpers et al. found that guided self-help and face-
to-face treatments did not differ significantly, and these findings were sustained at 
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longer term follow-ups of up to a year. The authors also found no difference in drop-
out rates across the two treatment modalities. 
Barak, Hen, Boniel-Nissim and Shapira (2008) conducted a broader meta-
analysis exploring the effectiveness of internet-based psychological interventions for 
a range of identified problem areas. Problem areas ranged from weight loss, stress, 
smoking cessation, to anxiety and depression across a total of 92 studies. Overall, 
across all dependent measures included in these studies, the effect size was found to 
be medium. Barak et al. (2008) also made comparisons across problem type and 
found that strongest effect sizes were for internet-based programs targeting anxiety 
disorders and the smallest were for weight loss. Barak et al. also found CBT to be 
significantly more efficacious than psycho-education or behavioural therapy. 
Although Barak et al. evaluated a large number of studies, they did not isolate the 
effects specific for psychological problems and physical problems clearly. The 
following section explores the use of internet-based treatment for health behaviour 
and chronic illness specifically. 
Internet-Based Interventions Targeting Health Behaviour and Chronic Illnesses 
Self-management approaches for health conditions have long been advocated 
(Bodenheimer, Lorig, Holman, & Grumbach, 2002; Coleman & Newton, 2005). In 
terms of chronic illnesses, a self management approach details the requirement for 
the individual to “manage the symptoms, treatment, physical and psychosocial 
consequences and life style changes inherent in living with a chronic condition” 
(Barlow, Wright, Sheasby, Turner, & Shapira, 2002, p. 178). Barlow et al. (2002) 
extends on this to suggest that effective self-management requires an individual to 
monitor their condition and influence cognitive, behavioural and emotional 
contingencies in order to maintain a high QoL. In a review of RCTs and non-RCTs 
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(i.e., within-group changes) targeting self-management strategies for a variety of 
chronic health conditions, Barlow et al. found support for the use of a variety of 
formats (e.g., booklets, lectures, audiotapes, buddy system, internet) in terms of 
increasing knowledge, promoting self-management behaviours, self-efficacy and 
health status. Interestingly, although few trials targeted psychological well-being, 
those that did found a greater improvement in mood. This review found support for 
self-management strategies, however, the internet was not a focus in this review as a 
limited number of studies had used internet-based treatment as this point in time. 
Given the need for promotion of self-management strategies in the area of 
health behaviour change and management of medical illnesses, it is not surprising 
that the internet has been growing as a platform to provide this service. Although 
most health based internet sites focus on information provision, there has been an 
increase in evidenced based strategies directed towards behaviour change in the 
context of health and illness. Using the internet to target such health psychology 
areas is thought to be highly useful considering the typically structured nature of the 
treatment approaches in these areas (Ritterband et al., 2003). 
Cuijpers et al. (2008) systematically reviewed RCTs or comparitative trials 
focusing on internet-based treatment for health problems, while excluding studies 
focusing on mental disorders.  Included studies used CBT to target behaviour change 
with participants who had existing physical disorders or health problems. The final 
study number was 12, and the included health conditions varied from chronic pain, 
insomina, chronic diseases (heart, lung, or diabetes), to tinnitus. Included trials 
varied greatly from self-help material over the internent with and without minimal 
support (emails or telephone calls), and predominately online contact with a therapist 
or moderator (in group or individual format). The content of the interventions 
typically included psycho-education, cognitive restructuring, relaxation techniques 
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and social skills training. Finally, the interventions varied in length, ranging from 4 
to 20 weeks. 
Effect sizes for studies targeting pain were moderate to large, and small effect 
sizes were found for headaches, and these findings were comparable to previously 
reported face-to-face treatment. For other health problems, results could not be 
grouped, and the effect sizes for these ranged from small to moderate. Several 
limitations of reviewed studies were reported, including: limited use of control 
groups other than wait-list controls; and none compared internet-based treatments 
directly to face-to-face or other treatments. 
In addition to chronic illness, internet-based treatments have also targeted 
behaviour change including smoking, alcohol, other substance abuse, weight loss, 
and HIV risk behaviours. Webb, Joseph, Yardley, and Michie (2010) systematically 
reviewed studies that compared a treatment condition that promoted some form of 
health behaviour change to a control condition or comparison group. Included studies 
were required to have a measure of behaviour related to health (e.g., alcohol 
consumption and physical activity). Importantly, Webb et al. (2010) also aimed to 
explore and identify which characteristics of internet-based interventions were 
related to significant positive health behaviour changes.  
Webb et al. (2010) found an overall small effect size found with great 
variability in the level of effect between 85 included studies.  The most commonly 
used behaviour change techniques included information provision, self-monitoring, 
and problem solving (includes identifying barriers). Although not used in many 
interventions, the use of stress management and communication skills training had 
the largest effect sizes. There was also greater benefit for the use of more strategies 
in a single intervention. 
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Webb et al. (2010) developed a coding system in order to explore the different 
modes of internet-based treatment delivery. Each type of delivery mode was divided 
into three categories: (i) automated functions – use of an enriched environment (e.g., 
videos, games), automated tailored feedback, automated follow-up reminders (e.g., 
tips); (ii) communicative functions – access to an advisor for advice, schedule 
contact with advisor (including emails); and (iii) supplementary modes – email, 
telephone, Short Messaging Service (SMS), CD-room, or videoconferencing. Studies 
using automated tailored feedback and an enriched online environment had small and 
significant effects on behaviour change, whereas automated follow-up reminders did 
not have a significant effect. For communicative functions, there were small to 
medium effects found for provision of access to an advisor and small effects for 
scheduled contact or peer-to-peer access. For supplementary modes – SMS had large 
effects, telephone use small-to-medium, and use of email had small effects. 
Internet-Based Treatment for Erectile Dysfunction 
Internet-based psychologcial treatments have also been developed for sexual 
dysfunction, including ED. A small number of programs have been developed and 
evaluated in populations of men without prostate cancer. Firstly, Leusink and Aarts 
(2006) developed a  website providing basic behavioural exercises and information 
on pharmaceutical treatment for ED with the option of a prescription for PDE5 
inhibitors. Use of the website by 98 men resulted in 81% of the participants reporting 
that their erections improved as a result of website use. However this study did not 
use a control group, as such it cannot be determined if erections improved 
spontaneously. The focus of this website was for men to initiate seeking help from a 
professional for their ED, and the website also focused heavily on medical treatment 
for ED. 
89 
 
 
 
Other researchers have developed specific internet-based psychological 
interventions and evaluated these in comparison to some form of an intervention 
group. McCabe, Price, Piterman and Lording (2008) and McCabe and Price (2008) 
developed a five module (over 10 weeks) internet-based CBT program for men 
suffering from ED called Rekindle aimed at targeting the psychological and 
interpersonal contributors to ED. The program consisted of sensate focus, 
communication exercises, and unlimited email contact with a therapist, and partners 
were heavily involved in the treatment process. Modules were covered in sequential 
order and were fed as each module was completed.  
Firstly, Rekindle was evaluated by McCabe and Price (2008) by comparing 
Rekindle on its own to Rekindle in conjunction with oral medication for ED in a 
sample of 12 men with ED. Results found that both groups improved across 
measures of sexual functioning, relationship functioning (relationship satisfaction) 
and personal well-being. Therefore, the use of medication in addition to 
psychological internet-based treatment did not seem to have any additive benefit to 
sexual function. Although the sample size for this pilot study was very small, 
McCabe and Price highlighted many benefits for men with ED, including those 
facing time constraints and embarrassment about accessing help. The authors also 
highlighted such a program may only be suitable for men who are motivated and 
committed.   
McCabe et al. (2008) compared Rekindle to a control group with a total of 31 
men. Findings revealed improved erectile functioning and sexual relationship 
satisfaction and quality for men who completed the program, and improvements 
were maintained over the 3-month follow up. However, other areas of sexual 
function, orgasmic function, sexual desire and overall satisfaction did not improve 
and while sexual relationship satisfaction improved, general relationship satisfaction 
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did not. The authors suggest that this is because the program used did not directly 
target general relationship functioning. While this study demonstrated benefits in 
erectile function from this program, targeting general relationship functioning may 
impact on other areas including sexual desire and overall satisfaction. This may be 
particularly relevant for a prostate cancer sample, where gains in actual erectile 
function may be limited by the impact of cancer treatment. 
A more recent study by Andersson et al. (2011) evaluated another internet-
based CBT program for ED using a sample of 78 men randomised to receive the 
treatment or a control condition. The 7 week CBT program provided a series of 
modules covering the biospsychosocial information on ED in terms of aetiology and 
maintenance, relationship exercises, exposure tasks, relaxation strategies, and repalse 
prevention. Therapists’assistance via emails provided support, clarified information, 
and reviewed participants progress through feedback. The control group had access 
to an anonymous forum with weekly topics added by a moderator. Results found that 
the treatment had a significantly postive impact on erectile performance in 
comparison to the control and this difference increased at the follow-up assessment 
point. There were no treatment effects for anxiety and depression. 
Internet use for Cancer Patients 
The types of internet health resources available for cancer patients have been 
divided into three categories: basic information, various types of social support and 
evidenced based interventions (Leykin et al., 2011). While the use of internet-based 
interventions has grown in both the mental health and general health setting, it has 
received relatively limited attention in the cancer setting, although in recent years 
growth in the cancer setting has started.  Internet-based resources for cancer have 
been criticised for frequently consisting of support sites and provision of information 
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(Chambers et al., 2010; Leykin et al., 2011). While these sites play a role in assisting 
cancer patients, they fail to actually treat and decrease psychological symptoms, for 
example anxiety and depression (Leykin et al., 2011). In addition to information 
provision and support, evidence based internet interventions aim to engage 
participants in learning and practicing methods of behaviour change that are 
empirically supported (Leykin et al., 2011). This section will firstly briefly highlight 
the use of online support groups in cancer followed by internet-based psychological 
interventions. 
Online support groups and forums for cancer patients. Although it is 
widely accepted that the online environment may be used by cancer survivors to 
share information and provide support, often in the form of online support groups, 
few researchers have investigated the efficacy of such groups. Three studies 
exploring the efficacy of online support groups are briefly outlined below.  
Winzelberg et al. (2003) investigated the efficacy of an internet support group 
for women with breast cancer, aimed at assisting women to develop new strategies to 
cope with their diagnosis. Seventy-two women were randomised to receive either a 
12 week internet-based social support group moderated by a mental health 
professional or a wait-list control group. Participants in the support group could read 
personal stories from survivors, were encouraged to share their personal experiences, 
and use a personalised and private web-based journal, with new topics introduced 
each week. Positive treatment effects were found for depression, cancer-related 
trauma, and levels of stress, but not for anxiety and other measures of coping. 
Satisfaction and acceptability with the support group was also reported to be high 
and participants logged into the site around three times per week. Although 
Winzelberg et al. (2003) found some evidence for the utility of online support groups 
for women with breast cancer, this study design did not allow for comparison to 
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another treatment group (e.g., face-to-face support group, information provision or 
psychological internet-based intervention). 
Salzer et al. (2010) explored the efficacy of an internet peer support program 
compared to a internet-based educational control condition using a RCT for 78 
women recently diagnosed with breast cancer. Limited details of the support program 
were given, other than that it was unmoderated and unstructured.  The intervention 
resulted in declines across QoL  and psychological distress in comparison to the 
control condition, while there was no differences for perceived social support and 
self efficacy. In contrast, acceptability and perceived benefit of the support program 
was rated as high, suggesting the women did receive some benefit from the 
intervention. The authors suggest that declines in QoL may be influenced by the 
sample consisting of newly diagnosed women with limited opportunity to receive 
advice from women with more experience. 
Finally, Wiljer et al. (2011) explored the utility and efficacy of a 12-week 
internet-based support group (forum) for women with gynecologic cancer focusing 
on psychosexual distress by randomising 27 women to a wait-list control condition 
or the intervention. Moderators posted weekly topics to encourage discussion and 
women were encouraged to post other discussions relevant to them. This was a pilot 
study and the authors explored the efficacy and feasibility of the program through 
semi-structured interviews and found that women reported several benefits from the 
support program including increased emotional well-being, positive outcomes for 
body image and sexuality. Women reported finding the online environment 
beneficial for dicussing sexual concerns.  
Internet-based interventions for people with cancer.  Two studies, using 
cancer samples, have developed interventions using a mixture of social support and 
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information provision or coping skills training. Firstly, van den Brink et al. (2003) 
developed an electronic health information support system for head and neck cancer 
patients in the Netherlands. The intervention group were loaned a computer with 
internet access for a period of 6 weeks after being discharged from hospital. Patients 
could communicate with hospital staff, gain information, montior symptoms and 
have contact on an online forum with fellow patients.  
Subsequently, van den Brink et al. (2007) evaluated the program with a cohort 
of head and neck cancer patients treated by surgery and the majority were men. The 
authors reported that patient use and satisfaction with the program were very high. 
Patient age was not a barrier (mean age 59 years and range 38-78) and nor was 
limited experiences with computers. Although the program demonstrated improved 
QoL outcomes compared to a control group, several QoL subscales were not 
significantly different to the control group, and only one of the improved outcomes 
remained at a 12 week follow-up.  
Owen et al. (2005) evaluated the efficacy of a 12 week online self-guided 
coping skills group in a peer based format using 62 women with early stage breast 
cancer. Participants were randomised into either a wait-list control group or the 
online intervention providing a bulletin board for asynchronous group discussion, a 
medical dictionary, a series of useful resources, information and coping advice for 
the management of physical symptoms, and six CBT-based coping skills training 
exercises.  Automatic emails were sent as reminders to engage in exercises and the 
forum. Fifty-three women completed post-test measures at 12 weeks from baseline. 
Although there were no main effects across QoL variables for the intervention group 
compared to the control group, Owen et al. found that women with lower self-
perceived health status improved on this variable across time as a result of being in 
the intervention group. Although this program offers some support for combining 
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CBT based strategies with peer support, the study design did not allow for evaluation 
of these aspects in isolation. 
Internet use for Prostate Cancer Patients 
The internet as a medium has been viewed as offering a unique opportunity for 
provision of psychosocial interventions and social support in prostate cancer 
survivors (Chambers et al., 2010).  In seeking support for psychosocial issues related 
to prostate cancer and its treatment, there have been several potential barriers 
implicated, and many of these barriers may be overcome by internet-based treatment. 
In addition to those benefits of internet-based options highlighted at the beginning of 
this chapter, the common morbidities of prostate cancer for which men may need 
assistance (e.g., sexual problems and incontinence) may increase stigma that men 
associate with seeking help. Specifically, it has been suggested that men may not be 
comfortable requesting information or assistance for managing ED (Wootten, 
Burney, Foroudi et al., 2007). In fact, both men with prostate cancer and health 
professionals may display discomfort and embarrassment with discussing sexual and 
intimacy issues (Galbraith & Crighton, 2008; Incrocci, 2006b). The anonymity and 
convenience of the internet means that discussion about often embarrassing and 
sensitive issues such as sexual dysfunction can be easier to disclose (Hall, 2004). 
The internet has also been found to be an attractive means to obtain medical 
information for prostate cancer survivors, especially information surrounding sexual 
rehabilitation (Davison, Keyes, Elliot, Berkowitz, & Goldenberg, 2004; Neese et al., 
2003). Participants in this research generally had a positive view of using the internet 
(Davison et al., 2004; Neese et al., 2003). Schover et al. (2004) found that help-
seekers for sexual problems were more likely to be distressed about ED and have 
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more positive attitudes regarding help seeking and have lower sexual satisfaction. 
These are the kinds of men that could be targeted in an internet-based intervention.  
Online support groups and forums for prostate cancer patients. Social 
support has been advocated for people with cancer because of its potential positive 
impact on QoL. In particular social support is thought to be beneficial for mental and 
physical health, in addition to helping adjustment to a diagnosis of cancer and what it 
entails (Lepore & Revenson, 2007). Face-to-face support groups for prostate cancer 
are common in Australia and have been found to provide men with information and 
emotional support while reducing feelings of social isolation (Steginga, Pinnock, 
Gardner, Gardiner, & Dunn, 2005). The online environment may provide additional 
benefits. Chism and Kunkel (2009) suggested that social networking sites and online 
groups can offer a non-threatening space for men to explore and express difficulties 
and concerns. 
It is generally acknowledged that online support groups for men with prostate 
cancer exist in the form of both information and support. Most research has focused 
on evaluating the content of messages of already running online groups, with limited 
research detailing specific trials evaluating the efficacy of online support groups for 
men with prostate cancer. Blank, Schmidt, Vangsness, Monteriro and Santagata 
(2010) recently explored the content of messages over a 1 month period on prostate 
and breast cancer groups’ websites. Two internet resources were included, WebMD 
and Google Groups. Both of these are free and individuals can create comments and 
respond to topics as they choose. Interestingly, 80% of posts were from cancer 
survivors compared to those newly diagnosed. Blank et al. (2010) further categorised 
the content of messages into several categories and sub-categories. Although 
women’s messages were more likely to offer emotional support, men were more 
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likely to post messages related to intimacy issues, with 77.6% of intimacy classified 
posts for men with prostate cancer being related to sexual performance. This suggests 
that men may find a forum or bulletin board as a valuable to explore intimacy issues. 
Consistent with Blank et al.’s (2010) findings, others have suggested that 
women are more emotionally expressive and men prefer to share information (Kiss 
& Meryn, 2001; Zakowski et al., 2003). Zakowski et al. (2003) also stated that 
although men tend to seek support primarily from their partners, compared to multi 
social supports that women access, there is little evidence that men do not want to 
engage in support groups. The lack of empirically developed support groups, 
including online, for men with cancer means that men may be disadvantaged, 
especially single men who lack support from a partner. The groups that do exist that 
have been evaluated in Blank et al.’s (2010) study have not been designed 
specifically for evaluation and do not have a particular moderator who posts 
comments, as seen in previous studies using support groups for women (Salzer et al., 
2010; Wiljer et al., 2011; Winzelberg et al., 2003). It could be that a moderator 
forum increases engagement and the benefits men may receive from online support 
groups. 
Internet-based treatment for prostate cancer patients.  Although there have 
been several studies exploring the efficacy of internet-based programs to assist with 
screening and treatment decisions (e.g., Berry et al., 2006; Frosch, Bhatnagar, Tally, 
Hamori, & Kaplan, 2008), to date there have only been two psychological internet-
based interventions targeting men with prostate cancer dealing with survivorship 
issues. Firstly, Kazer, Bailey, Sanda, Colberg, and Kelly (2011) developed an 
intervention to assist men with the uncertainty that comes with having prostate 
cancer treated by active surveillance. This 5 week program included general 
97 
 
 
 
information about prostate cancer and active surveillance, cognitive reframing, self-
care management strategies (e.g., weight loss, exercise, smoking cessation), and 
tailored emails addressing specific problems or issues relevant to individuals (e.g., 
disease progression or relationship concerns). Kazer et al. evaluated the program 
using a single-subject design using nine men and found eight out of 12 measures of 
QoL demonstrated improvements at 5 weeks, but returned to baseline or below at the 
follow-up time point (e.g., emotional health and sexual function). Acceptability rates 
were quite high (e.g., satisfaction with information and ease of use of website), 
suggesting further investigation of this program using a more rigorous trial is 
warranted.  
There has been one internet-based study that has used a sample of men treated 
for localised prostate cancer using active treatment. Schover et al. (2012) designed an 
internet-based version of Canada et al.’s (2005) couples’ sexual rehabilitation 
treatment program, and compared this to a 3-session version of the face-to-face 
counselling program. Initially, 121 couples who underwent surgery or radiotherapy 
in the past 3 months to seven years were randomised into a wait-list control group or 
one of two intervention conditions: face-to-face counselling versus internet-based 
counselling with email contact with a counsellor. An internet-based replication trial 
was used for 71 couples who lived too far away from the study site to be randomised 
into the face-to-face intervention. Couples were recommended to complete the 
internet-based program in 4 to 8 weeks, however up to 12 weeks was accepted. As 
well as covering most aspects of the face-to-face program reported in Canada et al.’s 
study (see in previous chapter) focusing on sexual functioning, the internet program 
incorporated a videotape of couples’ personal experiences, and behavioural 
homework with feedback. Both groups were given telephone check-up calls. The 
researchers attempted to keep the face-to-face and internet versions of the 
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intervention similar by stream lining homework tasks. Sexual functioning and 
relationship functioning measures were taken, at baseline, post-intevention and at 3 
months, 6 months, and 12 months post-intervention.  
Schover et al. (2012) found that the internet-based program was as effective as 
a brief traditional face-to-face sexual therapy program. Outcomes across all measures 
for participants in the wait-list control condition did not change over the 3 month 
waiting period. When the two internet-based programs were combined, the strongest 
gains found in sexual function and sexual satisfaction were for couples who changed 
from not using ED medical treatment or oral medication only to a more invasive 
option. No gains were found for relationship functioning, however scores were high 
across all groups at baseline. Interestingly, recruitment into the second internet-based 
intervention was much faster than the randomised trial, suggesting that internet-based 
programs are appealing for couples. Despite the benefits of this innovative study, 
drop-out rates across all three groups were still high, ranging from 25-39%.  
Summary and Conclusions 
The internet is growing as an acceptable platform for delivery of psychological 
treatment programs for a variety of psychological disorders and medical conditions 
including cancer. The internet has been viewed as having many advantages, 
including breaking down the barriers that many people face in terms of accessing 
support, both in terms of available resources and in terms of stigma, fear and 
uncertainty in accessing mental health services, factors that deter many people in 
accessing support (Gega et al., 2004; Klein et al., 2009). Additionally, psycho-
education and self-directed therapeutic techniques can easily be formatted onto an 
online format. In particular, the structured nature of CBT, with weekly cognitive and 
behavioural strategies with homework, appears to be particularly amendable to the 
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internet, and programs are sometimes developed from face-to-face therapies and 
adapted to the internet. 
Comprehensive reviews and meta-analyses suggest that for CBT at least, 
internet-based treatment is as effective as face-to-face for anxiety and depression 
(Barak et al., 2008; Griffiths et al., 2010; Spek et al., 2007) and for chronic illness 
and health behaviour change (Barak et al., 2008; Cuijpers et al., 2008; Webb et al., 
2010).  
The use of internet-based treatment in cancer is still in its infancy. Most 
research has focused on developing and evaluating peer support based programs with 
mixed outcomes, and there have been a small number of studies that have used peer 
support in conjunction with other intervention strategies demonstrating some 
promising results. Only one study (Owen et al., 2005) used more complex 
intervention strategies that were seen in previous internet-based research for mental 
health and other health conditions for women with breast cancer. Although emerging 
evidence suggests some utility for the use of peer support programs or peer 
discussion in conjunction with other psychological treatment, further research is 
needed to clarify this and no studies have evaluated the use of developed peer 
support or forums using prostate cancer samples.  
There has only been one study to date investigating the efficacy of an internet-
based psychological intervention for men treated for localised prostate cancer 
(Schover et al., 2012). While this study found that an internet-based version of a 
couple’s sexual counselling program was as effective as brief traditional face-to-face 
program, this program was heavily therapist assisted and focused predominately on 
sexual rehabilitation. To date, no internet-based, self-directed, with minimal support, 
intervention has been developed and evaluated for men treated for localised prostate 
cancer with a focus on a range of identified problem areas. The next chapter provides 
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further rationale for the current study and outlines the development of an internet-
based program for men treated for prostate cancer. 
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Chapter 7:  Rationale for Future Research and Development of an 
Internet-Based Program 
This chapter firstly outlines the rationale for the current study, followed by a 
description of the various components of a psychosocial internet-based program for 
men treated for localised prostate cancer. Secondly, it outlines the development of 
the program with a detailed overview of the content and structure of the program. 
The processes involved in the development of this program and the specific program 
modules are discussed in detail in the current chapter. 
Rationale for the Current Study 
The primary aim of the present study was to develop and evaluate a treatment 
program designed to address the psychosocial functioning of men who have been 
treated for localised prostate cancer. From the review of literature covered in the 
previous chapters, it is clear that the impact of prostate cancer and its treatment on a 
man and his partner’s life is well established. Prostate cancer is a life changing 
experience which is likely to influence a man’s sense of self, his emotional health, 
his physical health and his relationships with others. Although survival rates for 
prostate cancer are high, treatment for prostate cancer typically results in several 
major morbidities, including incontinence of bladder and bowl, sexual dysfunction, 
and psychological difficulties. Partners are likely to be influenced by prostate cancer 
and its treatment, and the couple’s relationship may be negatively impacted.  
Research has indicated that men with prostate cancer have many unmet needs. 
An Australian population-based study explored the needs of men who had been 
diagnosed with prostate cancer between three and 12 months after diagnosis (Smith 
et al., 2007). The majority of the sample had localised prostate cancer and about half 
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had undergone surgery at the time of data collection. Smith et al. (2007) identified 
that 74% of men reported some form of unmet support need in relation to their 
prostate cancer diagnosis. The most common reported unmet need was psychological 
support, where 54% of men expressed that they felt they had some level of unmet 
psychological support (Smith et al., 2007). Forty-seven percent of men reported 
sexuality to be an area in need of some assistance or support. Not surprisingly, 
having surgery predicted needs in the sexuality domain. Similarly, Stegina et al. 
(2001) reported that approximately a third of men reported unmet needs in the 
sexuality and psychological health domain in a sample of men who had been treated 
for prostate cancer and who were members of a support group.  
The current health care system in Australia provides no standard model of care 
in terms of accessibility of appropriate and timely psychosocial support services for 
men with prostate cancer. This is a common theme worldwide (Holland et al., 2011). 
In Australia, rural and regional patients may have the most difficulty accessing 
appropriate support (Clinical Oncological Society of Australia, 2006), even though 
people in these areas have been identified as having a disadvantage in terms of 
mental health outcomes (Burris and Andrykowski, 2009). Around one third of 
Australian’s live outside Australia’s major cities in rural and regional areas 
(Australian Institute of Health and Welfare, 2007). The psychosocial services that are 
available often have long waiting lists and involve out-of-pocket costs and other 
restrictions (COSA, 2006). Research has found that telephone and internet-based 
support are particularly important for men with cancer, predominately prostate 
cancer, living outside metropolitan regions in Australia (Corboy et al., 2011). Klein 
et al. (2009) also highlighted that rural and regional areas also lack access to general 
mental health treatment, which suggests that men with comorbid mental health issues 
in these areas may be particularly vulnerable. 
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Although there are several support group options through organisations such as 
The Cancer Council and the Prostate Cancer Foundation of Australia, these do not 
provide specific psychosocial interventions aimed at reducing distress. Smith et al. 
(2007) strongly recommended access to the spectrum of support services for prostate 
cancer patients, including nursing specialists, psychological counselling, peer support 
groups and consumer information. In Australia, Chambers et al. (2008) suggested 
that current medical and support services are largely focused on patient outcomes 
and do not take into account a couple’s relationship, as well as overlooking the 
female partners’ needs.  
The medical model also focuses on care at diagnosis, where there is a tendency 
to focus on prognosis and treatment (Incrocci, 2006b).  However, some men may not 
be fully aware of the potential side effects and difficulties faced post-treatment until 
sometime after treatment (Beck et al., 2009). Men have different needs at different 
times. Although it has been suggested that men have information needs at diagnosis 
and when considering treatment options (Beck et al., 2009), Incrocci (2006b) 
suggested that at this time there may be a tendency to focus on prognosis and 
treatment, with little time to appreciate the importance of sexual function. Symptom 
distress may increase post-treatment when some of the discussions and stressors have 
subsided. As such, men may not be aware of the impact ED has on their lives and 
underestimate the ease of use of medical treatments. Beck et al. (2009) suggested that 
even if men are well informed of the potential side effects and difficulties faced post-
treatment, there are always some men who do not believe they will experience these 
side effects or overestimate their ability to adjust to side effects.  
The internet has been emerging as a platform for e-health in recent years and 
research has found support for the effectiveness of internet interventions in a variety 
of psychological disorders, health conditions, ED in the general population, and in 
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cancer. As highlighted previously, the internet has been viewed as particularly 
attractive for men treated for prostate cancer given the anonymity involved when 
discussing sensitive topics such as sexual problems. An internet-based intervention 
may enable some of the unmet needs of men treated for prostate cancer to be 
addressed, including providing services to those in geographically isolated locations 
or those who prefer not to seek treatment via other formats or those with sub-clinical 
levels of mental health problems.  
Although internet-based treated has been adovcated in the area of cancer 
(including prostate cancer), there has been very little empirical research, with only 
one study addressing the needs of men treated for localised prostate cancer which 
focused on sexual rehabilitation (Schover et al., 2012). The cost effectiveness of 
internet interventions is frequently cited as a reason to use the internet as a delivery 
platform (Griffiths, Lindenmeyer, Powell, Lowe, & Thorogood, 2006). Given the 
prevalence of prostate cancer in Australian men, a more self-directed program may 
be able to assist a greater number of men in the long term, and address a broader set 
of needs than can be addressed in face-to-face treatment. A self-directed internet-
based program is also likely to improve accessibility to men located in rural and 
regional areas who have been highlighted by COSA (2006) as having limited support 
and service options for cancer.  
Description of Components of an Internet-based Program for Men Treated for 
Prostate Cancer  
The following section outlines a justification for the various components of a 
psychosocial internet-based treatment program for men treated for prostate cancer. 
This is based on past research and recommendations from authors working in this 
area. 
105 
 
 
 
Theoretical framework for program. The internet-based psychological 
intervention that was developed and evaluated in this thesis was predominately CBT 
based. CBT is an evidenced-based psychological therapy aimed at treating a range of 
problems including mental health, interpersonal difficulties, adjustment and personal 
problems (Sheldon, 2011). CBT assists people to understand the relationship 
between their thoughts, feelings and behaviours. In doing this, the underlying 
premise of CBT is that thoughts and feelings influence behaviour and that cognitions 
can be altered (Taylor, 2006).   
CBT is thought to be helpful for those with medical illnesses because it 
addresses the stressors associated with such an illness, associated psychological 
distress and other QoL concerns (Taylor, 2006). For many, cancer can be a threat 
across several areas of a patient’s life, and thus may trigger cognitive beliefs related 
to illness, oneself, others and the world (Mooer & Greer, 2010). In addressing the 
difficulties and unment needs of men treated for prostate cancer, a CBT approach 
aims to promote active problem solving and alter cognitions and behaviours. Since 
CBT can also be used to assists clients to test fears or avoidant behaviours through 
behavioural experiements, it may be particularly helpful when addressing some of 
the sexual difficulties seen in prostate cancer. Typical techniques in CBT include 
psychoeducation, relaxation, thought monitoring, cognitive structuring, behavioural 
experiements, problem solving, and activity scheduling. 
As highlighted previously, CBT is thought to be particularly amendable to the 
internet due to its structured format and ability to be converted to text (Cujpers, 
2008; Ritterband et al., 2009; Spek et al., 2007). In addition, Ritterband et al. (2009) 
stated that promoting cognitive and behavioural change is a common goal for 
internet-based interventions. As such, it appears CBT is well suited to help men 
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adjust to the psychological, physical and social difficulties associated with prostate 
cancer and its treatment. 
The majority of internet-based research covered in the previous chapter for 
psychological and phyiscal health problems were CBT based, and one review study 
found that CBT demonstrated greater efficacy than psycho-education or behavioural 
therapy (Barak et al., 2008). In terms of prostate cancer, the use of CBT has been 
found to have benefits in face-to-face, telephoned based formats and internet formats 
(Canada et al., 2005; Molton et al., 2008; Penedo et al., 2007; Schover et al., 2012). 
CBT internet-based programs have also been used to treat ED in the general 
population (Andersson et al., 2011; McCabe & Price, 2008; McCabe et al., 2008).  
Psychological distress has been identified as a risk factor for men with prostate 
cancer. As highlighted previously, past research has failed to adequately address this, 
instead often focusing exclusively on general symptom or stress management. CBT 
based strategies in the current project were able to assist men treated for prostate 
cancer by identifying symptoms and building skills and strategies to improve any 
psychological distress. A CBT based program could also assist with education and 
development of communication skills for men to use with health professionals, 
friends, partners, and other family members.  The relationship with an intimate 
partner was particularly targeted, where general communication and sexual 
communication would be specifically targeted as suggested by past researchers 
(Wincaze & Carey, 2001) and integrated into successful programs (Canada et al., 
2005; Schover et al., 2012).  
Interventions targeting sexual difficulties in populations with and without 
prostate cancer have also incorporated strategies from sex therapy (e.g., sensate 
focus). Such programs have been found to be effective in assisting men treated for 
prostate cancer in face-to-face formats (Canada et al., 2005; Molton et al., 2008; Titta 
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et al., 2007) and internet format (Schover et al., 2012). Sex therapy works to address 
the emotional, cognitive and interpersonal aspects of ED. Specifically, it was found 
in Chapter 5 that those who used sex therapy strategies were more likely to have a 
positive influence on sexual function outcomes. Strategies were also be included in 
the proposed program that aimed to broaden a man’s concept of sexuality and 
masculinity, which has been suggested by others to be useful for sexual rehabilitation 
(Fergus et al., 2002) and used successfully by previous RCTs (Canada et al.; 2005; 
Molton et al.; Schover et al., 2012). In addition, the use of medical aids in 
conjunction with psychological strategies has been suggested to be of benefit 
(Canada et al., 2005; Fergus et al., 2002; Schover et al., 2012; Titta et al., 2007) and 
was included in the program.  
Although the focus of the program and this thesis was on sexual, 
psychological, and relationship functioning, a comprehensive program needed to also 
address other problems and difficulties that men treated for prostate cancer typically 
experience. Psycho-education and CBT based strategies were used to assist men with 
anxiety associated with urinary dysfunction, and to assist with coping with 
uncertainty about the future. 
Level of therapist assistance. In light of the rapid increase of psychological 
internet-based interventions, researchers have begun to explore the utility of different 
components of such treatment. Although most internet-based treatment is generally 
described as self-help, one of the major ways that psychological internet-based 
treatment can vary is the level of contact/support by a therapist or advisor (Cuijpers 
et al., 2008; Spek et al., 2007). This can vary from no assistance, automatic emails, 
minimal personalised or tailored emails, therapist assisted tailored emails to 
telephone calls  (Cuijpers et al., 2008; Spek et al., 2007). At the extreme end, 
therapists may provide individual or group therapy at a specified time, at a level of 
108 
 
 
 
therapist assistance comparable to face-to-face therapy (Cuijpers et al., 2008; Spek et 
al., 2007). 
Spek et al. (2007) found a greater overall effect when minimal support was 
provided in comparison to no support for interventions targeting anxiety and 
depression and Webb et al. (2010) found greater treatment effects for automated 
tailored feedback compared to automated follow-up reminders. One group of 
researchers who had previously identified that the use of emails enhanced outcomes 
for a self-directed behavioural based internet intervention for obesity/weight loss 
(Tate, Jackvony, & Wing, 2003), later found automatic tailored emails was as 
effective as personalised human emails for a similar intervention, and both were 
more effective than no emailing (Tate, Jackvony, & Wing, 2006). 
Although the exact optimal level of therapist assistance may not be known, it 
seems reasonable that some level of minimal assistance is appropriate and beneficial 
for programs that are in a self-directed format. In particular, some sort of weekly 
feedback in the form of email contact is thought to increase accountability and 
enhance responsiveness (Tate, 2011). This was integrated into the current program. 
Structural components. Leykin et al. (2011) made several recommendations 
when calling for the need for more methodological rigorous trials for psychosocial 
internet-based interventions for patients with cancer, many of which were 
incorporated in the proposed program.  
Leykin et al. (2011) highlighted that an important decision for online 
intervention developers is whether to use a sequential flow of lessons where 
subsequent lessons are gated or an adaptable structure where individuals can chose 
the order of lessons. For this study the second option was taken to increase 
engagement and sense of control for men, while potentially reducing attrition rates. 
Research using formats other than internet in prostate cancer that have been highly 
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tailored have allowed men to identify problem areas such as ED and relationship 
concerns (Giesler et al., 2005).  In addition to an open gated program, the use of a log 
book was implemented to allow the program to have some level of personalisation. 
The use of an interactively enriched environment (e.g., use of audio, video) has 
been found to contribute to more effective internet-based programs (Barlow et al., 
2009). Webb et al. (2010) also suggested that these programs should be as interactive 
as possible with the use of online exercises and videos, while using limited amounts 
of text on each screen shot. The current program used videos, audios and online 
exercises while incorporating components of CBT including offline exercises (i.e., 
homework) in order to practice and consolidate new skills. Based on past 
recommendations for internet-based treatments for cancer patients, a mood monitor 
was included as a form of self-monitoring (Leykin et al., 2011). 
Forums/online support.  A forum was developed for men treated for prostate 
cancer. Social support may come from peers, moderators or other men on some form 
of online forum, either in isolation or conjunction with internet-based interventions. 
An online forum was developed for those treated for prostate cancer based on an 
asynchronous format where weekly topics are given by a moderator. This was based 
on research using such forums in samples of women with cancer. Similar the study 
by Wiljer et al. (2011), posts were put up weekly by the moderator to encourage 
discussion.  
The Current Project 
There is a clear need for psychosocial assistance for men treated for prostate 
cancer. Although there is some emerging research providing evidence for the benefit 
of various programs, further research is required concerning psychosocial treatments. 
Very few interventions have aimed to target sexual, psychological and relationship 
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functioning in a comprehensive program, and no research that the author is aware of 
has addressed these factors in a comprehensive internet-based intervention. Further, 
no psychosocial internet-based program for men treated for prostate cancer has been 
developed in a self-directed format with minimal assistance. While this program was 
designed to be largely self-directed, past research clearly suggests that some level of 
contact or assistance may be necessary. We aimed to create a program with minimal 
support with the intent to develop a program that could be disseminated effectively 
and efficiently at minimal cost in the future. 
In an attempt to address the gaps in the research, the current study aimed to 
develop and evaluate the efficacy of a manualised CBT internet-based program 
aimed at improving sexual, psychological and relationship functioning, among men 
treated for prostate cancer. The program was designed to target men who were 
married or single and had been treated for localised prostate cancer in the last five 
years. This timeframe was selected since past research has found many men struggle 
with the impact of prostate cancer and its treatment (e.g., erectile dysfunction) up to 
five years post treatment. Partners were encouraged to be involved in the treatment 
process. Even though intervention research has not yet clearly found support for the 
inclusion of partners, quantitative and focus group research highlight the importance 
of partner inclusion. 
The first part of the empirical investigation of this thesis involved the 
development of the program for men treated for prostate cancer. The content of the 
program aimed to overcome some of the limitations of past research by including 
psycho-education plus skill-based strategies; addressing the complex multi-
dimensional nature of sexuality; acknowledging the couple’s relationship and 
including the partner; and targeting psychological distress directly. A summary of the 
main strategies identified to form a comprehensive psychosocial intervention are 
111 
 
 
 
outlined below. These are incorporated into specific modules that are outlined in 
detail later in this chapter.  
x Psycho-education for psychological functioning in relation to cancer and 
treatment. 
x Exploring the overall impact of prostate cancer (including aspects such as 
urinary difficulties). 
x Sexual problems and cancer and the impact of ED and cancer on the 
relationship. 
x Education and assistance with the use of medical aids. 
x Targeting negative cognitions surrounding cancer and ED/sexuality. 
x Skills training in general and sexual communication. 
x Broadening definitions of sexuality and sexual range of sexual activity. 
x Addressing masculinity and identity issues. 
x Addressing worries and concerns about the future. 
The second part of the empirical investigation of this thesis involved an 
evaluation of the internet-based psychosocial program for men treated for prostate 
cancer using a RCT. The program included a control group and comprehensive 
measures addressing the multi-dimensional nature of sexuality were used. A variety 
of outcomes measures were used to adequately cover sexual, psychological and 
relationship functioning. Data were collected at pre-test and post-test. Three 
treatment groups were formed in this study: (i) access to the online modular program 
(Modules-only); (ii) access to the online modular program plus the online forum 
(Modules-plus-Forum); (iii) access to the online forum only (Forum-only).  
This study design was chosen to evaluate the online modular program in 
comparison to a more basic level of care, which in this case was peer support. Past 
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RCTs have used a variety of control conditions from wait-list control groups, care as 
usual, or some basic information provision. Cuijpers et al. (2008) has criticised past 
internet-based RCTs for failing to use control groups beyond wait-list control, since 
there may be an overestimation of intervention efficacy when those in a wait-list 
control condition are unlikely to make self-directed steps to improving their situation 
if they are “waiting”. Basic moderated forums have been used in previous studies as 
a control group as a means to control for spontaneous improvement or to control for 
the general attention and the possible beneficial effects from sharing one’s distress 
with others (e.g., Andersson et al., 2011; Hesser et al., 2012).  Since online support 
groups may themselves have positive effects for people with cancer (e.g., Wiljer et 
al., 2011 and Winzelberg et al., 2003) it was thought that the use of three groups 
(Modules, Modules-plus-Forum, and Forum) would allow for exploration of the 
benefit of combining the internet psychosocial intervention with peer support 
(forum). 
Development of an Internet-based Program for Men Treated for Prostate 
Cancer  
An internet-based CBT program was developed to assist men who have been 
treated for localised prostate cancer. The processes involved in the development of 
this program and the program modules are discussed in detail in this section. An 
overview of the program and its components is provided before detailing 
participant’s experience of entering the program and each of the modules. 
Program aims. There were several aims which informed the development of 
the online self-directed psychosocial intervention for men with prostate cancer 
including: (i) attempting to overcome the barriers for men in accessing appropriate 
support (e.g., rural communities, anonymity for ED); (ii) targeting the common 
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problems men experience after treatment for prostate cancer, including psychological 
adjustment difficulties, management of side effects, relationship and sexuality 
concerns; (iii) creating a universal program that can be used by partnered and single 
men; and (v) providing both education and therapy in an attempt to improve the 
wellbeing and address the needs of men treated for localised prostate cancer. 
Program development.  A variety of sources were used to guide the 
development of both the content and structure of the internet program titled My Road 
Ahead. Firstly, previous research providing information about the psychosocial needs 
and problems of men and their partners, and research evaluating the efficacy of 
psychological treatments for men with prostate cancer, was used to guide the content 
for the program. Secondly, the development of the content of the program was 
assisted by a CBT group-based psychotherapy program developed by Melbourne 
Health called Below the Belt. This program is currently being evaluated through an 
unpublished RCT (A. Wootten, personal communication, November 25, 2010). 
Thirdly, the program content was guided by clinical practice. Specifically, a 
Clinical Psychologist who has provided face-to-face individual and group therapy for 
men who have been treated for prostate cancer over the past seven years played an 
integral role in My Road Ahead’s development. The structure of the program was 
largely guided by a multimedia company, Web Elements, and research detailing the 
use of internet-based treatments in other settings. Key learnings from a well-
established mental health online intervention platform, Anxiety Online, were also 
integrated into the development of My Road Ahead.  
The actual website was created by the research team in consultation with a 
multimedia company. In addition to building the My Road Ahead website, two 
owners of this company were prostate cancer survivors who also provided creative 
input that assisted in making My Road Ahead appealing to men with prostate cancer. 
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Finally, the program was pilot tested by several researchers and eight prostate cancer 
survivors.  
Overview of program. My Road Ahead was developed as a 6-module self-
directed program to assist men with many of the typical difficulties faced after 
prostate cancer and its treatment. The program was called My Road Ahead to reflect 
the cancer journey that many men with prostate cancer describe, emphasising a 
process and the need to take a number of steps along a path that eventually leads to 
psychological adjustment. My Road Ahead was largely CBT based, incorporating 
aspects of sex and relationship therapy. 
The program was designed with the following requirements in mind. My Road 
Ahead was a program for men who had received treatment for localised prostate 
cancer in the last five years. The program was open to men who did and did not have 
a partner and who were any sexual orientation. In order to get the most out of the 
program, men were required to be able to regularly commit at least one hour per 
module. However, it was expected that more than one hour would be necessary for 
some modules, particularly if a man was interested in or found particular benefit 
from a module. Modules were designed to take approximately one and a half weeks 
to complete. Many of the skills learnt in earlier modules were used in subsequent 
modules and were sometimes expanded on across modules. Therefore, men were 
informed that they should complete the modules in the designed order. However men 
were also informed that they could opt to access any of the modules they found 
relevant or interesting at any point in time. Men could only access the beginning of 
each module. 
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Program components. The following section outlines the major components 
of My Road Ahead. These components form the basis of the modules. The modules 
are covered in detail after this section. 
Partner involvement.  As mentioned previously, My Road Ahead was designed 
for men who do and do not have a partner. Men who had a partner were frequently 
encouraged to discuss the information they learnt from the program with their 
partners. Partner involvement was voluntary. At the beginning of Module 1 there was 
a video which encouraged men to bring their partner to the computer screen and 
listen to the video. There were handouts for men to print for their partners at the end 
of each module. These information sheets were generally 2-3 pages long and 
summarised the major components of each of the modules the men completed 
(Appendix A). The partner information sheets contained some specific exercises for 
partners that mirrored the exercises men completed and joint exercises for partners to 
complete with men.  
Single men.  For men who did not have a partner, they were encouraged to use 
a close friend or family member to complete some of the online and offline exercises. 
Throughout the program alternative diagrams and examples were provided 
specifically for single men and their needs in mind. 
Videos.  Men were recruited for videos through three different urologists’ 
patients and public patients from the Royal Melbourne Hospital and the Willian 
Buckland Radiation therapy centre. Of the 151 patients who were sent letters, 16 
offered their services, and a final 9 were selected based upon availability. Videoing 
took place over two days by a Clinical Psychologist using a semi-structured 
interview. 
There were two to four online videos in each module from various health 
professionals and prostate cancer survivors. Each video ran for between 1 and 3 
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minutes. A Clinical Psychologist was featured throughout My Road Ahead, providing 
information and advice about using the program, relevant psycho-education and 
summaries of module key points. At the end of each module, the Clinical 
Psychologist summarised the module, provided an overview of the offline exercises 
and encouraged men to practice skills newly acquired. When relevant, these videos 
also encouraged men to include their partners, highlighting the importance of 
communication and organising time to work through things together. Where 
applicable, other health professionals participated in the videos. 
Videos reporting prostate cancer survivors’ experiences formed an important 
feature of My Road Ahead. Each module commenced with an edited video with four 
or more men discussing their own experiences and thoughts relevant to that specific 
module. Placement of these videos at the beginning of each module was hoped to 
normalise men’s experiences and demonstrate that My Road Ahead has been 
developed in consultation with men who actually have prostate cancer. 
Online exercises.  In an attempt to make My Road Ahead as interactive as 
possible and provide men with an opportunity to develop specific skills throughout 
the modules, there were several online exercises throughout the program. Men were 
requested to type their responses directly into online worksheets which were then 
stored in their own personal logbook. Many online exercises were expanded and 
developed upon across each of the modules. For example, initial CBT exercises 
involving thought monitoring later involved challenging thoughts.  
Offline exercises.  Men and their partners were asked to complete a range of 
activities in-between modules to assist them develop and practise the skills learnt 
throughout the program. Offline exercises were generally relevant to the content and 
skills learnt in the immediately preceding module. Men had the option to download 
the offline exercises in paper form or log their work in the logbook online. 
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Offline exercises were reviewed by participants before commencing the next 
module. This involved a series of questions related to the outcomes of the offline 
exercises and consideration of any difficulties completing this. Example questions 
included – “How did sharing this exercise with your partner go?” and “What was 
learnt from this exercise?” 
Mood monitor.  Throughout My Road Ahead, men were given the opportunity 
to track their mood at the beginning and end of each module. Mood was measured 
across five different continuums: (i) “sad” to “happy”; (ii) “anxious” to “relaxed”; 
(iii) “angry” to “calm”; (iv) “confused” to “informed”; and (v) “lost” to “in control”. 
Users were able to drag a tab along five different points on each of the mood 
continuums. The mood monitor was recorded into each participant’s logbook and 
produced a graph over time which men could view at any point. The mood monitor 
was anticipated to increase awareness of the relationship between actions and 
wellbeing, and increase engagement in the program. 
Personal logbook & bookmarks.  Responses men entered into the online 
worksheets and offline exercises were entered into a personalised logbook that men 
could visit at any point. Upon program completion men could use the logbook as a 
resource for reflection and as a summary of what they have learnt and achieved. Men 
could also use the logbook for recording and developing future orientated goals. 
Additionally, participants were able to bookmark any specific pages or subjects of 
interest, for example, a particular diagram related to sexual function.  
Moderated forum.  This forum was developed to offer men the opportunity to 
share experiences, ask questions and share information. This was a space to share 
thoughts, ideas, tips or information with other men who might be going through 
similar experiences. There was a separate forum for those men who had access to the 
modules and those that did not. 
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Website set-up earlier pages.  Before consenting to participate in the study 
and program, men obtained some background information on the program from the 
home screen. The “What is My Road Ahead” tab provided some basic background 
information about the program and a video of David Parkin introduced My Road 
Ahead. David Parkin was a high profile ex-footballer who had prostate cancer. There 
was also a “FAQ” tab which has 10 questions related to the program, research and 
privacy. A tab titled “Seek help” directed men to emergency contacts, support 
contacts, and useful websites. 
Program entry. The start-up pages for My Road Ahead can be found in 
Appendix B. Once participants selected the “sign up” option they were taken through 
a series of pages which summarised the program and the research. This section also 
covered expectations of participants and required men to tick three statements related 
to their commitment to the program and agreement to complete the questionnaires. 
This was aimed at increasing motivation and commitment, similarly to a therapeutic 
contract drawn during face-to-face therapy. On the following page, men were 
requested to download the consent form and give consent to participate in the 
research. Once they had consented, participants were asked to form an account 
creating a username (which was used on the forum if they have access to this) and 
password. Due to the sensitive and private nature of the program, passwords were 
necessary to ensure security of website users. After creating an account, men were 
immediately sent an email requesting that their My Road Ahead account was 
validated. Once validating their accounts men are asked to complete the first set of 
questionnaires, a series of demographic questions and questionnaires. Immediately 
following questionnaire completion participants were informed which treatment 
condition they had been randomised to: the Modules only, the Modules-plus-Forum 
or Forum only.  
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Men were then provided with sliding screen shots relevant to which of the 
three groups they had been randomised to (see Appendix C). Each group received a 
screen shot covering information on completing questionnaires and a remainder that 
access was only for 10 weeks. Those with access to the modules were given sliding 
screen shots on an overview of modules; program features including video content, 
online exercises, offline exercises, book marking topics of interest, logbook, mood 
monitor; and partner or close friend/family member’s involvement. Those with 
access to the forum were given three sliding screen shots recommending participants 
“share their experiences”, “help others by providing support” and “ask questions”. 
Participants who had access to the modules also received a video from a Clinical 
Psychologist explaining the main aims of the program and how to get the most out of 
the program.  
Specific treatment modules. My Road Ahead consisted of 6 modules, with 
earlier modules designed to provide a “stepping stone” for the next module. Each of 
these modules is described below. Some example pages from these modules are in 
Appendix D. Appendix D also displays the home screen seen by participants who 
have access to the modules, the logbook and an example of the mood monitor. Login 
details to review the modules are: username (healthprovider) and password (health). 
The website is www.myroadahead.org. 
Module 1: Prostate cancer and you.  The purpose of Module 1 was to provide 
an overview of how prostate cancer and its treatment can affect the different areas a 
man’s life, and to address some of the common emotional reactions that accompany 
prostate cancer and its treatment. On completion of this module it was anticipated 
that men would begin to understand and explore how prostate cancer impacts 
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different aspects of their lives and emotions. The module also aimed to provide some 
self-care strategies. 
Module 1 commenced with a video of prostate cancer survivors discussing their 
reaction to cancer diagnosis and treatment, including emotional reactions such as 
depression, anxiety and anger. This was immediately followed by a video from a 
Clinical Psychologist emphasising the importance of physical, social and emotional 
changes associated with prostate cancer and its treatment and that these areas would 
be addressed in My Road Ahead. This video also emphasised the need to 
acknowledge the impact prostate cancer has on both the man and his loved ones. 
This module moved into further education around emotional reactions to 
prostate cancer and treatment. Emphasis was placed on normalising reactions and 
highlighting that there is no normal or correct way to feel, and that emotions can vary 
across the different stages of a cancer journey. While a variety of emotional reactions 
were presented, anxiety, grief/sadness, and anger were covered in more detail. A 
diagram was used to demonstrate the common and unique symptoms of anxiety and 
depression using some prostate cancer specific examples. An online worksheet 
exercise requested that men consider what factors have been leading to worry in their 
lives. This exercise was anticipated to encourage men to begin self-reflection. 
Further psycho-education on anxiety, using a flow diagram, explained the 
flight, fight, or freeze response. This was used to highlight the difference between 
low levels of anxiety (which may be beneficial) and high levels of anxiety which 
may occur in the absence of any real significant danger. The cognitive behavioural 
model of anxiety was introduced using a diagram to explain how cognitions, 
emotions and behaviours can form a vicious cycle. Finally, examples of when worry 
and anxiety become signs of concern were provided to assist men to gauge their level 
of anxiety. 
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Psycho-education around depression was covered next, beginning by 
differentiating between depression and normal feelings of sadness. Participants were 
able to complete a depression checklist and if a certain pattern of symptoms was 
selected, suggestions were given to make contact with health professionals for an 
accurate diagnosis or assistance. Psycho-education ended with information on anger, 
normalising this as a common emotion. Additionally, men were encouraged to 
further explore any symptoms of anger as this may encompasses other emotional 
reactions.  
Module 1 covered guided suggestions for taking care of one’s self. A video 
from a Clinical Psychologist made suggestions such as exercise, finding ways to let 
off steam, writing things down, and talking to others. The importance of talking to 
others was further stressed by emphasising the benefit of sharing feelings with 
partners and close friends or family. Men and significant others were encouraged to 
express their feelings and thoughts without the need to make changes or take 
responsibility for the problems or emotions of others.  
For offline exercises men were requested to download a “My feelings about 
prostate cancer” worksheet which asks participants to write down some feelings they 
have experienced with regards to their prostate cancer journey. Men were asked to 
share this with their partner or someone close to them, requesting that the confidant 
attempts to neither help nor change how they feel. If men had a partner, the partners 
were asked to complete a similar exercise. The closing of Module 1 entailed a video 
from a clinical psychologist summarising the module and encouraging participation 
in offline exercises.  
Module 2: Tools for effective communication and helpful thinking.  Module 
2 covered strategies to assist men to cope with the challenges that prostate cancer and 
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its treatment often brings. Specifically, the purpose of this module was for men to 
learn how communication plays a role in coping with prostate cancer and for men to 
begin to develop assertive communication skills which can aid communication about 
sensitive and personal topics. Secondly, in Module 2 men were further educated 
about the connection between cognitions, emotions and behaviour.  
Module 2 commenced with a video entailing prostate cancer survivor’s stories 
relevant to the importance and difficulties involved in communicating. This was 
followed by an explanation of the benefits of communication and highlighting some 
common times when communication can be difficult during the cancer journey (e.g., 
with medical staff or discussing sex with partners). The importance of effective 
communication with a partner was also emphasised. 
Module 2 progressed to educating men about the definition of communication, 
also covering some common unhelpful communication strategies. The first online 
exercise for Module 2 requested men brainstorm what communication means to them 
and list some of the ways they communicate. This exercise was immediately 
followed by a list of several common communication mistakes and men were 
requested to select whether they used any of these. After selecting an option an 
explanation was provided as to why each communication style was ineffective. 
Module 2 continued to assertiveness skills training. Initially three main 
communication styles, passive, assertive, and aggressive, were described and an 
explanation of the benefits of the assertive style was highlighted. An online exercise 
requested that men enter the details of a particular time they found communication 
difficult. This exercise encouraged men to consider whether any emotions interfered 
with their ability to communicate and any factors that could have improved 
communication. It was anticipated that men would also begin to acknowledge that 
people tend to communicate differently about prostate cancer. Participants then 
123 
 
 
 
progressed to a three step process for communicating assertively which uses a 
prostate cancer specific example. Men were given the opportunity to practice the 
assertive communication technique using an online worksheet and were encouraged 
to use this in a variety of contexts. 
The next section of Module 2 continued with socialisation on CBT and men 
were introduced to the power of “thoughts”. Flow charts, using prostate cancer 
specific examples throughout, demonstrated how cognitions can influence emotions 
with subsequent charts integrating behaviours and physical sensations. A video from 
a Clinical Psychologist normalised the experience of negative thoughts associated 
with prostate cancer and secondly explained when and how negative thoughts can 
become a problem. The psychologist also provided education on how balancing 
negative thoughts with more positive ones can improve one’s ability to cope. Men 
were then asked to identify unhelpful thoughts and were introduced to a thought 
monitoring sheet identifying situations/triggers, unhelpful thoughts, feelings, 
physical sensations, and behaviours/actions. 
Module 2 offline exercises encouraged men to continuing assertiveness 
practice and thought monitoring using two record sheets. If participants had a partner 
they were asked to practice assertive communication with their partners. Module 2 
closed with a video with a Clinical Psychologist recapping the module and 
encouraging homework completion. Again, couples were encouraged to work 
through the module and exercises together and single men were encourage to find a 
significant other to communicate with. 
Module 3: Coping with physical changes.  Module 3 aimed to provide an 
overview of the physical changes that typically occur as a result of prostate cancer 
and its treatment. This module focused on incontinence and aimed to provide 
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strategies to manage this, while encouraging men to use these strategies for other 
physical changes.  
Module 3 began with a video of prostate cancer survivors discussing the impact 
on incontinence on their lives and some coping strategies they have used. A diagram 
of a man was presented to highlight the different areas of the body that are affected 
by prostate cancer and its treatment, including the head and brain, shoulders, arms 
and legs, chest, stomach and abdomen, groin, the urine system, and the sexual 
system. The major role stress plays in influencing each of these body parts was 
covered, for example, the impact of stress on breathing for the chest region. 
Following this overview, Module 3 considered tools and strategies for coping 
with some of these physical changes, with a focus on incontinence in this module. 
After providing brief information around the nature of incontinence in prostate 
cancer, the range of emotions associated with incontinence was normalised. 
Participants were introduced to the anxiety-avoidance cycle by completing an online 
exercise requesting they identify a recent situation when incontinence led to worry or 
anxiety. Further education on the anxiety-avoidance cycle, with the assistance of 
diagrams, described how emotions and thoughts surrounding incontinence can lead 
to activity avoidance (e.g., sexual contact or social situations) due to fear of leakage 
or losing control.  
Men were then directed to learn tools and strategies for managing incontinence. 
This commenced with a video from a urology nurse presenting some tips for 
managing incontinence successfully, including pelvic floor exercises and 
incontinence pads. After the video, four specific tools were covered to assist in 
breaking the anxiety-avoidance cycle. Firstly men were taught how to identify and 
challenge their automatic thoughts related to incontinence. Using an online 
worksheet, men were encouraged to note any thoughts during a specific situation 
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identified earlier in this module. Men then attempted to challenge these thoughts with 
the assistance of an illustrated example. 
The second tool was risk assessment. An online worksheet asked men to 
answer a series of questions to assist in developing a more accurate assessment of a 
situation and potentially lower subsequent levels of anxiety. Example questions 
include – “what is the worst thing that could happen?” and “what is the likelihood of 
that happening?”  
The third tool was relaxation. The benefits of relaxation and some tips for 
practising relaxation were covered first. Three downloadable MP3 audio files were 
provided, covering different relaxation scripts: a simple breathing relaxation 
covering abdominal breathing, progressive muscle relaxation, and visualisation with 
a guided imagery on a boat aimed at relieving stress. By covering three different 
types of relaxation it was hoped that men would find at least one beneficial.  
The final tool was worry exposure, where men were encouraged to confront 
their worries. It was suggested that men visualise their specific worries until their 
worry begins to reduce. A specific example was used to illustrate this and a video 
from a clinical psychologist was used to further explain how exposure can help break 
this cycle. 
For Module 3 offline exercises encouraged men to use each of the four tools 
covered in this module to address any worry or anxiety they may have about 
incontinence. Again, men were also encouraged to share what they had learnt with 
their partner or close friend. Module 3 concluded with a summary of the module 
from a clinical psychologist. 
Module 4: Sexuality and masculinity.  The aim of this module was to educate 
men and their partners about ED and prostate cancer. Module 4 also aimed for men 
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to consider how ED impacts on their sense of masculinity and sexuality. By the end 
of Module 4 it was anticipated that men would learn about the broader impact of ED, 
learn about traditional male role norms about sexuality and masculinity, and be able 
to identify and challenge thoughts around sexuality and masculinity. 
The module began with a video from prostate cancer survivors describing their 
personal experiences with ED and what types of strategies they have used to cope 
(including medical aids). Background information about ED and prostate cancer 
treatment was provided via a video from an urologist and screen text. The urologist 
focused on medical explanations for ED with pictures of men’s sexual organs. The 
urologist also highlighted other potential physical changes men might expect in this 
bodily region and the likelihood of performance anxiety occurring. 
Module 4 briefly covered the male typical sexual response cycle. This model 
was used to emphasise how a lack of an erection may lead to changes in sexual 
behaviour, leading to further decreases in arousal, highlighting to men that they can 
still actually enjoy arousal and experience an orgasm without an erection. Men were 
also educated about the overall impact of ED, the benefits of sex and sexual 
intimacy, and the reasons why changes to sexual intimacy should be addressed. 
Although intimacy and communication were addressed in more detail in Module 5, 
Module 4 briefly explained the impact of ED on intimacy and relationships, 
highlighting the importance of including their partner when addressing sexual 
problems. 
Module 4 then covered acknowledging and accepting the loss associated with 
changes to sexual function. To assist this process, an online exercise requested that 
participants consider how ED has impacted their lives. Another online exercise asked 
men to brainstorm norms or stereotypes in society surrounding manhood and 
sexuality. Men were then asked what “being a man” means to them. Subsequently, 
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men were provided with a list of masculinity stereotypes – for example “physical 
strength” and “not being emotional”. A video from a clinical psychologist listed the 
different sources people typically develop sexual beliefs and myths from. The 
clinical psychologist continued by explaining how the thoughts that were identified 
in previous exercises can be used as clues for personal beliefs about sex and 
intimacy. Following this a list of eight common myths related to sex, ED and 
prostate cancer were presented.  For example, “a man wants sex anytime with 
anybody”.  Once men selected whether they held that belief or not, they were 
provided with an explanation as to why each statement was a myth.  
Men were encouraged to use an online worksheet to explore any unhelpful 
thoughts about ED and sex. A four step process asked participants to identify a recent 
situation where they felt anxious, upset or concerned about their sexual ability. This 
required detailing the events of the situation, identification of any emotions, thoughts 
and subsequent actions/behaviours. Men were also encouraged to challenge any 
thoughts or beliefs by attempting to consider alternative perspectives of the situation. 
A video from a clinical psychologist assisted with this process by providing a list of 
questions used to challenge negative thoughts/beliefs. Example questions included 
“What evidence do I have to support this idea?” or “What would you say to someone 
else who had this thought?” The clinical psychologist also worked through an 
example related erection failure. 
For offline exercises, men were asked to continue to identify and challenge 
their thoughts related to ED and masculinity. If men had a partner they were 
encouraged to share their responses to the first online exercise from this module with 
each other. Partners were also asked to complete this exercise using their personal 
downloadable partner information sheet. Couples were encouraged to share any 
thoughts and thought disputation they had achieved with regards to ED, sex and 
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masculinity. Finally, couples were encouraged to undertake a joint activity during the 
coming week, suggestions were given. Single men were encouraged to pick an area 
of their lives they feel sexual function has impacted and were challenged to make a 
difference to this area through their behaviour or thoughts (e.g., meeting new people 
if they had been avoiding social situations). Module 4 concluded with a summary 
video from a clinical psychologist.  
Module 5: Sexual and intimacy.  Module 5 followed on from Module 4, by 
aiming to assist men to enjoy intimacy and sexual interactions in the absence of 
erections or compromised sexual function. This module aimed to encourage men to 
consider how their thoughts and beliefs about masculinity, ED, and sexuality, 
identified in the previous module, can influence their intimate behaviour, and 
consequently impact on their relationship. Strategies targeted to meet these gains 
included challenging thoughts, communication, broadening definitions of sexuality, 
and the use of medical aids. 
Module 5 commenced with a video of prostate cancer survivors describing how 
ED has affected their relationships and ability to be intimate. Some men highlighted 
that intimacy had become more important to them, while the importance of sexual 
intercourse had diminished. This video was immediately followed by a video from a 
clinical psychologist discussing how ED affects men’s relationships with their 
partners as well as other people, often resulting in withdrawal. It was anticipated that 
this introduction would prompt men to consider how intimacy had been impacted in 
their lives.  
Module 5’s first online exercise involved a worksheet requesting men 
contemplate a time when they had difficulty obtaining an erection, and identify any 
thoughts, emotions, and behaviours associated with this situation. It was anticipated 
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that a subsequent series of flowcharts would educate men about the impact of 
positive or negative evaluation of a sexual stimulus on arousal, through the pathway 
of negative thoughts and emotional responses. Additionally, the direct impact that 
stress and tension has on adrenaline and arousal was acknowledged. The second 
online exercise requested men think of a situation when specific thoughts interferred 
with intimacy, while acknowledging associated emotions and behaviours. A diagram 
was used to display common thoughts men have that can impact on sex and intimacy 
(e.g.,“I can’t satisfy my partner”), along with common emotions and behaviours.  
The impact of previously identified patterns on partners and other people was 
highlighted. Partnered men were asked to consider what impact changes in sexual 
functioning have had on their partner from their perspective and from their partner’s 
perspective. A description of some of the typical partner reactions was given in 
conjunction with a video of a prostate cancer survivor’s partner. This partner 
highlighted how females typically place less emphasis on sexual intercourse than 
males, and the ways intimacy with her partner has been maintained and actually 
enhanced post-prostate cancer treatment.  
Module 5 progressed to developing strategies assisting men to broaden their 
definition of sex and sexuality. An online worksheet requested men brainstorm what 
good sex means to them. Following this, various ideas to assist men to broaden their 
definition of sex were covered including oral stimulation and exploring different 
positions. Another online worksheet requested men elicit a description of a good 
sexual experience, and secondly broaden the description with consideration of the 
aims of the sexual experience. Further strategies to assist with broadening the 
definition of what good sex means were provided including creating a positive sexual 
environment by minimising disturbances, bringing the focus to here and now, and 
focusing on things that trigger arousal.  
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Communication was the focus of the next section of Module 5, beginning with 
a video from a clinical psychologist stressing the importance of communication in 
the face of ED. The clinical psychologist also discussed what single men could 
consider when entering a new relationship. Following the video, a series of 
communication pointers were provided for use when talking about sex (e.g., 
“Discuss what you like and don’t like”). The differences between males and females 
were highlighted again, emphasising that women are often less interested in sex 
when their emotional needs are not being met. The application of assertiveness skills 
developed in Module 2 was encouraged by applying these to a situation or topic 
related to sexual intimacy for discussion with their partners. This online exercise also 
required men to consider what they would like to know from their partner, and how 
they may be able to improve the situation. An example was provided to assist men 
with this exercise. 
Finally, Module 5 covered erectile aids. A video from a urology nurse 
practitioner discussed the different ED medical aid options using visual examples of 
these aids. The nurse begun with the most simple aid (Viagra) and progresses 
towards more complex and invasive procedures (injections). A link was provided to a 
TreatED booklet supported by the Prostate Cancer Foundation of Australia and 
Impotence Australia. Following this, an online exercise suggested that partnered men  
select an erectile aid for potential use and consider the aid’s pros and cons and how 
potential difficulties using this aid may be overcome. Finally, the limitations of 
erectile aids were highlighted, emphasising the benefits of applying the strategies 
learnt in this module in conjunction with any medical aid use.  
Offline exercises for Module 5 included using each of the strategies covered to 
address sexuality and intimacy difficulties or concerns. These included continuing to 
monitor and challenge thoughts related to intimacy and sex; using assertive 
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communication style to address issues around sex and intimacy with their partners; 
and working on creating a positive erotic or sensual focus.  
Module 6: Planning for the future.  The final module for My Road Ahead 
aimed for men to explore the impact of cancer on their personal beliefs about death 
and mortality. Module 6 also aimed to assist men to develop strategies to cope with 
fear of cancer recurrence. Finally, Module 6 provided a conclusion and summary of 
My Road Ahead aimed at consolidating the skills learnt during the entire program. 
Module 6 commenced with a video of prostate cancer survivors’ experiences 
related to coping with uncertainty and their experiences of anxiety in relation to 
cancer recurrence. This module continued into normalising the range of thoughts and 
emotions that typically arise in response to a cancer diagnosis, especially related to 
feelings of vulnerability and mortality. Warning signs related to depression in 
relation to living with uncertainty were provided, for example, recurring very dark 
thoughts about the future. An online exercise asked men to list thoughts related to 
fear and uncertainty they have experienced, while considering any emotional 
responses.  
After covering thoughts and feelings around mortality, Module 6 addressed 
fear of cancer recurrence. This response was normalised in relation to frequent PSA 
tests and anxiety. A video from a clinical psychologist discussed the difficulties with 
living with uncertainty and strategies that may assist including challenging negative 
thoughts and taking action to overcome worry (e.g., seeking GP advice). The clinical 
psychologist worked through a particular example in this video. An online exercise 
required men to identify any instances when they experienced fear of cancer 
recurrence, assisting men to challenge any thoughts by reality testing. 
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Mindfulness was introduced as a tool to assist with coping with uncertainty and 
fear of cancer recurrence. After providing some background on mindfulness, three 
basic mindfulness exercises were suggested: (i) noticing five things that can be seen, 
heard, and physically felt; (ii) noticing every detail while completing a daily chore 
such as dish washing; and (iii) mindfulness of the breath.  
The final component of Module 6 summarised the learning achievements 
throughout My Road Ahead. An online exercise suggested that participants consider 
the thought processes they had developed to manage stress and difficulties in their 
lives. Additionally, men were asked to identify their emotions and behaviours that 
may be viewed as warning signs for becoming stressed or worried. 
A video from a clinical psychologist encouraged men to, when possible, have a 
positive outlook even though the prostate cancer journey is often described as one of 
the hardest times of a peron’s life. The psychologist listed some of the benefits and 
positive changes prostate cancer has brought to the lives of some men. The video 
also suggested men contemplate plans and goals for the future. Following this 
suggestion, an online exercise encouraged men to think about short-term, medium-
term and long-term goals.  
In an attempt to mirror the maintenance of treatment gains sessions that 
frequently occur in face-to-face therapy, the final online exercise asked men to 
contemplate what they have learnt during the program, followed by consideration of 
any positive things that may have come about as a result of having cancer. My Road 
Ahead concluded with two videos.  Firstly, David Parkin thanked participants and 
encouraged men to seek further support if required. Secondly, a clinical psychologist 
provided an additional thank you, and suggested men reflect on where they have 
come from and their level of satisfaction of where they were presently. Participants 
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were also encouraged to use their logbooks for reflection and to create future 
orientated goals using an action plan. 
Website construction and set-up. After an electronic document detailing the 
content for modules was developed, a multimedia company was employed to assist 
with construction of the website. As sections of the My Road Ahead website were 
constructed, regular testing and reviewing took place by IT professionals, 
researchers, and psychologists, which in turn lead to program refinements. 
When designing the website, several end use factors were taken into 
consideration. The program was aimed to be appealing to men through the use of 
images and icons that were designed to be attractive and engaging to men. Ease of 
use was also an important priority in the development of My Road Ahead. This was 
achieved by placing limited information on each website page with arrows allowing 
men to proceed to the next page or take a step backwards. In addition, videos, 
diagrams, tables, and flowcharts were used wherever possible. 
In order to create the idea of a “journey” the home screen consisted of a 
pathway that lit up in different colours as men progressed through the modules. As 
mentioned previously, although it was recommended that men complete the modules 
in sequential order, they could access the beginning of each of the six modules in any 
point in time. This option was chosen as a means to increase motivation and decrease 
attrition rates. When completing the questionnaires or modules, a line across the top 
of the website represented the portion of questionnaire or module completed. On the 
main screen a percentage of the entire program that had been completed was clearly 
visible down the bottom of the screen which also detailed the amount of time left to 
access the program. 
There were several tabs across the top of the website screen allowing men to 
access the components of the program previously mentioned (e.g., mood monitor, 
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logbook). In addition participants could continue to access the overview information, 
FAQ, and seek help information.  
Chapter Summary 
The first part of this chapter outlined the rationale for the current study, which 
was the development and evaluation of a self-directed CBT internet-based 
psychosocial intervention for men treated for prostate cancer. A rationale for the 
various structural and content components of the proposed program was also 
provided. The second part of this chapter detailed the processes involved in the 
development of an internet-based CBT program for men treated for prostate cancer. 
The program, entitled My Road Ahead was developed from a variety of sources. In 
addition an online moderated forum was also created during the development phase 
of this study. The next chapter discusses the hypotheses and method of the study. 
Chapter 9 and10 reports on the results of the evaluation of My Road Ahead, and an 
overall discussion of the research project is provided in Chapter 11. 
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CHAPTER 8: Hypotheses and Method of Study 
 The purpose of this study was to evaluate the efficacy of My Road Ahead, an 
internet-based program for men treated for prostate cancer utilising a RCT. This 
involved comparing the outcome measures of participants undertaking the online 
intervention (Modules group and Modules-plus-Forum group) with the group that 
only had access to the forum (Forum-only group). The Forum-only group was 
considered the control group. Details about these three groups are outlined in the 
procedure section. The efficacy was examined by comparing pre-test and post-test 
changes in sexual function (including sexual QoL), psychological function, and 
relationship function across the three groups. This chapter outlines the method for 
this study. 
Hypotheses  
The present study hypothesised that men who are allocated to the Modules-
plus-Forum group would demonstrate significantly greater improvement than the 
Modules only group, which in turn both would demonstrate significantly greater 
improvement than the Forum only group, from pre-test to post-test for each of the 
following variables: 
1. Sexual function (including sexual QoL). 
2. Psychological function. 
3. Relationship function. 
A secondary aim was to explore and evaluate feasibility and acceptability of 
My Road Ahead in terms of retention rates, degree of program completion, and 
module and forum satisfaction feedback. 
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Method 
Participants.  Eligibility criteria for participation consisted of the following: 
(1) treatment for localised prostate cancer in the last 5 years; (2) being aged 18 years 
or over; (3) willingness and ability to commit at least 1 hour per week, for a 
minimum of 10 weeks; and (4) regular access to the internet. Men who were unable 
to meet the above criteria were excluded from the study.  
The study was open to men located within Australia. Participants were 
recruited from April 2012 to August 2012 through a number of mediums. Firstly, a 
database of men treated for prostate cancer at the Royal Melbourne Hospital were 
sent a letter of invitation and a postcard size advertisement to participate in the 
research project (Appendix E). Urology centres, private hospitals, and some 
physiotherapy centres and sexual rehabilitation specialists across Australia were sent 
a general letter and postcard flyers and larger size advertisements to place at their 
worksites. Advertisements were included in these mail outs with varying levels of 
detail using postcards, A3 sized posters, and A4 sized flyers (see Appendix F). 
Health professionals were also sent a flyer with information about the features of My 
Road Ahead, an outline of the research, and test login details to view the website. 
Finally Men’s Sheds groups across Australia were sent five postcards each to 
distribute to any interested men. It was anticipated that this would allow them to 
gauge the applicability and usefulness of My Road Ahead for their patients. An 
advertisement was placed on the Prostate Cancer Foundation of Australia and 
Beyondblue websites (see Appendix G). In addition a male specific magazine called 
Man’s Space made reference to My Road Ahead in a journalist’s article about the 
impact of prostate cancer. All of these services and professionals contacted were 
informed that they could contact the research team if wanting more advertising 
material. 
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A power analysis was conducted to estimate the target sample size using 
G*Power 3.1.3 software. In order to detect medium effect sizes (.30) at alpha ≤ 0.05 
with power set at 80%, a sample size of 111 is needed. This means we aimed to 
collect pre-test and post-test data from 37 men in each group. Considering attrition 
rates for self-directed online programs are moderate to high, this was also taken into 
account when aiming for certain sample size. 
Figure 1 represents the time line for evaluating the efficacy of My Road Ahead. 
This figure includes the time line for the larger project of which the current thesis 
was part of.    
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Figure 8.1. Outline of recruitment and enrolment into My Road Ahead. 
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Measures.  Questionnaires were used to assess changes over time in sexual 
function, psychological function, and relationship function. Questionnaires were 
completed at pre-treatment and immediately post-treatment (10 weeks post-
treatment). The following section outlines each of the measures used to evaluate this 
program. These measures and the associated dependent variables are outlined in 
Table 8.1. Questionnaires were identical for each testing time point, and for each 
treatment group. However, pre-treatment questionnaires also included demographic 
questions and the post-treatment questionnaires included satisfaction and feedback 
questions for the forum and modules. See Appendix H for the complete 
questionnaire, with demographic questions and post-treatment satisfaction questions. 
These questions were answered online and have been converted to a word document 
for the Appendices. 
Demographics. Demographic details requested included age, date of birth, 
ethnic background, relationship status and duration of relationship, sexual 
orientation, education, employment status, gross annual income, prostate cancer date 
of diagnosis, date of treatment, type of treatment, and incidence of other health 
conditions (both physical and mental). Information on prior access to support was 
also collected, including access to support groups and psychologists as well as 
accessing information from the cancer council or other online resources. Specific 
questions were also asked about past sessions with specialists for sexual 
rehabilitation, and the degree of use and satisfaction with erectile function medical 
aids. 
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Table 8.1 
Measures Used to Assess Changes in Psychological Function, Sexual Function, and Relationship Function 
Measure Author Dependent variable 
Sexual function:   
 Erectile function domain – International Index of Erectile Function (IIEF) Rosen et al., 1997 Erectile function 
 Sexual desire domain – International Index of Erectile Function (IIEF) Rosen et al., 1997 Sexual desire 
 Intercourse satisfaction – International Index of Erectile Function (IIEF) Rosen et al., 1997 Intercourse satisfaction 
 Orgasm function – International Index of Erectile Function (IIEF) Rosen et al., 1997 Orgasm function 
 Overall satisfaction – International Index of Erectile Function (IIEF) Rosen et al., 1997 Overall sexual satisfaction 
 IIEF total score Rosen et al., 1997 IIEF total score 
 Sexual intimacy – Prostate Cancer Quality of Life Scale (PCQoL) Clark et al., 2003 Sexual intimacy 
 Masculine self-esteem – Prostate Cancer Quality of Life Scale (PCQoL) Clark et al., 2003 Masculine self-esteem 
 Sexual confidence – Prostate Cancer Quality of Life Scale (PCQoL) Clark et al., 2003 Sexual confidence 
Psychological function:   
 Stress – Depression Anxiety Stress Scale (DASS) Lovibond & Lovibond, 1995 Stress 
 Anxiety – Depression Anxiety Stress Scale (DASS) Lovibond & Lovibond, 1995 Anxiety 
 Depression – Depression Anxiety Stress Scale (DASS) Lovibond & Lovibond, 1995 Depression 
Relationship function:   
 Kansas Marital Satisfaction Survey (KMSS) Schumm et al., 1986 Overall relationship satisfaction 
 Marital affection – Prostate Cancer Quality of Life Scale (PCQoL) Clark et al., 2003 Marital affection 
 General communication – Communication Patterns Questionnaire (CPQ) Christensen & Heavey, 1990 General communication 
 Sexual communication – Dyadic Sexual Communication Scale (DSC) Catania, 1986 Sexual communication 
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Depression, Anxiety and Stress Scale (DASS-21). Psychological function and 
distress was measured using the Depression Anxiety and Stress Scales (DASS-21) 
short version (Lovibond & Lovibond, 1995).  The DASS-21 consists of 21 items 
with seven items allocated to three different negative emotional states (depression, 
anxiety and stress). The depression scale measures dysphoria, hopelessness, 
devaluation of life, self-deprecation, lack of interest/involvement, anhedonia and 
inertia.  The anxiety scale measures autonomic arousal, skeletal muscle effects, 
situational anxiety, and subjective experience of anxious affect.  The stress scale 
assesses difficulty relaxing, nervous arousal, and being irritable and impatient.  
Respondents were asked to indicate the extent to which a statement applied to them 
in the last week on a 4-point Likert scale covering the response categories: 0 = did 
not apply to me at all; 1 = applied to me to some degree, or some of the time; 2 = 
applied to me to a considerable degree, or a good part of the time; and 3 = applied to 
me very much, or most of the time. Higher numbers reflect greater applicability of 
statements to ones behaviour and emotions. Final scores were multiplied by two and 
scores ranged from 0 to 42 for each of the three subscales, with a higher score 
indicating greater levels of stress, anxiety, or depression. An example of an item 
from each of the subscales is depression (‘I felt down-hearted and blue’); anxiety (‘I 
felt close to panic); and stress (‘I found it hard to wind down’). 
The DASS-21 has been found to have psychometric properties equivalent to 
the full version (42-items) (Henry & Crawford, 2005). Additionally, Henry and 
Crawford (2005) found evidence for good construct validity by demonstrating that 
the DASS-21 measures three separate scales with an underlying common factor. The 
DASS-21 has also been found to demonstrate sound internal consistency. With 
reliabilities for each of the subscales using a large adult population at; depression (α 
= 0.88), anxiety (α = 0.82), and stress (α = 0.90) (Henry & Crawford, 2005). Antony, 
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Bieling, Enns, and Swinson (1998) also found high levels of internal consistency 
using a clinical and community sample: depression (α = .94), anxiety (α = .87), and 
stress (α = .91). Antony et al. (1998) also found that the DASS-21 demonstrated 
good concurrent validity, through correlations with other measures of anxiety and 
depression. For the current study, good reliability was found for each of the 
subscales: depression (α = 0.96), anxiety (α = 0.89), and stress (α = 0.93). 
Prostate Cancer Quality of Life Scale (PCQoL). The impact of prostate cancer 
and its treatment on sexuality, confidence, masculine identity and marital affection 
was measured using the Prostate Cancer Quality of Life Scale (PCQoL) (Clark et al., 
2003). This scale focuses on the behavioural, interpersonal and emotional changes 
that patients attribute to prostate cancer. The PCQoL scale was developed in an 
attempt to create a scale that addresses the complex psychosocial consequences for 
men treated for prostate cancer, rather than the focusing on severity and associated 
bother of symptoms, as other prostate cancer QoL scales do. The domains of sexual 
intimacy, sexual confidence and masculine self-esteem encompass many of the items 
found in common subscales of sexual bother and sexual satisfaction in a more in 
depth way. For example items such as “I feel good about the way I deal with my own 
sexual needs and desires” and “Trying to have sex is too complicated” cover items 
found in the Prostate-Health Related Quality-of-Life Questionnaire used by Nelson 
et al. (2009) and implicitly provide information of the degree of bother associated 
with sexual symptoms found in the EPIC or UCLA-PI (see Table 1).  
The PCQoL scale was developed from focus groups with 130 men (t 50 years 
old) who had been diagnosed with early stage prostate cancer 12-24 months 
previously (39% treated with prostatectomy, 39% treated with radiotherapy, 8% 
treated with hormone therapy, 5% brachytherapy and 9% chose watchful waiting) 
(Clark et al., 2003). The entire scale contains 84 Likert type items that fall into 11 
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scales including: 1. Urinary control (behavioural and interpersonal implications of 
impaired control of one’s bladder); 2. Sexual intimacy (ability to perform sexually 
and feelings of frustration, embarrassment or failure); 3. Sexual confidence 
(confidence and anxiety about intimate activity and sexual thoughts); 4. Marital 
affection (misgivings about demonstrations of affection with one’s spouse), 5. 
Masculine self-esteem (negative evaluations regarding ones level of perceived 
masculinity); 6. Health worry (uncertainty about one’s health); 7. PSA concern; 8. 
Cancer control; 9. Informed decision; 10. Regret; and, 11. Positive outlook. Since 
evaluation of My Road Ahead forms part of a larger evaluation, men were given the 
entire PCQoL scale. However, for this thesis only subscales number 2, 3, 4, and 5 
were used. An example of an item from each of the subscales is: sexual intimacy 
(‘I’m worried that I might embarrass myself if I  try to have sex’); sexual confidence 
(“I’m confident in my sexual ability’); marital affection (‘My spouse or partner 
seems cool and distant from me’); and masculine self-esteem (‘I’m not the man I 
used to be’). These four subscales were computed by adding item responses and 
transforming into scaled scores of 0 to 100.  
Clark et al. (2003) evaluated the psychometric properties of the scale during its 
development. Using a sample of 742 men with and without prostate cancer the 
internal consistency was found to range from .77 to .93 for most scales, with .60 for 
the PSA Concern subscale. Validity was assessed by evaluating correlations between 
each of the subscales and by correlating the subscales with the Mental Component 
Summary of the SF-12. Subscales generally correlated more strongly with the Mental 
Component Summary of the SF-12 than the Physical Component Summary, 
providing evidence that the PCQoL was accessing aspects of prostate cancer QoL 
beyond physical symptomatology. Evidence for discriminant validity for the PCQoL 
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was found by the scale’s ability to discriminate between men who did and did not 
have prostate cancer on each of the scales that were not specific to cancer. 
For the current study good reliability was found for each of the subscales used: 
sexual intimacy (α = .95); sexual confidence (α = .87); marital affection (α = 0.85), 
and masculine self-esteem (α = .94). For the purpose of this study “marital affection” 
relates to relationship functioning and “sexual intimacy”, “sexual confidence” and 
“masculine self-esteem” relate to sexual QoL fitting under the broader term of sexual 
functioning. 
The International Index of Erectile Function. The International Index of 
Erectile Function (IIEF) is a widely used 15-item self-report measure that was 
developed to assess sexual function among men with ED (Rosen et al., 1997). The 
IIEF attempts to assess the multi-dimensional nature of sexual functioning in men 
and produces scores on five domains of sexual function as well as a total score. The 
domains include: erectile function, orgasm function, sexual desire, intercourse 
satisfaction, and overall satisfaction (Rosen et al., 1997). The IIEF instructs 
respondents to answer items according to functioning during the past 4 weeks. Items 
are rated on a 5 or 6-point Likert scale where the categories change slightly 
depending on the item. Higher scores generally represent a more favourable 
outcome. Responses to items are summed to determine the total IIEF score (range 5–
75). Scores ranges for individual domain scores are erectile function (1–30), orgasm 
function (0–10), sexual desire (2–10), intercourse satisfaction (0–15), and overall 
satisfaction (1–10). Example items for each of the subscales are: erectile function 
(‘How often were you able to get an erection during sexual activity’), intercourse 
satisfaction (‘How much have you enjoyed sexual intercourse’), sexual desire (‘How 
often have you felt sexual desire’), orgasm function (‘When you had sexual 
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stimulation or intercourse, how often did you ejaculate’) and overall satisfaction 
(‘How satisfied have you been with your overall sex life’), 
The IIEF was initially developed after it was recognised that there was a need 
for better efficacy instruments for ED, particularly for clinical trials. After the initial 
development of the questionnaire through consultation with male patients and their 
partners as well as a review of literature, a panel of international experts further 
refined and validated the IIEF. The IIEF is internationally recognised and has been 
converted to many languages; as such the IIEF’s psychometric properties have been 
reviewed in a variety of populations.  
During the development of the scale the psychometric properties of the IIEF 
were evaluated (Cappelleri et al., 1999; Rosen et al., 1997) using a mixture of 
samples including men involved in a clinical trial for sildenafil and aged matched 
men without ED. Across three studies, Rosen et al. (1997) reported a high internal 
consistency using Chronbach’s alpha across the total IIEF scale (.91 - .96), erectile 
function (.92 - .96), orgasm function (.92 - .99), sexual desire (.77 - .91), intercourse 
satisfaction (.73 - .88), and overall satisfaction (.74 - .87). Test-retest reliability was 
also accessed using a 4 week interval. Test-retest reliability was found to be total 
IIEF scale (r = .82), erectile function (r = .84), orgasm function (r = .64), sexual 
desire (r = .71), intercourse satisfaction (r = .81), and overall satisfaction (r = .77). 
Construct validity was also found for the IIEF by Rosen et al. (1997). In this 
study evidence for discriminant validity was found by the outcomes for clinically 
documented men with ED to an age matched control group. Significant differences 
were found across each of the domains. Evidence for convergent validity was found 
by significant positive correlations between each of the IIEF domain scores and 
blinded clinician ratings of sexual function. 
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The psychometric properties of the IIEF have been reported in studies 
consisting of prostate cancer survivor samples. For example, Schover et al. (2002a) 
using a sample of men with localised prostate cancer found the reliability of the IIEF 
to be high using Cronbach’s alpha: total IIEF scale (.97), erectile function (.98), 
orgasm function (.87), sexual desire (.93), intercourse satisfaction (.94), and overall 
satisfaction (.89). Schover et al. also reported means and standard deviations on each 
of the domains for their prostate cancer sample which were IIEF scale (M = 27.8, SD 
= 21.6), erectile function (M = 9.7, SD = 10.4), orgasm function (M = 3.6, SD = 3.7), 
sexual desire (M = 5.3, SD = 2.5), intercourse satisfaction (M = 3.8, SD = 4.8), and 
overall satisfaction (M = 5.0, SD = 2.8). Schover et al. reported that scores on the 
orgasmic function, sexual desire, and intercourse satisfaction were significantly 
lower than those means reported by Rosen et al.’s (1997) study with 111 men with 
ED, indicating that men with prostate cancer may report lower sexual functioning 
than men with ED and no prostate cancer. 
For the current study, good reliability was found for each of the subscales: total 
score scale (α = .95), erectile function (α = .96), orgasm function (α = .70), sexual 
desire (α = .89), intercourse satisfaction (α = .87), and overall satisfaction (α = .90). 
Kansas Marital Satisfaction Scale. The KMSS (Schumm et al., 1986) is a 
common measures of relationship satisfaction. It is a 3-item self-reported 
questionnaire measuring general relationship satisfaction. The questionnaire requires 
respondents select a response along a 7-point scale of: extremely dissatisfied, very 
dissatisfied, somewhat dissatisfied, somewhat satisfied, very satisfied, and extremely 
satisfied. Final scores on the KMS scale range from 3 to 21, with higher scores 
indicating higher relationship satisfaction. An example item is “how satisfied are you 
with your partner as a spouse’. 
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The construct validity of the KMS scale has been evaluated. Schumm et al. 
(1986) explored the concurrent validity of the KMS scale against two other measures 
of marital adjustment, the Dyadic Adjustment Scale (DAS) and the Quality of 
Marriage Index (QMI). Support for the concurrent validity of the KMS scale was 
found by strong correlations with the DAS (r = .83) and QMI (r = .91) (Schumm et 
al., 1986). Similarly, Crane, Middleton, and Ben (2000) found evidence for construct 
validity by strong correlations between the KMS scale and the DAS, with 
comparatively greater correlations with the DAS Satisfaction subscale. Additionally, 
Schumn et al. found support for discriminant validity by assessing the relationship 
between the KMS scale and a variety of unrelated measures of satisfaction with 
factors such as local weather and local politics, with correlations ranging from r = -
.10 to .37. Crane et al. (2000) also found that the KMS scale could identify 
relationship distress by using scores of 16 or below to demonstrate marital distress 
using a sample of 486 clinical and non-clinical married individuals. 
A recent meta-analysis of 398 articles evaluated the reliability of seven 
different relationship satisfaction measures using Cronbach’s alpha estimates 
(Graham, Diebels, & Barnow, 2011). The authors found the KMS scale to be the 
strongest overall measure based on reliability alone with an average of α = .95 across 
studies. Although initially designed for married couples, Graham et al. (2011) found 
that the KMS was slightly more reliable in unmarried and same-sex relationships 
than married different-sex relationships, giving support for the use of KMS for 
individuals in a variety of relationship types. For the current study, good reliability 
was found for this scale (α = .95). 
Communication Patterns Questionnaire-Short Form. The Communication 
Patterns Question was originally developed by Christenesen and Sullaway (1984) 
and consisted of 35 items covering typical couple interactions and communication. 
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The Communication Patterns Questionnaire-Short Form (CPQ-SF) 
(Christensen and Heavey, 1990) is an 11-item self-report questionnaire that measures 
communication within intimate relationships. The CPQ-SF asks respondents to 
identify typical communication styles when either issues or problems arises and 
during discussion of issues or problems. Respondents are asked to rate the likelihood 
that certain issues/problems occur in communication on a 9-point scale from very 
unlikely to very likely, with total scores ranging from 0 to 99. Example items 
included: ‘Female tries to start a discussion while male tries to avoid a discussion’ 
and ‘Both spouses suggest possible solutions and compromises’. 
The CPQ-SF has been divided into several different subscales. In order to 
reduce the number of variables in the analysis of this study, Christensen and 
Heavey’s (1990) original conceptualisation into a demand/withdraw (6 items) and 
positive interactions (3 items) subscale was used. Dewand/withdraw which assesses a 
couple’s total amount of negative communication and positive interactions consists 
of items assessing level of mutual discussion, mutual expression and mutual 
negotiation. The validity of these subscales has been found by moderate correlations 
with measures of marital interaction and marital adjustment in a large sample of 
married and unmarried individuals (Futris, Campell, Nielsen, & Burwell, 2010).  
The CPQ-SF has been used previously by researchers in evaluating the efficacy 
of a couple based intervention in a prostate cancer sample, however the 
demand/withdraw subscale was used but applied to cancer related communication.   
(Manne et al., 2011). Reliabilities were found to be between .78 and .81 for 
coefficient alpha. Reliability has been found to be good for demand/withdraw (α = 
.74) and positive interactions (α = .78) by Christensen and Heavey. For the current 
study, good reliability was found for the subscales of the CPQ-SF, demand/withdraw 
subscale (α = .78) and positive interactions (α = .87). 
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Dyadic Sexual Communication Scale. The Dyadic Sexual Communication 
Scale (DSCS) (Catania, Pollack, McDermott, Qualls, & Cole, 1990) was originally 
developed as a 13-item scale to measure a respondent’s self-reported perception of 
their communication related to sexual relationships. Specifically related to discussion 
around sexual matters with their partners. The original 13-item scale was found to 
discriminate between those that have and did not have sexual problems (Catania, 
1986). Subsequently, Choi, Catania, and Dolcini (1994) created a 4-item version of 
the DSCS using a large sample of married 18 to 49 year old males and females 
investigating the correlates with extramarital sex as part of a National AIDS 
Behavioral Survey. The short-form DSC has 4 items requesting ratings on a 5-point 
scale: strongly disagree, disagree, neutral, agree, and strongly agree. An example 
item from this scale is: “Do you find some sexual matters too difficult to discuss with 
your partner?”. Range of scores is from 4 to 20. 
The 13-item version of this scale has been used in a prostate cancer sample by 
Garos et al. (2007), however the 4-item version was deemed appropriate for this 
study considering the number of other questionnaires included in the analysis. 
Reliability of the 4 item version of the DSC was found to be acceptable taken from a 
male sample as part of the larger study mentioned above (Cronbach’s alpha = .65) 
(Choi et al., 1994). Normative data from this study found the mean score on the DSC 
4-item was 13.22. The current study found that the 4-item DSC had good reliability 
at (α = .85). 
Treatment Satisfaction Questions. The post-treatment questionnaire covered 
satisfaction with modules and the forums, and level of inclusion in each. Three 
questions were rated on a 10-point scale and covered satisfaction with program (“not 
at all” to “extremely”), enjoyment of program (“not at all” to “very much”), and 
usefulness of program (“not at all” to “very useful”). Respondents were given open-
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ended questions to express the opinion of the best and worst part of the modules and 
forum and how each could be improved, including any additional features they might 
find useful. If men did not work through all the modules they were asked for reasons, 
using 11 listed reasons and an “other” verbatim option. Men were also asked to 
provide the number of hours per week they spent online using My Road Ahead. Men 
were asked if they engaged in any other types of mental health support, including 
support groups and cancer information services. 
Questions were included around the level of inclusion or exclusion of partners. 
If partners were included, men were asked additional questions as to whether 
information sheets were given to partners, if they viewed the online information and 
completed the offline exercises together. An open-ended question was asked to 
evaluate which joint exercises men found most beneficial with their partners. 
Website analytics.  The My Road Ahead administrative website allowed 
information to be download detailing the date each module was accessed. Summary 
statistics provided information on the precent completed of each module. 
Procedure  
Ethics approval for the study was obtained from Melbourne Health Human 
Research Ethics Committee, Deakin University Human Research Ethics Committee 
and Swinburne University Human Research Ethics Committee (Appendix I). Men 
were invited to participate in the study through several sources (outlined previously). 
Each advertisement contained a website link to My Road Ahead, which when visited 
provided some information on the program. Men interested in proceeding created an 
account, which they were subsequently requested to validate. Prior to validation 
participants were requested to download the consent form and plain language 
statement and give their consent to participate in the research (see Appendix J). 
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Men were randomised to one of the three treatment groups immediately after 
completing the pre-treatment questionnaire by computer sequential randomisation. 
Men were informed which program they were allocated to after completion of the 
questionnaires. Three treatment groups were created (Modules, Modules-plus-Form, 
and Forum only) in order to evaluate whether an online modular program was more 
efficacious than a basic level of support offered from an online forum.   
Of the 67 men who created an account, 2 (2.99%) failed to electronically 
validate their account. Men who failed to validate their account were sent an email 
explaining that they had created an account but failed to validate it, providing them 
with an opportunity to then validate the account or make contact with the 
administrative team if having any difficulties. Participants were given IT assistance 
as required. Of the 65 who validated their account, 8 (12.31%) failed to complete 
pre-treatment questionnaires. The final sample consisted of 57 men who were 
allocated into the modules-only (n = 19), modules-plus-forum (n = 19) and forum-
only (n = 19) groups. After completing questionnaires, men were advised which 
group they were allocated to. 
Online modules. The treatment evaluated during this study was a self-directed 
online program to address the psychosocial needs of men treated for prostate cancer. 
Those two research groups receiving the online modules (Modules and Modules-
plus-Forum) were provided with a video and text giving an overview to the modules. 
Before commencing the modules, these groups were also provided with suggestions 
of how to get the most from their program including: committing a minimum of one 
hour per week to each of the modules; completing offline exercises; building and 
using a personalised logbook; and partner involvement.  
It was recommended that participants complete the modules in their specified 
order and skills acquired in previous modules were used in subsequent modules. 
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However participants were able to access the beginning of each module at any point. 
Each module comprised of a similar format, commencing with an overview of the 
module, videos entailing prostate cancer survivors’ experiences, videos from health 
professionals providing information, education on specific topics, development of 
strategies to address difficult areas for men with prostate cancer, online exercises, 
offline exercises, and information for partners. More detailed information on each 
module is outlined in the previous chapter. 
Forum.  The Modules-plus-Forum and Forum group were allocated access to 
the My Road Ahead forum. As outlined previously the Forum group was considered 
to be similar to a control group in this study. A separate forum was created for each 
of these groups. Upon completion of the questionnaires, participants allocated to 
these groups were given information about the use of the forum (see Appendix K). 
At any time point, men in either group could gain access to the forum. Those who are 
enrolled into the Modules-plus-Forum were given prompts at the end of each module 
to login to the online forum if they were interested. 
The two forums were divided into two topic areas: ‘introduce yourself’ and 
‘general’. Weekly topics were placed on the forum in the hope to encourage 
discussion. Topics were varied and covered those areas identified as important to 
men treated for prostate cancer, including sexuality, psychological distress, 
relationships (intimate and other), urinary dysfunction, and coping with uncertainty. 
Some topics were general whereas some were specific. Examples topics are included 
Appendix L.  
The forums were checked daily (week days only) by a moderator. The 
moderator was a provisional psychologist who screened comments by participants 
and decided if they were appropriate for posting on the forums. Posts that involved 
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any obscene language or negative comments around specific health professionals or 
services were omitted. 
Email contact. Weekly email contact was given to all participants in this study 
from a provisional psychologist. Emails were relatively generic and were aimed at 
motivating participants to return to the modules and/or forum. Emails varied 
depending on whether a participant was using the program at the appropriate rate or 
not. Emails also included contact details for any participants who were having 
technical difficulties or difficulty understanding the content and requirements of the 
program. Example emails are in Appendix M. 
Follow-up data collection. For all three groups, participants were requested to 
complete post-test questionnaires at 10 weeks after completing pre-test 
questionnaires. A series of automatic and personalised emails were sent to all men 
encouraging them to complete the questionnaire. Follow-up questionnaires were 
completed at 12 weeks and 6 months after completion of the program. For the 
purpose of this thesis, only the immediate follow-up data are reported. At these 
specified time points, men were sent reminder emails to login and complete 
questionnaires. At 10 weeks, participants no longer had access to the modules or 
forum. After completing the final follow-up questionnaire, participants who were 
randomised to the forum-only group received an email notifying them that they had 
access to the My Road Ahead online modules. These participants were not requested 
to complete pre-test questionnaires.  
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CHAPTER 9: Results I 
 
The results for My Road Ahead are presented in the next two chapters. This 
chapter presents pre-test descriptive data and attrition rates during the study. The 
next chapter presents results regarding the efficacy of My Road Ahead. Statistical 
analyses were conducted using SPSS version 21. 
Descriptive Data at Pre-Test  
Table 9.1 contains the pre-test descriptive data for the total sample (N = 57). 
Before reporting these statistics, data were screened for missing values. There were 
limited missing values. One participant who responded that he was single on two 
occasions within the survey later answered three questionnaires that were designed 
for those in a relationship (this case was entered as missing). In addition, two 
participants who responded that they were married, completed three partner related 
questionnaires, but skipped the marital affection subscale of the PCQoL scale. For 
these two cases, mean substitution was used for this variable, based on the mean for 
the group as recommended by Tabachnick and Fiddel (2001).  For ED aid use, there 
were missing data for one person who selected “yes” to injection therapies but did 
not select any further options for the type, frequency and satisfaction. The categorical 
data for this variable were left as it is, however the two metric variables covering 
frequency and satisfaction level were also replaced with mean substitution based on 
group means.  No other missing values were observed, an expected finding given that 
the website did not permit unfinished questions. 
Mean age of participants was 61.42 (SD = 6.79, Range = 42 to 76 years). The 
sample was not ethnically diverse, consisting entirely of men who identified as 
Anglo-Celtic/Caucasian or European. The sample was predominately from urban 
155 
 
  
locations. Just over half of participants were employed part-time with several other 
men engaged in other forms of employment. The sample was generally well educated 
with almost half having some form of university degree, however almost a third had 
only completed some level of high school.  
The majority of the sample established that they were heterosexual, with four 
men identifying as bisexual, and one as homosexual. In regards to relationship status, 
almost all men selected that they were either married/partnered/defacto, with only 
two men having selected that they were either dating or in a casual relationship, and 
a final three men were single. Of those in some form of relationship, most had been 
in that relationship for more than 10 years. 
In accordance with the prerequisite for entry into this study, all men were 
diagnosed and had been treated for localised prostate cancer. Mean time since 
diagnosis was 24.00 months (SD = 17.37, Range = 6 to 70 months). Time since first 
treatment for prostate cancer was 21.70 months (SD = 16.63, Range = 6 to 60 
months). The majority of participants had undergone a radical prostatectomy, with 
only a small number of participants having had radiation therapy, hormone therapy 
and active surveillance. Robotic surgery was the most common type of radical 
prostatectomy. While the majority of men had undergone only one treatment five 
men had a combination of treatment. Three men had radiotherapy and radical 
prostatectomy, two men had radiotherapy and hormone therapy, incidicating that all 
participants had treatment for localised prostate cancer.  For those men who selected 
active surveillance, this was after some form of active treatment (radiotherapy or 
radical prostatectomy). Table 9.1 also provides information on the incidence of past 
illnesses, including diabetes, another cancer and heart conditions. Five men reported 
ever being diagnosed with mental illness (all reported depressive disorder diagnosis 
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and two with comorbid anxiety) and eight men were currently taking anti-
depressants. 
Almost half of the men sampled reported that they had accessed some type of 
psychosocial support, and the source of this support varied greatly, with the Cancer 
Council Information and Support Service being the most popular source for men. 
Many men had also seen healthcare practitioners, with the largest proportion seeing a 
urology nurse specialist, a physiotherapist, followed by a sexual rehabilitation 
specialist. 
The majority of men had used some form of medical intervention for ED. The 
most commonly used aid was a PDE5 inhibitor, followed by injection therapy, 
vacuum devices and only one man had a penile implant. Since more than one type of 
PDE5 inhibitor and injection therapy could be selected, averages for frequency and 
satisfactions scores were taken. Men were asked about their frequency of use of 
PDE5 inhibitors (three different types) with 57.15% of the time men selecting that 
they “tried it once or twice and gave up” and 77.78% reporting low satisfaction. 
Views of injection therapies were more positive, with 34.48% of the time “tried it 
once or twice and gave up” being selected and 44.83% selecting low satisfaction. 
Only eight men reported using vacuum devices, and 66.67% only used it once or 
twice and 83.33% reported low satisfaction. Only one man had obtained a penile 
implant, reporting low satisfaction.  
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Table 9.1 
Participant Characteristics at Pre-Test (N = 57) 
Continuous variables Mean SD Min Max 
Age in years 61.42 6.79 42 76 
PCa treatment     
Months since diagnosis 
(months)  
24.00 17.37 6 70 
Months since first treatment 
(any)  
21.70 16.63 6 60 
Sexual function & sexual QoL     
Erectile function 8.25 9.33 1 30 
Orgasm function 3.60 3.05 0 10 
Sexual desire 6.14 2.24 2 10 
Intercourse satisfaction 4.10 4.41 0 13 
Overall satisfaction 4.30 3.49 0 10 
IIEF total score 26.39 19.07 3 71 
Sexual confidence  35.75 30.52 0 100 
Sexual intimacy  53.88 32.69 0 100 
Masculine self-esteem  68.04 26.54 0 100 
Psychological function     
Stress 9.40 9.64 0 38 
Anxiety 3.54 5.44 0 24 
Depression 7.68 9.00 0 28 
Relationship function     
Relationship satisfaction 16.70 4.92 3 21 
Marital affection  85.12 21.64 16.67 100 
General communication      
Demand/withdraw 13.62 8.23 6 35 
Positive interactions 18.06 7.16 3 27 
Sexual communication  12.58 4.10 4 20 
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Table 9.1 (continued) 
Categorical variables n %   
Ethnicity     
Anglo-celtic/Caucasian 38 66.67   
European 19 33.33   
Locationa     
Urban 46 80.70   
Rural  9 15.79   
Semi-rural 2 3.51   
Education     
Post-graduate degree 9 15.78   
Undergraduate degree 14 24.56   
Diploma 9 15.78   
TAFE/other certificate 8 14.04   
High school (Year 9+) 17 29.82   
Employment status     
Full-time 33 57.89   
Part-time/casual 7 12.28   
Retired 12 21.05   
Unemployed/disability 
support 
3 5.26   
Self-employed 2 3.51   
Sexual orientation     
Heterosexual 52 91.23   
Homosexual 1 1.75   
Bisexual 4 7.02   
Relationship status     
Married/defacto 52 91.23   
Dating/casual 2 3.51   
Single  3 5.26   
Relationship duration (N = 54)     
6-12 months 1 1.75   
1-5 years 1 1.75   
5-10 years 4 7.02   
10+ years 48 88.89   
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Table 9.1 (continued) 
Prostate Cancer Tx     
Prostatectomy 55 96.49   
Radiation therapy 5 8.77   
Hormone therapy 2 2.30   
Active surveillance 2 3.51   
Risk health factors reported     
Another cancer 5 8.77   
Diabetes 4 7.02   
Heart condition 3 5.26   
Mental illness 5 8.77   
Current anti-depressants 8 14.04   
Past anti-depressants 11 19.30   
Past support     
Psychologist  6 10.53   
Psychiatrist 3 5.26   
Counsellor 3 5.26   
Support group 8 14.04   
Cancer Councilb 10 17.54   
Telephone 4 7.02   
Online  6 10.53   
Any support 24 42.11   
Healthcare practitioners     
Urology nurse specialist 30 52.63   
Physiotherapist 19 33.33   
Sexual rehabilitation specialist 7 12.28   
Erectile aids     
Used PDE5 inhibitors 38 66.7   
Used injection therapy 25 43.86   
Used vacuum devices 6 10.53   
Used penile implants 1 1.75   
Overall used some Tx  44 77.19   
Note . aAs classified by the Australian Bureau of Statistics (ABS, 2012a): urban = population 
over 99,000; semi-rural = 1000-99,000; rural = less than 1000 people. bThe Cancer Council 
Information and Support Service.   
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Mean values for depression, anxiety and stress were found to be in the normal 
range, suggesting this sample of men treated for prostate cancer experienced low 
levels of psychological distress. However, based on the DASS severity ratings, 
26.32% of the sample experienced either moderate or severe depression. When 
considering relationship satisfaction and using a criterion score of 16 or less to 
identify dissatisfaction with the overall relationship (Crane et al., 2000), summary 
scores for this variable suggested minor dissatisfaction may have been present among 
the sample at pre-test (M = 16.70; SD = 4.92).  
Measures of sexual function across the subscales of the IIEF and the IIEF total 
score where very similar to Schover et al.’s (2002a) previously reported means from 
a sample of men treated for prostate cancer. Schover et al. classified having ED as a 
total IIEF score of under 22. This was reported to be a generous cut-off. In the 
current sample 52.36% of men had a total IIEF score of under 22.   
Measures of sexual QoL (sexual intimacy, sexual confidence, and masculine 
self-esteem) were very similar to the means found by Clark et al. (2003) when using 
a sample of men with prostate cancer. Clark et al.’s PCQoL scale does not have 
specific formalised degrees of severity. However, in their study, Clark et al. found 
men treated for prostate cancer were found to have statistically lower scores and 
poorer QoL on each of these subscales in comparison to a sample of men without 
prostate cancer. Therefore, results from our sample provide further evidence that men 
treated for prostate cancer may have lower QoL across sexuality and masculine 
identity domains in comparison to men without prostate cancer.  
Treatment versus Control at Pre-Test. 
Participants were randomly assigned to one of three treatment groups – 
modules-plus-forum (n = 19), modules (n = 19), or forum (n = 19). To investigate 
whether randomisation produced equivalence between groups at pre-test, continuous 
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variables were compared using ANOVAs (Analysis of Variance), and dichotomous 
variables were compared using chi-square test for independence. The default chi-
square value was Pearson’s chi-square. An alpha level of p < .05 was used to identify 
significant group differences for each variable. It was not possible to run comparison 
for all categorical descriptive variables due to the small numbers in cells for some 
variables (e.g., relationship status). For the purpose of comparison, some variables 
were combined in order to conduct chi-square analyses via a dichotomous variable. 
These included location, employment and education. Expected cell count was less 
than five for several chi-square analyses and a series of 2x2 cross tabs were 
conducted to evaluate these variables (see Appendix N). For other variables where 
re-categorisation was not appropriate and 2x2 cross tabs were not possible due to 
extremely small cell counts, the number of participants and percentages were still 
entered into Table 9.2.  
Assumption testing. Before conducted ANOVAs a series of assumptions 
needed to be tested and met. The dependent variables that were included in each of 
the ANOVAs were screened for univariate outliers. Outliers where evaluated using 
grouped data based on recommendations from Tabachnick and Fiddel (2001) when 
comparing groups for analyses. Using the criterion of Z = ± 3.29 (Tabachnick & 
Fiddel, 2001) for univariate outliers, there were no outliers for any variable at pre-
test. Normality was also assessed by testing for absolute values of two for skewness 
(Curran, West, & Finch, 1996). Three variables had skewness scores above the 
absolute value of two (erectile function, relationship satisfaction, and marital 
affection). Transformation of these variables made no difference to pre-test 
comparisons (ANOVAs), as such original scores were retained. In addition, the 
violation of skewness was minimal. According to Levene’s test, homogeneity of 
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variance could be assumed for all dependent variables expect for depression and 
sexual confidence. Welch’s statistic was reported for these variables. 
As can be seen in Table 9.2, participants randomly assigned to each of the three 
groups did not differ significantly in terms of demographic and study variables, 
except for current use of anti-depressants. More participants in the Modules only 
group reported using anti-depressants than the Forum only group. This suggests that 
overall equivalence of groups had been achieved through random allocation. For 
those descriptive variables where analysis of statistical significance between groups 
was not possible due to small cell numbers, it appears randomisation has worked.  
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Table 9.2 
Pre-Test Comparison between Participants Randomly Assigned to the Modules, 
Modules-plus-Forum, and Forum Group 
 Modules 
(n =19) 
Modules-plus-
Forum 
(n =19) 
Forum 
(n =19) 
  
Continuous variables Mean (SD) Mean (SD) Mean (SD) F p 
Age in years 61.58 (6.93) 60.95 (6.77) 61.74 (7.02) 0.07 .933 
PCa treatment      
Months since 
diagnosis   
21.26 (18.00) 26.00 (13.86) 24.74 (20.25) 0.37 .692 
Months since first 
treatment 
17.63 (19.35) 23.26 (14.17) 21.32 (20.50) 0.33 .722 
Sexual function & sexual 
QoL 
     
Erectile function 10.16 (10.18) 8.32 (9.80) 6.26 (7.95) 0.82 .445 
Orgasm function 3.84 (2.99) 3.21 (2.92) 3.74 (3.35) 0.23 .797 
Sexual desire 6.00 (2.13) 6.32 (2.36) 6.11 (2.33) 0.10 .910 
Intercourse 
satisfaction 
4.89 (4.27) 4.16 (4.65) 3.26 (4.39) 0.64 .529 
Overall satisfaction 4.84 (3.48) 3.74 (3.41) 4.32 (3.68) 0.47 .630 
IIEF total score 29.74 (20.34) 25.74 (20.26) 23.68 (16.93) 0.49 .618 
Sexual confidencea 43.42 (27.91) 38.16 (37.95) 25.66 (22.43) 2.46 .185 
Sexual intimacy 61.09 (30.11) 58.08 (33.27) 42.48 (33.07) 1.83 .170 
Masculine self-esteem 74.67 (22.99) 71.55 (22.05) 57.89 (31.76) 2.24 .116 
Psychological function      
Stress 7.68 (9.39) 10.74 (10.20) 9.79 (9.59) 0.49 .615 
Anxiety 2.42 (4.35) 3.16 (4.18) 5.05 (7.19) 1.19 .311 
Depressiona 4.42 (5.83) 9.37 (11.22) 9.26 (8.67) 2.74 .079 
Relationship functionb      
Relationship 
satisfaction 
16.00 (5.36) 16.44 (5.24) 17.71 (4.18) 0.55 .580 
Marital affection 86.27 (18.95) 85.65 (24.56) 83.33 (22.24) 0.09 .918 
General 
communication 
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Table 9.2 (continued) 
 Positive 
interactions 
19.17 (5.67) 18.33 (8.31) 16.59 (7.44) 0.58 .565 
Demand/withdraw 13.06 (7.84) 14.67 (9.65) 13.12 (7.35) 0.21 .809 
Sexual 
communication 
13.50 (4.26) 11.83 (3.78) 12.41 (4.30) 0.76 .473 
Categorical variables n (%) n (%) n (%) χ2  p 
Ethnicity    0.63 .729 
Anglo-
celtic/Caucasian 
14 (73.7) 12 (36.8) 12 (36.8)   
European 5 (26.3) 7 (63.2) 7 (63.2)   
Locationcd      
Rural 16 (84.2) 14 (73.7) 16 (84.2)   
Urban 3 (15.8) 5 (26.3) 3 (15.8)   
Education  (university 
degree) 
8 (42.1) 6 (31.6) 9 (47.4) 1.02 .597 
Employment status  (full-
time) 
10 (52.6) 12 (63.2) 11 (57.9) 0.43 .805 
Sexual orientationc      
Heterosexual 17 (89.47) 18 (94.74) 17 (89.47)   
Homosexual 1 (5.26) 0 (0.00) 0 (0.00)   
Bisexual 1 (5.26) 1 (5.26) 2 (10.53)   
Relationship statusc      
Married/defacto 18 (94.74) 18 (94.74) 16 (84.11)   
Dating/casual 0 (0.00)  0 (0.00) 2 (10.53)   
Single  1 (5.26) 1 (5.26) 1 (5.26)   
Relationship duration       
6-12 months 0 (0.00) 0 (0.00) 1 (5.6)   
1-5 years 0 (0.00) 0 (0.00) 1 (5.6)   
5-10 years 2 (11.1) 0 (0.00) 2 (11.1)   
10+ years 16 (88.89) 18 (100.00) 14 (77.8)   
Prostate cancer treatment      
Radical 
prostatectomyc 
18 (94.74) 18 (94.74) 19 (100)   
Radiotherapyc 2 (10.53) 3 (15.79) 0 (0.00)   
Hormone therapyc 1 (5.26) 1 (5.26) 0 (0.00)   
Active surveillancec 1 (5.26) 1 (5.26) 0 (0.00)   
Risk factors reported      
Another cancercd 1 (5.26) 1 (5.26) 3 (15.79)   
Diabetescd 2 (10.53) 1 (5.26) 1 (5.26)   
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Table 9.2 (continued) 
Heart conditioncd 0 (0.00) 2 (10.53) 1 (5.26)   
Mental illnesscd 3 (15.79) 2 (10.53) 0 (0.00)   
Current anti-
depressantscd 
5 (26.32)* 3 (15.79) 0 (0.00)*   
Past anti-depressantscd 4 (21.05) 4 (21.05) 3 (15.79)   
Past support      
Psychologistcd 0 (0.00) 2 (10.53) 4 (21.05)   
Psychiatristcd 1 (5.26) 2 (10.53) 0 (0.00)   
Counsellorcd 0 (0.00) 0 (0.00) 3 (15.79)   
Support groupcd 3 (15.79) 3 (15.79) 2 (10.53)   
Cancer Councilcde 3 (15.79) 4 (21.05) 3 (15.79)   
Telephonecd 2 (10.53) 1 (5.26) 1 (5.26)   
Onlinecd 1 (5.26) 4 (21.05) 1 (5.26)   
Any support 6 (31.58) 9 (47.37) 9 (47.37) 1.30 .523 
Healthcare practitioners      
Urology nurse 
specialist 
12 (63.2) 11 (57.9) 7 (36.8) 2.96 .228 
Physiotherapist 8 (42.11) 4 (21.05) 7 (36.84) 2.05 .358 
Sexual rehabilitation 
specialistcd 
1 (5.26) 3 (15.79) 3 (15.79)   
Erectile aids      
Used PDE5 inhibitors 14 (73.7) 10 (52.6) 14 (73.7) 2.53 .283 
Used injection therapy 8 (42.1) 9 (74.4) 8 (42.1) 0.14 .931 
Used vacuum 
devicescd 
2 (10.5) 2 (10.5) 2 (10.5)   
Used penile implantscd 0 (0.00) 1 (5.3) 0 (0.00)   
Overall used some 
Txcd 
16 (84.21) 12 (63.16) 16 (84.21)   
aWelch statistics reported for ANOVA. bn = 52 for relationship function variables. cExpected 
cell count less than five in < 80% of cells, chi-square statistic unable to be computed.  d See 
Appendix N for 2x2 table cross tabs.  e The Cancer Council Information and Support Service.  
*Significant difference between Modules and Forum group at p < 0.05. 
Attrition and Treatment Adherence 
This section explores level of attrition and descriptive characteristics related to 
attrition. The next chapter covers level of program use. In terms of attrition, a man 
was classified as having dropped out if he either failed to complete post-test data 
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and/or completed less than 40% of the modules. A flow chart demonstrating attrition 
rates during the study is provided in Figure 2. There was a moderate level of attrition. 
Of the 57 men who completed pre-test data and were randomised into one of the 
three groups, 16 (28.07%) were considered to have dropped out. There were four 
participants who failed to complete post-test data even though they completed more 
than 40% of the modules. There were slightly higher drop-out rates in the Modules 
group (n = 7) compared to the Forum group (n = 4) and Modules-plus-Forum group 
(n = 5). This meant that the final sample sizes were slightly uneven: Modules (n = 
12), Forum (n = 15), and Modules-plus-forum (n = 14). 
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Figure 9.2.  Number of participants and attrition for My Road Ahead. 
 
Validated account but did not 
complete pre-test 
questionnaire (n= 65) 
Completed pre-test & 
randomised (n = 57) 
Forum 
(n = 19) 
Modules 
(n = 19) 
Modules-
plus-forum 
(n = 19) 
Dropped 
out (n = 4) 
 
Completed 
post-test   
(n = 15) 
Dropped out (n = 7) 
x Did not complete 
post-test (n = 4) 
x Completed post-test 
& <40% of modules 
(n = 3) 
Dropped out (n = 5) 
x Did not complete 
post-test (n = 4) 
x Completed post-test 
& <40% of modules 
(n = 1) 
Completed 
post-test & 
≥ 40% 
modules  
(n = 12) 
 
Completed 
post-test & ≥ 
40% modules  
(n = 14) 
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Assumption testing.  Data were screened again for outliers and violations of 
normality based on grouped data (“completed” and “dropped out”) prior to attrition 
analyses. Outliers were screened at the criterion of Z = ± 3.29. Two outliers were 
found for the variables anxiety and stress, both within the “completed” group data. 
All variables demonstrated acceptable skewness except for anxiety which was above 
the absolute value of two. For stress, converting this outlier value to three standard 
deviations above the mean resulted in a consequent Z score less than 3.29. Using this 
strategy for anxiety, along with converting the outlier to one unit above the second 
highest value did not improve the normality of the variable including the level of 
skewness. This variable was therefore transformed using the square root 
transformation for mildly positively skewed data. Transformation (using SQRT) left 
no outliers.  Independent samples t-tests produced different results for transformed 
data and are therefore presented below for t-tests as this represents a better example 
of normality. Means and standard deviations for anxiety are based on the raw data in 
Table 9.3.  
Pre-test data were compared between participants who completed treatment 
and those who dropped out of treatment. Independent-samples t-tests were used to 
compare continuous variables, and chi-square tests for independence were used to 
compare dichotomous variables. For all chi-square analyses, Yates’ Correction for 
Continuity was the default option applied, and Fisher’s Exact Probability Test was 
applied when expected cell counts were less than five. An alpha level of p < .05 was 
used to identify significant group differences for each variable. The results of these 
analyses are displayed in Table 9.3. Levene’s test for equal variance of the two 
groups was violated for stress and depression.  
As indicated in Table 9.3, participants who dropped out compared to those who 
did not drop out differed significantly at pre-test according to age, where younger 
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men were more likely to drop out of treatment. Men who dropped out were also more 
likely to report higher levels of anxiety and to have a history of mental illness. Men 
who stayed in the RCT were more likely to have previously accessed the Cancer 
Council Information and Support Service. When all types of support were added 
together, men who had accessed any type of support were more likely to remain in 
the study. 
Table 9.3 
Pre-Test Comparison between Participants who Completed My Road Ahead and 
Participants who Dropped Out 
 Completed 
treatment 
(n = 41) 
Dropped out of 
treatment 
(n = 16) 
  
Continuous variables Mean (SD) Mean (SD) t (55) p 
Age in years 62.61 (5.78) 58.38 (8.33) 2.19 .033* 
PCa treatment     
Months since diagnosis 
(months) 
24.07 (16.87) 23.81 (19.18) 0.05 .960 
Months since first treatment 
(any) 
21.78 (16.31) 21.50 (17.98) 0.06 .955 
Sexual function & sexual QoL     
Erectile function 8.12 (8.96) 8.56 (10.54) -0.16 .874 
Orgasm function 3.51 (3.05) 3.81 (3.12) -0.33 .741 
Sexual desire 6.17 (2.11) 6.06 (2.62) 0.16 .871 
Intercourse satisfaction 4.22 (4.41) 3.81 (4.53) 0.31 .757 
Overall satisfaction 4.41 (3.50) 4.00 (3.58) 0.40 .691 
Total sexual function 26.44 (18.46) 26.25 (21.16) 0.03 .974 
Sexual confidence 36.43 (30.36) 33.98 (31.87) 0.27 .788 
Sexual intimacy 54.09 (33.2) 53.35 (31.96) 0.08 .939 
Masculine self-esteem 69.28 (23.85) 64.84 (33.12) 0.56 .575 
Psychological function     
Stress 8.00 (8.22) 12.75 (11.61) -1.50 .149 
Anxietya 2.63 (4.91) 5.88 (6.17) -2.25* .028 
Depression  6.88 (8.12) 9.75 (10.95) -0.95 .352 
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Table 9.3 (continued) 
Relationship functionb      
Relationship satisfaction 16.56 (4.85) 17.07 (5.28) -0.33 .744 
Marital affection 85.76 (19.20) 83.33 (28.12) 0.36 .723 
General communication      
Positive interactions 17.18 (7.21) 20.50 (6.68) -1.51 .138 
Demand/withdraw 14.67 (8.76) 10.71 (5.82) 1.56 .124 
Sexual communication 12.36 (4.11) 13.21 (4.15) -0.67 .508 
Categorical variables n (%) n (%) χ2 p 
Ethnicity   0.00 1.00 
Anglo-celtic/Caucasian 27 (65.85) 11 (68.8)   
European 14 (34.15) 5 (31.2)   
Locationc   0.00 1.00 
Rural 8 (19.51) 3 (18.75)   
Urban 33 (80.49) 13 (81.25)   
Education (university degree)c 19 (46.34) 4 (25.00) 1.38 .229 
Employment status (full-time) 24 (58.5) 9 (56.2) 0.00 1.00 
Sexual orientationc   0.89 .179 
Heterosexual 36 (87.80) 16 (100)   
Homosexual/Bisexual 5 (12.20) 0 (0)   
Relationship statuscd     
Married/defacto 38 (92.68) 14 (87.50)   
Dating/casual 1 (2.44) 1 (6.25)   
Single  2 (4.88) 1 (6.25)   
Relationship durationcd     
6-12 months 0 (0.00) 1 (6.25)   
1-5 years 1 (2.44) 0 (0.00)   
5-10 years 3 (7.32) 1 (6.25)   
10+ years 35 (85.37) 13 (81.25)   
Prostate Cancer Tx     
Radical prostatectomyc  39 (95.12) 16 (100.00) 0.01 1.00 
Radiotherapyc 5 (12.20) 0 (0.00) 0.89 .308 
Hormone therapyc 2 (4.88) 0 (0.00) 0.01 1.00 
Active surveillancec 1 (2.44) 1 (6.25) 0.00 .486 
Risk factors reported     
Another cancerc 4 (9.76) 1 (6.25) 0.00 1.00 
Diabetesc 4 (9.76) 0 (0.00) 0.52 .568 
Heart conditionc 2 (4.88) 1 (6.25) 0.00 1.00 
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Table 9.3 (continued) 
Mental illnessc 1 (2.44) 4 (25.00) 4.77  .019* 
Current anti-depressantsc 4 (9.76) 4 (25.00) 1.13 .202 
Past anti-depressantsc 6 (14.63) 5 (26.32) 1.11 .260 
Past support     
Psychologistc  4 (9.76) 2 (12.50) 0.00 1.00 
Psychiatristc 3 (7.32) 0 (0.00)  0.20 .552 
Counsellorc 3 (7.32) 0 (0.00)  0.20 .552 
Support groupc 8 (19.51) 0 (0.00)  2.19 .090 
Cancer Councilce 10 (24.39) 0 (0.00)  3.12   .048* 
Telephonec 4 (9.76) 0 (0.00)  0.52 .568 
Onlinec  5 (12.20) 1 (6.25) 0.03 .665 
Any supportc 22 (53.66) 2 (12.50) 6.40  .007** 
Healthcare practitioners     
Urology nurse specialist 24 (58.54) 6 (37.5) 1.29 .238 
Physiotherapistc 16 (39.02) 3 (18.75) 1.31 .214 
Sexual rehabilitation 
specialistc 
5 (12.20) 2 (12.50) 0.00 1.00 
Erectile aids     
Used PDE5 inhibitors 28 (68.29) 10 (62.50) 0.01 .758 
Used injection therapy 20 (48.78) 5 (31.25) 0.81 .255 
Used vacuum devicesc 3 (7.32) 3 (18.75) 0.61 .335 
Used penile implantsc 1 (2.44) 0 (0.00) 0.61 1.00 
Overall used some Txc  31 (75.61) 13 (81.25) 0.01 .740 
Note. a t-test based on transformed data.  bn = 52 for relationship function variables. c Expected 
cell count less than five in < 80% of cells.  dChi-square statistic unable to be computed.  eThe 
Cancer Council Information and Support Service 
* p < 0.05. ** p < 0.01 
 
Chapter summary 
This chapter presented results regarding pre-test descriptive data of a sample of 
men treated for prostate cancer who had signed up to take part in My Road Ahead. 
The results were collected from a sample of men who had been treated for localised 
prostate cancer who were currently single or in some form of relationship and of any 
sexual orientation. 
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In relation to the descriptive data, there was a moderate range of age with the 
men predominately being in a long-term heterosexual relationship. The mean time 
since treatment for prostate cancer was almost two years and most men had 
undergone a radical prostatectomy. A substantial number of men had previously 
accessed some form of psychosocial support. The majority of men had also used 
some form of ED aid previously. Despite this, reports of frequency and satisfaction 
with aid use were generally low. 
There was a moderate level of attrition in this study, 28.07% were considered 
to have “dropped out”. Independent samples t-tests and chi-square tests for 
independence revealed significant differences between those who completed 
treatment and those who dropped-out. In particular men who dropped out of the 
study were younger and reported higher levels of anxiety or a history of a mental 
illness. The next chapter investigates the efficacy of My Road Ahead. 
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CHAPTER 10: Results II 
This chapter presents the results regarding the efficacy of My Road Ahead. Pre-
test to post-test changes in sexual, psychological and relationship function were 
compared across the three groups. The second part of this chapter reports on 
qualitative and quantitative data regarding the feasibility and usability of My Road 
Ahead. 
Assumption Testing 
Prior to assessing equivalence between groups at pre-test and evaluating the 
efficacy of My Road Ahead,  pre-test and post-test data were cleaned again based on 
the final sample of 41 participants. Data were screened for missing values, outliers 
and violations of normality. Assumptions were investigated among dependent 
variables by group (three treatment groups). There was a limited amount of missing 
data for post-test variables. One man failed to answer the marital affection 
questionnaire and this was replaced by the group mean for this variable. Outliers 
were not found for pre-test and post-test data for each of the variables. Violations of 
skewness (absolute values above two) were found for anxiety at pre-test and post-
test, marital affection at pre-test. Marital affection was negatively skewed for the 
Modules group at pre-test time point. Transformation of this variable led to improved 
skewness values, however when transforming all variables at each of the time points 
for repeated measures analysis, this changed the meaning of the results including 
interactions. It was decided that this variable would be left as an absolute value as it 
was only just above two (skewness = 2.05).  
Anxiety at pre-test was positively skewed for each of the three groups, with 
violations for the Modules and Forum group (absolute values above two). None of 
the transformations for positively skewed data returned the anxiety data to normality. 
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For baseline comparisons of pre-test data across the three groups, both parametric 
and non-parametric analyses were run to compare the three groups on this variable 
with no difference in the outcomes (substantive conclusions). Therefore Table 10.1 
reports parametric results as these are the original and intended metric of the 
variables. For non-parametric tests, Kruskal-Wallis Test revealed no significant 
difference in depression across the three treatment groups, chi-square (2, 435) = 4.03, 
p = .13. For anxiety at post-test, the skewness value was just above two for anxiety 
for the Forum group. The SQRT transformation of this variable improved its level of 
skewness. However, results of repeated measures analysis for anxiety did not differ 
when using transformed data (for both pre-test and post-test) compared to 
untransformed, therefore the original data were used.  
At baseline comparison Levene’s test, homogeneity of variance could be 
assumed for all dependent variables expect for depression. Welch’s statistic was 
reported for this variable. Data were also screened for homogeneity of variance, and 
homogeneity of variance-covariance matrices. According to Levene’s test, 
homogeneity of variance could be assumed for all variables, except for masculine 
self-esteem, sexual intimacy, anxiety and marital affection at post-test. Assessment 
of Box’s M also revealed no violation of the assumption of homogeneity of variance-
covariance matrices except for anxiety. Analyses involving these variables used a 
more stringent significance value of p < .01. 
Participant Characteristics Among Treatment and Control Groups after 
Attrition  
Following attrition, it was considered important to assess whether the treatment 
groups were equivalent. Pre-test descriptive data for the three groups after attrition 
are presented in Table 10.1. To assess equivalence between groups at pre-test, 
continuous variables were compared using ANOVAs and dichotomous variables 
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were compared using chi-square tests for independence. The default chi-square value 
was Pearson’s Chi-square. For several variables, chi-square analyses were unable to 
be computed due to low cell count. A series of 2x2 cross tabs were calculated for 
these variables and can be found in Appendix O, and for those that the cell counts 
were still too small Table 10.1 still contains this data in order to be able to visually 
compare the groups. An alpha of p <.05 was used to detect significant group 
differences for each variable. As can be seen in Table 10.1, significant group 
differences between any of the variables were not found at pre-test, suggesting that 
equivalence between the three groups could be assumed for all variables. 
Table 10.1 
Pre-Test Comparison between the Modules, Modules-plus-Forum, and Forum Group 
after Attrition 
 Modules 
(n = 12) 
Modules-
plus-Forum 
(n = 14) 
Forum 
(n = 15) 
  
Continuous variables Mean (SD) Mean (SD) Mean (SD) F p 
Age in years 63.17 (5.57) 62.50 (5.23) 62.27 (6.68) 0.08 .923 
PCa treatment      
Months since diagnosis 
(months) N = 57 
21.75 (16.29) 26.79 (14.92) 23.40 (19.62) 0.30 .745 
Months since first 
treatment (any) N = 57 
19.83 (16.32) 24.36 (14.71) 18.42 (4.76) 0.27 .765 
Sexual function & sexual 
QoL 
     
Erectile function 9.00 (9.32) 8.64 (9.32) 6.93 (8.83) 0.21 .816 
Orgasm function 3.92 (2.97) 3.36 (3.05) 3.33 (3.29) 0.14 .867 
Sexual desire 6.08 (2.27) 6.79 (1.93) 5.67 (2.13) 1.04 .365 
Intercourse satisfaction 4.42 (4.25) 4.57 (4.40) 3.73 (4.80) 0.14 .869 
Overall satisfaction 4.92 (3.55) 3.86 (3.25) 4.53 (3.83) 0.30 .743 
IIEF total score 28.33 (18.98) 27.21 (18.68) 24.20 (18.92) 0.18 .838 
Sexual confidence 48.44 (25.99) 33.93 (38.19) 29.17 (23.70) 1.45 .248 
Sexual intimacy 63.99 (29.98) 58.93 (35.15) 41.67 (32.33) 1.79 .181 
Masculine self-esteem 78.91 (17.48) 70.09 (21.40) 60.83 (28.34) 2.03 .146 
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Table 10.1 (continued) 
Psychological function      
Stress 5.33 (6.29) 10.43 (9.96) 8.13 (8.63) 1.15 .327 
Anxiety 0.83 (2.33) 2.86 (3.66) 3.87 (6.91) 1.32 .280 
Depressiona 3.33 (4.62) 9.00 (10.55) 7.73 (7.25) 2.72 .086 
Relationship functionb       
Relationship 
satisfaction 
14.27 (5.83) 17.38 (4.09) 17.53 (4.42) 1.78 .183 
Marital affection 83.60 (22.38) 86.54 (22.19) 86.67 (14.71) 0.09 .912 
General 
communication 
     
Positive interactions 18.00 (5.90) 18.00 (8.24) 15.87 (7.41) 0.39 .679 
Demand/withdraw 15.73 (8.81) 15.23 (10.40) 13.40 (7.58) 0.25 .777 
Sexual communication 13.18 (4.29) 11.54 (4.03) 12.47 (4.19) 0.47 .628 
      
Categorical variables n (%) n (%) n (%) χ2  dof 
Ethnicitycd      
Anglo-
celtic/Caucasian 
8 (66.67) 9 (64.28) 10 (66.67)   
European 4 (33.33) 5 (35.71) 5 (33.33)   
Locationcd      
Rural 10 (83.33) 11 (78.57) 12 (80.00)   
Urban 2 (16.67) 3 (21.43) 3 (20.00)   
Education  (has university 
degree) 
5 (41.67) 6 (42.86) 8 (53.33) 0.47 2, 41 
Employment status  
(works full-time) 
7 (58.33) 9 (64.28) 8 (53.33) 0.36 2, 41 
Sexual orientationc      
Heterosexual 10 (83.33) 13 (92.86) 13 (86.67)   
Homosexual 1 (8.33) 0 (0.00) 0 (0.00)   
Bisexual 1 (8.33) 1 (7.14) 2 (13.33)   
Relationship status c      
Married/defacto 11 (91.67) 13 (92.86) 14 (93.33)   
Dating/casual 0 (0.00) 0 (0.00) 1 (6.67)   
Single  1 (8.33) 1 (7.14) 0 (0.00)   
Relationship durationc      
1-5 years 0 (0.00) 0 (0.00) 1 (6.67)   
5-10 years 1 (8.33) 0 (0.00) 2 (13.33)   
10+ years 10 (83.33) 13 (92.86) 12 (80.00)   
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Table 10.1 (continued) 
Prostate cancer treatment      
Radical 
prostatectomycd 
11 (91.67) 13 (92.86) 15 (100.00)   
Radiotherapycd 2 (16.67) 3 (21.43) 0 (0.00)   
Hormone therapycd 1 (8.33) 1 (7.14) 0 (0.00)   
Active surveillancecd 1 (8.33) 0 (0.00) 0 (0.00)   
Risk factors reported      
Another cancercd 1 (8.33) 1 (7.14) 2 (13.33)   
Diabetescd 2 (16.67) 1 (7.14) 1 (6.67)   
Heart conditioncd 0 (0.00) 1 (7.14) 1 (6.67)   
Mental illnesscd 0 (0.00) 1 (7.14) 0 (0.00)   
Current anti-
depressantscd 
2 (16.67) 2 (14.29) 0 (0.00)   
Past anti-
depressantscd 
1 (8.33) 3 (21.29) 2 (13.33)   
Past support      
Psychologist cd 0 (0.00) 1 (7.14) 3 (20.00)   
Psychiatristcd 1 (8.33) 2 (14.29) 0 (0.00)   
Counsellorcd 0 (0.00) 0 (0.00) 3 (20.00)   
Support groupcd 3 (25.00) 3 (21.29) 2 (13.33)   
Cancer Councilcde 3 (25.00) 4 (28.57) 3 (20.00)   
Telephonecd 2 (16.67) 1 (7.14) 1 (6.67)   
Online cd 1 (8.33) 3 (21.29) 1 (6.67)   
Any support 6 (50.00) 8 (57.14) 8 (53.33) 0.13 2, 41 
Healthcare practitioners      
Urology nurse 
specialistcd 
9 (75.00) 10 (71.43) 5 (33.33)   
Physiotherapistcd 6 (50.00) 4 (28.57) 6 (40.00)   
Sexual rehabilitation 
specialistcd 
0 (0.00) 2 (14.29) 3 (20.00)   
Erectile aids      
Used PDE5 inhibitorscd 8 (66.67) 9 (64.29) 11 (73.33)   
Used injection therapy 6 (50.00) 7 (50.00) 7 (46.67) 0.04 2, 41 
Used vacuum devicescd 1 (8.33) 2 (14.29) 0 (0.00)   
Used penile implantscd 0 (0.00) 1 (7.14) 0 (0.00)   
Overall used some Txcd 9 (75.00) 10 (71.43) 12 (80.00)   
aWelch statistics reported for ANOVA. bn = 52 for relationship function variables. cExpected 
cell count less than five in < 80% of cells, chi-square statistic unable to be computed.  d See 
Appendix O for 2x2 table cross tabs.  eThe Cancer Council Information and Support Service. 
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Efficacy of My Road Ahead 
The efficacy of My Road Ahead was evaluated by a series of mixed ANOVAs 
testing sexual, psychological and relationship functioning. A mixed model 
MANOVA was not selected due to the small sample size for three groups. For each 
of these ANOVAs, the between subjects factor was group (Modules, Module-plus-
Forum and Forum) and the repeated measures factor was time (pre-test and post-
test). Only participants who had provided pre-test and post-test data and completed 
greater than 40% of the program were included in the analyses, leaving 12 
participants in the Modules group, 14 in the Modules-plus-Forum group and 15 in 
the Forum only group. The significance level for each analysis was set at p < 0.05, 
expect when homogeneity of variance was violated (as highlighted previously). 
Sexual function and sexual QoL.  To investigate the first hypothesis, that 
men who completed the modules (Modules or Modules-plus-Forum groups) will 
demonstrate significantly greater improvement in sexual function and sexual QoL 
from pre-test to post-test than those who received the forum only (Forum group), a 
series of mixed model ANOVA were conducted. The dependent variables that 
contribute to sexual function and sexual QoL are found in Table 10.2 with the means 
and standard deviations at pre-test and post-test.  
Using Wilk’s lambda, each of these analyses failed to reveal a significant 
interaction effeqqzct for group by time for erectile function, F(2, 38) = 0.94, p = 
.400, partial K2 = .05, observed power = 0.20, orgasmic function, F(2, 38) = 0.62, p = 
.545, partial K2 = .03, observed power = 0.15, sexual desire F(2, 38) = 0.06, p = .943, 
partial K2 = .00, observed power = 0.06, intercourse satisfaction, F(2, 38) = 0.06, p 
=.944, partial K2 = .00, observed power = 0.12, overall satisfaction, F(2, 38) = 0.52, p 
= .601, partial K2 = .03, observed power = 0.13, IIEF sexual function total, F(2, 38) = 
.64, p =.531, partial K2 = .03, observed power = 0.15, sexual confidence, F(2, 38) = 
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0.39, p = .682, partial K2 = .02, observed power = 0.11, sexual intimacy, F(2, 38) = 
1.86, p = .169, partial K2 = .09, observed power = 0.36, and masculine self-esteem, 
F(2, 38) = 0.30, p =.741, partial K2 = .02, observed power = 0.60. This result fails to 
support the first hypothesis, suggesting that any changes in sexual function and 
sexual QoL factors from pre-test to post-test were similar for the treatment groups 
(Modules and Modules-plus-Forum) and the control group (Forum).  
Although there was no significant interaction effect for each of the sexuality 
variables, there were some main effects of time that were worth exploring in more 
detail. There was a significant main effect of time for sexual intimacy, F(1, 38) = 
9.76, p = .003, partial K2 = .20, observed power = 0.86, and for masculine self-
esteem, F(2, 38) = 7.81, p = 0.008, partial K2 = .17, observed power = 0.78, 
suggesting that overall all groups improved across time in their levels of sexual 
intimacy and masculine self-esteem.  
Although there was no interaction effect for sexual intimacy, pairwise 
comparisons revealed that while at pre-test there was no significant difference 
between the three groups, at post-test there was a significant difference between the 
Modules and Forum group (p = 0.001), and the Modules-plus-Forum and Forum 
group (p = 0.030). Although the interaction was not significant, it was in the 
expected direction.  
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Table 10.2 
Summary Scores for Sexual Function and Sexual QoL at Pre-Test and Post-test for the Modules, Modules-plus-Forum and Forum Group 
Dependent variable Modules (n = 12) 
 
Modules-plus-Forum (n = 14) 
 
Forum (n = 15) 
 
Pre-test 
Mean (SD) 
Post-test 
Mean (SD) 
Pre-test 
Mean (SD) 
Post-test 
Mean (SD) 
Pre-test 
Mean (SD) 
Post-test 
Mean (SD) 
Erectile function 9.00 (9.32) 9.25 (8.38) 8.64 (9.32) 10.07 (8.58) 6.93 (8.83) 10.53 (11.64) 
Orgasm function 3.92 (2.97) 3.17 (2.66) 3.36 (3.05) 3.57 (2.34) 3.33 (3.29) 3.67 (3.64) 
Sexual desire 6.08 (2.27) 5.75 (2.22) 6.79 (1.93) 6.43 (2.31) 5.67 (2.13) 5.47 (2.17) 
Intercourse satisfaction 4.42 (4.25) 4.58 (4.74) 4.57 (4.40) 4.71 (4.34) 3.73 (4.80) 4.27 (5.11) 
Overall satisfaction 4.92 (3.55) 4.92 (3.09) 3.86 (3.25) 4.64 (3.08) 4.53 (3.83) 4.60 (3.31) 
IIEF total score 28.33 (18.98) 27.67 (18.74) 27.21 (18.68) 29.43 (16.56) 24.20 (18.92) 28.53 (23.56) 
Sexual confidence 48.44 (25.99) 55.73 (26.17) 33.93 (38.19) 41.07 (33.85) 29.17 (23.70) 29.58 (27.80) 
Sexual intimacy 63.99 (29.98) 85.42 (14.48) 58.93 (35.15) 68.62 (24.87) 41.67 (32.33) 45.48 (36.41) 
Masculine self-esteem 78.91 (17.48) 89.58 (10.09) 70.09 (21.40) 75.22 (24.38) 60.83 (28.34) 68.96 (26.45) 
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Psychological function.  A series of ANOVAs for relationship function were 
conducted to test the second hypothesis that those men who participated in My Road Ahead 
modules (Modules and Modules-plus-Forum groups) would report significantly greater 
improvements in psychological function from pre-test to post-test than those who receive the 
forum only (Forum group). The means and standard deviations for each of the psychological 
function dependent variables can be found in Table 10.3.  
This hypothesis was not supported. Using Wilk’s lambda each of the ANOVAs failed 
to reveal a significant interaction effect for group by time for stress, F(2, 38) = 0.70, p = .501, 
partial K2 = .04, observed power = 0.16, anxiety, F(2, 38) = 0.38, p = .685, observed power = 
0.11, partial K2 = .02, and depression, F(2, 38) = 1.02, p = .371, partial K2 = .05, observed 
power = 0.21. 
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Table 10.3 
Summary Scores for Psychological Function at Pre-Test and Post-test for the Modules, Modules-plus-Forum and Forum group 
Dependent variable Modules (n = 12) 
 
Modules-plus-Forum (n = 14) 
 
Forum (n = 15) 
 
Pre-test 
Mean (SD) 
Post-test 
Mean (SD) 
Pre-test 
Mean (SD) 
Post-test 
Mean (SD) 
Pre-test 
Mean (SD) 
Post-test 
Mean (SD) 
Stress 5.33 (6.29) 5.83 (5.75) 10.43 (9.96) 9.43 (8.68) 8.13 (8.63) 9.47 (10.01) 
Anxiety 0.83 (2.33) 0.83 (1.34) 2.86 (3.66) 2.86 (4.35) 3.87 (6.91) 4.33 (6.28) 
Depression 3.33 (4.62) 3.12 (4.13) 9.00 (10.55) 6.29 (7.60) 7.73 (7.24) 7.60 (10.99) 
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Relationship function.  To investigate the third hypothesis, that men who 
participated in modules (Modules or Modules-plus-Forum groups) would report 
significantly greater improvements in relationship function from pre-test to post-test 
than those who received the Forum only, a series of mixed ANOVAs were 
conducted. The means and standard deviations for each of these dependent variables 
at pre-test and post-test are presented by group in Table 10.4. 
Since Levene’s test was violated, a stricter p value was used, and using 
Wilk’s lambda, the ANOVA for marital affection was approaching a significant 
interaction effect for group by time, F(2, 36) = 4.10, p = .025, partial K2  = .19, 
observed power = 0.69. Although not significant, the effect size for this interaction 
was large, where the Modules and Modules-plus-Forum groups demonstrated 
improvements in marital affection over time, whereas the Forum group demonstrated 
decreased marital affection over time. There was no interaction effect for relationship 
satisfaction, F(2, 36) = 0.73, p = .491, partial K2 = .04, observed power = 0.16. 
None of interaction effects for communication variables were significant, 
including positive interactions, F(2, 36) = 1.63, p = .211, partial K2  = .08, observed 
power = 0.32, and demand/withdraw, F(2, 36) = 2.41, p = .104, partial K2  = .12, 
observed power = 0.46. The interaction for demand/withdraw approached 
significance (p = 0.104) with a moderate effect size. Although not significant, the 
Modules-plus-Forum and Modules group the level of demand/withdraw 
communication decreased while this type of communication increased for the Forum 
group. Finally, there was no significant interaction for sexual communication, F(2, 
36) = 0.04, p = .959, partial K2  = .00, observed power = 0.06. 
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Table 10.4 
Summary Scores for Relationship Function at Pre-Test and Post-test for the Modules, Modules-plus-Forum and Forum Group 
Dependent variable Modules (n = 11) 
 
Modules-plus-Forum (n = 13) 
 
Forum (n = 15) 
 
Pre-test 
Mean (SD) 
Post-test 
Mean (SD) 
Pre-test 
Mean (SD) 
Post-test 
Mean (SD) 
Pre-test 
Mean (SD) 
Post-test 
Mean (SD) 
Relationship satisfaction 14.27 (5.83) 14.45 (7.49) 17.38 (4.09) 14.38 (6.17) 17.53 (4.42) 15.60 (5.84) 
Marital affection 83.60 (22.38) 95.83 (6.72) 86.54 (22.19) 87.82 (17.55) 86.67 (14.71) 80.56 (22.64) 
General communication       
Positive interactions 18.00 (5.90) 20.73 (7.23) 18.00 (8.24) 16.46 (7.82) 15.87 (7.41) 17.33 (7.35) 
Demand/withdraw 15.73 (8.84) 13.73 (7.90) 15.23 (10.40) 13.31 (7.83) 13.40 (7.58) 16.60 (11.80) 
Sexual communication 13.18 (4.29) 13.64 (4.03) 11.54 (4.03) 11.62 (4.17) 12.47 (4.19) 12.80 (4.33) 
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Usability and Feasibility of Modules  
The following section provides results from the satisfaction questionnaires for 
the module aspect of My Road Ahead. Apart from where stated otherwise, all men 
who completed the post-test questionnaires and had access to the modules are 
included in these analyses (nmodules-plus-form = 15 and nmodules= 15). This includes three 
additional men in the Modules group and one additional man from the Modules-plus-
Forum group who completed the post-test questionnaire but where excluded in the 
evaluation of My Road Ahead due to failure to complete a certain level of the 
modules.  
Engagement.  Data detailing the percentage amount of modules completed 
were available for all participants who had access to the modules (n = 38).  Table 
10.5 covers the percent of men who completed each of the modules across the 
Modules group and Modules-plus-Forum group for the total sample. Most men 
completed the modules in the recommended order (Module 1 through to Module 6). 
On average the Modules-plus-Forum group completed a greater percentage of the 
program (M = 72.37, SD = 32.21) than the Modules only group (M = 61.88, SD = 
3.79), however this difference was not significant, t(36) = -0.94, p = .352). Although 
not significant, this slightly higher level of retainment in the Modules-plus-Forum 
group, may suggest that having access to the forum may have potentially increased 
engagement in the modules. Not surprisingly, the final sample of participants that 
were used to evaluate the efficacy of My Road Ahead (n = 26) reported a higher level 
of engagement in terms of the percent completed of the total program, Modules (M = 
86.00, SD =21.67) and Modules-plus-Forum (M = 87.43, SD = 17.16).  
Self-reported average number of hours spent on the modules was 1.82 hours 
per week (SD = 1.31). Time spent on modules was slightly higher for the Modules-
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plus-Forum group (M = 2.08, SD = 1.50) than the Modules only group (M = 1.52, SD 
= 1.02), however this difference was not significant, t(26) = 1.14, p = .264. 
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Table 10.5 
Number of Participants who Completed each of the Modules Broken down into Percentage Categories (n = 38) 
Precent 
complete 
Module 1 Module 2 
 
Module 3 
 
Module 4 
 
Module 5 
 
Module 6 
 
Total 
Modules Modules-
plus-
Forum 
Modules Modules-
plus-
Forum 
Modules Modules-
plus-
Forum 
Modules Modules-
plus-
Forum 
Modules Modules-
plus-
Forum 
Modules Modules-
plus-
Forum 
Modules Modules-
plus-
Forum 
0% 1 
(5.26) 
1 
(5.26) 
3 
(15.79) 
1 
(5.26) 
6 
(31.58) 
3 
(15.79) 
8 
(42.11) 
3 
(15.79) 
10 
(52.63) 
5 
(26.32) 
11 
(57.89) 
8 
(42.11) 
1  
(5.26) 
1  
(5.26) 
1-20% 0 
(0.00) 
1 
(5.26) 
0 
(0.00) 
1 
(5.26) 
1 
(5.26) 
1 
(5.26) 
0 
(0.00) 
0 
(0.00) 
1 
(5.26) 
2 
(10.53) 
0 
(0.00) 
1 
(5.26) 
2 
(10.53) 
0  
(0.00) 
21-40% 0 
(0.00) 
0 
(0.00) 
0 
(0.00) 
0 
(0.00) 
0 
(0.00) 
0 
(0.00) 
0 
(0.00) 
2 
(10.53) 
0 
(0.00) 
1 
(5.26) 
0 
(0.00) 
0 
(0.00) 
5 
(26.32) 
3 
(15.79) 
41-60% 0 
(0.00) 
0 
(0.00) 
2 
(10.53) 
3 
(15.79) 
1 
(5.26) 
0 
(0.00) 
0 
(0.00) 
0 
(0.00) 
0 
(0.00) 
0 
(0.00) 
0 
(0.00) 
0 
(0.00) 
1 
(5.26) 
2 
(10.53) 
61-80% 0 
(0.00) 
0 
(0.00) 
0 
(0.00) 
0 
(0.00) 
0 
(0.00) 
0 
(0.00) 
1 
(5.26) 
1 
(5.26) 
0 
(0.00) 
2 
(10.53) 
0 
(0.00) 
1 
(5.26) 
3 
(15.79) 
4 
(21.05) 
81-
100% 
17  
(89.47) 
17 
(89.14) 
14 
(73.68) 
14 
(73.68) 
11 
(57.89) 
15 
(78.95) 
10 
(52.63) 
13 
(68.42) 
8 
(42.11) 
9 
(47.37) 
8 
(42.11) 
9 
(47.37) 
8 
(42.11) 
9 
(47.37) 
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Men were given a list of possible reasons they did not finish the program.  The 
most common reason for not finishing was “too busy” (n = 10), “nothing, got what I 
needed” (n = 4), “lack of motivation” (n = 3), “program not useful” (n = 2), “internet 
server provider problems” (n = 1), “computer problems” (n = 1), ““too unwell” (n = 1), 
“program too difficult to understand” (n = 1), “too much text” (n = 1), “ran out of time” 
(n = 1). Table 10.6 highlights the various methods that participants believed would 
increase engagement in the modules (selected from a list of options). 
Table 10.6 
Participant Reported Methods to Increase Engagement in My Road Ahead  
Methods of engagement Number selected option (n = 30) 
SMS reminders 4 
Email therapist 8 
Phone therapist 4 
Web cam therapist 4 
Chat room 4 
Conference call with other program 
participants 
3 
Face-to-face therapists 6 
More use of video 3 
More online activities 0 
  
 
Feedback on modules satisfaction and usability.  Level of program satisfaction 
was rated as moderate on a 10-point scale (M = 6.90, SD =1.92). There was no 
significant difference, t(28) = 0.65, p  = .519, for the ratings from those who 
participated in the Modules only (M = 7.13, SD = 2.00) and the Modules-plus-Forum 
group (M = 6.67, SD = 1.92). Similar results were found for the level of enjoyment of 
the program, Modules only (M = 6.73, SD = 2.02) and the Modules-plus-Forum group 
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(M = 6.47, SD = 2.03), with no significant difference between the two groups, t(28) = 
0.36, p  = .721. 
Ninety percent of men who used the modules reported that they were easy to use; 
the 10% who reported that they were not easy were from the Modules-plus-Forum 
group. On a 10-point scale the level of usefulness of the information and exercises from 
My Road Ahead mean rating was 6.43 (SD = 1.96), and the two groups were similar, 
t(28) = -.28, p = .785. In total, 93.3% of men reported that they would recommend the 
program to other men with prostate cancer. 
Men were asked to provide feedback on the best and worst aspects of the modules 
and how they thought it could be improved. A total of 26 men provided this feedback. 
The most frequently reported positive aspects of the modules were: learning about 
others’ experiences and learning that one is not alone (n = 5); learning new skills and 
making changes (n = 6); the content (specific or general) (n = 6); a chance to reflect on 
cancer journey/increase level of awareness (n = 4); structural components of program 
(e.g., videos) (n = 4); and anonymity (n = 1). Below are some direct quotes from men 
regarding the best parts of the modules. 
“Gave me better insight into my issues and thought processes, and how to manage 
them constructively”. 
“Encouraging me to think about issues that have an impact on life and 
relationships”. 
For the negative aspects, the most frequently reported comments were: timing of 
program too late or not relevant (n = 5); structural/IT aspects (n = 3); too long (n = 2); 
specific or general content (n = 5); not having a partner or being able to include partner 
(n = 2); and having a negative experience related to program (n = 2). Example quotes 
regarding the worst parts of the program are below. 
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“The first two sections were not relevant to me”. 
“For me, it was 5 years too late – I had already worked through many if not most 
issues myself”. 
Finally, participants provided feedback on how the program could be improved. 
Common themes that arose were: changes to specific or general content (n = 4); target 
program to men sooner after treatment or before treatment (n = 4); fix structural or IT 
issues, including clarity around navigating program (n = 4); tailor program (n = 3); and 
more face-to-face therapy (n = 2). Example quotes covering suggestions on how to 
improve the program are below. 
“Maybe the program could be modified into some streams, depending on the 
results of the initial questionnaire, participants may be streamed to different 
modules based on their particular state of mind and/or their stage in the treatment 
cycle…”. 
“Selecting prostate cancer patients for videos that can communicate clearly (not 
all could) plus videos of spouses talking about impact on them…”. 
Partner inclusion.  Men were encouraged to include their partners when using 
My Road Ahead. Of the men who indicated that this question was applicable to them, 
exactly half reported including their partner in the program. There was a higher level of 
partner involvement in the Modules group (61.54%) compared to the Modules-plus-
Forum group (36.36%), however, this was not significantly different (χ2(1, 24) = 0.67, p 
= .414). Of the twelve men who stated that they included their partner in the treatment 
process, 83.33% stated that they printed or emailed their partner the information sheets. 
All of these men said that they at least sometimes included their partner in viewing the 
online information, videos, or interactive exercises and completed the offline exercises 
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together. When asked which particular exercises were most beneficial these were some 
of the responses. 
“They were helpful as they resulted in my wife and I communicating - this was the 
real benefit for me (and her too I think) - we talked about the issues”. 
“Where we discussed erectile problems and ways to cope”.  
Men who did not include their partner were asked to give reasons why. Twelve 
men gave a response to this question. These responses could be classified as follows: 
their partner not being perceived as interested or receptive to such suggestions (n = 5); 
relationship or communication difficulties (n  = 2); and not seeing it being relevant or 
helpful (n = 2). For example, one man’s response alluded to the communication 
difficulties that may have been present in their relationship by stating “Scared of the 
answers I may have gotten”. 
Usability and Feasibility of Forum 
These data were taken from all participants who completed the post-test 
questionnaire from the Forum group (N = 15) and the Modules-plus-Forum group (N = 
15). This means there was one additional participant included in the Modules-plus-
Forum group who was excluded from efficacy analyses due to completing only 33% of 
the modular content.  
Engagement.  The self-reported average amount of minutes spent on the forum 
per week was less for the Modules-plus-Forum (M = 4.00, SD = 6.56) than the Forum 
(M = 19.29, SD = 27.91). Four cases had missing data from the Modules-plus-Forum 
group and one from the Forum group, and the difference between these groups was 
found to be approaching significance (t(16.14) = -1.91, p = .066) . Of the 38 men who 
had access to the forum, 21 posted at least one comment. The total number of posts for 
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the Forum group was 36, compared to 27 for the Modules-plus-Forum group. A total of 
10 men made comments on the forum and 11 men on the Modules-plus-Forum forum. 
The average number of posts for those who did post any comments was 3.60 for the 
Modules-plus-Forum group and 2.45 for the Forum only group. Generally men 
responded to the weekly comments and topic ideas from the moderator. Occasionally 
men started their own discussion or responded directly to previous comments from 
other men. Posts from men related to introducing self, offering advice or support, 
requesting advice or support, sharing personal stories, and general advocacy around 
prostate cancer. Some examples of posts are below. 
(i) Introducing self 
Men were encouraged to introduce themselves on the forum, giving any level of 
personal information they felt appropriate. An example of a participants introduction is 
below.  
“I'm 57 and had radical prostatectomy Jan 2008 when my PSA was just 5.4 
I experience erectile problems and have to wear incontineance pads 24/7. I 
believe surgery was the best procedure for myself as I wanted the cancer out of 
me where it could be examined”. 
(ii) Offering advice/support 
Offering advice and support was a strong theme and many men were open about 
their experiences and gave suggestions to other men when dealing with a range of 
problems. Some examples are outlined below. 
[Regarding Viagra]: “Hi. What worked for us was to take it 2 hours after dinner 
and 1hour before sex. We also raised the bed so I could stand at the side - this 
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made penetration much easier with only a three quarter erection. Hope this 
helps”. 
“I know how you feel - I think. I find it really hard to describe how I am actually 
feeling to other people. In fact I have taken to virtually lying most of the time. I 
pretend things are going OK, but the reality is that I feel really tired most of the 
time, not interested in work, things upset me easily and I feel like taking things out 
on the people who are closest to me. I feel like building a huge wall around me 
and escaping from the world. I sound pretty pathetic if I do say so! I hope that 
with time I will be able to feel more like my 'old' self”. 
“ED is not just the man's problem in a marriage relationship. sexual willingness 
and stimulation by wife has a big impact on ED when a man is still able to 
experience orgasm”.  
(iii) Asking for advice/support 
Directly asking for advice or support was not as strong a theme as giving. An 
example of this theme is below. 
“Does anyone have any experience using vacuum pumps? Someone has suggested 
trying this to me…” 
(iv) Sharing personal stories 
Some men used the forum as a means to share their experiences with others, 
without explicitly asking for advice or support. An example of this type of comment is 
below. 
“I have been very lucky in having a partner with which I can talk to openly about 
the operation and its effects. It is becoming increasingly frustrating though but I 
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am feeling like we may be drifting apart to some extent. I think this is because we 
used to be able to 'communicate' via physical means before as opposed to more 
verbal pathways currently”. 
(v) General advocacy 
Finally, the forum was used as a platform for some men to express their opinion 
about prostate cancer and treatment related topics. PSA testing was one such area that a 
few men related to, see example below. 
“I have read the comments re PSA. I now have many friends who have had 
prostate surgery based on biopsy results following an elevated PSA and all 
showed cancerous changes on post surgery examination of the removed prostate. 
I think it is essential until something else becomes available to use this diagnostic 
test and feel it has served me and my friends well. The post surgical problems are 
minor compared with the alternative”. 
Feedback on forum satisfaction and usability.  Level of forum satisfaction was 
lower for the Modules-plus-Forum group (M = 3.20, SD = 2.40) compared to the Forum 
group (M = 5.87, SD = 2.59) and this difference was significant, t(28) = -2.93, p = .007. 
Similar results were found for the level of reported enjoyment when using the forum 
with the Modules-plus-Forum group reporting significantly lower enjoyment (M = 3.07, 
SD = 2.52) compared to the Forum group (M = 5.33, SD = 2.80), t(28) = -2.31, p = 
0.028. 
In terms of ease of use, 80.00% of the Forum group compared to only 40.00% of 
the Modules-plus-Forum group reported that the forum was easy to use. A chi-square 
test (with Yate’s Continuity Correction and Fisher’s Exact test) revealed that this 
difference was approaching significance, χ2(1, 30) = 3.47, p = 0.060. 
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In terms of the rated usefulness of posts by the moderator and men, there was a 
significant difference between the Forum and Modules-plus-Forum group in terms of 
the rated usefulness of posts by both other men (t(28) = -2.66, p = .014) and the 
moderator t(28) = -3.08, p = 0.005. Men in the Forum group were more likely to report 
that the other men’s (M = 5.07, SD = 3.15) and the moderator’s posts (M = 5.60, SD 
=3.00) were more useful than the Modules-plus-Forum group (Mother men’s = 2.47, SD 
=2.10 and Mmoderator’s  = 2.67, SD = 2.16). 
Men were given a list of possible reasons that they did not use the forum at all or 
very much.  The most common reason for not finishing was “too busy” (n = 9); “lack of 
motivation” (n = 4); “computer problems” (n = 2); “program not useful” (n = 2); “too 
unwell” (n = 1), and “program too difficult to use” (n = 1). 
Men were asked to provide feedback on the best and worst aspects of the forum 
and how they thought it could be improved. Twenty-two men provided feedback and 
the most frequently reported positive aspects of the forum were: learning about others 
experiences (n = 11); offering support and help to others’ (n = 5); and anonymity (n = 
1). For the negative aspects, the most frequently reported comments were related to 
there not being enough participants or comments (n = 7); IT or computer related issues 
with accessing forum (n = 2), structural aspects (too much text) (n = 1), and negative 
experiences including learning about others worse off and there being too many 
negative comments (n = 2) .  
In terms of suggestions for improvements men suggested having more men and 
posts, and more encouragement to use (N = 5), using “chat” (N = 1), and more 
instructions on how to use, such as an electronic tour (N = 2). Two men gave specific 
strategies to improve forum which are listed below. “Provide comments from a 
specialist. Perhaps Q & A”. 
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“Provision of areas such as ‘chat’ and maybe even relevant multimedia targeted 
at certain issues”. 
Chapter Summary 
This chapter presented results regarding the efficacy of My Road Ahead for 
improving sexual, psychological and relationship function. My Road Ahead was 
evaluated with a sample of men predominately treated for localised prostate cancer by 
surgery in the past five years. 
The results of this study did not support the hypotheses that those that were 
allocated to the Modules-plus-Forum group would demonstrate significantly greater 
improvement than the Modules only group, which in turn both would demonstrate 
significantly greater improvement than the Forum only group, from pre-test to post-test 
across sexual, psychological and relationship functioning. There were some trends 
towards significance in some of the sexual QoL and relationship variables.  
Feedback regarding the usability and feasibility was also covered in this chapter. 
Overall program satisfaction was good with the majority of men reporting that they 
would recommend the program to someone else. Satisfaction with the forum was 
generally low to average. Feedback on My Road Ahead provided valuable information 
to direct future research. This will be covered in the next chapter along with an overall 
discussion of the results regarding the development and evaluation of My Road Ahead. 
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CHAPTER 11:  Discussion 
This chapter discusses the findings from the development and evaluation of My 
Road Ahead, and examines these findings in the context of previous research. 
Implications of the findings regarding the efficacy and feasibility of My Road Ahead are 
explored in terms of future treatment of psychosocial issues and needs for men treated 
for prostate cancer. Limitations of the research will also be highlighted. Considering My 
Road Ahead is a unique and innovative intervention, there will be a particular focus on 
both the limitations regarding the evaluation of this program and the development, 
content and structure of the website, which will assist future research evaluating My 
Road Ahead and the development and evaluation of other internet-based programs.  
Development of an Internet-Based CBT Program for Men Treated for Prostate 
Cancer 
The first part of this thesis focussed on the development of My Road Ahead, an 
internet-based CBT program for men treated for prostate cancer. This program was 
developed to address the identified unmet psychosocial needs of men treated for 
prostate cancer. Despite the strong evidence for the need for psychosocial interventions 
for men with prostate cancer and their partners, treatments designed to target the 
complexity of sexual, psychological and relationship functioning in prostate cancer 
survivors have only been undertaken in the last 10 years. 
The development of an online psychosocial intervention for men treated for 
prostate cancer demonstrated a major advance in this field in terms of providing support 
for men using a different platform, making treatment accessible for men who may not 
seek other forms of treatment, and in terms of the potential to disseminate this program 
broadly across Australia and internationally. A self-directed program with minimal 
therapist assistance allows for sustainable dissemination at a minimal long-term cost. It 
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seems that internet-based psychological support is efficacious in other areas of mental 
health and with other physical illnesses. However this had not been explored for men 
treated for prostate cancer.  
As a result of the many unmet needs of men treated for prostate cancer and 
limitations of current interventions, the first part of this thesis aimed to address the gap 
in the literature and community, by developing a program to assist men with many of 
the difficulties they face after treatment for prostate cancer. My Road Ahead was 
developed from a variety of sources including a group-based CBT program, clinical 
expertise, multimedia expertise and a comprehensive literature review. My Road Ahead 
had a strong theoretical basis, and the program was largely CBT based with elements of 
sex therapy and a small component of mindfulness mediation strategies. The overall 
aims were to address several areas which have been identified as relevant for men 
including psychological distress, sexual difficulties, relationship difficulties, in addition 
to addressing urinary dysfunction, uncertainty about the future and communication with 
friends and health professionals. Partner involvement was considered an important 
aspect of this program and was optional, with joint exercises and partner information 
sheets. My Road Ahead was open to homosexual or bisexual men and single men, who 
have been frequently neglected in the literature and past interventions. 
Considering this is the first self-directed internet-based program for men with 
prostate cancer, the components and structure of the program were developed with 
consideration of the literature regarding the useability and feasibility of various 
structural components of internet-based interventions in other areas.  Several 
recommendations from past research were incorporated into My Road Ahead including 
weekly email contact, a highly interactive interface (e.g., videos and online exercises), a 
mood monitor, and open access to modules.   
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The final program was a 10 week internet-based CBT program for men treated for 
prostate cancer. The modular aspect of My Road Ahead consisted of six modules 
including online descriptive content, videos from prostate cancer survivors and health 
professionals, online exercises, offline exercises, and information and exercises for 
partners. In addition an asynchronous forum was developed, moderated with weekly 
topics posted to promote discussion. The modular aspect of My Road Ahead was 
considered the treatment that was later evaluated. The forum was developed as a means 
to firstly assess whether the modular aspect of My Road Ahead was more effective than 
some form of basic support, and to secondly to explore the useability and feasibility of a 
forum for a group of men treated for prostate cancer.  
This section has provided a brief overview of development of the program the 
content and structure. Later sections in this chapter highlight the significant contribution 
this program is likely to make in the future, both in terms of further research and for 
men living with prostate cancer. The next section outlines the evaluation of My Road 
Ahead. 
Evaluation of an Internet-Based CBT Program for Men Treated for Prostate 
Cancer 
The efficacy of My Road Ahead was evaluated with a sample of men who had 
been diagnosed and treated for localised prostate cancer. As previously highlighted, the 
evaluation of My Road Ahead in this thesis forms part of a larger study which will 
evaluate the program with a larger sample size and across an extended time period. 
Firstly, the efficacy of My Road Ahead was evaluated across three areas: sexual function 
(includes sexual QoL), psychological function, and relationship function. Secondly the 
usability and feasibility of My Road Ahead was evaluated. Attrition was also explored 
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in detail. This section examines the findings from the evaluation of My Road Ahead and 
discusses these findings in relation to past research.  
 Efficacy of My Road Ahead.  Fifty-seven men were randomised into one of the 
three intervention arms for the evaluation of My Road Ahead. All participants 
completed pre-test questionnaires which included demographic and baseline details. The 
mean age of participants was 61.25, however age ranged more than 30 years and the 
sample predominately identified as Anglo Celtic/Caucasian or European. The majority 
of men were in a heterosexual relationship. Nearly all men had surgery to treat their 
localised prostate cancer and, although the mean time since diagnosis was 24 months, 
the upper end time since diagnosis was almost six years. The wide range of time since 
both diagnosis and treatment for men in this sample suggests that many men may have 
had unmet psychosocial needs at a range of times post-diagnosis and treatment for 
which they were seeking assistance with. 
Sexual function and sexual QoL.  The first hypothesis, that men who completed 
the modular aspect of My Road Ahead (Modules or Modules-plus-Forum) would 
demonstrate significantly greater improvement in sexual function and sexual QoL from 
pre-test to post-test than those who receive the Forum, was not supported by the results 
of this study. The multi-dimensional nature of sexuality was captured through the use of 
a variety of measures including the IIEF (sexual function) and three subscales from the 
Prostate Cancer QoL scale (sexual intimacy, sexual confidence and masculine self-
esteem).  
Not finding a positive impact of the My Road Ahead intervention on sexual 
function is consistent with past research using telephoned based and face-to-face and 
educative and skilled based interventions (Campbell et al., 2006; Lepore et al., 2003; 
McCorkle; Mischel et al., 2002; Northhouse et al., 2007; Weber et al., 2004). Findings 
were contrary to other past research that did find some level of positive impact on 
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sexual function (Cananda et al., 2005; Giesler et al., 2005; Molton et al., 2008; Penedo 
et al., 2007; Titta et al., 2006) and in an internet-based intervention (Schover et al., 
2012). Many of the programs that have had a positive impact on sexual function, placed 
sexual function as a major focus (Canada et al., 2005; Giesler et al., 2005; Molton et al., 
2008; Schover et al., 2012; Titta et al., 2006) or screened for men with sexual problems 
(Canada et al., 2005; Schover et al., 2012; Titta et al., 2006). Although My Road Ahead 
placed sexual function and sexuality as a major focus, some men did not complete the 
modules covering these topics. Although sexuality was a theme throughout the program, 
it was predominately confined to Module 4 and Module 5. 
In the sexual domain, measures of sexual function specifically were most 
commonly explored in past interventions, followed by measures of sexual bother. In this 
study three measures of sexual QoL were taken (sexual intimacy, sexual confidence, 
and masculine self-esteem) which encompass the impact of sexual function changes and 
prostate cancer on broader areas of sexual self-concept and sexuality. While no other 
study has used these variables, lack of significant treatment effects for sexual intimacy, 
sexual confidence, and masculine self-esteem is consistent with past research exploring 
the impact on an intervention on sexual bother (Campbell et al., 2007, Giesler et al., 
2005). However, other research has found a positive impact on sexual bother (Lepore et 
al.; 2003; Weber et al., 2004) and role limitations of sexual activity (Giesler et al., 
2005).  
Although there were no treatment effects for each of the sexual QoL measures 
covered in the current study (sexual intimacy, sexual confidence, and masculine self-
esteem), improvements were found for all groups for sexual intimacy and masculine 
self-esteem across time. This suggests that both the module and forum components of 
My Road Ahead led to improvements in sexual QoL across the sexual intimacy and 
masculine self-esteem areas. Given the main effects of time for masculine self-esteem 
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and sexual intimacy, it is possible that both the forum and the modules had a positive 
impact on these QoL areas. A larger sample size is needed to tease out the effects of the 
forum versus the modules of My Road Ahead, and whether some level of basic peer and 
moderator support through the forum accounts for positive treatment effects. Peer 
support was incorporated into two past interventions that had positive effects on sexual 
bother (Lepore et al., 2003; Weber et al., 2004). 
 In addition, there was a moderate effect size for the interaction for sexual 
intimacy, with the Modules and Modules-plus-Forum group demonstrating a greater 
increase in QoL in this domain than the Forum-only group. However this interaction 
was only approaching significance and requires further exploration with a larger sample 
size. With a larger sample size further analyses could explore the potential interaction 
effects for those men with poor sexual intimacy, sexual confidence and masculine self-
esteem at baseline, where it would be hypothesised that those with poorer function 
across these measures would be more likely to demonstrate gain from the intervention. 
Although only approaching significance, it is not surprising that My Road Ahead 
tended to have a greater impact on QoL related sexuality variables rather than sexual 
function itself. Given the nature of the treatment for prostate cancer and the likelihood 
of ED, My Road Ahead was developed with a major focus on improving intimacy, 
communication, and masculine self-esteem, rather than focusing directly on actual 
sexual function. This is consistent with past researchers who have highlighted that men 
can either utilise medical interventions and try to return as close to possible to pre-
treatment erectile functioning, or they can redefine their concept of sexuality and 
masculinity (Fergus et al., 2002). Given the limited success of medical interventions, 
which was also evident in the current study’s sample of men, it seems likely that a 
combination or a focus on the latter option may be beneficial.  
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Psychological function.  The second hypothesis, that men who completed the 
module components of My Road Ahead (Modules or Modules-plus-Forum) would  
demonstrate significantly greater improvement in psychological function from pre-test 
to post-test compared to those who received the Forum, was not supported by the results 
of this study. Psychological distress remained stable across time for all groups.  
The lack of significant impact of psychosocial interventions on psychological 
distress for men treated for prostate cancer was contrary to some previous research 
(Canada et al., 2005; Weber et al., 2004; Weber et al., 2007) but is consistent with other 
past research (Berglund et al., 2007; Collins et al., 2013; Giesler et al., 2005; Lepore et 
al., 2003; Manne et al., 2011).  
Although psychological distress has been reported to be elevated in this 
population, low baseline rates of psychological distress have been previously reported 
in these samples during studies targeting psychological distress (Canada et al., 2005; 
Lepore et al., 2003). This is consistent with our sample where a lack of significant 
findings may be a result of this sample displaying relatively low levels of distress at 
baseline. It is possible that those seeking help or willing to participate in an internet-
based program tend to have higher levels of psychological health. 
Considering pre-test scores of psychological distress were not clinically 
elevated, the small decrease that was evident for the Modules-plus-Forum group for 
depression may not have been large enough to detect clinically relevant changes over 
time. It is possible that having a cohort of men treated for prostate cancer with a higher 
level of psychological distress may have seen improvements across these specific 
measures. There is often an assumption in the prostate cancer literature that men suffer 
from psychological distress. However given the inconsistent rates reported it is clear 
that a large proportion of men do not. Holland et al. (2011) highlight how some level of 
“distress” is a normal response in response to cancer, which at the upper end may be 
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considered pathological characterised by anxiety or depression symptoms and disorders.  
It could be that My Road Ahead is appropriate for men who do not have high 
psychological distress. 
In addition, it is possible that the intervention prevented the development of 
psychological distress at a later time point. Follow-up evaluation of the participants in 
the current study would provide such information. Roth et al. (1998) suggested that the 
detection of psychological distress was important and opportunities for educational and 
supportive type interventions may act as a preventative measure against distress and 
development of psychological disorders. More discussion related to psychological 
distress is found in the attrition section of this discussion. 
Relationship function.  The third hypothesis, that men who completed the 
modular aspect of My Road Ahead (Modules or Modules-plus-Forum) would 
demonstrate significantly greater improvement in relationship function from pre-test to 
post-test than those who received the forum only (Forum group), was not supported by 
the results of this study.  
Firstly, there was no interaction effect for relationship satisfaction, suggesting that 
the program did not impact on this variable. Results found an interaction for marital 
affection which was approaching significance and worth considering due to the large 
effect size. The interaction was consistent with the anticipation that the module aspects 
of the program would improve marital affection as this was a major focus of the 
program. A larger sample size is needed to confirm this trend. 
Both general and sexual communication skills were targeted in My Road Ahead, 
however there were no interaction treatment effects for these variables; 
demand/withdraw communication, positive interactions, and sexual communication. 
However there was a non-significant moderate effect size for this interaction for 
demand/withdraw communication which requires further investigation. For 
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demand/withdraw communication the intervention led to a decrease of this negative 
form of communication for the Modules and Modules-plus-Forum group and an 
increase in this type of communication for the Forum. This is not surprising since this 
was targeted in the program. For marital affection, demand/withdraw communication, 
and sexual intimacy there was a trend towards the Modules group demonstrating greater 
improvement than the Modules-plus-Forum group. One explanation for this was that the 
Modules group were more likely to include their partners in intervention (36.36% of 
men from the Modules-plus-Forum group versus 61.54% of men from the Modules 
group). Although this difference in partner inclusion was not significant, it may be 
clinically meaningful. Qualitative feedback from men suggests that for both treatment 
groups many partners were not included due to partner’s lack of interest or 
communication difficulties. Some partners may benefit from a separate program 
targeting their own needs before or in conjunction with a couple based program. It 
should be highlighted that there were no reports that partners became distressed from 
the partner handouts or during the course of their partner accessing the program. 
While the lack of positive findings for relationship functioning and partner 
outcomes was surprising given the previously highlighted importance of addressing the 
dyadic relationship, this is generally consistent with past intervention research. 
Although past research has strongly suggested that a man’s intimate relationship is 
impacted by prostate cancer, and the inclusion of the partner is important, intervention 
studies have not found support for this so far.  Many studies have not found 
improvements in dyadic adjustment or marital distress across supportive educative 
interventions (McCorkle et al., 2007; Giesler et al., 2005), three 
counselling/psychological therapy interventions (Canada et al., 2005; Collins et al., 
2013; Manne et al., 2011), and an internet-based counselling intervention (Schover et 
al., 2012). Many of these studies placed relationship functioning as a major focus. For 
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example, Schover et al.’s (2012) internet-based study directly targeted relationship 
functioning through improved sexual communication and affection but found no 
improvement on relationship functioning variables.  
In terms of past research aiming to improve intimate relationship communication 
patterns for men treated for prostate cancer, there are only a few studies that have taken 
an actual measure of communication. The only positive effect found for communication 
was from Northouse’s (2007) couple based supportive/educative intervention which 
found an improvement in men’s communication with their spouse about their illness. 
Although Manne et al.’s (2011) couple based intervention placed relationship 
functioning as a major focus and used several communication enhancement strategies, 
the authors did not find any treatment main effects for a variety of relationship 
communication outcomes, including level of disclosure, responsiveness, and use of 
mutually constructive communication.  
The current study found no treatment effect for sexual communication. Although 
several studies have targeted this in their intervention (Canada et al., 2005; Giesler et 
al., 2005; Molton et al., 2008; Schover et al., 2012; Titta et al., 2006), this study used a 
measure of sexual communication. Within the My Road Ahead modules there were 
exercises that explicitly aimed to improve men’s level of sexual communication. The 
scale used to measure this, the Dyadic Sexual Communication Scale has been used in its 
full form by previous researchers using a prostate cancer sample to explore couples’ 
sexual dysfunction and relational problems (Garos et al., 2007). In the current study the 
4-item abbreviated form was utilised. It is possible that this measure was not 
appropriate for this cohort of men and further testing of this measure may be required. 
Alternatively, it may be that the intervention did not improve communication in this 
area. With a larger sample size, the current study could explore whether those with 
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poorer relationship satisfaction and communication were more likely to improve on 
those measures.  
Attrition. Overall attrition from My Road Ahead was 28%, which was similar to 
past internet-based research treating mental health, psychosocial impact of physical 
health conditions, and sexual problems (Cuijpers et al., 2008; McCabe & Price, 2008; 
Spek et al., 2007), and similar to Schover et al.’s (2012) rate specific to a prostate 
cancer sample. A comparison of men who completed treatment and those who 
discontinued treatment was made using the criterion of completing at least 40% of the 
module aspect of My Road Ahead. Analyses revealed that those who dropped out of 
treatment had significantly higher levels of anxiety, were of a younger age, and were 
less likely to have sought previous psychosocial support before participating in the 
study. This suggests that those men who are most in need may not have found this 
intervention an appropriate means of support.   
Those individuals who had previously sought support may be more suitable to 
an internet-based intervention which is largely self-directed. These men may have a 
greater understanding of the processes involved in engaging in some form of support or 
treatment and possess a higher level of motivation that is necessary to engage in 
internet-based treatment programs. The finding that men who were younger were more 
like to drop out was unexpected, especially given the platform of the program. 
However, literature suggests that older men are comfortable using the internet to seek 
information, advice and support (Davison et al., 2004). It may be that the content of the 
program was not as appealing to younger men. Future programs may need to adjust 
program content and design for different age groups. Indeed some past researchers have 
excluded men under a certain age for these reasons (Molton et al., 2008; Penedo et al., 
2006; Penedo et al., 2007; Weber et al., 2004; Weber et al., 2007). 
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The finding that men with higher levels of anxiety were more likely to drop-out 
was an unexpected finding in this study, however it should be noted that levels were 
still in the normal range for those that dropped out. It is possible that a certain cohort of 
men with prostate cancer need to be directed to specialist services for anxiety and 
distress (e.g., telephone, internet or face-to-face options). This notion fits into proposed 
models of “stepped care” which have become prominent in the cancer setting. These 
models suggest different types of psychosocial care for increasing levels of distress and 
that matching the type of intervention to the level and type of distress or problem is the 
most efficient model of care (Hutchinson, Steginga, & Dunn, 2006). Indeed others have 
emphasised the need to screen for psychological distress when considering further 
supportive care for men with prostate cancer (Korfage et al., 2006). This is discussed in 
greater detail in the implications section later in this discussion. 
Interestingly, the five men who identified themselves as homosexual or bisexual 
remained in this study. Although this difference did not reach statistical significance, it 
is an important finding. Programs and research on prostate cancer thus far are heavily 
skewed towards heterosexual men, with only one study acknowledging homosexual 
men by asking about sexual orientation (Manne et al., 2011). Latini et al. (2009) has 
previously emphasised that homosexual men may have differing needs in the face of ED 
and relationship disruption. Research has only begun to explore and identify the unique 
needs of homosexual and bisexual men which are likely to then be translated into 
programs specific to their needs. The retainment of these men in our study highlights 
that even though the language and content of My Road Ahead was biased towards 
heterosexual men; homosexual and bisexual men found benefit from the program and 
also found the internet platform as an acceptable means of delivery. 
Given the nature of the study design, reasons for attrition were not directly 
identified from men who did not complete post-test questionnaires. However, some 
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reasons for not completing the entire program are covered in the next section, alongside 
discussion around general feasibility and acceptability feedback from participants. 
Feasibility and Usability of My Road Ahead 
A secondary aim of the present study was to evaluate the feasibility and 
acceptability of a self-directed internet-based intervention for men treated for localised 
prostate cancer.  There will be greater focus in this section on the module aspects of the 
program which was considered the intervention. As mentioned previously, attrition rates 
were relatively low and acceptable, especially for a self-directed internet-based 
program. Around half of the participants completed the entire program (six modules). 
For many men being too busy was a reason for not completing the program, with only 
two men reporting that they did not find the program useful. However, after attrition, 
the average percent complete for the entire program was above 85% for both groups. 
Although not significant, the Modules-plus-Forum group tended to spend more 
time on the modules and complete a greater percent of the program than the Modules 
group. It is possible that having access to the forum increased engagement in the 
modules, however a larger sample size is needed to see if this relationship reaches 
significance. Email contact appeared to enhance the engagement in the modules aspect 
of the program with men often returning to the program within 0-7 days after a weekly 
reminder email was sent. This is consistent with past research (Spek et al., 2007; Tate et 
al., 2003) which suggests that accountability and motivation is increased through 
personalised contact including emails.                                            
Overall satisfaction with the program was considered to be good, even though 
many men did not finish the program and some reported several areas for improvement, 
almost all men reported that they would recommend My Road Ahead to someone else. 
Several men provided qualitative feedback regarding what they had taken from 
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participation in the modules, with themes of gaining new skills, learning from others 
and getting a chance to reflect on their cancer journey being prominent. However, 
feedback would suggest there are many areas that could be improved. Several men felt 
that the timing of the program was too long after diagnosis and treatment of prostate 
cancer. Some men had issues with the specific or general nature of the content. 
However, there was also conflicting feedback from participants where  some specific 
changes that one man suggested was an area that another man reported he specifically 
appreciated or enjoyed (e.g., the videos). Two men reported that they wanted some form 
of face-to-face therapy, highlighting that internet-based programs may not meet the 
needs of some individuals.  
Although men were informed via the website and through weekly emails that they 
were able to access whichever module was of interest or relevant to them, most men 
tended to complete the modules in the recommended order. Some feedback suggested 
that men had missed or misinterpreted these instructions and that more obvious tailoring 
the program to specific needs may be beneficial. Many of the feedback points covered 
in this section highlight the need for further tailor interventions, which is discussed in 
greater detail later in this chapter. 
Overall satisfaction with the forum was considered low to adequate. Interestingly 
there was greater engagement (in terms of posting comments) from the Forum group 
compared to the Modules-plus-Forum group, although this difference was only 
approaching significance. Men in the Forum group rated the forum with significantly 
greater satisfaction and more enjoyable than the Modules-plus-Forum group. A 
potential reason for this could be that the Modules-plus-Forum group may have felt 
overwhelmed with expectations that they would complete the modules and post 
comments on the forum. Although only approaching significance, the Modules-plus-
Forum group also rated the forum as more difficult to use than the Forum group, which 
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could either reflect a difference in the capabilities of the two groups or the fact that the 
Modules-plus-Forum group felt inundated with instructions.  
Around half the men who gave qualitative feedback about the positive aspects of 
the forum said that they valued learning about others’ experiences, and several men also 
reported appreciating the opportunity to provide support and help others. Feedback 
regarding the negative aspects of the forum and the most frequently reported reason for 
not engaging in the forum more were related to their not being enough participants or 
comments on the forum. Suggestions for improvements regarding many of these aspects 
are covered later in this chapter. Finally there was some feedback regarding the forum 
and the modules aspect of My Road Ahead that were related to computer and or website 
related difficulties. 
Research Limitations and Recommendations for Future Research  
Although this thesis attempted to overcome several methodological problems 
related to past research, there were still some limitations evident in the current thesis 
that require consideration. This section will combine limitations of the current research 
with future recommendations. Future recommendations are explored in terms of study 
design, and improvements for My Road Ahead and for future internet-based 
interventions for men with prostate cancer. 
Sample.  The first limitation was related to the sample size used to evaluate the 
efficacy of My Road Ahead. As a result, the reliability of the results may have been 
compromised as it was likely that there was insufficient power for some analyses to 
detect significant differences. A small sample size also meant that further sub-group 
analyses were not possible. Several possibilities for further analyses were evident 
including evaluating whether improvements across dependent variables were related to 
partner inclusion, baseline characteristics, and baseline levels on dependent variables. 
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Past researchers have found that while there were no main effects of treatment, there 
were improvements on certain variables for those reporting higher distress or lower 
relationship functioning at baseline (e,g., Manne et al., 2011). Given the low levels of 
distress and high levels of relationship functioning that was evident at baseline in the 
current sample, a larger sample size would allow exploration of moderator effects. 
Other moderator effects worth exploring could be masculine self-esteem, considering 
past research has found greater benefit from interventions with men with lower general 
self-esteem (Helgeson et al., 2006) and interpersonal sensitivity (where there is an 
increased likelihood for masculinity to feel threatened) (Molton et al., 2008). 
A further limitation of characteristics of the sample was related to demographic 
characteristics, were the current study had a reasonably homogenous sample, consisting 
mostly of educated, Caucasian and European men, who were not a representative 
sample of the population who have prostate cancer in Australia. Further, due to 
recruitment options and processes, the sample had almost entirely undergone a radical 
prostatectomy. Finally, although this study aimed to recruit men from rural locations, 
80.49% were from urban locations. This percentage is higher than recent figures 
relaying 2011 figures from the Australian Bureau of statistics that found around two 
thirds of the Australian population live in these areas (ABS, 2012b). 
In terms of recruitment, apart from aiming to obtain a larger sample size, it may 
be beneficial to recruit a certain number of participants and commence the RCT at a 
specified time point, rather than allowing men to enter treatment immediately following 
registration. This would be particularly beneficial for the forum, increasing the amount 
of activity on the forum, which was reflected as an issue in the qualitative feedback. 
Feedback from the modules suggested that having a reduced timeframe since diagnosis 
and treatment as an entry requirement into My Road Ahead might be appropriate. Men 
could also be targeted that have a certain level of distress or sexual and relationship 
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difficulties. More strict recruitment processes may reduce the variance of dependent 
measures and therefore increase the likelihood significant treatment effects are found. 
However, since allowing any man who feels that he needs assistance is more ethical, it 
may be more appropriate to increase level of tailoring for the intervention (discussed 
“program modification” section). 
Research design.  In terms of the research design of the current study there are 
several options for changes and improvements in terms of evaluating the efficacy of My 
Road Ahead in the future. The design of the current study, with three intervention 
groups, was considered a more sophisticated method in comparison to using a wait-list 
control group, however interaction effects were more difficult to find since it was 
hypothesised that all three groups would improve across dependent measures to some 
degree. Future evaluation of My Road Ahead could return to a more common research 
design, comparing the intervention with standard treatment (control group) or a three 
group design (Modules, Forum and control group). If the efficacy of My Road Ahead is 
established through one of these designs, an evaluation using a similar research design 
to the current study could be consequently implemented. 
Limitations in this study were evident in the use of particular measures. Although 
the IIEF is widely used in prostate cancer and other ED research it is not without 
problems. The wording for this scale can be confusing for some individuals and does 
not highlight whether a man has been masturbating or engaging in other sexual 
activities. An important finding from this study was the potential usefulness of the 
PCQoL (Clark et al., 2003). This scale was utilised for its ability to discriminate 
between actual sexual function and sexuality in a broader context including sexual 
confidence, sexual intimacy, and masculine self-esteem. Out of all the scales used in the 
current study the subscales of the PCQoL were able to identify some changes and 
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trends. Future research should consider using this scale in addition to scales that 
measure sexual function (e.g., IIEF). 
Another potential means to analyses data would be to use intent to treat (ITT) 
analysis. In the current study, those participants who did not complete 40% or more of 
the program were excluded from analyses. ITT deals with noncompliance and 
withdrawal from a study by a statistical approach that includes every participant (Gupta, 
2011).  
The post-test assessment used in the evaluation of the efficacy of My Road Ahead 
in this study was only taken at an immediate follow-up time point post-treatment. It is 
possible that trends towards significant findings in the current study may not have been 
maintained at later time points. On the other hand it is also possible that when 
introducing follow-up assessment points (e.g., 3 months and 6 months) significant gains 
may have been made for the different groups. This may have given the men time to put 
into practice many of the skills they learnt. For example, men may have recently had a 
conversation with their partner and decided on an erectile aid to use and just begun 
implementing a plan. 
Future research may also seek to compare a therapist assisted version or face-to-
face or telephone based treatment with similar content to My Road Ahead. Greater use 
of objective usability testing through the use of website analytics would be beneficial to 
incorporate in future research where the amount of time spent on each page and module 
can be accurately identified. The current study used emails to increase motivation and 
commitment, which seemed to increase engagement. There are other means by which 
such support can be provided including the use of text messages, follow-up telephone 
support, or even an occasional face-to-face meeting (Ritterband et al., 2009). In a 
review of studies using the internet to promote health behaviour change, Webb et al. 
(2010) found that the use of SMS had large effects compared to the use of telephone 
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and emails. Given the increasing use of the internet on Smartphones, the use of SMS 
and Smartphone Applications (commonly known as “Apps”), integrating these tools is 
likely to be of benefit in conjunction with internet-based treatments in the future. Apps 
could be in the form of reminders, tips, and thought monitoring, and Smartphones in 
general could be used to view the program or connect on the forum. Luxton, McCann, 
Bush, Mishkind, and Reger (2011) reported that Smartphones and their Apps are 
already being used in behavioural health care for symptom assessment, psycho-
education, and tracking of treatment progress. 
Program modification.  Several recommendations can be made related to the 
content of both the modules and forum of My Road Ahead, some of which have already 
been covered. The use of internet-based treatment is currently rapidly increasing across 
many areas, and has only just begun to be applied to the area of cancer, including 
prostate cancer. The following recommendations come from the feedback in the current 
trial from participants, from the researchers’ experiences in running this study, and other 
internet-based treatment in areas other than prostate cancer. 
With regards to the content of the program, Module 1 may have focused too 
heavily on clinical depression. This module may benefit from a more even balance and 
differentiation between normal emotional responses including grief and sadness and 
depression and abnormal grief reactions. 
In terms of the structural components of My Road Ahead, there are other 
important structural changes that could be made to modules. An open gated structure for 
the modules was chosen for My Road Ahead to increase engagement. Future research 
could modify this to what Leykin et al. (2011) referred to as an “adaptable lesson flow”. 
A recommended personalised program could be automatically developed by a man’s 
responses to a baseline questionnaire and by indicating which areas they are distressed 
or interested about. This is similar to the use of screening questions in face-to-face 
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interventions in prostate cancer (e.g., Collins et al., 2013; Giesler et al., 2005). This may 
increase both engagement and the benefits gained from the program. Tailoring has been 
recommended by other authors for men treated for prostate cancer (Cockle-Hearne et 
al., 2010; Latini, Hart, Honoré Goltz, Lepore, & Schover, 2011). Support for tailoring 
also comes from intervention studies reporting moderator effects. Tailoring may retain 
those men with higher distress for example (drop-out related to anxiety) or those men 
who found the content was too long or not relevant to them, or that they were too busy. 
These suggestions are also consistent with feedback from some of the men in the 
current RCT.  
Tailoring through developing a personalised program would mean that men, for 
example with sexual problems as their only concern, would be directed to the modules 
relevant to them earlier. If men are not being directed to the entire program, more 
content could be added to particular modules in the hope to address specific needs more 
thoroughly. For example, more detail could be added about the use of medical treatment 
aids in conjunction with psychosocial strategies in Module 5. In addition, the use of 
videos could increase to include actors covering difficult situations and later modelling 
effective communication strategies (Schover, 2012, November). 
Even though the forum was not the major focus of My Road Ahead, there are 
several recommendations for future research and use of online forums in this 
population. This is important since there is very little empirical research assessing 
online support for cancer patients, especially prostate cancer. Past face-to-face research 
has matched long-term prostate cancer survivors as peer support partners to more 
recently diagnosed men (Weber et al., 2004; Weber et al., 2007). Similarly, the My 
Road Ahead forum could implement past survivors as moderators on the forum. 
Another innovative idea is for men to be able to set up their own home page, similar to 
what is found on social networking sites. This was raised at the 2012 IPOS conference 
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(Owen, Bantum, Criswell, & Stanton, 2012, November) where Owen et al.’s (2012) 
unpublished research depicted a website with a blog personal page set-up where men 
could communicate as a group or to individuals. Another idea worth considering and 
identified by some men in this study, is the use of online chat groups, either audio or 
text based. 
More broadly speaking, the development and evaluation of My Road Ahead has 
provided the foundation for not only improvements to this program itself, but to future 
adjunct programs. These may include a program specific to the needs of homosexual 
and bisexual men, single men, those living in rural locations, and a separate program for 
the partners of men with prostate cancer or a more tailored couple based intervention 
program. In addition, programs may be developed for men at different stages of disease 
and at different times post-treatment. My Road Ahead sets the stage for an exciting time 
in the area of internet-based treatment for men with prostate cancer. Implications are 
discussed in more detail below. 
Implications for Treating the Psychosocial Needs of Men Treated for Prostate 
Cancer  
Although at this stage we cannot conclude that My Road Ahead was effective in 
improving sexual, psychological and relationship functioning, there were some trends 
towards improvements in some broader sexual QoL measures and marital affection 
measure, which as stated in the previous section need to be explored using larger 
samples and with other potential methodological changes. Regardless, the internet is a 
rapidly growing platform for delivery of psychosocial interventions for cancer patients, 
and this study provided several important findings likely to influence both future 
research and delivery of care. 
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As highlighted previously, internet-based interventions have many advantages. 
Internet-based interventions have been growing in many fields of psychology including 
general psychological distress, more severe mental health disorders, management of 
health conditions, and in influencing health behaviour change. As highlighted in the 
Chapter 6, internet-based interventions vary greatly in terms of the level of therapist 
assistance. My Road Ahead was designed with the specific intent to provide 
psychosocial support requiring minimal therapist support, which affords a major 
advantage in terms of disseminating this program in the future. Ritterband et al. (2009) 
suggested that developing an internet-based intervention that is able to significantly 
impact on behaviour change, elimination of symptoms, and maintain these changes is a 
major achievement for wide-scale dissemination goals. The current study suggests that a 
self-directed online psychosocial intervention for men with prostate cancer is acceptable 
and feasible. However there are several areas of improvement that have been 
highlighted in previous sections and further evaluation research with a larger sample 
size will add certainty to the program’s feasibility. 
With a growing number of men with prostate cancer the health community needs 
to find a means to deliver interventions effectively. There have been many calls for the 
integration of the assessment, provision of information and the delivery of more 
complex interventions as part of routine cancer care (Holland et al., 2011; Hutchinson et 
al., 2006).  As mentioned previously, models of stepped-care have been proposed as a 
means to disseminate care efficiently and effectively. Here the level of distress is 
matched to the psychosocial intervention and more complex and usually costly 
treatment is available for those who do not benefit from more basic levels of care 
(Bower & Gilbody, 2005; Hutchinson et al., 2006; Krebber et al., 2012). Decisions are 
usually made through assessment and patient preferences (Krebber et al., 2012). 
Stepped care is considered similar to tailored interventions (Latini et al., 2011). In 
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tailored psychosocial interventions the intervention is tailored to the needs of the 
specific individual and stepped care is often driven by cost concerns where the most 
appropriate intervention is given to an individual (Latini et al., 2011).  
Scogin, Hanson and Welsh (2003) suggested that self-directed programs can often 
serve as one of the first steps in such a model. Internet-based interventions in particular 
may be placed well into this first step, where additionally supportive options are 
available if the internet-based program is not sufficient or effective (Cuijpers et al., 
2008). In Krebber et al.’s (2012) protocol paper evaluating stepped-care for neck and 
lung cancer patients, their internet program fitted into the more basic level of guided 
self-help via the internet or a booklet. Given that My Road Ahead was a CBT skills 
based program it may be suited to address higher levels of care in addition to Krebber et 
al.’s identified level. In reviewing Hutchinson et al.’s (2006) tiered model of stepped 
care, a comprehensive CBT internet-based program could potentially cover mild to 
moderate levels of distress in areas such as communication skills and stress 
management. Specialist care for moderate to severe distress may be more appropriate 
for mood and anxiety disorders. Therefore, My Road Ahead and similar future internet-
based programs may be suited to mild to moderate presentations of distress and 
associated levels of needs. At the same time internet-based interventions may be a 
simply a preference for many men, in terms of anonymity and convenience.  
Finally, as highlighted previously My Road Ahead signifies the development of 
the first self-directed comprehensive psychosocial intervention for men treated for 
prostate cancer, and as such provides the foundation for future programs and 
refinements of My Road Ahead itself.  
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Summary and Conclusion 
The primary aim of the present study was to investigate the efficacy of an 
internet-based psychosocial intervention for men treated for prostate cancer, focusing on 
sexual, psychological and relationship functioning. A secondary aim was to investigate 
the feasibility and acceptability of such a program for men treated for prostate cancer. A 
self-directed CBT program was developed and tested through a complex process 
resulting in a comprehensive, interactive and flexible program which took advantage of 
the benefits of online technology and used this as a platform to roll out a manualised 
intervention to address many of the needs of men with prostate cancer. 
My Road Ahead was administered to 57 men treated for localised prostate cancer 
in the last 60 months. Results from the evaluation of the study found no significant 
treatment effects for sexual functioning, psychological functioning, and relationship 
functioning measures. There were some trends for interaction effects for sexual 
intimacy and marital affection that should be evaluated by using a larger sample size. A 
larger sample size is necessary to clarify whether My Road Ahead is effective and to 
allow for further analyses into the factors that may predict outcomes. A larger sample 
size will also allow further exploration of the potential benefits or lack of benefits from 
the forum itself and the forum in conjunction with the modules. Results also revealed 
that an internet-based program is both feasible and acceptable to men treated for 
prostate cancer. However this finding should be interpreted cautiously given the small 
sample size and several recommendations for future research and changes to My Road 
Ahead have been made. In particular, the development of a website that allows the 
internet-based intervention to be more clearly and strongly tailored to the needs of 
participants seems appropriate when taking into consideration that while men treated 
with prostate cancer have several identifiable unmet needs, there is great variability in 
terms of actual patterns of needs at different times and for specific individuals. 
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Module 4: Partner Information 
Prostate cancer and erectile dysfunction 
Your partner is now at Module 4 of the program. This module looks at why sexual function 
often changes after prostate cancer treatment and what can be done about it. Some 
partners find the changes to their man’s sexual functioning confusing and frustrating and 
this sheet may help you understand what is going on. There are also some communication 
exercises for you to participate in. The next module addresses relationship and intimacy 
issues in more detail.  
Prostate cancer & erectile dysfunction (ED) 
You are probably already aware that ED is a very common side effect of treatment for 
prostate cancer. This is because the nerves necessary for erections are often damaged 
during radiation and surgery. This does not mean that they are permanently damaged but 
that there will be a period of time where function is impaired, usually many months and 
sometimes this damage does not recover.  
What can be done about men’s changes to sexual function? 
(1) Challenge thoughts associated with masculinity, intimacy, and sexuality (this module 
looks at this) 
(2) Use medical aids (covered in module 5) 
(3) Improve communication between a couple (covered in module 5) 
Sex, intimacy, and relationships 
Although intimacy and communication will be addressed in more detail in the next 
module, it is important to highlight that sexual issues affect both members of a couple and 
the best way to tackle ED is together.  
The flow diagram below represents an overview of how ED can impact on your sex life and 
relationship.  
 
It is important not to wait until your partner’s erections return to how they were before 
treatment. Not being intimate or communicating as well as not having sex for a period of 
time means other problems may arise even when erections return. 
Research has found that some men and their partners find that having to deal with ED 
actually results in improvements to their sex lives and relationships in the long run! This 
might be because it forces the couple to think about things differently and to explore new 
ways of achieving sexual pleasure together.  
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ED affects you too 
It is important for both the man and has partner to acknowledge the loss associated with 
ED. Research suggests that some women choose not to talk to their partner about ED and 
loss of sexual activity for fear of upsetting him or because they think it shouldn’t be 
important or discussed in the context of having cancer. Since ED is an issue that affects 
both members of a couple it is important to communicate and come up with solutions 
together. Make sure you join your partner with the exercise he is asked to do to get the 
most benefit from this program. 
 
Exercise:  
 
Think about how your partner’s ED has impacted on your life. Write down the changes you 
have noticed in your partner with regards to sexual functioning – both physically and 
emotionally, and how this has affected you. This shouldn’t be a blame based exercise and 
try not to feel guilty about how you are feeling. This is simply an exercise to acknowledge 
how things have been affecting you. Your partner has also been asked to complete this 
exercise. When you have both finished use what you have written to share your 
experiences.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Important things for you to know 
x It is not you! Sometimes partners think that the changes to their partner’s sexual 
functioning are because they are less attracted to them or they are somehow causing 
the problem. This is rarely the case. 
x Be positive and non-judgemental. Don’t assign blame. 
x Your partner’s sexual problems can impact on your sexual functioning. Since dealing 
with sexual problems in relationships can be difficult, now can be an excellent time to 
think about and discuss any sexual issues you may have. Sexual problems are extremely 
common in women but are probably less spoken about than they are in men. Common 
issues for women include: loss of desire and arousal, and pain during sex. It is also a 
good time to think about your needs and what you might like to change in your sexual 
relationship.  
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Sexual beliefs & myths 
When there are changes in our sexual functioning and sexual relationships it can be helpful 
to look at some sexual beliefs we may hold that are not entirely accurate. We all develop 
certain attitudes and beliefs about sex and sexuality which come from our family, peers, 
teachers, religious beliefs, sexual partners, and the media. Below is a list of statements 
related to sex, ED and prostate cancer.  
 
Myth  Feedback Tick if this 
is a belief 
you hold 
A man wants sex 
at anytime with 
anybody 
People often believe this when they hold the view that 
men are always ready, willing and able to have sex. This 
is not the case and holding such a view can be 
damaging to a man’s self esteem. 
□ 
ED is mostly in a 
man’s mind 
ED can have both psychological and physiological 
causes. Problems with blood flow or nerve damage can 
have a big impact on erections. Psychological factors 
such as stress and anxiety may contribute to ED. 
□ 
ED is just the 
man’s problem 
If a man has a partner then they are likely to be 
impacted by ED, especially if the change in sexual 
function leads to withdrawal or loss of intimacy or 
mood changes. If all sexual contact is avoided then this 
is a problem shared by both members of a couple. 
□ 
Men should know 
everything about 
sex 
Some believe that men should just know how to have 
sex or please their partners and not need to seek help 
or knowledge from elsewhere (ie counsellors or books). 
It may not be until something changes, such as the case 
with ED, where there are major changes to our sex lives 
that we realise sex is not a simple and logical process. 
No-one can claim that they know everything about sex 
– adapting to changes means learning new ways of 
having a sexually satisfying relationship.  
□ 
Penetrative sex is 
the only way to 
have sex 
It is possible to have intimacy and a satisfying sex life 
without penetrative sex. Holding the view that 
penetrative sex is the only way to have sex means that 
if a man has ED he will avoid all forms of sexual contact 
for fear that all physical contact must lead to sex. This 
will result in the man (and his partner) feeling 
unattractive, unwanted, depressed or anxious. 
□ 
Only men should 
initiate sex and 
take the lead 
Men often do initiate sex but that doesn’t mean that 
they prefer to! Women have very similar sexual desires 
and needs to men and there is no reason why a woman 
shouldn’t initiate sex. 
□ 
A man can only Neither an erection nor ejaculation is necessary for a □ 
262 
 
  
have an orgasm 
with an erection 
man to have an orgasm.   
Prostate cancer 
treatment 
negatively impacts 
on a man’s sex 
drive (libido) 
Researchers have found that the only prostate cancer 
treatment to impact on libido is the use of hormone 
therapy. No other treatments for prostate cancer have 
been linked to loss of libido from a physical point of 
view; that is, there doesn’t seem to be a physical or 
medical reason why libido changes after surgery or 
radiotherapy. However the stress and anxiety related to 
the diagnosis and treatment of prostate cancer may be 
enough to impact on libido and many men report a 
significant drop in libido after prostate cancer 
treatment.  
□ 
 
What may be happening for your man? 
Partners of men with prostate cancer are often unaware of the significant impact that ED 
can have on a man’s sense of masculine identity and his confidence and self esteem. 
Having no or limited erections can often make your partner feel he is somehow “less of a 
man”. 
Research has found that men who are more likely to conform to the stereotype of 
masculinity may struggle more adjusting to the changes ED may bring. 
Masculine stereotypes include: 
x Physical strength 
x Self-reliance 
x Being in control 
x Being rational and not being emotional 
x Be the breadwinner 
x Be tough and ready for violence 
x Sexual performance (potency) 
x Being strong 
 
Exercise:  
 
Think about the stereotypes listed above. Are there any that you think your partner relies 
on when he thinks of what a man should be like, or what he should be like as a man? 
 
Do you think it might be worth talking to him about expanding his idea of what it means to 
be a man?  
Things to try and do this week:  
(i) Sit down with your partner and share what each of you has written for the first 
exercise.  
 
(ii) Also, do something this week that you and your partner enjoy. It may be something 
that you used to do that you haven’t done for a while or it may be something you 
have always wanted to do. 
263 
 
  
Appendix B: Welcome/start-up pages/instructions 
  
264 
 
  
 
 
 
265 
 
  
 
 
266 
 
  
 
  
267 
 
  
 
 
268 
 
  
 
 
  
269 
 
  
 
 
* screenshot depends on which group allocated 
  
270 
 
  
Appendix C: Overview of My Road Ahead once questionnaires are completed 
271 
 
  
 
 
272 
 
  
 
 
273 
 
  
 
 
274 
 
  
 
 
275 
 
  
 
 
276 
 
  
 
 
277 
 
  
 
 
  
278 
 
  
Appendix D: Module component of My Road Ahead 
279 
 
  
 
Homescreen 
 
Logbook  
280 
 
  
 
Mood monitor 
  
281 
 
  
Example screen shots from Module 1 
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Example screen shots from Module 4 
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Example screen shots from Module 5 
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Urology Department 
The Royal Melbourne Hospital 
Grattan Street 
Parkville, 3050 
[Name] 
[Address] 
[Suburb, postcode] 
 
Friday, 6 September 2013 
Dear [first name], 
  
The Urology Department at the Royal Melbourne Hospital, in collaboration with the 
Australian Prostate Cancer Research Centre Epworth, Swinburne University of 
Technology and Deakin University, is conducting research into providing an internet 
based psychological support program for men who have been diagnosed and treated 
for prostate cancer, My Road Ahead.   
We are writing to you to invite you to participate in phase three of the study which is a 
randomised controlled trial of the effectiveness of My Road Ahead, the online program 
that has been developed. Participation will involve taking part in one of three internet-
based groups; either taking part in the 10 week intervention, the 10 week intervention 
plus using an online forum, or just using the forum. If you agree to take part you will be 
randomly assigned to one of these three groups.  
My Road Ahead aims to support men through the challenges often faced after 
treatment for prostate cancer.  
A flyer is attached for your information.  Please go to www.myroadahead.org for further 
details and click on “What is My Road Ahead” link to hear about how this program 
works. 
 
Participation in this study is completely voluntary.  We would like to emphasise that you 
do not have to participate in this research project to receive any medical care that you 
may require. 
 
Yours sincerely, 
 
 
 
Anthony Costello, F.R.A.C.S., M.D. 
Professor and Director of Urology 
The Royal Melbourne Hospital 
 
 
 
 
SUITE 8.6, LEVEL 8 
THE EPWORTH CENTRE 
32 ERIN STREET 
RICHMOND  VIC  3121 
ABN  54 100 124 874 
PROF ANTHONY J. COSTELLO 
 
 MD FRACS  MBBS  
 
 UROLOGIST  
 
 
PROVIDER NO.  017329GJ 
 
 
 
 
 
 
TELEPHONE (03) 9429 9555 
FACSIMILE  (03) 9429 9759 
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www.myroadahead.org 
My Road Ahead is an online support program designed to be used by men after treatment for 
prostate cancer. This program aims to support men through the challenges often faced after 
treatment for prostate cancer. Men are not routinely offered psychosocial support despite strong 
evidence that being diagnosed with prostate cancer poses significant quality of life concerns for men 
and their partners and consequently a significant potential of developing a range of mental health 
disorders, including Major Depression and Anxiety disorders. Sexual dysfunction poses a particular 
threat to a man's psychological functioning as well as relationship functioning. Lack of psychosocial 
support is in part due to lack of available resources and this project aims to provide a structured, 
self-directed psychological support intervention that is accessible and appealing over the internet. 
To watch the introductory video click here: https://www.myroadahead.org/what-is-my-
road-ahead  
Research 
The My Road Ahead Program is being offered as part of a randomised controlled trial. This research 
involves an evaluation the efficacy of My Road Ahead. Men who agree to participate in the program 
will be randomised into one of three groups: (1) My Road Ahead only; (2) My Road Ahead plus 
online moderated bulletin board; or (3) online moderated bulletin board only. Eligible men include 
those that have received treatment between 6 months and 5 years ago. 
As this is a research program men will be required to consent to take part in the study and complete 
a range of questionnaires over a period of 6 months to assess their quality of life, mood state, 
relationship functioning, communication styles and their medical history. All participant information 
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will be kept strictly confidential. Participants in all groups will be asked to complete these 
questionnaires at 5 time points, when they consent to participate (baseline week 1), at the midpoint 
of the 10 week program (week 5), at the conclusion of the 10 week program (week 10), 12 weeks 
later (week 22) and 6 months after completing the 10 week program. They will also be asked to log 
into the online intervention at least once per week for between 1-2 hours per week over the course 
of the 6 modules.  
 
Accessing the Health Provider Login 
Please have a look at the program in more detail using the following details. Below is a heath 
provider login for you to use. Please DO NOT pass this on to anyone else. If your patients would like 
to use the program they will need to create their own login.  
Web link: http://www.myroadahead.org 
Username: healthprovider 
Password: health 
 
Details of the online program 
My Road Ahead is a 6-module online self-directed psychological support covering a range of topics 
including: 
Module 1: Introduction to the program and the emotional impact of prostate cancer 
Module 2: Tools for helpful thinking and effective communication 
Module 3: Coping with physical changes 
Module 4: Sexuality and masculinity 
Module 5: Sexuality and intimacy 
Module 6: Putting it all together and planning or the future. 
 
 
Some important features of the program include: 
 
Moderated bulletin board: This forum offers the opportunity to share experiences, ask questions and 
share information. This is a space to share thoughts, ideas, tips or information with other men who 
might be going through similar experiences. Unlike other forums on the internet this forum will be 
moderated by the experienced researchers. Only appropriate information will be included on this 
forum. A link to the bulletin board is provided here: http://www.myroadahead.org/forum/. 
Partner inclusion: My Road Ahead has been designed for men who do and do not have a partner. If 
a man does have a partner he is encouraged to discuss the information he learns from the program 
with them. Additionally, there are specific handouts for partners and specific exercise designed for 
partner inclusion. There are alternative exercises for men without partners. 
Online & offline exercises: My Road Ahead consists of several online exercises for men to participate 
in as they proceed through the program. This provides men with an opportunity to practice and 
consolidate what they have learnt in each module. Some of the skills acquired are also used in later 
modules. For example, the following link involves a communication based exercise: 
http://www.myroadahead.org/module/two/page/20. 
Logbook: As the men go through the program they have the option to bookmark any topics of 
particular interest. Answers to offline exercises will also be transferred to the logbook. At the end of 
the program the men will be able to use the logbook to look back and reflect on where they have 
come from as well as any goals they would like to work towards in the future. Here is a link to the 
logbook: http://www.myroadahead.org/logbook. 
Video: There are online videos in each module with information from various health professionals or 
prostate cancer survivor’s reporting on their personal experiences. An example video about men’s 
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experience with sexual difficulties can been viewed via this link: 
http://www.myroadahead.org/module/four/page/3. 
How do men participate? 
To participate, men simply log in to the following website: www.myroadahead.org 
 
How has this program been funded? 
beyondblue and the Prostate Cancer Foundation of Australia have funded this program.  
 
Who are the researchers? 
Chief Investigator: 
x Dr Addie Wootten, Department of Urology, Royal Melbourne Hospital and the Australian 
Prostate Cancer Research Centre at Epworth 
 
Co-Investigators: 
x Ms Katherine Chisholm, Department of Psychology; Deakin University 
x Professor Marita McCabe, Department of Psychology; Deakin University 
x Dr Jo Abbott, National eTherapy Centre; Swinburne University of Technology 
x A/Prof Britt Klein, National eTherapy Centre; Swinburne University of Technology 
x A/Prof David Austin, National eTherapy Centre; Swinburne University of Technology 
x Professor Anthony Costello, Department of Urology, Royal Melbourne Hospital and the 
Australian Prostate Cancer Research Centre at Epworth 
x A/Prof Declan Murphy, Department Robotic Surgery, Peter MacCallum Cancer Centre and 
the Australian Prostate Cancer Research Centre at Epworth 
 
Further Information 
Dr Addie Wootten 
Email: myroadaheadhelp@gmail.com 
Telephone: (03) 9936 8032 
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Post card sized flyer 
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Appendix G: Advertising on Beyond Blue 
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Programs and projects 
Improving awareness of depression and anxiety amongst men is a key priority for 
beyondblue. Many of beyondblue's programs and services include a significant focus 
on the particular needs of men. These include: 
Online support program for men after treatment for prostate cancer NEW! 
 
Men who have received treatment for prostate cancer in the last 
5 years are invited to take part in a study investigating the 
benefits of a newly developed online support program called 
My Road Ahead. If you would like to learn more about this 
please go to www.myroadahead.org 
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Appendix H: Questionnaire 
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Demographics and Background Questions 
How did you hear about or find this program? 
o Doctor or other health professional  
o Friend or family member 
o Advertisement  
o Support group  
o Surfing on the internet  
o Media (TV, radio, magazine, newspaper) 
o Other: Please specify 
ABOUT YOU 
Date of birth:  
Residential postcode: 
Employment status: 
o Full time 
o Part time 
o Casual 
o Retired 
o Student 
o Home duties 
o Disability Support 
o Unemployed 
o Other: Please specify  
Gross annual household income: 
o Less than $20,000 
o Between $20,000 and $50,000 
o Between $50,000 and $75,000 
o Between $75,000 and $125,000 
o Over $125,000 
o Decline to answer  
Education history: 
What is the highest level of education you have achieved? 
o None  
o Primary school 
o High school up to Year 9 
o High school year 10 to year 12 
o TAFE / Trade certificate / skills based training or apprenticeship 
o Other certificate 
o Diploma 
o Undergraduate university degree 
o Postgraduate university degree  
o Other: Please specify 
English Language 
x Is English your first language 
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Please indicated your ethnic background: 
x Anglo-celtic/Caucasian 
o List of countries  
x Asian 
o List of countries  
x African 
o List of countries  
x European 
o List of countries  
Please choose which country you were born in: 
[Full list of countries provided]. 
RELATIONSHIPS 
Sexual orientation:  
o Heterosexual 
o Homosexual  
o Bisexual  
o Transgender or intersex 
Marital status:  
o Married 
o Partner/DeFacto 
o Dating or casual relationship  
o Single  
Duration of relationship:  
o 1 month or less 
o between 1 and 6 months 
o between 6 months and 12 month 
o between 1 year and 5 years 
o between 5 years and 10 years 
o more than 10 years 
DIAGNOSIS 
What was the date of your prostate cancer diagnosis: 
What treatment have you had for your prostate cancer: 
x Radical prostatectomy  
o Date of surgery  
 Open  
 Laparoscopic 
 Robotic  
x Radiotherapy  
o Date 
o Date  
o Date 
x Brachytherapy 
o Date 
x Hormone therapy  
o Date  
x High Intensity Focused Ultrasound (HIFU)  
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o Date 
x Chemotherapy  
o Date 
x Watchful waiting/active surveillance 
 
YOUR HEALTH 
Have you ever been diagnosed with another form of cancer? 
x No  
x Yes – (verbatim response follows) 
 
Do you have any of the following health concerns (yes/no): 
x Diabetes 
x Heart condition  
x Do you take nitrate medication 
x Have you ever been diagnosed with a mental illness 
o Yes  
 Details (space to write) 
x Are you currently taking anti-depressant medication for low mood 
x Have you taken anti-depressant medication for low mood in the past 
o Yes  
 Date 
 
SUPPORT 
Since your diagnosis of prostate cancer, how frequently have you sought support from 
the following: 
x Psychologist  
o How frequently have you accessed this type of support? (open?) 
x Psychiatrist 
o How frequently have you accessed this type of support? (open question) 
x Counselor or relationship counselor 
o How frequently have you accessed this type of support? (open question) 
x Support group  
o How frequently have you accessed this type of support? (open question) 
x The Cancer Council information and support service  
o How frequently have you accessed this type of support? (open question) 
x Other telephone support  
o Please specify: 
o How frequently have you accessed this type of support? (open question) 
x Online support  
o How frequently have you accessed this type of support? (open question) 
x Other: Please specify (open question) 
o How frequently have you accessed this type of support? (open question) 
 
x Since your diagnosis of prostate cancer have you consulted with any of the 
following healthcare practitioners? 
o Urology nurse specialist  
 How frequently have you accessed this type of support? (open 
question) 
o Physiotherapist  
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 How frequently have you accessed this type of support? (open 
question) 
o Sexual rehabilitation specialist/ endocrinologist/ sexual health  
 How frequently have you accessed this type of support? (open 
question) 
 
TREATMENTS 
 
Prior use of erectile function interventions: 
Since your diagnosis of prostate cancer have you received any of the following treatments 
for erectile dysfunction or sexual rehabilitation 
x Oral medications (yes/no) 
o Viagra   
 How frequently have you used this type of treatment ? (Tried it a 
few times and gave up/ On and off/ Regularly) 
 How satisfied have you been with this?  (Low/Moderate/High) 
o Levitra 
 How frequently have you used this type of treatment ? (Tried it a 
few times and gave up/ On and off/ Regularly) 
 How satisfied have you been with this?  (Low/Moderate/High) 
o Cialis 
 How frequently have you used this type of treatment ? (Tried it a 
few times and gave up/ On and off/ Regularly) 
 How satisfied have you been with this?  (Low/Moderate/High) 
x Injection therapies (yes/no) 
o Caverject 
 How frequently have you used this type of treatment ? (Tried it a 
few times and gave up/ On and off/ Regularly) 
 How satisfied have you been with this?  (Low/Moderate/High) 
o Tri- or bi-mix 
 How frequently have you used this type of treatment ? (Tried it a 
few times and gave up/ On and off/ Regularly) 
 How satisfied have you been with this?  (Low/Moderate/High) 
x Vacuum devices (yes/no) 
 How frequently have you used this type of treatment ? (Tried it a 
few times and gave up/ On and off/ Regularly) 
 How satisfied have you been with this?  (Low/Moderate/High) 
x Penile implant devices (yes/no) 
 What date was this surgically implanted: 
 How satisfied have you been with this?  (Low/Moderate/High) 
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MY ROAD AHEAD QUESTIONNAIRE 
Thank you for taking part in My Road Ahead. We would like to know how you are 
going at the moment. We would greatly appreciate it if you could take the time 
to complete the questionnaires. These questionnaires will tell us how you are 
feeling, physically and emotionally and are very important for our research 
evaluating whether My Road Ahead has any benefits for men who took part in 
the program.  
YOUR QUALITY OF LIFE 
(Prostate Cancer QoL Scale) 
These questions ask about how you may feel about urinary problems and how 
they may affect your life. If you have no problems at all in these areas, simply 
circle the number under "not at all." 
How true has each of the following statements been for you during the past 4 
weeks? 
 
URINARY PROBLEMS 
How true has each of the following statements been for you during the past 4 
weeks? 
 
 
Not at 
All 
A Little 
Bit 
Some- 
what 
Quite a 
Bit 
Very 
Much 
1.1 
Leaking urine makes me feel 
dirty. 
1 2 3 4 5 
1.2 I am sometimes embarrassed 
or humiliated because of my 
urinary problems. 
1 2 3 4 5 
1.3 I'm often afraid of having an 
accident and making a mess. 
1 2 3 4 5 
1.4 My urinary problems make me 
feel helpless. 
1 2 3 4 5 
1.5 I feel nervous when I don't 
know where the bathrooms 
are. 
1 2 3 4 5 
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1.6 My urinary problems 
complicate everything I do. 
1 2 3 4 5 
1.7 I avoid situations in which I 
might not be able to get to a 
bathroom in time. 
1 2 3 4 5 
1.8 My urinary problems have 
affected my enjoyment of life. 
1 2 3 4 5 
 
 
SEX 
How true has each of the following statements been for you during the past 4 
weeks? 
 
Not at 
All 
A Little 
Bit 
Some- 
what 
Quite a 
Bit 
Very 
Much 
2.1 Trying to have sex is too 
complicated. 
1 2 3 4 5 
2.2 My sex life feels unnatural to 
me. 
1 2 3 4 5 
2.3 I feel helpless to act on my 
sexual urges. 
1 2 3 4 5 
2.4 When it comes to getting 
close physically, I have to be 
careful not to start something 
I can't finish. 
1 2 3 4 5 
2.5 I am worried that I might 
embarrass myself if I try to 
have sex. 
1 2 3 4 5 
2.6 Thinking about my sex life 
leaves me with an uneasy 
feeling. 
1 2 3 4 5 
2.7 When I hear talk about sex I 
feel like the odd man out. 
1 2 3 4 5 
3.1 I'm confident in my sexual 
ability. 
1 2 3 4 5 
3.2 I am able to enjoy physical 
intimacy. 
1 2 3 4 5 
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3.3 I feel good about my sexuality. 1 2 3 4 5 
3.4 I feel good about the way I 
deal with my own sexual 
needs and desires. 
1 2 3 4 5 
 
RELATIONSHIPS 
The following statements are about your relationship with your spouse or 
partner. 
YOUR PARTNER 
How true has each of the following statements been for you during the past 4 
weeks? 
 
  
 Yes No  
 
Do you have a spouse or a 
partner who is like a spouse 
to you? 
1 2 
o  If NO, go to 
Section FIVE. 
 
Not at 
all 
A little 
bit 
Some-
what 
Quite a 
bit 
Very 
much 
4.1 My spouse or partner seems 
cool and distant from me. 
1 2 3 4 5 
4.2 My partner avoids embracing, 
kissing or caressing me. 
1 2 3 4 5 
4.3 I feel that my spouse or 
partner may want to turn to 
others for affection. 
1 2 3 4 5 
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MANHOOD 
How true has each of the following statements been for you during the past 4 
weeks? 
 
TREATMENT 
How true is each of the following statements for you? 
 
Not at 
All 
A Little 
Bit 
Somew
hat 
Quite a 
Bit 
Very 
Much 
6.1 I am confident that my cancer 
is under control. 
1 2 3 4 5 
6.2 I worry that my cancer might 
come back. 
1 2 3 4 5 
6.3 I worry about my cancer 
spreading. 
1 2 3 4 5 
 Not at All 
A Little 
Bit 
Some-
what 
Quite a 
Bit 
Very 
Much 
5.1 I feel as if I am no longer a 
whole man. 1 2 3 4 5 
5.2 I feel like I've lost part of my 
manhood. 1 2 3 4 5 
5.3 I'm not the man I used to be. 
 
1 2 3 4 5 
5.4 I feel that others think that I'm 
not the man I used to be. 1 2 3 4 5 
5.5 I feel weak and small. 
 
1 2 3 4 5 
5.6 I worry about being compared 
unfavorably to other men. 1 2 3 4 5 
5.7 I feel I have been too 
emotional. 
 
1 2 3 4 5 
5.8 It's hard to think things 
through coolly and logically. 1 2 3 4 5 
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6.4 I wonder whether the 
treatment I got for prostate 
cancer really worked. 
1 2 3 4 5 
6.5 It worries me that I can't tell 
what is going on with my 
prostate cancer. 
1 2 3 4 5 
7.1 I had all the information I 
needed when a treatment was 
chosen for my prostate 
cancer. 
1 2 3 4 5 
7.2 My doctors told me the whole 
story about the effects of the 
treatments. 
1 2 3 4 5 
7.3 I knew the right questions to 
ask my doctor. 
1 2 3 4 5 
7.4 I had enough time to make a 
decision about my treatment. 
1 2 3 4 5 
7.5 I am satisfied with the choices 
I made in treating my prostate 
cancer. 
1 2 3 4 5 
8.1 I wonder if I would have been 
better off with a different 
treatment. 
1 2 3 4 5 
8.2 I sometimes wonder whether 
it was really worthwhile being 
treated at all. 
1 2 3 4 5 
8.3 I sometimes feel the 
treatment I had was the 
wrong one for me. 
1 2 3 4 5 
8.4 If I had to do it over, I would 
choose some other treatment 
1 2 3 4 5 
8.5 I sometimes wish I could 
change my mind about the 
kind of treatment I chose for 
my prostate cancer 
1 2 3 4 5 
9.1 I feel that my cancer has given 
me a better outlook on life. 
1 2 3 4 5 
9.2 I feel that coping with cancer 
has made me a stronger 
person. 
1 2 3 4 5 
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OUTLOOK  
During the past 4 weeks, how much have you felt… 
PSA 
How true has each of the following statements been for you during the past 4 
weeks? 
 
 
 
  
 Not at 
All 
A Little 
Bit 
Some-
what 
Quite a 
Bit 
Very 
Much 
10.1 My health could take a turn 
for the worse at any time. 
1 2 3 4 5 
10.2 I sometimes worry about 
dying before my time. 
1 2 3 4 5 
10.3 I worry about what my doctor 
will find next. 
1 2 3 4 5 
10.4 I worry that changes in my 
medical condition will not be 
detected early. 
1 2 3 4 5 
10.5 I am uneasy about the present 
state of my health. 
1 2 3 4 5 
10.6 I live in fear that my PSA will 
rise. 
1 2 3 4 5 
 Not at 
All 
A Little 
Bit 
Somew
hat 
Quite a 
Bit 
Very 
Much 
11.1 I keep close track of my PSA. 1 2 3 4 5 
11.2 Knowing my PSA level is 
comforting to me. 
1 2 3 4 5 
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YOUR MOOD 
(Depression, Anxiety, Stress Scale) 
Please read each statement and select a number which indicates how much the 
statement applied to you over the past week. There are no right or wrong answers. 
Do not spend too much time on any statement. 
Your Mood - Source: www.psy.unsw.edu.au 
The rating scale is as follows: 
x 0. Did not apply to me at all 
x 1. Applied to me to some degree, or some of the time 
x 2. Applied to me to a considerable degree, or a good part of time 
x 3. Applied to me very much, or most of the time 
 Did not 
apply to me 
at all 
Applied to 
me to some 
degree, or 
some of the 
time 
Applied to 
me to a 
considerable 
degree, or a 
good part of 
time 
Applied to 
me very 
much, or 
most of the 
time 
1. I found it hard to wind 
down. 
1 2 3 4 
2. I was aware of dryness 
of my mouth. 
1 2 3 4 
3. I couldn't seem to 
experience any positive 
feeling at all. 
1 2 3 4 
4. I experienced breathing 
difficulty (eg, excessively 
rapid breathing, 
breathlessness in the 
absence of physical 
exertion) 
1 2 3 4 
5. I found it difficult to 
work up the initiative to 
do things. 
1 2 3 4 
6. I tended to over-react 
to situations. 
1 2 3 4 
7. I experienced trembling 
(eg, in the hands). 
1 2 3 4 
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8. I felt that I was using a 
lot of nervous energy 
1 2 3 4 
9. I was worried about 
situations in which I might 
panic and make 
a fool of myself. 
1 2 3 4 
10. I felt that I had nothing 
to look forward to. 
1 2 3 4 
11. I found myself getting 
agitated. 
1 2 3 4 
12. I found it difficult to 
relax 
1 2 3 4 
13. I felt down-hearted 
and blue 
1 2 3 4 
14. I was intolerant of 
anything that kept me 
from getting on with what 
I was doing. 
1 2 3 4 
15. I felt I was close to 
panic. 
1 2 3 4 
16. I was unable to 
become enthusiastic 
about anything 
1 2 3 4 
17. I felt I wasn't worth 
much as a person. 
1 2 3 4 
18. I felt that I was rather 
touchy. 
1 2 3 4 
19. I was aware of the 
action of my heart in the 
absence of physical 
exertion (eg, sense of 
heart rate increase, heart 
missing a beat). 
1 2 3 4 
20. I felt scared without 
any good reason. 
1 2 3 4 
21. I felt that life was 
meaningless. 
1 2 3 4 
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SEXUAL FUNCTIONING 
(International Index of Erectile Function) 
Please read each statement and indicate how much the statement applied to you 
over the past week by ticking a circle.  There are no right or wrong answers.  Do 
not spend too much time on any statement. Over the past 4 weeks… 
1. How often were you able to get an 
erection during sexual activity? 
0 = No sexual activity 
1 = Almost never/never 
2 = A few times (much less than half the time) 
3 = Sometimes (about half the time) 
4 = Most times (much more than half the time) 
5 = Almost always/always 
2. When you had erections with sexual 
stimulation, how often were your 
erections hard enough for 
penetration? 
 
0 = No sexual activity 
1 = Almost never/never 
2 = A few times (much less than half the time) 
3 = Sometimes (about half the time) 
4 = Most times (much more than half the time) 
5 = Almost always/always 
3. When you attempted sexual 
intercourse, how often were you 
able to penetrate (enter) you 
partner? 
 
0 = Did not attempt intercourse 
1 = Almost never/never 
2 = A few times (much less than half the time) 
3 = Sometimes (about half the time) 
4 = Most times (much more than half the time) 
5 = Almost always/always 
4. During sexual intercourse, how 
often were you able to maintain 
you erection after you had 
penetrated (entered) you partner? 
 
0 = Did not attempt intercourse 
1 = Almost never/never 
2 = A few times (much less than half the time) 
3 = Sometimes (about half the time) 
4 = Most times (much more than half the time) 
5 = Almost always/always 
5. During sexual intercourse, how 
difficult was it to maintain your 
erection to completion of 
intercourse? 
 
0 = Did not attempt intercourse 
1 = Extremely difficult 
2 = Very difficult 
3 = Difficult 
4 = Slightly difficult 
5 = Not difficult 
6. How many times have you 
attempted sexual intercourse? 
 
0 = No attempts 
1 = One to two attempts 
2 = Three to four attempts 
3 = Five to six attempts 
4 = Seven to ten attempts 
5 = Eleven + attempts 
7. When you attempted sexual 
intercourse, how often was it 
satisfactory for you? 
0 = Did not attempt intercourse 
1 = Almost never/never 
2 = A few times (much less than half the time) 
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 3 = Sometimes (about half the time) 
4 = Most times (much more than half the time) 
5 = Almost always/always 
8. How much have you enjoyed sexual 
intercourse? 
0 = No intercourse 
1 = No enjoyment 
2 = Not very enjoyable 
3 = Fairly enjoyable 
4 = Highly enjoyable 
5 = Very highly enjoyable 
9. When you had sexual stimulation or 
intercourse, how often did you 
ejaculate? 
0 = No sexual stimulation/intercourse 
1 = Almost never/never 
2 = A few times (much less than half the time) 
3 = Sometimes (about half the time) 
4 = Most times (much more than half the time) 
5 = Almost always/always 
10. When you had sexual stimulation 
or intercourse, how often did you 
have the feeling of orgasm or 
climax? 
 
0 = No sexual stimulation/intercourse 
1 = Almost never/never 
2 = A few times (much less than half the time) 
3 = Sometimes (about half the time) 
4 = Most times (much more than half the time) 
5 = Almost always/always 
11. How often have you felt sexual 
desire? 
1 = Almost never/ never 
2 = A few times (much less than half the time) 
3 = Sometimes (about half the time) 
4 = Most times (much more than half the time) 
5 = Almost always/always 
12. How would you rate you level of 
sexual desire? 
 
1 = Very low/none at all 
2 = Low 
3 = Moderate 
4 = High 
5 = Very high 
13. How satisfied have you been with 
your overall sex life? 
 
1 = Very dissatisfied 
2 = Moderately dissatisfied 
3 = About equally satisfied and dissatisfied 
4 = Moderately satisfied 
5 = Very satisfied 
14. How satisfied have you been with 
you sexual relationship with your 
partner? 
 
1 = Very dissatisfied 
2 = Moderately dissatisfied 
3 = About equally satisfied and dissatisfied 
4 = Moderately satisfied 
5 = Very satisfied 
15. How do you rate you confidence 
that you could get and keep an 
erection? 
 
1 = Very low 
2 = Low 
3 = Moderate 
4 = High 
5 = Very high 
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ARISING ISSUES & ISSUE DISCUSSION 
(Communications Patterns Questionnaire) 
 Very 
unlikely 
       Very 
likely 
When issues or problems arise, how likely is it that… 
1. Both spouses avoid 
discussing the problem 
1 2 3 4 5 6 7 8 9 
2. Both spouses try to discuss 
the problem 
1 2 3 4 5 6 7 8 9 
3. Female tries to start a 
discussion while males 
tries to avoid a discussion 
1 2 3 4 5 6 7 8 9 
4. Male tries to start a 
discussion while female 
tries to avoid 
1 2 3 4 5 6 7 8 9 
During a discussion of issues or problems, how likely is it that…. 
5. Both spouses express 
feelings to each other 
1 2 3 4 5 6 7 8 9 
6. Both spouses blame, 
accuse, or criticise each 
other 
1 2 3 4 5 6 7 8 9 
7. Both spouses suggest 
possible solutions an 
comprises 
1 2 3 4 5 6 7 8 9 
8. Female pressures, nags, or 
demands while male 
withdraws, becomes 
silent, or refuses to discuss 
the matter further 
1 2 3 4 5 6 7 8 9 
9. Male pressures, nags, or 
demands while female 
withdraws, becomes 
silent, or refuses to discuss 
the matter further 
1 2 3 4 5 6 7 8 9 
10. Female criticises while 
male defends himself 
1 2 3 4 5 6 7 8 9 
11. Male criticises while 
female defends herself 
1 2 3 4 5 6 7 8 9 
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YOUR RELATIONSHIP SATISFACTION 
(Kanas Marital Satisfaction Survey) 
1. How satisfied are you with your relationship? 
o Extremely dissatisfied 
o Very dissatisfied 
o Somewhat dissatisfied 
o Mixed 
o Somewhat Satisfied 
o Very Satisfied 
o Extremely Satisfied 
 
2. How satisfied are you with your partner as a spouse? 
o Extremely dissatisfied 
o Very dissatisfied 
o Somewhat dissatisfied 
o Mixed 
o Somewhat Satisfied 
o Very Satisfied 
o Extremely Satisfied 
 
3. How satisfied are you with your relationship with your partner? 
o Extremely dissatisfied 
o Very dissatisfied 
o Somewhat dissatisfied 
o Mixed 
o Somewhat Satisfied 
o Very Satisfied 
o Extremely Satisfied 
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INTIMACY AND COMMUNICATION 
(Dyadic Sexual Communication Scale) 
Your communication about sex and sexual intimacy. 
Here is a list of statements different people have made about discussing sex with 
their primary partner. Please select how much you agree or disagree with it. 
 
YOUR CONFIDENCE  
I feel confident in most areas of my life. 
o Almost never/never 
o A few times (much less than half the time) 
o Sometimes (about half the time) 
o Most times (much more than half the time) 
o Almost always/always 
 
 
 
 Disagree 
strongly 
Disagree Neutral Agree 
Strongly 
agree 
1 Do you find some sexual matters 
too difficult to discuss with your 
partner? 
 
1 2 3 4 5 
2 Does your partner have difficulty in 
talking to you about what he/she 
likes during sex and sexual 
intimacy? 
 
1 2 3 4 5 
3 Is talking about sex and sexual 
intimacy with your partner fun for 
the both of you. 
 
1 2 3 4 5 
4 Do you find that it is easy for you to 
tell your partner what you do or do 
not like to do during sex? 
 
1 2 3 4 5 
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Post-treatment Questionnaire 
Thank you for taking part in My Road Ahead. We would like to know how you are 
going at the moment. We would greatly appreciate it if you could take the time to 
complete the questionnaires. These questionnaires will tell us how you are feeling, 
physically and emotionally and are very important for our research evaluating 
whether My Road Ahead has any benefits for men who took part in the program.  
SUPPORT 
Since you started the program have you received any other type of psychological or mental 
health support: 
x Psychologist  
o How frequently have you accessed this type of support? (open?) 
x Psychiatrist 
o How frequently have you accessed this type of support? (open question) 
x Counsellor or relationship counsellor 
o How frequently have you accessed this type of support? (open question) 
x Support group  
o How frequently have you accessed this type of support? (open question) 
x The Cancer Council information and support service  
o How frequently have you accessed this type of support? (open question) 
x Other telephone support  
o Please specify: 
o How frequently have you accessed this type of support? (open question) 
x Online support  
o How frequently have you accessed this type of support? (open question) 
x Other: Please specify (open question) 
o How frequently have you accessed this type of support? (open question) 
 
Since commencing this program have you consulted with any of the following healthcare 
practitioners? 
o Urology nurse specialist  
 How frequently have you accessed this type of support? (open 
question) 
o Physiotherapist  
 How frequently have you accessed this type of support? (open 
question) 
o Sexual rehabilitation specialist/ endocrinologist/ sexual health  
 How frequently have you accessed this type of support? (open 
question) 
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TREATMENTS 
 
Prior use of erectile function interventions: 
Since commencing this program have you received any of the following treatments for 
erectile dysfunction or sexual rehabilitation: 
x Oral medications (yes/no) 
o Viagra   
 How frequently have you used this type of treatment ? (Tried it a few 
times and gave up/ On and off/ Regularly) 
 How satisfied have you been with this?  (Low/Moderate/High) 
o Levitra 
 How frequently have you used this type of treatment ? (Tried it a few 
times and gave up/ On and off/ Regularly) 
 How satisfied have you been with this?  (Low/Moderate/High) 
o Cialis 
 How frequently have you used this type of treatment ? (Tried it a few 
times and gave up/ On and off/ Regularly) 
 How satisfied have you been with this?  (Low/Moderate/High) 
x Injection therapies (yes/no) 
o Caverject 
 How frequently have you used this type of treatment ? (Tried it a few 
times and gave up/ On and off/ Regularly) 
 How satisfied have you been with this?  (Low/Moderate/High) 
o Tri- or bi-mix 
 How frequently have you used this type of treatment ? (Tried it a few 
times and gave up/ On and off/ Regularly) 
 How satisfied have you been with this?  (Low/Moderate/High) 
x Vacuum devices (yes/no) 
 How frequently have you used this type of treatment ? (Tried it a few 
times and gave up/ On and off/ Regularly) 
 How satisfied have you been with this?  (Low/Moderate/High) 
x Penile implant devices (yes/no) 
 What date was this surgically implanted: 
 How satisfied have you been with this?  (Low/Moderate/High) 
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Program Satisfaction Questionnaire 
(For those participants who completed the modules aspect of My Road Ahead]) 
Please select the reason(s) why you chose to use this online program:  
x Preference for anonymity 
x Nothing else available 
o Preference for self-help methods of support 
o Financial constraints 
o Convenience factor (travel, time) 
x  Mobility restrictions due to disability or chronic health condition 
x Concerns about possible stigma 
x Curious 
x Other  (Please specify) 
Please rate how satisfied you are with the My Road Ahead program? (1 = not at all Æ 10 = 
extremely satisfied) 
How much did you enjoy using the program (1 = not at all Æ 10 = very much) 
Did you ask your partner to be involved? 
x Not applicable  
x No  
o Please specify why 
x Yes  
o Did you print out or email the partner information sheets for your partner 
 Yes  
 No  
o Did you include your partner in viewing the online information, videos or 
interactive exercises?    
 No  
 Sometimes  
 Frequently  
o Did you complete the offline exercises together 
 No  
 Sometimes  
 Frequently  
o What exercises with your partner did you find the most beneficial  
 Please specify: 
Was My Road Ahead easy to use? (Yes/No) 
How useful did you find the information and exercises provided in My Road Ahead name]? 
(1 = not at all Æ 10 = very useful) 
Would you recommend [insert name] to a friend, colleague or family member with prostate 
cancer? (yes/no) 
If you did not work through the entire My Road Ahead program – what stopped you? 
Please tick as many as apply to you:   
x Nothing – I got what I needed 
x Too busy 
x Too unwell 
x Lack of motivation 
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x Program was boring 
x Program was too difficult to use 
x Program material was too hard to understand 
x The program was not useful 
x Too much text to read 
x Internet Server Provider problems 
x Computer problems 
x Other (please specify)  
Please select any of the following features that would have engaged you more with the 
online program.  
x SMS reminders,  
x Email therapist,  
x Phone therapist,  
x Web cam therapist,  
x Chat room,  
x Conference call with other program participants 
x Face-to-face therapist 
x More use of video 
x More use of audio 
x More online activities 
x Other (please specify) 
 
What was the best part of the program?  
x Please specify:  
What was the worst part of the program?  
x Please specify:  
How could the program be improved?  
x Please specify:  
How many hours per week did you spend on average reading / viewing the content in the 
online program?  
x Please specify:  
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Forum Satisfaction Questionnaire  
(For those participants who completed the forum aspect of My Road Ahead) 
Please rate how satisfied you are with the forum? (1 = not at all Æ 10 = extremely satisfied) 
How much did you enjoy using the forum (1 = not at all Æ 10 = very much) 
Was the forum easy to use? (Yes/No) 
How useful did you find the information posted on the forum by other men with prostate 
cancer (1 = not at all Æ 10 = very useful) 
How useful did you find the information posted on the forum by the moderator? (1 = not at 
all Æ 10 = very useful) 
If you didn’t use the forum much what stopped you from using it more? 
Please tick as many as apply to you:   
x Nothing – I got what I needed 
x Too busy 
x Too unwell 
x Lack of motivation 
x Program was boring 
x Program was too difficult to use 
x Program material was too hard to understand 
x The program was not useful 
x Too much text to read 
x Internet Server Provider problems 
x Computer problems 
x Other (please specify)  
What was the best part of the forum?  
o Please specify:  
What was the worst part of the forum?  
o Please specify:  
How could the forum be improved?  
o Please specify:  
How many minutes per week did you spend on average reading / viewing the content in the 
forum?  
o Please specify:  
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Participant Information and Consent Form 
Royal Melbourne Hospital; Melbourne Health 
Full Project Title: My Road Ahead: An online psychological support 
intervention for men after treatment for localised prostate cancer. 
Principal Researcher:  Dr Addie Wootten 
Associate Researchers: 
Deakin University: Prof Marita McCabe, Miss Katherine Chisholm 
Swinburne University: Dr Jo Abbott, A/Prof David Austin, A/Prof Britt Klein,  
Royal Melbourne Hospital: Prof Anthony Costello, A/Prof Declan Murphy,  
1. Introduction 
You are invited to take part in this research project. This is because you have been 
treated for prostate cancer. The research project is aiming to develop and evaluate 
a psychological support program for men who have been treated for localised 
prostate cancer. This program will be accessible over the internet.  
This Participant Information and Consent Form tells you about the research project. 
It explains the procedures involved. Knowing what is involved will help you decide if 
you want to take part in the research. 
Please read this information carefully. Ask questions about anything that you don’t 
understand or want to know more about. Before deciding whether or not to take 
part, you might want to talk about it with a relative, friend or healthcare worker. 
Participation in this research is voluntary. If you don’t wish to take part, you don’t 
have to. You will receive the best possible care whether you take part or not. 
If you decide you want to take part in the research project, you will be asked to 
sign the consent section. By signing it you are telling us that you: 
x understand what you have read;  
x consent to take part in the research project; 
x consent to participate in the research processes that are described; 
consent to the use of your personal and health information as described 
You will be given a copy of this Participant Information and Consent Form to keep. 
2. What is the purpose of this research project? 
My Road Ahead is an online internet based program that has been initiated by the 
principal investigator, Dr Addie Wootten, in collaboration with a team of researchers 
and clinicians from the Royal Melbourne Hospital, Swinburne University of 
Technology and Deakin University. The research has been funded by beyondblue 
and the Prostate Cancer Foundation of Australia (PCFA). This program is being 
developed because of the known impact that prostate cancer can have on many 
aspects of life including psychologically, emotionally and socially or within 
relationships and aims to offer a self-directed program to help people cope with 
these challenges. 
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There are three phases of this research. You have been invited to take part in 
phase three – a randomised controlled trial of the effectiveness of the online 
program, My Road Ahead.  
Phase one was conducted to develop the program and explore all aspects of the 
content of the program. During phase two feedback was obtained from men who 
had experienced prostate cancer. This phase informed the pilot test conducted in 
phase two about the usability and acceptability of the online program. 
The purpose of this phase of the project is to conduct a randomised controlled trial 
examining the effectiveness of the online program, My Road Ahead, compared to 
My Road Ahead plus a moderated bulletin board and a bulletin board alone. 
Approximately 150 participants will be recruited to this study.  
You have been invited to take part in this study because you have been treated for 
localised prostate cancer in the last five (5) years.  
The My Road Ahead Program: 
The My Road Ahead program has been developed by a group of researchers and 
clinicians who have examined what challenges men face after treatment for 
prostate cancer. After treatment for prostate cancer men have reported 
experiencing challenges such as stress, anxiety, sadness, depression, and changes 
in identity, masculinity, relationships, intimacy and sexuality. Of course, each man 
will experience their own individual responses to prostate cancer but many men 
report some of these challenges. The My Road Ahead program aims to offer a way 
for men to develop their own ways of coping with these challenges and improving 
how they feel, in terms of their emotions and their relationships and connections 
with others.  
The My Road Ahead program is a six (6) module online program that offers a range 
of topics to work through at an individual pace. It is anticipated that each module 
will take about one (1) to two (2) weeks to complete (1-2 hours per week), 
totalling ten (10) weeks across the program. 
 Module 1: Introduction & Relaxation and Stress Management 
 Module 2: Emotions and psychological distress 
 Module 3: Coping with physical changes 
 Module 4: Sexuality and Masculinity 
 Module 5: Sexuality and Intimacy 
 Module 6: Living with uncertainty and planning for the future 
The moderated bulletin board: 
A moderated bulletin board will be hosted on the website. This bulletin board will be 
moderated by a psychologist, or provisional psychologist under supervision, and will 
offer a ‘virtual space’ for participants to ask questions of each other as well as the 
researchers and psychologist. The content of the information displayed on the 
bulletin board will be guided by the types of questions and comments received from 
the participants and will only be moderated in the form of answering questions and 
making sure that all content is not offensive. It will be updated each day (Monday 
to Friday) and accessible across the course of the study. You can use an 
anonymous name when using this bulletin board. 
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3. What does participation in this research project involve? 
This is a randomised controlled trial (RCT) comparing the responses of participants 
randomly assigned to take part in one of three groups:  
Group 1: Participating in the My Road Ahead program 
Group 2: Participating in the My Road Ahead program plus the moderated bulletin 
board 
Group 3: Participating in the moderated bulletin board only (with optional access to 
the My Road Ahead program offered at the end of the study) 
Before allocation to one of the groups all participants will be asked to provide a 
current email address, a password and complete five short online surveys assessing  
 Mood, including stress, anxiety and depression 
 Quality of life including emotional, physical, functional and social  
aspects of quality of life 
 Detailed intimate questions about your sexual functioning 
 Relationship satisfaction 
 Communication styles within your relationship  
 Program satisfaction (groups 1 & 2) 
We anticipate that the questionnaires will take approximately 45 minutes to 
complete.  
Participants in all groups will be asked to complete these questionnaires at three 
(4) time points.  
1. Baseline, after giving your consent to participate in the study (week 1) 
2. At week 10   
3. At week 22  
4.  At 6 months post program 
You will also be asked to complete a brief questionnaire about your mood at the 
midpoint (week 5).  
The first 30 participants to take part in this study will also be asked to undertake a 
brief (20-30 minute) telephone interview. If you are one of the first 30 participants 
you will be invited to provide your telephone number and first name when you 
complete the week 12 questionnaire. If you wish to take part in this interview and 
provide your contact details a researcher will then call you to conduct the telephone 
interview where you will be asked about your experience with the program, any 
difficulties you encountered and any suggestions for improving the program for the 
future.  
Use of the online program will involve engaging in the online program over the 
internet and working through each of the six (6) modules over the 10 weeks of 
access (for 1-2 hours each week). Each module will cover a different topic and 
provide information to you by video, audio, written text and animated diagrams. 
You will be given interactive tasks to complete online while working through the 
program and offline in your everyday life (e.g. communication tasks). There will be 
10 weeks between the start of the first questionnaire and the second questionnaire 
so that if it takes you a bit longer than one module per week you will have time to 
complete all six by the time the second questionnaire is to be completed.  
At the start of each week you will receive a reminder email about where you are up 
to in the program and a reminder to return to the program again if you have not 
yet completed it.  
Use of the moderated bulletin board will involve your logging into the program 
website and accessing the bulletin board, where you can ask questions of the 
psychologist or other men taking part in the study. You can use this bulletin board 
as much or as little as you like. 
You will not be paid for your participation in this research. 
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4. What are the possible benefits? 
We cannot guarantee or promise that you will receive any benefits from this 
project. 
However, the potential benefit of engaging in the study include learning new ways 
of relaxing, communicating or managing incontinence or sexual difficulties as well 
as the benefits often found by people when they explore their own emotional state 
in relation to a distressing experience such as cancer. The program may enable you 
to process some emotions about your prostate cancer experience that you have not 
processed before.  
5. What are the possible risks? 
We do not anticipate any risks of your participation. However, talking about 
emotions and the psychological impact of prostate cancer could potentially highlight 
your own emotions. You will be given support at all times by the research team. 
Referral to alternative free psychological or medical support can be offered if 
required. If after considering the questions you have any concerns or feel 
distressed about the issues raised then please contact the researchers who can 
arrange counselling for you. Dr Addie Wootten, Clinical Psychologist can be 
contacted on (03) 9342 7458 or addie.wootten@mh.org.au If at any point you 
decide you no longer wish to participate in the study you are free to withdraw.  It 
would be appreciated if you give us an opportunity to discuss this with you and to 
gain some feedback from you about your experience in this research; however you 
are not obliged to do so. This could be conducted online or by email.  
6. What if new information arises during this research project? 
During the research project, new information about the risks and benefits of the 
project may become known to the researchers. If this occurs, you will be told about 
this new information. This new information may mean that you can no longer 
participate in this research. If this occurs, the person(s) supervising the research 
will stop your participation. In all cases, you will be offered all available care to suit 
your needs and medical condition. 
7. Are there alternatives to participation? 
You do not have to participate in this research project in order to receive any 
medical care you may require. You do not have to participate in this research 
project in order to receive any medical care you may require. If you require support 
there are a number of options you could consider. The Cancer Council Victoria 
offers a cancer information and support service that can be contacted by calling 13 
11 20.  If you would like to speak with a trained counsellor over the telephone 
Lifeline offers a 24 hour service by calling 13 11 14. If you would like to access 
individual psychological therapy it is best to talk to your GP about obtaining a 
referral to a psychologist in your local area. Alternatively arrangements can be 
made for you to access psychological or psychiatric services through the public 
hospital service in Victoria.  
8. Do I have to take part in this research project? 
Participation in any research project is voluntary. If you do not wish to take part 
you don’t have to. If you decide to take part and later change your mind, you are 
free to withdraw from the project at any stage. 
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Your decision whether to take part or not to take part, or to take part and then 
withdraw, will not affect your routine treatment, your relationship with those 
treating you or your relationship with Royal Melbourne Hospital. 
9. What if I withdraw from this research project? 
If you decide to withdraw from this project, please notify a member of the research 
team by completing a short online exit survey before you withdraw. This notice will 
allow that person or the research supervisor to inform you if there are any health 
risks or special requirements linked to withdrawing.  
10. How will I be informed of the results of this research project? 
A summary of the feedback and outcome of the research will be available for you, 
written in plain language, after the completion of the project.  Information 
contained in the summary will not identify individual participants.  Please contact 
the researchers to obtain this information and the results of the study will also be 
made available on the program website at the conclusion of the study. 
11. What else do I need to know? 
x What will happen to information about me? 
Any identifying information obtained in connection with this project will remain 
confidential.  The type of information collected and stored will include the online 
consent form and questionnaires obtained from you. Information will be kept in 
electronic files stored on the secure server of which can only be accessed by the 
researchers involved in the project.  In any publication or report, information will be 
provided in such a way that you cannot be identified.  Data will be published in 
group format, and if published in individual format (e.g. a quote) it will not identify 
you.  Information will be stored for a period of seven years and then disposed of by 
shredding and electronic deletion.  In this time, we may use the data for other 
research and development purposes but the data would refer to group data and 
would not be identifiable. If the data is used again it will be kept for a further (7) 
years before being destroyed. 
x How can I access my information? 
In accordance with relevant Australian and/or Victorian Privacy and other relevant 
laws you have the right to access the information collected and stored by the 
Researchers about you.  You also have the right to request any information with 
which you disagree be corrected.  Please contact the researchers if you would like 
to access your information. 
x What happens if I am injured as a result of participating in this 
research project? 
If you suffer an injury as a result of participating in this research project, hospital 
care and treatment will be provided by the public health service at no extra cost to 
you if you elect to be treated as a public patient.  
x Is this research project approved? 
The ethical aspects of this research project have been approved by the Human 
Research Ethics Committee of Royal Melbourne Hospital.   
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This project will be carried out according to the National Statement on Ethical 
Conduct in Human Research (2007) produced by the National Health and Medical 
Research Council of Australia. This statement has been developed to protect the 
interests of people who agree to participate in human research studies. 
12. Who can I contact? 
Who you may need to contact will depend on the nature of your query, therefore, 
please note the following: 
For further information: 
If you require further information or if you have any problems concerning this 
project, you can contact the principal researcher.   
Name: Dr Addie Wootten 
Role: Clinical Psychologist 
Telephone: (03) 9342 7458 
Email: addie.wootten@mh.org,au 
For complaints:  
If you have any complaints about any aspect of the project, the way it is being 
conducted or any questions about your rights as a research participant, then you 
may contact   If you have any complaints about any aspect of the project, the way 
it is being conducted or any questions about your rights as a research participant, 
then you may contact either the ethics committee of Royal Melbourne Hospital 
(Reference number: 2010.282) Swinburne University (reference number: To be 
provided once obtained) or Deakin University (reference number: To be provided 
once obtained)..  
Royal Melbourne Hospital: 
Name:  Ms Angela Gray; 
Position: Manager, Human Research Ethics Committee;  
Telephone: (03) 9342 8530. 
 
Swinburne University: 
Research Ethics Officer 
Office of Research and Graduate Studies (H68) 
Swinburne University of Technology 
PO Box 218 
Hawthorn, VIC, 3122 
Telephone: (03) 9214 5218 
Email: resethics@swin.edu.au  
  
Deakin University: 
The Manager, Office of Research Integrity,  
Deakin University, 221 Burwood Highway, Burwood Victoria 3125,  
Telephone: 9251 7129,  
Facsimile: 9244 6581;  
Email: research-ethics@deakin.edu.au  
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13. Consent 
Online Consent Form 
Randomised Controlled Trial 
Version 4, dated 30/01/2012 
 
Full Project Title:  My Road Ahead: An online psychological support intervention 
for men after treatment for localised prostate cancer.  
 
 
 
 
I have read and I understand the Participant Information version 4 dated 
30/01/2012 
I freely agree to participate in this project according to the conditions in the 
Participant Information.  
I have been given the option of printing a copy of the Participant Information and 
Consent Form to keep.  
The researcher has agreed not to reveal my identity and personal details if 
information about this project is published or presented in any public form.   
I understand that if I select “I agree to the study conditions” button located below I 
am giving my consent to participate in this research project without the need for 
my signature.  
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Appendix K: Example pages from the forum 
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Appendix L: Example moderator comments on the forum  
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Example 1 
“Feeling a bit down and low” 
Many men who have prostate cancer and receive treatment often report changes in 
their feelings and emotions. The reactions can vary greatly depending on the 
individual and their circumstances. Does anyone feel like sharing what the prostate 
cancer has been like for them emotionally? 
Example 2 
 “Erectile dysfunction” 
Erectile dysfunction is extremely common for those men who have been treated for 
prostate cancer. There are many different medical aids that are offered to men to 
assist with erectile dysfunction, including Viagra, vacuum pumps, and penile 
implants. Has anyone used these or anything else, and would like to discuss any 
positive or negative outcomes? 
Example 3 
 “Intimacy and relationships” 
I speak regularly to men after they have had treatment for prostate cancer and a 
common problem discussed is the impact that sexual difficulties can have on their 
intimate relationship. Some men talk about not knowing how to be intimate 
anymore and a wall developing between partners. Some single men also speak 
about not knowing how to even consider starting a new relationship because of 
their worries about sexual difficulties. Has anyone experienced changes on their 
relationship or on their confidence in starting a new relationship because of sexual 
difficulties? 
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 Appendix M: Example weekly emails to participants 
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Hello Bruce,  
We hope that this email finds you well. 
Well done for finishing Module 2! We hope that you got something out of this 
module.  
Don’t forget you only have 10 weeks in total and you have had access to My Road 
Ahead for 4 weeks now. Whenever you are ready we suggest you move on to Module 2. 
However you are welcome to look at any of the modules that you think might be of 
interest or relevant to you. 
Also, don’t forget to check out recent posts on the forum. 
Cheers, 
The My Road Ahead Research Team  
If you would like to talk to someone about My Road Ahead or if you are having any 
technical difficulties please email us – myroadaheadhelp@gmail.com OR call (03) 9936 
8032. 
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Appendix N: Assumption testing - Chi-square tests 
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Table 
Chi-square Statistics for 2 x 2 Crosstab Comparisons Referred to in Table 9.3  
Variable 
Modules & 
Modules-plus-
Forum 
Modules & 
Forum 
Modules-plus-
Forum & 
Forum 
Location 0.16 (.693) 0.00 (1.00) 0.16 (.693) 
Prostate cancer treatment    
Radical prostatectomy 0.00 (1.00) 0.00 (1.00) 0.00 (1.00) 
Radiotherapy 0.00 (1.00) 0.53 (.486) 1.45 (.230) 
Hormone therapy 0.00 (1.00) 0.00 (1.00) 0.00 (1.00) 
Active surveillance 0.00 (1.00) 0.00 (1.00) 0.00 (1.00) 
Risk factors reported    
Another cancer 0.00 (1.00) 0.28 (.604) 0.28 (.604) 
Diabetes 0.00 (1.00) 0.00 (1.00) 0.00 (1.00) 
Heart condition 0.53 (.486) 0.00 (1.00) 0.00 (1.00) 
Mental illness 0.00 (1.00) 1.45 (.230) 0.53 (.486) 
Current anti-depressants 0.16 (.693) 3.69 (0.046)* 1.45 (.230) 
Past anti-depressants 0.00 (1.00) 0.00 (1.00) 0.00 (1.00) 
Past support    
Psychologist 0.53 (.486) 2.52 (.105) 0.20 (.660) 
Psychiatrist 0.00 (1.00) 0.00 (1.00) 0.53 (.486) 
Counsellor 0.00 (1.00) 1.45 (.230) 1.45 (.230) 
Support group 0.00 (1.00) 0.00 (1.00) 0.00 (1.00) 
Cancer Council^ 0.00 (1.00) 0.00 (1.00) 0.00 (1.00) 
Telephone 0.00 (1.00) 0.00 (1.00) 0.00 (1.00) 
Online 0.92 (.340) 0.00 (1.00) 0.92 (.340) 
Healthcare practitioners    
Sexual rehabilitation specialist 0.28 (.604) 0.28 (.604) 0.00 (1.00) 
Erectile aids    
Used vacuum devices 0.00 (1.00) 0.00 (1.00) 0.00 (1.00) 
Used penile implants 0.00 (1.00) - 0.00 (1.00) 
Overall used some Tx 1.22 (.269) 0.00 (1.00) 1.22 (.269) 
Note. p values are in parentheses. All chi-square analysis in table used Yate’s Correction for 
Continuity and Fisher’s Exact Test. 
^The Cancer Council Information and Support Service. 
 *p < 0.05 
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Appendix O: Assumption Testing: Chi-square 
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Table 
Chi-square Statistics for 2 x 2 Crosstab Comparisons Referred to in Table 10.1 
Variable Modules & 
Modules-plus-
Forum 
Modules & 
Forum 
Modules-plus-
Forum & 
Forum 
Ethnicity 0.00 (1.00) 0.00 (1.00) 0.00 (1.00) 
Location 0.00 (1.00) 0.00 (1.00) 0.00 (1.00) 
Prostate cancer treatment    
Radical prostatectomy 0.00 (1.00) 0.01 (.444) 0.00 (.483) 
Radiotherapy 0.00 (1.00) 0.82 (.188) 1.65 (.100) 
Hormone therapy 0.00 (1.00) 0.00 (1.00) 0.00 (1.00) 
Active surveillance 0.01 (.462) 0.01 (.444) - 
Risk factors reported    
Another cancer 0.00 (1.00) 0.00 (1.00) 0.00 (1.00) 
Diabetes 0.02 (.580) 0.04 (.569) 0.00 (1.00) 
Heart condition 0.00 (1.00) 0.00 (1.00) 0.00 (1.00) 
Mental illness 0.00 (1.00) - 0.00 (.483) 
Current anti-depressants 0.00 (1.00) 0.82 (.188) 0.61 (.224) 
Past anti-depressants 0.14 (0.598) 0.00 (1.00) 0.01 (.651) 
Past support    
Psychologist 0.00 (1.00) 1.06 (.231) 0.22 (.598) 
Psychiatrist 0.00 (1.00) 0.01 (.444) 0.61 (.224) 
Counsellor - 1.06 (.231) 1.34 (.224) 
Support group 0.00 (1.00) 0.08 (.628) 0.01 (.651) 
Cancer Council^ 0.00 (1.00) 0.00 (1.00) 0.01 (.682) 
Telephone 0.02 (.580) 0.04 (.569) 0.00 (1.00) 
Online 0.14 (.598) 0.00 (1.00) 0.38 (.330) 
Healthcare practitioners   2.82 (.066) 
Urology nurse specialist 0.00 (1.00) 3.12 (0.054) 0.07 (.700) 
Physiotherapist 0.51 (.422) 0.02 (.707) 0.00 (1.00) 
Sexual rehabilitation specialist 0.39 (.483) 1.06 (.231) 0.00 (1.00) 
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Table continued - Chi-square Statistics for 2 x 2 Crosstab Comparisons Referred to in 
Table 10.1 
Erectile aids    
Oral medications 0.00 (1.00) 0.00 (1.00) 0.02 (.700) 
Used vacuum devices 0.00 (1.00) 0.01 (.444) 0.61 (.224) 
Used penile implants 0.00 (1.00) - 0.00 (.483) 
Overall used some Tx 0.00 (1.00) 0.00 (1.00) 0.01 (.682) 
Note. p values are in parentheses. All chi-square analysis in table used Yate’s Correction for 
Continuity and Fisher’s Exact Test. 
 
 
 
